<!DOCTYPE HTML PUBLIC "-//IETF//DTD HTML//EN">
<html xmlns:o='urn:schemas-microsoft-com:office:office' xmlns:x='urn:schemas-microsoft-com:office:excel' xmlns='http://www.w3.org/TR/REC-html40'>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<style>

</style>
<!--[if gte mso 9]>

<![endif]-->
</head>
<body>
	<div id="ctl00_ContentPlaceHolder2_RadGrid1_GridData" class="rgDataDiv" style="overflow-x:auto;overflow-y:auto;width:100%;height:300px;">

<table class=" rgClipCells" id="ctl00_ContentPlaceHolder2_RadGrid1_ctl00" style="width:100%;table-layout:fixed;empty-cells:show;">
	<thead>
		<tr>
			<th scope="col">Trade Name</th><th scope="col">Generic Name</th><th scope="col">Registration No</th><th scope="col">Date Registered</th><th scope="col">Expiry Date</th><th scope="col">Form</th><th scope="col">Categories for Distribution</th><th scope="col">Strength</th><th scope="col">Manufacturers</th><th scope="col">Applicant Name</th><th scope="col">Principal Name</th>
		</tr><tr>
			<td style="white-space:nowrap;"></td><td style="white-space:nowrap;"></td><td style="white-space:nowrap;"></td><td style="white-space:nowrap;">&nbsp;</td><td style="white-space:nowrap;">&nbsp;</td><td style="white-space:nowrap;"></td><td style="white-space:nowrap;">
                                    
                                    
                                </td><td style="white-space:nowrap;"></td><td style="white-space:nowrap;"></td><td style="white-space:nowrap;"></td><td style="white-space:nowrap;"></td>
		</tr>
	</thead><tbody>
	<tr>
		<td>4CS CHILDRENS COUGH AND COLD SYRUP</td><td>DEXTROMETHORPHAN; CHLORPHENIRAMINE MALEATE; PARACETAMOL; PHENYLEPHRINE HYDROCHLORIDE</td><td>76/22.5.5/624</td><td>05/05/1976</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.5; 2; 120; 2.5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>5D</td><td>GLUCOSE</td><td>2016/23.2.1/5251</td><td>09/06/2016</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50G</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED</td>
	</tr><tr>
		<td>ABACAVIR</td><td>ABACAVIR</td><td>2015/7.13/5015</td><td>04/16/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>AUROBINDO PHARMA LTD;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>ABACAVIR SULFATE; LAMIVUDINE</td><td>ABACAVIR SULFATE; LAMIVUDINE</td><td>2018/7.13/5521</td><td>01/11/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 300MG</td><td>AUROBINDO PHARMA LIMITED;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>ABACAVIR SULFATE; LAMIVUDINE</td><td>ABACAVIR SULFATE; LAMIVUDINE</td><td>2018/7.13/5589</td><td>03/15/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120; 60MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ABACAVIR SULPHATE</td><td>ABACAVIR SULPHATE</td><td>2015/7.13/5082</td><td>09/21/2015</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20 MG/ML</td><td>HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE</td><td>ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE</td><td>2021/7.13/6216</td><td>12/15/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 50; 300MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE</td><td>ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE</td><td>2022/7.13/6279</td><td>04/07/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 50; 300 MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ABACAVIR SULPHATE; LAMIVUDINE</td><td>ABACAVIR SULPHATE; LAMIVUDINE</td><td>2024/7.13/6562</td><td>01/31/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120; 60MG</td><td>CIPLA LIMITED;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ABACAVIR SULPHATE; LAMIVUDINE</td><td>ABACAVIR SULPHATE; LAMIVUDINE</td><td>2015/7.13/4973</td><td>01/20/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 300MG</td><td>MYLAN LABORATORIES LTD;  MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ABACAVIR SULPHATE; LAMIVUDINE</td><td>ABACAVIR SULPHATE; LAMIVUDINE</td><td>2015/7.13/5083</td><td>09/07/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 300MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ABACAVIR SULPHATE; LAMIVUDINE</td><td>ABACAVIR SULPHATE; LAMIVUDINE</td><td>2021/7.13/6121</td><td>04/29/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120; 60MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ABACAVIR SULPHATE; LAMIVUDINE</td><td>ABACAVIR SULFATE; LAMIVUDINE</td><td>2019/7.13/5941</td><td>11/08/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 300MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>ABACAVIR/DOLUTEGRAVIR/LAMIVUDINE</td><td>ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60MG/5MG/30MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE</td><td>ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE</td><td>2019/7.13/5944</td><td>11/27/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 50; 300MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ABACAVIR; LAMIVUDINE</td><td>ABACAVIR; LAMIVUDINE</td><td>2024/7.13/6629</td><td>06/06/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 300MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>ABAMAT TABLETS</td><td>ABACAVIR SULPHATE</td><td>2008/7.13/4535</td><td>07/07/2008</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>MYLAN LABORATORIES LTD;  MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ABEVMY - 100</td><td>BEVACIZUMAB</td><td>2021/9.7/6140</td><td>06/14/2021</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG / 4ML</td><td>BIOCON LIMITED;  </td><td>BIOSIMILARS NEWCO LIMITED</td><td>BIOSIMILARS NEWCO LIMITED</td>
	</tr><tr>
		<td>ABEVMY - 400</td><td>BEVACIZUMAB</td><td>2021/9.7/6141</td><td>06/14/2021</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG /16ML</td><td>BIOCON LIMITED;  </td><td>BIOSIMILARS NEWCO LIMITED</td><td>BIOSIMILARS NEWCO LIMITED</td>
	</tr><tr>
		<td>ABHAYRAB</td><td>PURIFIED VERO CELL RABIES </td><td>2017/18.2/5468</td><td>10/31/2017</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5 IU/0.5 ML</td><td>HUMAN BIOLOGICALS INSTITUTE (A DIVISION OF INDIAN IMMUNOLOGICALS LIMITED);  </td><td>HUMAN BIOLOGICALS INSTITUTE</td><td>INDIAN IMMUNOLOGICALS LTD</td>
	</tr><tr>
		<td>ABIRAPRO 500MG</td><td>ABIRATERONE ACETATE</td><td>2025/9.5.2/6800</td><td>01/06/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>GLENMARK PHARMACEUTICALS LIMITED;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>ABZ</td><td>ALBENDAZOLE</td><td>2005/7.7/4364</td><td>04/20/2005</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>400MG</td><td>INDOCO REMEDIES LTD;  </td><td>INDOCO REMEDIES LTD</td><td>INDOCO REMEDIES LTD</td>
	</tr><tr>
		<td>ACCOFIL</td><td>FILGRASTIM</td><td>2024/10.7/6697</td><td>08/29/2024</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MCG/0.5ML</td><td>INTAS PHARMACEUTICALS LIMITED;  </td><td>FINE PHARMACEUTICALS PVT LTD</td><td>INTAS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ACETAZOLAMIDE</td><td>ACETAZOLAMIDE</td><td>94/12.5.1/2869</td><td>09/16/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>ACICLOVIR 200</td><td>ACYCLOVIR</td><td>2001/7.13/3974</td><td>10/22/2001</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ACID COMPONENT HAEMODIALYSIS CONCENTRATE</td><td>ACID COMPONENT HAEMODIALYSIS CONCENTRATE</td><td>92/23.3.2/2616</td><td>04/22/1992</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>210.7; 5.22; 3.56; 9; 6.31G</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>ACIDIC BICARBONATE HAEMODIALYSIS CONCENTRATE SW127A</td><td>CALCIUM CHLORIDE DIHYDRATE; GLACIAL ACETIC CHLORIDE; GLUCOSE MONOHYDRATE; MAGNESIUM CHLORIDE HEXAHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE</td><td>2018/23.3.2/5584</td><td>03/08/2018</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3.558; 5.219; 6.305; 6.432; 38.5; 210.678G</td><td>B.BRAUN AVITUM AG;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>ACIDIC BICARBONATE HAEMODIALYSIS CONCENTRATE SW139A</td><td>CALCIUM CHLORIDE DIHYDRATE; GLACIAL ACETIC CHLORIDE; GLUCOSE MONOHYDRATE; MAGNESIUM CHLORIDE HEXAHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE</td><td>2018/23.3.2/5582</td><td>03/08/2018</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3.558; 5.219; 6.305; 9.010; 38.5; 210.678G</td><td>B.BRAUN AVITUM AG;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>ACIDIC BICARBONATE HAEMODIALYSIS CONCENTRATE SW380A</td><td>CALCIUM CHLORIDE DIHYDRATE; GLACIAL ACETIC CHLORIDE; GLUCOSE MONOHYDRATE; MAGNESIUM CHLORIDE HEXAHYDRATE; POTASSIUM CHLORIDE; SODIUM CHLORIDE</td><td>2018/23.3.2/5583</td><td>03/08/2018</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3.558; 5.219; 6.305; 7.719; 38.5; 210.678G</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  B.BRAUN AVITUM AG;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>ACLOTAS</td><td>ACECLOFENAC</td><td>2015/3.1/5114</td><td>11/13/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>INTAS PHARMACEUTICALS LTD;  INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ACOVIR</td><td>ACYCLOVIR</td><td>2018/7.13/5526</td><td>01/11/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>800MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ACRIPTEGA</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2018/7.13/5737</td><td>11/15/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LAB LTD</td>
	</tr><tr>
		<td>ACTAN</td><td>ALUMINIUM HYDROXIDE</td><td>2019/16.1/5831</td><td>05/10/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>360MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>ACTEMRA 200</td><td>TOCILIZUMAB</td><td>2023/9.6/6489</td><td>10/18/2023</td><td>10/18/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/VIAL</td><td>CHUGAI PHARMA MANUFACTURING CO., LTD (CPMC);  </td><td>ROCHE PRODUCTS</td><td>CHUGAI PHARMA MANUFACTURING CO. LTD</td>
	</tr><tr>
		<td>ACTEMRA 400</td><td>TOCILIZUMAB</td><td>2023/9.6/6490</td><td>10/18/2023</td><td>10/18/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG/VIAL</td><td>CHUGAI PHARMA MANUFACTURING CO., LTD (CPMC);  </td><td>ROCHE PRODUCTS</td><td>CHUGAI PHARMA MANUFACTURING CO. LTD</td>
	</tr><tr>
		<td>ACTEMRA 80</td><td>TOCILIZUMAB</td><td>2023/9.6/6488</td><td>10/18/2023</td><td>10/18/2028</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG/VIAL</td><td>CHUGAI PHARMA MANUFACTURING CO., LTD (CPMC);  </td><td>ROCHE PRODUCTS</td><td>CHUGAI PHARMA MANUFACTURING CO. LTD</td>
	</tr><tr>
		<td>ACTIFED COLD TABLETS</td><td>PSEUDOEPHEDINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE</td><td>78/22.2.5/1111</td><td>06/12/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>30; 1.25MG</td><td>GLAXO R.S.A.(PTY) LTD;  GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD;  </td><td>GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD</td><td>GLAXOSMITHKLINE</td>
	</tr><tr>
		<td>ACTRAPHANE FLEXPEN</td><td>INSULIN HUMAN</td><td>2019/17.6/5891</td><td>06/27/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100 IU/ML</td><td>NOVO NORDISK PRODUCAO;  NOVO NORDISK PHARMACEUTIQUE;  NOVO NORDISK A/S;  NOVO NORDISK  A/S;  NOVO-NORDISK A/S;  </td><td>NOVO NORDISK KENYA LIMITED</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>ACTRAPHANE HM (GE)</td><td>BIO-SYNTHETIC BIPHASIC HUMAN INSULIN</td><td>86/17.6/1984</td><td>07/14/1986</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100IU/ML</td><td>NOVO-NORDISK A/S;  NOVO-NORDISK (PTY) LTD;  NOVO NORDISK PHARMACEUTIQUE;  NOVO NORDISK PHARMACEUTICAL INDUSTRIES INC;  NOVO NORDISK  A/S;  NOVO NORDISK A/S;  NOVO NORDISK PRODUCAO;  TEVA PHARMACEUTICAL WORKS PVT LTD;  </td><td>NOVO NORDISK KENYA LIMITED</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>ACTRAPID FLEXPEN</td><td>INSULIN HUMAN</td><td>2019/17.6/5889</td><td>06/27/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100 IU/ML</td><td>NOVO-NORDISK A/S;  NOVO NORDISK  A/S;  NOVO NORDISK A/S;  NOVO NORDISK PHARMACEUTIQUE;  NOVO NORDISK PRODUCAO;  </td><td>NOVO NORDISK KENYA LIMITED</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>ACTRAPID HM (GE)</td><td>BIO-SYNTHETIC HUMAN SOLUBLE INSULIN</td><td>86/17.6/1980</td><td>08/13/1986</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100 UNITS/ML</td><td>NOVO-NORDISK A/S;  NOVO-NORDISK (PTY) LTD;  NOVO NORDISK PHARMACEUTIQUE;  NOVO NORDISK PHARMACEUTICAL INDUSTRIES INC;  NOVO NORDISK  A/S;  NOVO NORDISK A/S;  TEVA PHARMACEUTICAL WORKS PVT LTD;  NOVO NORDISK PRODUCAO;  </td><td>NOVO NORDISK KENYA LIMITED</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>ACYCLOVIR</td><td>ACYCLOVIR</td><td>2002/7.13/4060</td><td>07/11/2002</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ACYCLOVIR</td><td>ACYCLOVIR</td><td>2002/7.13/4063</td><td>08/07/2002</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ACYCLOVIR</td><td>ACYCLOVIR</td><td>2002/7.13/4059</td><td>07/11/2002</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>5% M/M</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ADALAT XL 30</td><td>NIFEDIPINE</td><td>2017/12.6/5487</td><td>12/05/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>30MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>ADCO LAMIVUDINE</td><td>LAMIVUDINE</td><td>2009/7.13/4578</td><td>11/10/2009</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>ADCO-ACYCLOVIR</td><td>ACYCLOVIR</td><td>2005/7.13/4340</td><td>01/27/2005</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5G</td><td>ADCOCK INGRAM LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>ADCO-AMOXYCILLIN</td><td>AMOXICILLIN</td><td>96/7.1.1/3118</td><td>06/17/1996</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>ADCO-AMOXYCILLIN</td><td>AMOXICILLIN</td><td>97/7.1.1/3265</td><td>10/13/1997</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>ADCO-BETAMETHASONE</td><td>BETAMETHASONE</td><td>2005/14.2.1/4373</td><td>06/17/2005</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG/5G</td><td>ADCOCK INGRAM LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>ADCO-CIMETIDINE</td><td>CIMETIDINE</td><td>96/16.7/3097</td><td>05/29/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200MG</td><td>ADCOCK INGRAMS SA (PTY) LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>ADCO-CIMETIDINE</td><td>CIMETIDINE</td><td>96/16.7/3098</td><td>05/29/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>400MG</td><td>ADCOCK INGRAMS SA (PTY) LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>ADCO-CLOTRIMAZOLE</td><td>CLOTRIMAZOLE</td><td>2006/14.1.3/4425</td><td>05/16/2006</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>50MG/5G</td><td>ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>ADCO-CLOTRIMAZOLE</td><td>CLOTRIMAZOLE</td><td>2006/14.17/4424</td><td>05/16/2006</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>50MG/5G</td><td>ADCOCK INGRAM;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>ADCO-DOL</td><td>CAFFEINE; CODEINE PHOSPHATE; DOXYLAMINE SUCCINATE; PARACETAMOL</td><td>2007/2.2/4484</td><td>03/21/2007</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>450; 45; 5; 10MG</td><td>ADCOCK INGRAM LTD;  DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>ADCO-EFAVIRENZ</td><td>EFAVIRENZ</td><td>2010/7.13/4586</td><td>02/23/2010</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>ADCO-INDOGEL</td><td>INDOMETHACIN</td><td>2001/3.1/4003</td><td>12/17/2001</td><td>12/31/2027</td><td>GEL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>10MG/G</td><td>DATLABS PRIVATE LIMITED;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>ADCO-LINCTOPENT</td><td>BROMHEXINE HYDROCHLORIDE; ORCINOPRENALINE SULPHATE</td><td>2002/22.2.5/4072</td><td>09/22/2002</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5; 4MG</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>ADCO-LOPERAMIDE</td><td>LOPERAMIDE</td><td>2020/16.6/6058</td><td>12/08/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2MG</td><td>ADCOCK INGRAM LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>ADCO-MEFENAMIC ACID</td><td>MEFENAMIC ACID</td><td>2002/2.1/4077</td><td>11/11/2002</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MG/5ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>ADCO-PIROXICAM</td><td>PIROXICAM</td><td>96/3.1/3081</td><td>05/06/1996</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>ADCOCK INGRAMS SA (PTY) LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>ADCO-WINLOMYLON</td><td>NALIDIXIC ACID</td><td>76/7.2.5/745</td><td>09/15/1976</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>ADCOCK INGRAMS SA (PTY) LTD</td><td>STERLING PRODUCTS INTERNATIONAL INC</td>
	</tr><tr>
		<td>ADCO-ZIDOVUDINE</td><td>ZIDOVUDINE</td><td>2010/7.13/4585</td><td>02/23/2010</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>ADDAVEN</td><td>MULTINGREDIENT</td><td>2018/25.1/5610</td><td>05/07/2018</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>540.0MCG; 10.50MCG; 19.79MCG; 102.3MCG; 17.29MCG; </td><td>FRESENIUS KABI NORGE AS;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>ADDCLENA 10</td><td>LENALIDOMIDE</td><td>2022/9.6/6340</td><td>11/01/2022</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>ADDCLENA 15</td><td>LENALIDOMIDE</td><td>2022/9.6/6341</td><td>11/01/2022</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>ADDCLENA 5</td><td>LENALIDOMIDE</td><td>2022/9.6/6339</td><td>11/01/2022</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>ADRENALINE (EPINEPHRINE)</td><td>ADRENALINE ACID TARTRATE</td><td>2019/12.7/5824</td><td>04/23/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG/ML</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA;  </td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td>
	</tr><tr>
		<td>ADRENALINE (EPINEPHRINE) 1MG/1ML  (1:1000) FRESENIUS</td><td>ADRENALINE ACID TARTRATE</td><td>2004/12.7/4266</td><td>05/05/2004</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG/ML</td><td>INTRAMED (PTY) LTD;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>ADRIM-10</td><td>DOXORUBICIN HYDROCHLORIDE</td><td>2002/9.3.2/4046</td><td>05/14/2002</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/5ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>ADRIM-50</td><td>DOXORUBICIN HYDROCHLORIDE</td><td>2002/9.3.2/4047</td><td>05/14/2002</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/25ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>ADULT COUGH MIXTURE</td><td>CAMPHORATED OPIUM TINCTURE</td><td>82/22.2.5/5882</td><td>09/03/1982</td><td>12/31/2027</td><td>MIXTURE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>6.25 %</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AFINITOR</td><td>EVEROLIMUS</td><td>2015/9.7/4995</td><td>03/12/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>NOVARTIS PHARMACEUTICAL MANUFACTURING ;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>AFINITOR</td><td>EVEROLIMUS</td><td>2015/9.7/4993</td><td>03/18/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5 MG</td><td>NOVARTIS PHARMACEUTICAL MANUFACTURING ;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>AFINNITOR</td><td>EVEROLIMUS</td><td>2015/9.7/4994</td><td>03/12/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG</td><td>NOVARTIS PHARMACEUTICAL MANUFACTURING ;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>AFROX COMPRESSED MEDICAL OXYGEN</td><td>OXYGEN</td><td>2014/31/4881</td><td>05/14/2014</td><td>12/31/2027</td><td>GAS; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>99.5% V/V</td><td>BOC ZIMBABWE CORNER;  </td><td>BOC ZIMBABWE CORNER</td><td>BOC ZIMBABWE CORNER</td>
	</tr><tr>
		<td>AFROX LIQUID MEDICAL OXYGEN</td><td>OXYGEN</td><td>2014/31/4882</td><td>05/14/2014</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100%</td><td>BOC ZIMBABWE CORNER;  </td><td>BOC ZIMBABWE CORNER</td><td>BOC ZIMBABWE CORNER</td>
	</tr><tr>
		<td>AFTAPIL 72</td><td>LEVONORGESTREL</td><td>2024/21.2.2/6726</td><td>10/14/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.5MG</td><td>ACDIMA INTERNATIONAL TRADING;  </td><td>PENIEL PHARMACEUTICALS</td><td>ACDIMA INTERNATIONAL TRADING</td>
	</tr><tr>
		<td>AKUROSE</td><td>IRON SUCROSE</td><td>2021/10.1.1/6124</td><td>05/04/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>UNOSOURCE PHARMA LTD</td><td>AKUMS DRUG & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ALBUMARC</td><td>IPRATROPIUM BROMIDE  MONOHYDRATE</td><td>2025/22.1.2/6922</td><td>04/11/2025</td><td>&nbsp;</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MCG/2ML</td><td>MDI PHARMA;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA,</td>
	</tr><tr>
		<td>ALBUMARC</td><td>IPRATROPIUM BROMIDE  MONOHYDRATE</td><td>2025/22.1.2/6921</td><td>04/11/2025</td><td>&nbsp;</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MCG/ML</td><td>MDI PHARMA;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA,</td>
	</tr><tr>
		<td>ALBUNORM </td><td>ALBUMIN</td><td>2019/11.2/5945</td><td>11/27/2019</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20G/100ML</td><td>OCTAPHARMA AG;  </td><td>OCTAPHARMA AG</td><td>OCTAPHARMA AG</td>
	</tr><tr>
		<td>ALBUREL</td><td>ALBUMIN</td><td>2017/11.2/5331</td><td>03/07/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20%</td><td>RELIANCE LIFESCIENCE (PVT) LTD;  </td><td>WMT PHARMACEUTICALS PVT LTD</td><td>RELIANCE LIFESCIENCE (PVT) LTD</td>
	</tr><tr>
		<td>ALDACTONE</td><td>SPIRONOLACTONE</td><td>84/12.5.1/1839</td><td>09/25/1984</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>SEARLE PHARMACEUTICALS;  PFIZER MANUFACTURING;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>ALDROL 10</td><td>DONEPEZIL HYDROCHLORIDE</td><td>2022/13.10/6243</td><td>02/04/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ALDROL 5</td><td>DONEPEZIL HYDROCHLORIDE</td><td>2022/13.10/6242</td><td>02/04/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ALERID-10</td><td>CETIRIZINE HYDROCHLORIDE</td><td>2003/5/4206</td><td>10/20/2003</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ALFOXAN 250</td><td>MEFENAMIC ACID</td><td>91/2.1/2483</td><td>05/23/1991</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>250MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>ALFOXID</td><td>MEFENAMIC ACID</td><td>2001/3.1/3872</td><td>01/04/2001</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/5ML</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>ALFUTOR ER</td><td>ALFUZOSIN HYDROCHLORIDE</td><td>2015/12.3.1/5128</td><td>12/01/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>ALKALINE BICARBONATE HAEMODIALYSIS CONCENTRATE 8.4%</td><td>SODIUM HYDROGEN CARBONATE</td><td>2018/23.3.2/5581</td><td>03/08/2018</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100ML</td><td>B.BRAUN AVITUM AG;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>ALLDOX</td><td>DOXYCYCLINE</td><td>2004/7.2.4/4319</td><td>11/26/2004</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>LINCOLN PHARMACEUTICALS LTD;  </td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td><td>LINCOLN PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ALLERBAN</td><td>CHLORPHENIRAMINE MALEATE</td><td>2022/5/6325</td><td>08/29/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>4MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ALLERBAN SYRUP</td><td>CHLORPHENIRAMINE MALEATE</td><td>2015/5/5087</td><td>11/05/2015</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ALLERCET</td><td>CETIRIZINE HYDROCHLORIDE</td><td>2004/5/4250</td><td>02/16/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>ALLERCROM  </td><td>SODIUM CROMOGLYCATE</td><td>2019/19.9/5827</td><td>05/07/2019</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2.0 %V/V</td><td>FDC LTD;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>ALLERDERM</td><td>HYDROCORTISONE</td><td>95/14.2.1/2942</td><td>06/23/1995</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1% M/M</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>ALLERGEX</td><td>CHLORPHENIRAMINE MALEATE</td><td>2004/5/4307</td><td>09/17/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>4MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>ALLERGEX</td><td>CHLORPHENIRAMINE MALEATE</td><td>2011/5/4681</td><td>05/17/2011</td><td>12/31/2027</td><td>ELIXIR; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2MG/5ML</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LTD;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>ALLERGON</td><td>MEPYRAMINE MALEATE</td><td>91/14.3/2523</td><td>09/04/1991</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>2%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ALLESTOP</td><td>LORATADINE</td><td>2024/5/6580</td><td>04/11/2024</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>5 MG/5ML</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>ALLETECK</td><td>CETIRIZINE HYDROCHLORIDE</td><td>2022/5/6267</td><td>03/17/2022</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>5 MG/5ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS (PVT) LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>ALLOPURINOL</td><td>ALLOPURINOL</td><td>91/3.2/2571</td><td>12/19/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ALLTERA</td><td>LOPINAVIR; RITONAVIR</td><td>2009/7.13/4566</td><td>06/17/2009</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 50MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ALLTERA 50</td><td>LOPINAVIR; RITONAVIR</td><td>2019/7.13/5894</td><td>07/29/2019</td><td>12/31/2027</td><td>POWDER/SATCHETS; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40; 10MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ALMIRAL</td><td>DICLOFENAC SODIUM</td><td>2015/3.1/4975</td><td>01/22/2015</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75 MG/3ML</td><td>MEDOCHEMIE LTD;  </td><td>MEDOCHEMIE LTD</td><td>MEDOCHEMIE LTD</td>
	</tr><tr>
		<td>ALOVIR</td><td>ACYCLOVIR</td><td>2018/7.13/5525</td><td>01/11/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ALPHA GLYCERIN AND ICHTHAMMOL</td><td>GLYCERINE; ICHTHAMMOL</td><td>2024/14.1.4/6606</td><td>05/16/2024</td><td>12/31/2027</td><td>LIQUID</td><td>PHARMACY MEDICINES (P.)</td><td>10%W/W</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>ALPHA METFORMIN</td><td>METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6614</td><td>06/04/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>ALPHA PARACETAMOL</td><td>PARACETAMOL</td><td>2024/2.2/6605</td><td>05/16/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>ALPHA VITAMIN B6</td><td>PYRIDOXINE HYDROCHLORIDE</td><td>2024/24.1.2/6690</td><td>08/23/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>25MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>ALU 80-480</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2021/7.5/6165</td><td>08/23/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80; 480MG</td><td>STRIDES PHARMA SCIENCE LIMITED;  </td><td>STRIDES PHARMA SCIENCE LIMITED</td><td>STRIDES PHARMA SCIENCE LIMITED</td>
	</tr><tr>
		<td>ALUMINIUM HYDROXIDE; MAGNESIUM HYDROXIDE; SIMETHICONE</td><td>ALUMINIUM HYDROXIDE, MAGNESIUM HYDROXIDE; SIMETHICONE</td><td>2023/16.1/6472</td><td>08/30/2023</td><td>08/30/2028</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>400; 318.4; 50 MG/10ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>AMALAR</td><td>PYRIMETHAMINE; SULFADOXINE</td><td>2000/7.5/3802</td><td>11/15/2000</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>500; 25MG</td><td>BROWN &amp; BURK PHARM PVT LTD;  MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>AMBRAL</td><td>METRONIDAZOLE</td><td>83/7.6/1685</td><td>03/22/1983</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AMBRAL</td><td>METRONIDAZOLE</td><td>84/7.6/1787</td><td>03/09/1984</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AMILODIPINE 10 MG</td><td>AMLODIPINE</td><td>2019/12.6/5884</td><td>06/12/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>SAI MIRRA INNOPHARM PVT LTD;  </td><td>N2SA LIMITED</td><td>N2SA LIMITED</td>
	</tr><tr>
		<td>AMILORIDE</td><td>AMILORIDE HYDROCHLORIDE</td><td>93/12.5.1/2750</td><td>01/12/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AMINOPHYLLINE</td><td>AMINOPHYLLINE</td><td>83/22.1.1/1717</td><td>06/14/1983</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AMIODARONE HYDROCHLORIDE</td><td>AMIODARONE</td><td>2024/12.2/6724</td><td>10/14/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>UNISON PHARMACEUTICALS PVT LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>AMIODARONE HYDROCHLORIDE</td><td>AMIODARONE</td><td>2024/12.2/6725</td><td>10/14/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>UNISON PHARMACEUTICALS PVT LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>AMIROL 25</td><td>AMITRIPTYLINE HYDROCHLORIDE</td><td>2013/13.2.1/4781</td><td>06/24/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25 MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>AMLIN-5</td><td>AMLODIPINE BESYLATE</td><td>2016/12.6/5183</td><td>03/24/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>LINCOLN PHARMACEUTICALS LTD;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>AMLOCOR-10</td><td>AMLODIPINE BESYLATE</td><td>2005/12.6/4378</td><td>07/20/2005</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>AMLOCOR-5</td><td>AMLODIPINE BESYLATE</td><td>2005/12.6/4379</td><td>07/20/2005</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>AMLO-DA 10</td><td>AMLODIPINE</td><td>2024/12.6/6753</td><td>11/05/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>AMLO-DA 5</td><td>AMLODIPINE</td><td>2024/12.6/6753</td><td>11/05/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>AMLODIPAC 10</td><td>AMLODIPINE</td><td>2020/12.6/6033</td><td>09/02/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>AMLODIPAC 2.5</td><td>AMLODIPINE</td><td>2020/12.6/6031</td><td>09/02/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2.5MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>AMLODIPAC 5</td><td>AMLODIPINE</td><td>2020/12.6/6032</td><td>09/02/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>AMLODIPINE BESILATE</td><td>AMLODIPINE BESYLATE</td><td>2013/12.6/4811</td><td>11/04/2013</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>KOPRAN LTD;  </td><td>KOPRAN LTD</td><td>KOPRAN LTD</td>
	</tr><tr>
		<td>AMLOPRES-5</td><td>AMLODIPINE BESYLATE</td><td>2011/12.6/4704</td><td>09/08/2011</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>CIPLA LTD;  CIPLA LIMITED (GOA UNIT VII);  CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>AMLOSIN 10</td><td>AMLODIPINE BESYLATE</td><td>2014/12.6/4859</td><td>03/06/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>AMLOSIN 5</td><td>AMLODIPINE BESYLATE</td><td>2014/12.6/4858</td><td>03/06/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>AMLOTEL</td><td>AMLODIPINE; TELMISARTAN</td><td>2017/12.3.5/5451</td><td>10/17/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 80MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>AMLOTEL</td><td>AMLODIPINE; TELMISARTAN</td><td>2017/12.3.5/5453</td><td>10/18/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 80MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AMLOTEL</td><td>AMLODIPINE; TELMISARTAN</td><td>2017/12.3.5/5452</td><td>10/17/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 40MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>AMLOTEL</td><td>AMLODIPINE; TELMISARTAN</td><td>2017/12.3.5/5450</td><td>10/18/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 40MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>AMLOVAL 80/5</td><td>AMLODIPINE BESYLATE; VALSARTAN</td><td>2022/12.3.5/6285</td><td>06/03/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 80MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>AMLOVAL160/5</td><td>AMLODIPINE; VALSARTAN</td><td>2022/12.3.5/6286</td><td>06/03/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 160MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>AMLOVAR</td><td>AMLODIPINE BESYLATE</td><td>2016/12.3.5/5161</td><td>01/27/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>AMLOVAR</td><td>AMLODIPINE BESYLATE</td><td>2016/12.3.5/5160</td><td>01/27/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>AMLOVASC 10</td><td>AMLODIPINE BESYLATE</td><td>2016/12.3.5/5166</td><td>02/02/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10 MG</td><td>HETERO LABS LTD,;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AMLOVASC 5</td><td>AMLODIPINE BESYLATE</td><td>2016/12.3.5/5165</td><td>02/02/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>HETERO LABS LTD,;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AMLOZOR 5</td><td>AMLODIPINE BESYLATE</td><td>2024/12.6/6704</td><td>09/27/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>KOPRAN LTD;  </td><td>ZORWAY EXIM PVT LTD</td><td>ZORWAY EXIM PVT LTD</td>
	</tr><tr>
		<td>AMOCILLIN</td><td>AMOXICILLIN</td><td>82/7.1.1/1545</td><td>03/13/1982</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AMOCILLIN</td><td>AMOXICILLIN</td><td>86/7.1.1/1956</td><td>01/29/1986</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AMOCILLIN</td><td>AMOXICILLIN</td><td>82/7.1.1/1548</td><td>03/15/1982</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AMOCILLIN</td><td>AMOXICILLIN</td><td>86/7.1.1/1955</td><td>01/29/1986</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AMOXEN</td><td>AMOXICILLIN</td><td>98/7.1.1/3324</td><td>04/07/1998</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>AMOXEN</td><td>AMOXICILLIN</td><td>92/7.1.1/2748</td><td>02/15/1993</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  MILAN LABORATORIES (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>AMOXEN</td><td>AMOXICILLIN</td><td>92/7.1.1/2747</td><td>02/15/1993</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  MILAN LABORATORIES (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>AMOXEN</td><td>AMOXICILLIN</td><td>95/7.1.1/2920</td><td>05/02/1995</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>AMOXEN</td><td>AMOXICILLIN</td><td>96/7.1.1/3088</td><td>05/17/1996</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>AMOXYCILLIN</td><td>AMOXICILLIN</td><td>2004/7.1.1/4283</td><td>07/01/2004</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125 MG/5ML</td><td>MEDICAMEN BIOTECH LIMITED;  </td><td>MEDICAMEN BIOTECH LIMITED</td><td>MEDICAMEN BIOTECH LIMITED</td>
	</tr><tr>
		<td>AMPHO-B</td><td>AMPHOTERICIN B</td><td>2021/7.12/6098</td><td>02/08/2021</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>AMPHONEX</td><td>AMPHOTERICIN B</td><td>2024/7.12/6687</td><td>08/19/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>BHARAT SERUMS AND VACCINES LIMITED;  </td><td>BHARAT SERUMS AND VACCINES LIMITED</td><td>BHARAT SERUMS AND VACCINES LIMITED</td>
	</tr><tr>
		<td>AMPHOTRET</td><td>AMPHOTERICIN B</td><td>2015/7.12/5089</td><td>01/05/2015</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>BHARAT SERUMS &amp; VACCINES LTD;  </td><td>BHARAT SERUMS & VACCINES LTD</td><td>BHARAT SERUMS & VACCINES LTD</td>
	</tr><tr>
		<td>AMPICILLIN FRESENIUS</td><td>AMPICILLIN SODIUM</td><td>2010/7.1.1/4637</td><td>07/27/2010</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>SANDOZ AG, NUREMBERG;  SANDOZ GMBH;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>AMPICILLIN SODIUM</td><td>AMPICILLIN SODIUM</td><td>2001/7.1.1/3993</td><td>12/05/2001</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG/VIAL</td><td>UMEDICA LABORATORIES PVT. LTD;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>AMPICILLIN SODIUM  INJECTION</td><td>AMPICILLIN SODIUM</td><td>2012/7.1.1/4745</td><td>09/05/2012</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>KARNATAKA ANTIB &amp; PHARMA LTD;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AMPOFER</td><td>&nbsp;</td><td>2025/10.1/6875</td><td>02/26/2025</td><td>02/25/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>AMUCO 200</td><td>ACETYLCYSTEINE</td><td>2024/22.2.4/6632</td><td>06/06/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>NEUTEC ILAC;  </td><td>AUSTELL PHARMACEUTICALS (PTY) LTD</td><td>AUSTELL PHARMACEUTICALS (PTY) LTD</td>
	</tr><tr>
		<td>AMUCO 600</td><td>ACETYLCYSTEINE</td><td>2024/22.2.4/6633</td><td>06/06/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>NEUTEC ILAC;  </td><td>AUSTELL PHARMACEUTICALS (PTY) LTD</td><td>AUSTELL PHARMACEUTICALS (PTY) LTD</td>
	</tr><tr>
		<td>ANAEROBYL GOLD 200</td><td>METRONIDAZOLE</td><td>99/7.6/3505</td><td>04/08/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>SEARLE DIVISION OF MONS.ANTO P/L;  </td><td>MULLER & PHIPPS</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>ANAEROBYL GOLD 400</td><td>METRONIDAZOLE</td><td>99/7.6/3506</td><td>04/08/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>MULLER & PHIPPS</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>ANATERO</td><td>ANASTROZOLE</td><td>2014/9.5.2/4900</td><td>06/25/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1 MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ANDOLEX C SPRAY</td><td>BENZYDAMINE HYDROCHLORIDE; CHLORHEXIDINE GLUCONATE</td><td>2015/20.3.4/4974</td><td>01/22/2015</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>22.5; 18 MG/15 ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  TECHNIKON LABORATORIES (PTY) LTD;  ENSIGN LABORATIES LTD;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>ANDOLEX SOLUTION</td><td>BENZYDAMINE HYDROCHLORIDE</td><td>98/20.3.6/3302</td><td>02/05/1998</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>22.5MG/15ML</td><td>ALLIANCE PHARMA (PTY) LIMITED;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  INOVA PHARMACEUTICALS  PTY LTD;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>ANDOLEX-C LOZENGES</td><td>BENZYDAMINE HYDROCHLORIDE</td><td>2000/20.3.5/3746</td><td>07/24/2000</td><td>12/31/2027</td><td>TROCHE/LOZENGE; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>3MG</td><td>UNIQUE PHARMACEUTICAL LABORATORIES;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>ANDOLEX-C ORAL GEL</td><td>BENZYDAMINE HYDROCHLORIDE; CETYLPYRIDINIUM CHLORIDE</td><td>2019/20.3.4/5769</td><td>01/03/2019</td><td>12/31/2027</td><td>GEL</td><td>PHARMACY MEDICINES (P.)</td><td>10; 1MG/G</td><td>ENSIGN LABORATIES LTD;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>ANDOLEX-C ORAL RINSE</td><td>BENZYDAMINE HYDROCHLORIDE; CHLORHEXIDINE GLUCONATE</td><td>99/20.3.4/3526</td><td>05/18/1999</td><td>12/31/2027</td><td>LIQUID</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>95.85; 22.5MG</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  ENSIGN LABORATIES LTD;  TECHNIKON LABORATORIES (PTY) LTD;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>ANDROZ</td><td>SILDENAFIL</td><td>2017/31/5485</td><td>11/29/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>ANOMEX</td><td>HYDROCORTISONE ACETATE: LIDOCAINE: ZINC OXIDE: ALLANTOIN</td><td>2021/16.3/6209</td><td>11/22/2021</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.5; 0.25; 3.0; 5.0%W/W</td><td>BLISS GVS PHARMA LIMITED;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>ANTALGIC</td><td>PARACETAMOL</td><td>93/2.1/2794</td><td>06/04/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ANTALGIC</td><td>PARACETAMOL</td><td>75/2.1/518</td><td>08/18/1975</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ANTALGIC</td><td>PARACETAMOL</td><td>83/2.1/1663</td><td>02/02/1983</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ANTALGIC PAEDITRIC</td><td>PARACETAMOL</td><td>92/2.1/2657</td><td>05/29/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>125MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ANTHEL</td><td>ALBENDAZOLE</td><td>2007/7.7/4486</td><td>05/08/2007</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>400MG</td><td>LINCOLN PHARMACEUTICALS LTD;  </td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td><td>LINCOLN PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ANTI-THYROX</td><td>CARBIMAZOLE</td><td>2021/17.8.2/6169</td><td>09/01/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ANUSAPP</td><td>BISMUTH SUBGALLATE; PERU BALSAM; ZINC OXIDE</td><td>2022/16.3/6264</td><td>03/17/2022</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>60;50; 280 MG</td><td>SAPPS PHARMACEUTICALS;  </td><td>SAPPS PHARMACEUTICALS</td><td>SAPPS PHARMACEUTICALS</td>
	</tr><tr>
		<td>ANUSOL</td><td>BISMUTH OXIDE; BISMUTH SUBGALLATE; PERUBALSAM; ZINC OXIDE</td><td>98/16.3/3450</td><td>10/12/1998</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>24; 59; 49; 296MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>MDI HEALTHCARE</td><td>MDI HEALTHCARE</td>
	</tr><tr>
		<td>ANUSOL</td><td>BISMUTH OXIDE; BISMUTH SUBGALLATE; PERUBALSAM; ZINC OXIDE</td><td>77/16.3/825</td><td>01/19/1977</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>8.75; 22.5; 18.75; 107.5MG</td><td>LABORATOIRES M RICHARD;  DELPHARM ORLEANS;  </td><td>MDI HEALTHCARE</td><td>MDI HEALTHCARE</td>
	</tr><tr>
		<td>ANZAVIR-R</td><td>ATAZANAVIR SULPHATE; RITONAVIR</td><td>2013/7.13/4777</td><td>06/30/2013</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 100 MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>APO-ACETAZOLAMIDE</td><td>ACETAZOLAMIDE</td><td>91/19.7/2457</td><td>04/16/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>APOTEX INC.;  </td><td>AA PHARMA INC</td><td>AA PHARMA INC</td>
	</tr><tr>
		<td>APO-ACYCLOVIR</td><td>ACYCLOVIR</td><td>99/7.13/3523</td><td>05/18/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>APOTEX INC.;  </td><td>APOTEX INC.</td><td>APOTEX INC.</td>
	</tr><tr>
		<td>APO-AMITRIPTYLINE</td><td>AMITRIPTYLINE HYDROCHLORIDE</td><td>91/13.2.1/2474</td><td>04/25/1991</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>APOTEX INC.;  </td><td>APOTEX INC.</td><td>APOTEX INC.</td>
	</tr><tr>
		<td>APO-BROMAZEPAM</td><td>BROMAZEPAM</td><td>99/13.2.2/3518</td><td>05/13/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3MG</td><td>APOTEX INC.;  </td><td>APOTEX INC.</td><td>APOTEX INC.</td>
	</tr><tr>
		<td>APO-BROMOCRIPTINE</td><td>BROMOCRIPTINE MESYLATE</td><td>99/17.10.2/3517</td><td>05/13/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>APOTEX INC.;  </td><td>AA PHARMA INC</td><td>AA PHARMA INC</td>
	</tr><tr>
		<td>APO-CARBAMAZEPINE</td><td>CARBAMAZEPINE</td><td>90/13.1/2335</td><td>03/07/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>APOTEX INC.;  </td><td>APOTEX INC.</td><td>APOTEX INC.</td>
	</tr><tr>
		<td>APO-HYDRALAZINE</td><td>HYDRALAZINE HYDROCHLORIDE</td><td>93/12.3.1/2769</td><td>03/12/1993</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>APOTEX INC.;  </td><td>APOTEX INC.</td><td>APOTEX INC.</td>
	</tr><tr>
		<td>APO-ISDN</td><td>ISOSORBIDE DINITRATE</td><td>91/12.1/2451</td><td>04/23/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>APOTEX INC.;  </td><td>AA PHARMA INC</td><td>AA PHARMA INC</td>
	</tr><tr>
		<td>APO-LORAZEPAM</td><td>LORAZEPAM</td><td>90/13.2.2/2339</td><td>03/06/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.0MG</td><td>APOTEX INC.;  </td><td>APOTEX INC.</td><td>APOTEX INC.</td>
	</tr><tr>
		<td>APO-NAPROXEN 250MG</td><td>NAPROXEN</td><td>90/3.1/2349</td><td>03/09/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>&nbsp;</td><td>250MG</td><td>APOTEX INC.;  </td><td>APOTEX INC.</td><td>APOTEX INC.</td>
	</tr><tr>
		<td>APO-TRIFLUOPERAZINE</td><td>TRIFLUOPERAZINE HYDROCHLORIDE</td><td>90/13.2.3/2325</td><td>03/07/1990</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>APOTEX INC.;  </td><td>AA PHARMA INC</td><td>AA PHARMA INC</td>
	</tr><tr>
		<td>APO-TRIHEX</td><td>TRIHEXYPHENIDYL HYDOROCHLORIDE (BENZHEXOL)</td><td>91/13.4/2449</td><td>04/16/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>APOTEX INC.;  </td><td>AA PHARMA INC</td><td>AA PHARMA INC</td>
	</tr><tr>
		<td>APRETUDE</td><td>CABOTEGRAVIR (AS SODIUM)</td><td>2022/7.13/6301</td><td>07/06/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG</td><td>GLAXO OPERATIONS UK LTD;  </td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td>
	</tr><tr>
		<td>APRETUDE</td><td>CABOTEGRAVIR (AS SODIUM)</td><td>2022/7.13/6302</td><td>07/06/2022</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600 MG/3ML </td><td>GLAXO OPERATIONS UK LTD;  </td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td>
	</tr><tr>
		<td>APRITANT IV</td><td>FOSAPREPITANT DIMEGLUMINE</td><td>2018/16.2/5703</td><td>10/01/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/VIAL</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>AQUASIN TABLETS</td><td>FUROSEMIDE</td><td>78/12.5.1/1013</td><td>02/28/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>AQUEOUS CREAM BP</td><td>EMULSIFYING WAX; LIQUID PARFFIN; PARAFFIN SOFT WHITE</td><td>82/14.14/5874</td><td>01/19/1982</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>9; 6; 16%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ARCHIFAR</td><td>MEROPENEM</td><td>2023/7.2.5/6467</td><td>08/18/2023</td><td>08/18/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>MEDOCHEMIE LTD FACTORY C;  </td><td>MEDOCHEMIE LTD</td><td>MEDOCHEMIE LTD</td>
	</tr><tr>
		<td>ARCHIFAR</td><td>MEROPENEM</td><td>2023/7.2.5/6468</td><td>08/18/2023</td><td>08/18/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>MEDOCHEMIE LTD FACTORY C;  </td><td>MEDOCHEMIE LTD</td><td>MEDOCHEMIE LTD</td>
	</tr><tr>
		<td>ARIMIDEX</td><td>ANASTROZOLE</td><td>99/9.5.2/3636</td><td>12/09/1999</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1 MG</td><td>ZENECA INC.;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>ARIP MT10</td><td>ARIPIPRAZOLE</td><td>2023/13.2.3/6515</td><td>11/21/2023</td><td>11/21/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>ARIP MT15</td><td>ARIPIPRAZOLE</td><td>2023/13.2.3/6516</td><td>11/21/2023</td><td>11/21/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>ARIPIPRAZOLE</td><td>ARIPIPRAZOLE</td><td>2024/13.2.3/6791</td><td>12/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>KARLADE GLOBAL DMCC </td><td>KARLADE GLOBAL DMCC </td>
	</tr><tr>
		<td>ARIPIPRAZOLE</td><td>ARIPIPRAZOLE</td><td>2024/13.2.3/6792</td><td>12/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>KARLADE GLOBAL DMCC </td><td>KARLADE GLOBAL DMCC </td>
	</tr><tr>
		<td>ARIPRIPAZOLE</td><td>ARIPIPRAZOLE</td><td>2024/13.2.3/6790</td><td>12/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>KARLADE GLOBAL DMCC </td><td>KARLADE GLOBAL DMCC </td>
	</tr><tr>
		<td>ARTACIL</td><td>ATRACURIUM BESYLATE</td><td>2021/1.3/6136</td><td>05/31/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25; 2.5MG/ML</td><td>NEON LABORATORIES LIMITED;  </td><td>WMT PHARMACEUTICALS PVT LTD</td><td>NEON LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ARTECAP</td><td>ARTESUNATE</td><td>2018/7.5/5631</td><td>06/08/2018</td><td>12/31/2027</td><td>CAPSULES RECTAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>STRIDES ARCOLAB LTD;  </td><td>STRIDES ARCOLAB LTD</td><td>STRIDES ARCOLAB LTD</td>
	</tr><tr>
		<td>ARTEFAN</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2015/7.5/5112</td><td>11/13/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20; 120MG</td><td>AJANTA PHARMA;  </td><td>AJANTA PHARMA LTD</td><td>AJANTA PHARMA</td>
	</tr><tr>
		<td>ARTEFAN </td><td>ARTEMETHER; LUMEFANTRINE</td><td>2018/7.5/5595</td><td>04/05/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>80; 480MG</td><td>AJANTA PHARMA;  </td><td>AJANTA PHARMA</td><td>AJANTA PHARMA</td>
	</tr><tr>
		<td>ARTEFAN 40/240</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2018/7.5/5596</td><td>04/05/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>40; 240MG</td><td>AJANTA PHARMA;  </td><td>AJANTA PHARMA</td><td>AJANTA PHARMA</td>
	</tr><tr>
		<td>ARTEFAN DISPERSIBLE</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2015/7.5/5132</td><td>12/08/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120MG</td><td>AJANTA PHARMA;  </td><td>AJANTA PHARMA LTD</td><td>AJANTA PHARMA LTD</td>
	</tr><tr>
		<td>ARTEMAX</td><td>ARTESUNATE</td><td>98/7.5/3394</td><td>07/30/1998</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>GUILIN PHARMACEUTICAL WORKS;  </td><td>HAEMOTECH PVT LTD</td><td>GUILIN PHARMACEUTICAL WORKS</td>
	</tr><tr>
		<td>ARTEMETHER</td><td>ARTEMETHER</td><td>92/7.5/2728</td><td>09/24/1992</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG/ML</td><td>KUNMING PHARM FACTORY;  </td><td>HAEMOTECH PVT LTD</td><td>KUNMING PHARM FACTORY</td>
	</tr><tr>
		<td>ARTESUNATE</td><td>ARTESUNATE</td><td>2021/7.5/6155</td><td>07/27/2021</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ARTESUNATE; AMODIAQUINE HYDROCHLORIDE WINTHROP</td><td>ARTESUNATE; AMODIAQUINE HYDROCHLORIDE</td><td>2013/7.5/4808</td><td>10/29/2013</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>25; 67.5MG</td><td>MAPHAR LABORATORIES;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>ARTESUNATE; AMODIAQUINE HYDROCHLORIDE WINTHROP</td><td>ARTESUNATE; AMODIAQUINE HYDROCHLORIDE</td><td>2013/7.5/4809</td><td>10/29/2013</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 135MG</td><td>MAPHAR LABORATORIES;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>ARTESUNATE; AMODIAQUINE HYDROCHLORIDE WINTHROP</td><td>ARTESUNATE; AMODIAQUINE HYDROCHLORIDE</td><td>2013/7.5/4810</td><td>10/29/2013</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100; 270MG</td><td>MAPHAR LABORATORIES;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>ARTHREXIN</td><td>INDOMETHACIN</td><td>92/3.1/2610</td><td>04/09/1992</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  FABBRICA ITALIANA SINTETICI S.P.A VIALE MILANO;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>ASALEN</td><td>CAFFEINE; PARACETAMOL; PHENYEPHRINE HYDROCHLORIDE</td><td>78/22.2.5/1094</td><td>05/23/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>15; 150; 5MG</td><td>ADCOCK INGRAMS SA (PTY) LTD;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAMS SA (PTY) LTD</td><td>STERLING PRODUCTS INTERNATIONAL INC</td>
	</tr><tr>
		<td>ASCEPRIB IV 400</td><td>IBUPROFEN</td><td>2024/3.1/6612</td><td>06/11/2024</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG/100ML</td><td>B. BRAUN MEDICAL;  </td><td>ASCENDIS PHARMA (PTY) LTD</td><td>B. BRAUN MEDICAL</td>
	</tr><tr>
		<td>ASCEPRIB IV 600</td><td>IBUPROFEN</td><td>2024/3.1/6613</td><td>06/11/2024</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG/100ML</td><td>B. BRAUN MEDICAL;  </td><td>ASCENDIS PHARMA (PTY) LTD</td><td>B. BRAUN MEDICAL</td>
	</tr><tr>
		<td>ASCORBIC ACID</td><td>ASCORBIC ACID</td><td>90/24.1.3/2383</td><td>08/10/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ASCORBIC ACID</td><td>ASCORBIC ACID</td><td>77/24.1.3/0993</td><td>11/29/1977</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>ASCORBIC ACID</td><td>ASCORBIC ACID</td><td>89/24.1.3/2226</td><td>01/05/1989</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>&nbsp;</td>
	</tr><tr>
		<td>ASCORBIC ACID</td><td>ASCORBIC ACID</td><td>75/24.1.3/465</td><td>04/14/1975</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>ASMANOL</td><td>SALBUTAMOL SULPHATE</td><td>90/22.1.1/2385</td><td>08/10/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>4MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ASMANOL</td><td>SALBUTAMOL SULPHATE</td><td>91/22.1.1/2570</td><td>12/19/1991</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ASMANOL</td><td>SALBUTAMOL SULPHATE</td><td>90/22.1.1/2384</td><td>08/10/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ASMAVENT</td><td>SALBUTAMOL SULPHATE</td><td>2003/22.1.1/4099</td><td>02/16/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ASMAVENT</td><td>SALBUTAMOL SULPHATE</td><td>2003/22.1.1/4100</td><td>02/16/2003</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ASMED</td><td>SALBUTAMOL SULPHATE</td><td>2005/22.1.1/4353</td><td>02/17/2005</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG/5ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>ASMED 4MG TABLETS</td><td>SALBUTAMOL SULPHATE</td><td>2025/22.1.1/6870</td><td>02/13/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>4MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>ASPAVOR 10</td><td>ATORVASTATIN CALCIUM</td><td>2012/12.8/4722</td><td>01/17/2012</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>PFIZER PHARMACEUTICALS LLC;  PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>VIATRIS SOUTH AFRICA (PVT) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>ASPAVOR 20</td><td>ATORVASTATIN CALCIUM</td><td>2012/12.8/4723</td><td>01/18/2012</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20 MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  PFIZER PHARMACEUTICALS LLC;  </td><td>VIATRIS SOUTH AFRICA (PVT) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>ASPAVOR 40</td><td>ATORVASTATIN CALCIUM</td><td>2012/12.8/4724</td><td>01/18/2012</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40 MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  PFIZER PHARMACEUTICALS LLC;  </td><td>VIATRIS SOUTH AFRICA (PVT) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>ASPEN- WARFARIN </td><td>WARFARIN SODIUM</td><td>92/10.2/2609</td><td>04/09/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  COLUMBIA PHARMACEUTICALS (PVT) LTD;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>ASPIRIN</td><td>ASPIRIN</td><td>78/2.8/1051</td><td>03/20/1979</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>300MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ASPIRIN</td><td>ASPIRIN</td><td>89/2.1/2299</td><td>09/15/1989</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>300MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ASPIRIN</td><td>ASPIRIN</td><td>77/2.1/0852</td><td>03/03/1977</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>300MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>ASPIRIN</td><td>ASPIRIN</td><td>76/2.1/464</td><td>04/14/1975</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>300MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>ASPIRIN AND CODEINE PHOSPHATE</td><td>ASPIRIN; CODEINE PHOSPHATE</td><td>5/2.9/512</td><td>12/23/1976</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>400; 8MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>ASPLADIN</td><td>&nbsp;</td><td>2025/10.5/6925</td><td>04/16/2025</td><td>04/15/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ASPOCAN</td><td>POTASSIUM SELENATE; VITAMIN E</td><td>2024/7.12/6705</td><td>09/30/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ASTER 5</td><td>FINASTERIDE</td><td>2021/17.12/6171</td><td>09/03/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>GENEPHARM S.A.;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>ASTHALIN</td><td>SALBUTAMOL SULPHATE</td><td>2009/22.1.2/4553</td><td>03/04/2009</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MCG</td><td>CIPLA LTD;  CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ASTHALIN</td><td>SALBUTAMOL SULPHATE</td><td>2006/22.1.2/4410</td><td>02/21/2006</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>CIPLA LTD;  CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ASTHALIN RESPULES</td><td>SALBUTAMOL SULPHATE</td><td>2008/22.1.2/4531</td><td>04/29/2008</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2.5MG/2.5ML</td><td>CIPLA LTD;  CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ASTHATOR 5</td><td>MONTELUKAST SODIUM</td><td>2015/22.1.1/5127</td><td>12/01/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>ASTHATORIO</td><td>MONTELUKAST SODIUM</td><td>2015/22.1.1/5126</td><td>12/01/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>ASUNRA</td><td>DEFERASIROX</td><td>2016/10.7/5208</td><td>05/17/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400 MG</td><td>NOVARTIS PHARMA STEIN AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>ASUNRA</td><td>DEFERASIROX</td><td>2016/10.7/5209</td><td>05/17/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>NOVARTIS PHARMA STEIN AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA STEIN AG</td>
	</tr><tr>
		<td>ATAZANAVIR SULPHATE ; RITONAVIR</td><td>ATAZANAVIR SULPHATE; RITONAVIR</td><td>2022/7.13/6319</td><td>08/26/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 100MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>ATAZANAVIR SULPHATE ; RITONAVIR</td><td>ATAZANAVIR SULFATE; RITONAVIR</td><td>2024/7.13/6587</td><td>04/12/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 100MG</td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD;  </td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD</td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD</td>
	</tr><tr>
		<td>ATAZANAVIR SULPHATE; RITONAVIR</td><td>ATAZANAVIR SULPHATE; RITONAVIR</td><td>2022/7.13/6312</td><td>07/26/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 100MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>ATAZOR-R</td><td>ATAZANAVIR SULPHATE; RITONAVIR</td><td>2015/7.13/4977</td><td>02/02/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 100 MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ATENOLOL 100</td><td>ATENOLOL</td><td>2002/12.3.2/4051</td><td>05/30/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>ATENOLOL; CHLORTHALIDONE</td><td>ATENOLOL; CHLORTHALIDONE</td><td>2023/12.3.2/6415</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50; 25MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ATENOLOL; CHLORTHALIDONE</td><td>ATENOLOL; CHLORTHALIDONE</td><td>2023/12.3.2/6416</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100; 25MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ATENOLOL-50</td><td>ATENOLOL</td><td>2002/12.3.2/4050</td><td>05/30/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>ATENZ 50</td><td>&nbsp;</td><td>2025/12.3.2/6923</td><td>04/14/2025</td><td>04/13/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>KOPRAN LTD;  </td><td>ZORWAY EXIM PVT LTD</td><td>ZORWAY EXIM PVT LTD</td>
	</tr><tr>
		<td>ATOREM 10</td><td>ATORVASTATIN CALCIUM</td><td>2023/12.8/6422</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>ATOREM 20</td><td>ATORVASTATIN CALCIUM</td><td>2023/12.8/6423</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>ATORSTATIN 20</td><td>ATORVASTATIN</td><td>2021/12.8/6193</td><td>10/07/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>ATRIUM</td><td>ATRACURIUM BESYLATE</td><td>2025/1.3/6881</td><td>02/27/2025</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>SWISS PARENTERALS LTD;  </td><td>SWISS PARENTERAL LTD</td><td>SWISS PARENTERAL LTD</td>
	</tr><tr>
		<td>ATROPINE SULPHATE</td><td>ATROPINE SULPHATE</td><td>2020/13.10/6052</td><td>12/03/2020</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MCG/ML</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED;  </td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td>
	</tr><tr>
		<td>ATROPINE SULPHATE</td><td>ATROPINE SULPHATE</td><td>91/6.2/2505</td><td>06/12/1991</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.6MG/ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>AURONE</td><td>PHENAZONE</td><td>90/20.1.2/2364</td><td>05/27/1990</td><td>12/31/2027</td><td>SOLUTION/DROPS; OTIC</td><td>PHARMACY MEDICINES (P.)</td><td>175 MG/15ML</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>AURONE FORTE</td><td>BENZOCAINE; CHLOROBUTANOL; PHENAZONE</td><td>90/20.1.2/2363</td><td>05/27/1990</td><td>12/31/2027</td><td>SOLUTION/DROPS; OTIC</td><td>PHARMACY MEDICINES (P.)</td><td>150; 150; 750MG</td><td>SAD MEDICATION PTY LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>AUTRIN</td><td>ASCORBIC ACID; CYANOCOBALAMIN;  FERROUS FUMERATE; FOLIC ACID; INTRINSIC FACTOR</td><td>96/10.1.4/3074</td><td>04/03/1996</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>165; 15; 349.755;  2.455; 75MG</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  COLUMBIA PHARMACEUTICALS (PVT) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>AVACIS 10</td><td>CISPLASTIN</td><td>2018/9.4/5566</td><td>02/13/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/10ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVACIS 50</td><td>CISPLASTIN</td><td>2018/9.4/5567</td><td>02/13/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG/50ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVACOLCY</td><td>COLCHICINE</td><td>2025/3.2/6853</td><td>02/04/2025</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.5</td><td>RENATA LIMITED ;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>AVACORT-BF 100/6</td><td>BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE</td><td>2020/22.1.4/6007</td><td>06/29/2020</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100; 6MCG</td><td>ELPEN PHARMACEUTICALS CO. INC;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVACORT-BF 200/6</td><td>BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE</td><td>2020/22.1.4/6008</td><td>06/29/2020</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200; 6MCG</td><td>ELPEN PHARMACEUTICALS CO. INC;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVACORT-BF 400/12</td><td>BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE</td><td>2020/22.1.4/6009</td><td>06/29/2020</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>400;12MCG</td><td>ELPEN PHARMACEUTICALS CO. INC;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVADARC</td><td>DACARBAZINE</td><td>2017/9.1/5498</td><td>12/11/2017</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVADOC 120</td><td>DOCETAXEL</td><td>2018/9.4/5564</td><td>02/08/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120 MG/3ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVADOC 20</td><td>DOCETAXEL</td><td>2018/9.4/5562</td><td>02/08/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/0.5ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVADOC 80</td><td>DOCETAXEL</td><td>2018/9.4/5563</td><td>02/08/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG/2ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVAGEM</td><td>GEMCITABINE</td><td>2017/9.2.2/5497</td><td>12/11/2017</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVAGEM 1G</td><td>GEMCITABINE</td><td>2017/9.2.2/5496</td><td>12/08/2017</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVAPLAT-150</td><td>CARBOPLATIN</td><td>2018/9.4/5598</td><td>04/12/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVAPLAT-450</td><td>CARBOPLATIN</td><td>2018/9.4/5599</td><td>04/12/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>450MG/45ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVASALF 100/50</td><td>FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE</td><td>2020/22.1.4/5972</td><td>02/17/2020</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100; 50MCG</td><td>ELPEN PHARMACEUTICALS CO. INC;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVASALF 250/50</td><td>FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE</td><td>2020/22.1.4/5973</td><td>02/17/2020</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250; 50MCG</td><td>ELPEN PHARMACEUTICALS CO. INC;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVASALF 500/50</td><td>FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE</td><td>2020/22.1.4/5974</td><td>02/17/2020</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500; 50MCG</td><td>ELPEN PHARMACEUTICALS CO. INC;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVASTIN  100</td><td>BEVACIZUMAB</td><td>2016/9.7/5262</td><td>09/09/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>F. HOFFMAN-LA ROCHE LTD;  ROCHE DIAGNOSTICS GMBH;  F. HOFFMAN LA ROCHE LTD;  GENETECH, INC.;  ROCHE DIAGNOSTICS GMBH;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>AVASTIN  400</td><td>BEVACIZUMAB</td><td>2016/9.7/5263</td><td>09/09/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>F. HOFFMAN-LA ROCHE LTD;  ROCHE DIAGNOSTICS GMBH;  F. HOFFMAN LA ROCHE LTD;  GENETECH, INC.;  ROCHE DIAGNOSTICS GMBH;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>AVATOP</td><td>ETOPOSIDE</td><td>2018/9.4/5591</td><td>04/04/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/5ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>AVAXIGA 10</td><td>DAPAGLIFLOZIN</td><td>2024/17.7/6731</td><td>10/17/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>INVENTIA HEALTHCARE PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>AVAXIGA 5</td><td>DAPAGLIFLOZIN</td><td>2024/17.7/6730</td><td>10/17/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>INVENTIA HEALTHCARE PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>AVERTISO</td><td>MISOPROSTOL</td><td>2018/21.6/5752</td><td>12/17/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG</td><td>ACME FORMULATION PVT LTD;  </td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td>
	</tr><tr>
		<td>AVIBELA</td><td>LEVONORGESTREL</td><td>2024/21.2.2/6699</td><td>09/16/2024</td><td>12/31/2027</td><td>INTRAUTERINE DEVICE; INTRAUTERINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>52MG</td><td>ODYSSEA PHARMA SPRL;  </td><td>IMPACT RH360 LLC</td><td>IMPACT RH360 LLC</td>
	</tr><tr>
		<td>AVIGRA 100</td><td>SILDENAFIL CITRATE</td><td>2014/31/4870</td><td>05/02/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>FAREVA AMBOISE;  </td><td>VIATRIS SOUTH AFRICA (PVT) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>AVIGRA 25</td><td>SILDENAFIL CITRATE</td><td>2014/31/4872</td><td>05/02/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25 MG</td><td>FAREVA AMBOISE;  </td><td>VIATRIS SOUTH AFRICA (PVT) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>AVIGRA 50</td><td>SILDENAFIL CITRATE</td><td>2014/31/4871</td><td>05/02/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>FAREVA AMBOISE;  </td><td>VIATRIS SOUTH AFRICA (PVT) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>AVIRANZ</td><td>EFAVIRENZ</td><td>2006/7.13/4407</td><td>02/20/2006</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  SUN PHARMACEUTICAL INDUSTRIES LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>AVOCOMB</td><td>LAMIVUDINE; ZIDOVUDINE</td><td>2003/7.13/4130</td><td>04/16/2003</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150; 300MG</td><td>RANBAXY LABS LTD;  RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>AVONZA</td><td>EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMERATE</td><td>2017/7.13/5401</td><td>07/28/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400; 300; 300MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LAB LTD</td>
	</tr><tr>
		<td>AXCEL ACYCLOVIR</td><td>ACYCLOVIR</td><td>2018/7.13/5726</td><td>11/02/2018</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>5%</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL BETAMETHASONE</td><td>BETAMETHASONE</td><td>2018/14.2.1/5550</td><td>01/30/2018</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1%</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL CHLORPHENIRAMINE</td><td>CHLORPHENIRAMINE MALEATE</td><td>2024/5/6622</td><td>06/05/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>4MG</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL CHLORPHENIRAMINE-2</td><td>CHLORPHENIRAMINE MALEATE</td><td>2023/5/6366</td><td>01/20/2023</td><td>01/20/2028</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>2 MG/5ML</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL FUNGICORT</td><td>HYDROCORTISONE; MICONAZOLE NITRATE</td><td>2022/14.1.3/6311</td><td>07/25/2022</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2%; 1%W/W</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL FUSIDIC ACID</td><td>FUSIDIC ACID</td><td>2017/14.1.1/5355</td><td>04/13/2017</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.1G/100G</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL HYDROCORTISONE</td><td>HYDROCORTISONE</td><td>2023/14.2.1/6374</td><td>02/07/2023</td><td>02/07/2028</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1% W/W</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL LORATIDINE</td><td>LORATIDINE</td><td>2018/5/5558</td><td>02/06/2018</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5MG/5ML</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL MICONAZOLE</td><td>MICONAZOLE NITRATE</td><td>2018/14.1.3/5751</td><td>12/14/2018</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2%</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL NASATAB</td><td>CHLORPHENIRAMINE MALAETE; PARACETAMOL; PSEUDOEPHEDRINE</td><td>2024/22.2.5/6618</td><td>06/05/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>4; 500; 60MG</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL PARACETAMOL</td><td>PARACETAMOL</td><td>2018/2.1/5742</td><td>11/23/2018</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>250MG/5ML</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXCEL PARACETAMOL</td><td>PARACETAMOL</td><td>2024/2.1/6772</td><td>11/25/2024</td><td>12/31/2027</td><td>SYRUP</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>ACCESS PHARMACEUTICALS</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>AXETINE </td><td>CEFUROXIME SODIUM</td><td>2023/7.2.2/6403</td><td>04/21/2023</td><td>04/21/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.5GRAM</td><td>MEDOCHEMIE LTD FACTORY C;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>AXETINE </td><td>CEFUROXIME SODIUM</td><td>2023/7.2.2/6402</td><td>04/21/2023</td><td>04/21/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>750MG</td><td>MEDOCHEMIE LTD FACTORY C;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>AZARGA</td><td>BRINZOLAMIDE; TIMOLOL </td><td>2022/19.10. /6261</td><td>03/09/2022</td><td>12/31/2027</td><td>SUSPENSION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10; 5 MG/ML</td><td>S. A. ALCON-COUVRIER N.V.;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>AZININE</td><td>AZITHROMYCIN DIHYDRATE</td><td>2024/7.2.5/6549</td><td>01/25/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>INDOCO REMEDIES LIMITED;  </td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td><td>KARLADE GLOBAL DMCC </td>
	</tr><tr>
		<td>AZIPRON</td><td>RASAGILINE</td><td>2019/13.4/5928</td><td>09/17/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>AZITHROMYCIN DIHYDRATE</td><td>AZITHROMYCIN DIHYDRATE</td><td>2024/7.2.5/6557</td><td>02/09/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>INDOCO REMEDIES LIMITED;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>AZMANOL HFA INHALATION AEROSOL (SULBUTAMOL SULPHATE BP)</td><td>SALBUTAMOL SULPHATE</td><td>2019/22.1.2/5918</td><td>09/05/2019</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MCG</td><td>BEXIMCO PHARMACEUTICALS LTD;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>AZOPLUS</td><td>KETOCONAZOLE</td><td>2007/7.12/4501</td><td>08/09/2007</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/5ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>AZOPLUS</td><td>KETOCONAZOLE</td><td>2003/7.12/4109</td><td>04/16/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>AZOPT</td><td>BRINZOLAMIDE</td><td>2022/19.10. /6262</td><td>03/09/2022</td><td>12/31/2027</td><td>SUSPENSION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/ML</td><td>S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>AZULIX-2</td><td>GLIMEPIRIDE</td><td>2007/17.7/4482</td><td>02/26/2007</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>BACK-UP</td><td>LEVONORGESTREL</td><td>2024/21.2.2/6776</td><td>11/27/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.5 MG</td><td>RENATA LIMITED ;  </td><td>POPULATION SERVICES ZIMBABWE</td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td>
	</tr><tr>
		<td>BACQUIRE 500</td><td>CILASTATIN SODIUM; IMIPENEM</td><td>2013/7.2.5/4813</td><td>11/05/2013</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500; 500 MG</td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>BACTERIOSTATIC WATER FOR INJECTION</td><td>WATER FOR INJECTION</td><td>82/34/1256</td><td>09/01/1982</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PHARMACY MEDICINES (P.)</td><td>1G/50ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>BACTROCIN</td><td>&nbsp;</td><td>2025/14.1.1/6934</td><td>04/30/2025</td><td>04/29/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>BAYER ASPIRIN CARDIO 100</td><td>ASPIRIN</td><td>99/10.5/3596</td><td>09/17/1999</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>BECLATE 200</td><td>BECLOMETHASONE DIPROPIONATE</td><td>2010/22.1.3/4630</td><td>06/08/2010</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200 MCG/DOSE</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>BECLATE 50</td><td>BECLOMETHASONE DIPROPIONATE</td><td>2010/22.1.3/4631</td><td>06/08/2010</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MCG</td><td>CIPLA LTD;  CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>BEDAQUILINE</td><td>BEDAQUILINE</td><td>2024/7.3/6712</td><td>10/10/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>BEESIX</td><td>PYRIDOXINE HYDROCHLORIDE</td><td>83/22.2/1273</td><td>04/21/1983</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>50MG</td><td>LANCASTER INDUSTRIAL PVT LTD;  </td><td>LANCASTER INDUSTRIAL PVT LTD</td><td>LANCASTER GROUP</td>
	</tr><tr>
		<td>BEMOCIN 15 UNITS</td><td>BLEOMYCIN SULPHATE</td><td>2008/9.3.2/4541</td><td>12/10/2008</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15IU</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>BENCOLE</td><td>SULPHAMETHOXAZOLE; TRIMETHOPRIM</td><td>2003/7.2.3/4218</td><td>11/27/2003</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 40 MG/5ML</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>BENDAMUSTINE MYLAN</td><td>BENDAMUSTINE HYDROCHLORIDE</td><td>2018/9.3.2/5761</td><td>12/18/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/VIAL</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED (OTL)</td><td>MYLAN LABORATORIES LIMITED (OTL)</td>
	</tr><tr>
		<td>BENDAMUSTINE MYLAN</td><td>BENDAMUSTINE HYDROCHLORIDE</td><td>2018/9.3.2/5762</td><td>12/18/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/VIAL</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED (OTL)</td><td>MYLAN LABORATORIES LIMITED (OTL)</td>
	</tr><tr>
		<td>BENYLIN 4 FLU</td><td>DIPHENHYDRAMINE; PARACETAMOL; PSEUDOEPHEDRINE</td><td>2008/22.2.5/4515</td><td>02/22/2008</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>25; 1000; 45MG</td><td>WARNER-LAMBERT R.S.A.(PTY) LTD;  JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>BENYLIN CHILDRENS WET COUGH</td><td>GUAIFENESIN</td><td>2019/22.2.2/5922</td><td>09/13/2019</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG/10ML</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>BENYLIN DRY COUGH</td><td>DEXTROMETHORPHAN HYDROBROMIDE</td><td>2000/22.2.5/3769</td><td>08/29/2000</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>15MG/5ML</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>BENYLIN FOUR FLU</td><td>DIPHENHYDRAMINE HYDROCHLORIDE; PARACETAMOL; PSEUSOEPHEDRINE HYDROCHLORIDE</td><td>2023/22.2.5/6430</td><td>06/30/2023</td><td>06/30/2028</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 12.5; 22.5MG</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  JANSSEN-CILAG S.A;  MALLINCKRODT INC, GREENVILLE PLANT;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>BENYLIN ORIGINAL</td><td>AMMONIUM CHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE; MENTHOL</td><td>76/22.2.5/642</td><td>05/24/1976</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>125; 12.5; 2MG</td><td>WARNER-LAMBERT R.S.A.(PTY) LTD;  JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>BENYLIN PAEDIATRIC</td><td>DIPHENHYDRAMINE HYDROCHLORIDE</td><td>2023/22.2.5/6372</td><td>02/07/2023</td><td>02/07/2028</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>7 MG/5ML</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>BENYLIN WET COUGH</td><td>GUAIFENESIN</td><td>2019/22.2.2/5893</td><td>07/23/2019</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG/10ML</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>BENYLIN WET COUGH MENTHOL</td><td>GUAIFENESIN</td><td>2019/22.2.2/5828</td><td>05/08/2019</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG/10ML</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>BENZYL BENZOATE APPLICATION</td><td>BENZYL BENZOATE</td><td>82/14.1.5/5878</td><td>01/19/1982</td><td>12/31/2027</td><td>EMULSION; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>250MG/ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>BENZYL BENZOATE APPLICATION</td><td>BENZYL BENZOATE</td><td>81/14.1.5/5868</td><td>10/16/1981</td><td>12/31/2027</td><td>EMULSION; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>250G/1000ML</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BENZYLPENICILLIN</td><td>BENZYLPENICILLIN</td><td>2016/7.1.1/5265</td><td>09/14/2016</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5M IU</td><td>KARNATAKA ANTIB &amp; PHARMA LTD;  HETERO LABS LTD;  KARNATAKA ANTIBIOTICS &amp; PHARMACEUTICALS;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>BENZYLPENICILLIN</td><td>BENZYLPENICILLIN</td><td>2022/7.1.2/6278</td><td>04/07/2022</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MEGAUNIT/VIAL</td><td>INJECT CARE PARENTERALS PVT LTD;  </td><td>INJECTCARE PARENTERALS PVT LTD</td><td>INJECT CARE PARENTERALS PVT LTD</td>
	</tr><tr>
		<td>BENZYLPENICILLIN SODIUM</td><td>BENZYLPENICILLIN</td><td>87/7.1.1/2000</td><td>09/09/1986</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5X10^6 U</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>BENZYLPENICILLIN SODIUM</td><td>BENZYLPENICILLIN</td><td>2004/7.1.1/4280</td><td>07/01/2004</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MU</td><td>UMEDICA LABORATORIES PVT. LTD;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>BESEMAX</td><td>OPHENADRINE CITRATE; PARACETAMOL</td><td>99/2.2/3559</td><td>07/14/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>450; 35MG</td><td>ADCOCK INGRAMS SA (PTY) LTD;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>BESTINEM 1G</td><td>MEROPENEM</td><td>2015/7.2.5/4988</td><td>03/10/2015</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>BET CREAM</td><td>BETAMETHASONE DIPROPIONATE</td><td>2019/14.2.1/5806</td><td>03/18/2019</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1%W/V</td><td>LINCOLN PHARMACEUTICALS LTD;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>BETACIDE ANTISEPTIC</td><td>POVIDONE IODINE</td><td>2016/14.1.4/5301</td><td>12/05/2016</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>10%</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>BETACIDE ANTISEPTIC</td><td>POVIDONE IODINE</td><td>2016/14.1.4/5302</td><td>12/05/2016</td><td>12/31/2027</td><td>GEL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>BETACIDE MOUTHWASH AND GARGLE</td><td>POVIDONE IODINE</td><td>2016/20.3.4/5300</td><td>12/05/2016</td><td>12/31/2027</td><td>SOLUTION/MOUTHWASH; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1%M/V</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>BETACIDE SURGICAL SCRUB</td><td>POVIDONE IODINE</td><td>2016/14.1.4/5303</td><td>12/05/2016</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>7.5%</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>BETACO </td><td>DEXTROMETHORPHAN HYDROBROMIDE</td><td>97/22.2.1/3215</td><td>05/08/1997</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>15MG/5ML</td><td>ECOMED MANUFACTURING (PVT) LTD;  </td><td>ECOMED MANUFACTURING (PVT) LTD</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAFED</td><td>HYDROBROMIDE; PSEUDOEPHEDRINE</td><td>97/22.2.5/3244</td><td>06/24/1997</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>15MG; 30MG</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAFLEX SYRUP</td><td>CHLORPHENAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE</td><td>2024/22.2.5/6616</td><td>06/05/2024</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>20; 30; 15MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAFLU SYRUP</td><td>ASCORBIC ACID; CHLORPHENIRAMINE; PARACETAMOL; PSEUDOEPHEDRINE</td><td>2024/22.2.5/6617</td><td>06/05/2024</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>70; 2.2; 120; 15MG /5ML</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETALOC ZOK</td><td>METOPROLOL SUCCINATE</td><td>2017/12.3.2/5310</td><td>03/09/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>ASTRAZENECA AB;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>BETALOC ZOK</td><td>METOPROLOL SUCCINATE</td><td>2017/12.3.2/5311</td><td>03/09/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>ASTRAZENECA AB;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>BETALOC ZOK</td><td>METOPROLOL SUCCINATE</td><td>2017/12.3.2/5312</td><td>03/09/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>ASTRAZENECA AB;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>BETAMEF</td><td>MEFENAMIC ACID</td><td>2000/2.1/3732</td><td>05/23/2000</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>50MG/5ML</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAMINE</td><td>DIPHENHYDRAMINE HYDROCHLORIDE; AMMONIUM CHLORIDE</td><td>97/22.2.5/3250</td><td>07/30/1997</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>138; 14MG</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAMINE PLUS </td><td>AMMONIUM CHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE: PARACETAMOL </td><td>2024/22.2.5/6615</td><td>06/05/2024</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>138; 14; 120MG/5ML</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAMOL</td><td>PARACETAMOL</td><td>97/2.1/3214</td><td>05/08/1997</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/ 5ML</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAPRO</td><td>PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPOLIDINE HYDROCHLORIDE</td><td>97/22.2.5/3283</td><td>12/03/1997</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>30; 1.375MG</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAPRO</td><td>PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPOLIDINE HYDROCHLORIDE</td><td>2003/22.2.5/4151</td><td>05/20/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>30; 1.375MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAPRO DM</td><td>DEXTROMETHORPHAN; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE</td><td>2000/22.2.5/3730</td><td>05/19/2000</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10; 30; 1.25MG</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>BETAPYN</td><td>CAFFEINE; CODEINE PHOSPHATE; DOXYLAMINE SUCCINATE; PARACETAMOL</td><td>2014/2.2/4885</td><td>06/02/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>450; 50; 5; 10 MG</td><td>ADCOCK INGRAM LIMITED;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>BETASONE</td><td>BETAMETHASONE VALERATE</td><td>91/14.2.1/2569</td><td>12/19/1991</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1%</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>BETASONE</td><td>BETAMETHASONE VALERATE</td><td>92/14.2.1/2593</td><td>02/21/1992</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1%</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>BETOPTIC</td><td>BETAXOLOL HYDROCHLORIDE</td><td>98/19.10/3376</td><td>07/17/1998</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td> 0.5%</td><td>S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>BEtt</td><td>TETANUS (ADSORBED)</td><td>2016/18.2/5252</td><td>09/06/2016</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40 IU/0.5 ML</td><td>BIOLOGICAL E. LIMITED;  </td><td>BIOLOGICAL E. LIMITED</td><td>BIOLOGICAL E. LIMITED</td>
	</tr><tr>
		<td>BICALUTAMIDE</td><td>BICALUTAMIDE</td><td>2019/9.5.2/5774</td><td>01/28/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>BICATERO</td><td>BICALUTAMIDE</td><td>2015/9.5.2/5060</td><td>07/01/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>BILOCOR</td><td>BISOPROLOL</td><td>2018/12.3.2/5552</td><td>01/31/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>NICHE GENERICS LIMITED ;  </td><td>PHARMA DYNAMICS PTY LTD</td><td>PHARMA DYNAMICS PTY LTD</td>
	</tr><tr>
		<td>BILOCOR</td><td>BISOPROLOL</td><td>2018/12.3.2/5553</td><td>01/31/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>NICHE GENERICS LIMITED ;  </td><td>PHARMA DYNAMICS PTY LTD</td><td>PHARMA DYNAMICS PTY LTD</td>
	</tr><tr>
		<td>BILTRICIDE</td><td>PRAZIQUANTEL</td><td>82/7.8/1576</td><td>06/09/1982</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>600MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>BIMATOPROST</td><td>BIMATOPROST</td><td>2024/19.10. /6603</td><td>05/13/2024</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1 MG/ML</td><td>INDOCO REMEDIES LIMITED;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>INDOCO REMEDIES LIMITED</td>
	</tr><tr>
		<td>BIMATOPROST</td><td>BIMATOPROST</td><td>2024/19.10. /6604</td><td>05/13/2024</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.3MG/ML</td><td>INDOCO REMEDIES LIMITED;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>INDOCO REMEDIES LIMITED</td>
	</tr><tr>
		<td>BINAFIN</td><td>TERBINAFINE HYDROCHLORIDE</td><td>2024/14.1.3/6570</td><td>03/14/2024</td><td>&nbsp;</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1%W/W</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>BINFIN 5</td><td>FINASTERIDE</td><td>2016/17.12/5177</td><td>03/18/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5  MG</td><td>HETERO LABS LTD,;  HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>BIO-CIMETIDINE</td><td>CIMETIDINE</td><td>96/16.7/3090</td><td>05/22/1996</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>400MG</td><td>LEK PHARMACEUTICAL &amp; CHEMICAL WORKS;  MERCK E DARMSTADT;  UNIQUE PHARM LABS ;  </td><td>BIOTECH LABS PTY LTD</td><td>BIOTECH LABS PTY LTD</td>
	</tr><tr>
		<td>BIO-CIMETIDINE</td><td>CIMETIDINE</td><td>96/16.7/3089</td><td>05/22/1996</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200MG</td><td>LEK PHARMACEUTICAL &amp; CHEMICAL WORKS;  MERCK PHARMACEUTICAL MANUFACTURERS (PTY) LTD;  UNIQUE PHARM LABS ;  </td><td>BIOTECH LABS PTY LTD</td><td>BIOTECH LABS PTY LTD</td>
	</tr><tr>
		<td>BIOPLUS</td><td>CAFFEINE; CALCIUM CARBONATE; CALCIUM GLUCONATE; CYANOCOBALAMIN; D-PANTHENOL; NICOTINAMIDE; PYRIDOXINE; RIBOFLAVINE; THIAMINE</td><td>74/24.6.3/0308</td><td>09/27/1974</td><td>12/31/2027</td><td>SYRUP</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>270MG; 142.2MG; 1.35G; 51.99MCG; 15.6MG; 63MG; 13.</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>BIORAN</td><td>DICLOFENAC SODIUM</td><td>2007/3.1/4505</td><td>10/22/2007</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>RUSAN PHARMA;  </td><td>RUSAN PHARMA LTD</td><td>RUSAN PHARMA LTD</td>
	</tr><tr>
		<td>BIOTECH TRAZODONE</td><td>TRAZODONE</td><td>2017/13.2.1/5467</td><td>10/20/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>RIVOPHARM SA;  </td><td>BIOTECH LABS PTY LTD</td><td>BIOTECH LABS PTY LTD</td>
	</tr><tr>
		<td>BIOTET</td><td>OXYTETRACYCLINE HYDROCHLORIDE</td><td>92/14.1.1/2587</td><td>01/20/1992</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>3%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>BIOTET</td><td>OXYTETRACYCLINE HYDROCHLORIDE</td><td>87/19.1.1/2056</td><td>03/26/1987</td><td>12/31/2027</td><td>OINTMENT; OPHTHALMIC</td><td>PHARMACY MEDICINES (P.)</td><td>1%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>BIRATO 250</td><td>ABIRATERONE ACETATE</td><td>2020/9.5.2/5970</td><td>02/12/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>MSN LABORATORIES PRIVATE LIMITED, FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>BISOTROL 10</td><td>BISOPROLOL</td><td>2018/12.3.2/5630</td><td>06/05/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>BISOTROL 5</td><td>BISOPROLOL</td><td>2018/12.3.2/5629</td><td>06/05/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>BISPEC-10</td><td>SOLIFENACIN SUCCINATE</td><td>2020/21.7/6060</td><td>12/08/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>BISPEC-5</td><td>SOLIFENACIN SUCCINATE</td><td>2020/21.7/6059</td><td>12/08/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>BLACIDEC 10</td><td>SOLIFENACIN SUCCINATE</td><td>2022/21.7/6289</td><td>06/15/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>BLACIDEC 5</td><td>SOLIFENACIN SUCCINATE</td><td>2022/21.7/6288</td><td>06/15/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>BLEOCIP</td><td>BLEOMYCIN SULPHATE</td><td>2011/9.3.2/4664</td><td>02/14/2011</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15 IU/ VIAL</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>BLESOL</td><td>BLEOMYCIN</td><td>2016/9.3.2/5295</td><td>11/21/2016</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15 IU</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>BORTERO</td><td>BORTEZOMIB</td><td>2025/9.4/6801</td><td>01/06/2025</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3.5MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>BOTECH TRAZODONE</td><td>TRAZODONE</td><td>2017/13.2.1/5466</td><td>10/20/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>RIVOPHARM SA;  </td><td>BIOTECH LABS PTY LTD</td><td>BIOTECH LABS PTY LTD</td>
	</tr><tr>
		<td>BPROST-1</td><td>BIMATOPROST; TIMOLOL MALEATE</td><td>2021/19.10. /6179</td><td>09/09/2021</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>0.1MG/ML</td><td>INDOCO REMEDIES LIMITED;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>BPROST-2</td><td>BIMATOPROST</td><td>2021/19.10. /6180</td><td>09/09/2021</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.3MG/ML</td><td>INDOCO REMEDIES LIMITED;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>BREATHEZY</td><td>MONTELUKAST SODIUM</td><td>2015/21.1.1/5032</td><td>05/14/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>BREATHEZY CW 5</td><td>MONTELUKAST SODIUM</td><td>2015/21.1.1/5031</td><td>05/14/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>BREATHIN</td><td>SODIUM CHLORIDE</td><td>2020/20.2.4/6049</td><td>11/03/2020</td><td>12/31/2027</td><td>LIQUID</td><td>PHARMACY MEDICINES (P.)</td><td>0.65%W/V</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>BRIMONIDINE</td><td>BRIMONIDINE TATRATE</td><td>2019/19.10. /5931</td><td>09/24/2019</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG/ML</td><td>INDOCO REMEDIES LIMITED;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>BRIMONIDINE TARTRATE</td><td>BRIMONIDINE TATRATE</td><td>2015/19.10/5047</td><td>06/01/2015</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.2%</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>BRISCORIL</td><td>SALBUTAMOL SULPHATE</td><td>2025/22.2.5/6809</td><td>01/10/2025</td><td>&nbsp;</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2MG/50MG/1MG/5ML</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>BRIVANEXT 10</td><td>BRIVARACETAM</td><td>2025/13.1/6883</td><td>03/05/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>BRIVANEXT 100</td><td>BRIVARACETAM</td><td>2025/13.1/6886</td><td>03/05/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>BRIVANEXT 25</td><td>BRIVARACETAM</td><td>2025/13.1/6884</td><td>03/05/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>BRIVANEXT 75</td><td>BRIVARACETAM</td><td>2025/13.1/6885</td><td>03/05/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>BROMAZEPAM 3 KIARA</td><td>BROMAZEPAM</td><td>96/13.2.2/3060</td><td>03/19/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3MG</td><td>KIARA HEALTH (PTY) LTD;  </td><td>KIARA HEALTH (PTY) LTD</td><td>KIARA HEALTH (PTY) LTD</td>
	</tr><tr>
		<td>BROMAZEPAM 6 KIARA</td><td>BROMAZEPAM</td><td>96/13.2.2/3061</td><td>03/19/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>6MG</td><td>KIARA HEALTH (PTY) LTD;  </td><td>KIARA HEALTH (PTY) LTD</td><td>KIARA HEALTH (PTY) LTD</td>
	</tr><tr>
		<td>BRONCHALIX</td><td>CHOLINE THEOPHYLLINATE; EPHEDRINE HYDROCHLORIDE</td><td>84/22.1.1/1789</td><td>03/12/1984</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5; 50MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>BRONCHOPED</td><td>AMMONIUM CHLORIDE; SODIUM CITRATE; TERBUTALINE SULPHATE</td><td>96/22.2.5/3120</td><td>07/01/1996</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>60; 25; 1.25MG</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LTD;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>BRUFEN</td><td>IBUPROFEN</td><td>76/3.1/770</td><td>10/15/1976</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>BOOTS CO PTY LTD;  BOOTS CO LTD, NOTTINGHAM, UK;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>BRUFEN</td><td>IBUPROFEN</td><td>76/3.1/769</td><td>10/15/1976</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG</td><td>BOOTS CO PTY LTD;  BOOTS CO LTD, NOTTINGHAM, UK;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>BSS ALCON</td><td>MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE</td><td>2016/20.4/5196</td><td>04/22/2016</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.64 % M/V</td><td>ALCON LABORATORIES INCORPORATED, USA;  </td><td>ALCON LABORATORIES</td><td>ALCON LABORATORIES INCORPORATED, USA</td>
	</tr><tr>
		<td>BSV-HUMOG</td><td>MENOTROPHIN</td><td>2018/17.13/5580</td><td>03/06/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75IU</td><td>BHARAT SERUMS &amp; VACCINES LTD;  </td><td>BHARAT SERUMS & VACCINES LTD</td><td>BHARAT SERUMS & VACCINES LTD</td>
	</tr><tr>
		<td>BUDECORT 0.5MG RESPULES</td><td>BUDESONIDE</td><td>2021/22.1.3/6204</td><td>11/10/2021</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>0.5MG/2ML</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>BUDESONIDE</td><td>BUDESMA</td><td>2017/22.1.3/5392</td><td>07/07/2017</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG</td><td>GLENMARK PHARAMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>BUNASE 200</td><td>BUDESONIDE</td><td>2018/22.1.3/5746</td><td>12/06/2018</td><td>12/31/2027</td><td>SPRAY, METERED; NASAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>BUPILIN HEAVY</td><td>BUPIVACAINE HYDROCHLORIDE</td><td>2022/1.2.1/6252</td><td>02/16/2022</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG/ML</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>BUPITROY </td><td>BUPIVACAINE HYDROCHLORIDE</td><td>2025/1.2.1/6805</td><td>01/10/2025</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG/ML</td><td>TROIKAA PHARMACEUTICALS LTD;  </td><td>TROIKAA PHARMACEUTICALS LTD.</td><td>TROIKAA PHARMACEUTICALS LTD.</td>
	</tr><tr>
		<td>CABAZITAXEL MYLAN</td><td>CABAZITAXEL</td><td>2021/9.3/6203</td><td>11/08/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60MG/1.5ML</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>CADIPRIM</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>2000/7.2.3/3766</td><td>08/29/2000</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG; 80MG</td><td>CADILA PHARMACEUTICALS LTD;  </td><td>CADILA PHARMACEUTICALS LTD</td><td>CADILA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CAFEMOL </td><td>ASPRIN; CAFFEINE</td><td>76/2.2/621</td><td>05/05/1976</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>400; 24MG</td><td>ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  DATLABS (PVT) LTD;  </td><td>ADCOCK INGRAM</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>CAFEMOL CHILDREN'S SIZE</td><td>ASPIRIN</td><td>76/2.1/622</td><td>05/05/1976</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>81MG</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAMS SA (PTY) LTD;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAMS SA (PTY) LTD</td><td>STERLING PRODUCTS INTERNATIONAL INC</td>
	</tr><tr>
		<td>CAFFEINE CITRATE  (1ML)</td><td>CAFFEINE</td><td>2019/13.7/5819</td><td>04/03/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA;  </td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td>
	</tr><tr>
		<td>CAFFEINE; PARACETAMOL</td><td>CAFFEINE; PARACETAMOL</td><td>2024/2.2/6672</td><td>07/30/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PHARMACY MEDICINES (P.)</td><td>65; 500MG</td><td>SOFTGEL HEALTHCARE PVT. LTD.;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CAIPOLEX</td><td>CAPTOPRIL</td><td>2006/12.3.5/4412</td><td>03/09/2006</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>&nbsp;</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>CALAMINE LOTION</td><td>CALAMINE; ZINC OXIDE</td><td>2019/14.19/5905</td><td>08/08/2019</td><td>12/31/2027</td><td>LOTIONS</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>0.15; 0.05MG/G</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>CALAMINE LOTION</td><td>CALAMINE; ZINC OXIDE</td><td>81/14.19/5869</td><td>10/16/1981</td><td>12/31/2027</td><td>LOTION; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>150; 50G/1000ML</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>CALAMINE LOTION</td><td>CALAMINE; GLYCEROL; PHENOL; ZINC OXIDE</td><td>82/14.13/5978</td><td>01/19/1982</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>150; 5; 50MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CALCIGARD RETARD</td><td>NIFEDIPINE</td><td>95/12.3.1/2890</td><td>05/03/1995</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>TORRENT PHARMACEUTICALS LTD;  TORRENT PHARM LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>CALPOL PAEDIATRIC</td><td>PARACETAMOL</td><td>83/2.1/1671</td><td>02/02/1982</td><td>12/31/2027</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD;  </td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td><td>GLAXOSMITHKLINE</td>
	</tr><tr>
		<td>CALYZID</td><td>CALCIUM CARBONATE; LYSINE HYDROCHLORIDE; VITAMIN D3; ZINC GLUCONATE</td><td>2016/24.5/5230</td><td>06/24/2016</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>625 MG</td><td>S KANT HEALTHCARE LTD;  </td><td>SK AGE EXPORTS</td><td>S KANT HEALTHCARE LTD</td>
	</tr><tr>
		<td>CAMPHORATED OIL</td><td>CAMPHOR</td><td>98/14.15/3456</td><td>11/27/1998</td><td>12/31/2027</td><td>LINIMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>20G/100ML</td><td>LANCASTER INDUSTRIAL PVT LTD;  </td><td>LANCASTER INDUSTRIAL PVT LTD</td><td>LANCASTER GROUP</td>
	</tr><tr>
		<td>CANCYT</td><td>CYTARABINE</td><td>2018/9.2.2/5569</td><td>02/15/2018</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>NAPROD LIFE SCIENCES PVT LTD</td><td>NAPROD LIFE SCIENCES PVT LTD</td>
	</tr><tr>
		<td>CANDID</td><td>CLOTRIMAZOLE</td><td>2005/14.1.3/4354</td><td>03/01/2005</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1% W/W</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CANDID</td><td>CLOTRIMAZOLE</td><td>2001/14.1.3/3874</td><td>01/10/2001</td><td>12/31/2027</td><td>LOTION; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1 %W/W</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CANDID</td><td>CLOTRIMAZOLE</td><td>2000/20.3.4/3667</td><td>02/09/2000</td><td>12/31/2027</td><td>PAINT; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1 % W/V</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>CANDID</td><td>CLOTRIMAZOLE</td><td>2000/14.1.3/3665</td><td>02/21/2000</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1 % W/W</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CANDID</td><td>CLOTRIMAZOLE</td><td>2000/20.1.1/3666</td><td>02/09/2000</td><td>12/31/2027</td><td>SOLUTION/DROPS; OTIC</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1 % W/V</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CANDID V-1</td><td>CLOTRIMAZOLE</td><td>2004/14.17/4268</td><td>05/05/2004</td><td>12/31/2027</td><td>TABLET; VAGINAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CANDID V-6</td><td>CLOTRIMAZOLE</td><td>2000/14.17/3681</td><td>02/28/2000</td><td>12/31/2027</td><td>TABLET; VAGINAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100MG</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>CANDID-B</td><td>BECLOMETHASONE DIPROPIONATE; CLOTRIMAZOLE</td><td>2000/14.1.3/3817</td><td>11/16/2000</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.025; 1%</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CANDID-B</td><td>BECLOMETHASONE DIPROPIONATE; CLOTRIMAZOLE</td><td>2000/14.1.3/3668</td><td>02/09/2000</td><td>12/31/2027</td><td>LOTION; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1 % W/V</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>CANDIDEX</td><td>CLOTRIMAZOLE</td><td>2000/14.17/3854</td><td>12/07/2000</td><td>12/31/2027</td><td>PESSARY; VAGINAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CANDIDEX</td><td>CLOTRIMAZOLE</td><td>99/14.1.3/3630</td><td>11/26/1999</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1% W/W</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CANDIDEX</td><td>CLOTRIMAZOLE</td><td>99/14.17/3571</td><td>07/21/1999</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2% W/W</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CANDID-V-GEL</td><td>CLOTRIMAZOLE</td><td>2000/14.17/3669</td><td>02/09/2000</td><td>12/31/2027</td><td>GEL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2% W/W</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>CANDITRAL</td><td>ITRACONAZOLE</td><td>2001/7.1/4009</td><td>12/20/2001</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CANDIVOR</td><td>VORICONAZOLE</td><td>2023/7.12/6364</td><td>01/20/2023</td><td>01/20/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>ASPIRO PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>CANESPOR</td><td>BIFONAZOLE</td><td>86/14.1.3/1989</td><td>07/21/1986</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1%</td><td>BAYER AG;  KERN PHARMA S.L;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>CANESTEEN 1</td><td>CLOTRIMAZOLE</td><td>88/14.17/1934</td><td>11/25/1985</td><td>12/31/2027</td><td>TABLET; VAGINAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>500MG</td><td>BAYER PHARMA AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>CANESTEN</td><td>CLOTRIMAZOLE</td><td>74/14.1.3/0242</td><td>04/22/1974</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1.0%</td><td>BAYER AG;  GLAXO-WELLCOME;  PHARMACARE LIMITED;  PHARMACARE PTY LTD;  KERN PHARMA S.L;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>CANESTEN</td><td>CLOTRIMAZOLE</td><td>81/14.17/1395</td><td>03/19/1981</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1%</td><td>BAYER AG;  GLAXO-WELLCOME;  PHARMACARE LIMITED;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>CANESTEN 1 VC</td><td>CLOTRIMAZOLE</td><td>99/14.17/3632</td><td>12/03/1999</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>500MG </td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>CANI-MAKS</td><td>CLOTRIMAZOLE</td><td>2016/14.1.3/5291</td><td>10/06/2016</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1% W/W</td><td>S KANT HEALTHCARE LTD;  </td><td>SK AGE EXPORTS</td><td>SK AGE EXPORTS</td>
	</tr><tr>
		<td>CANOL</td><td>TOPOTECAN HYDROCHLORIDE</td><td>2017/9.5.2/5434</td><td>09/19/2017</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4MG</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>CAPOREX</td><td>CAPTOPRIL</td><td>2004/12.3.5/4314</td><td>10/18/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CARACA-12.5</td><td>CARVEDILOL</td><td>2015/12.3.2./5014</td><td>04/14/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5 MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CARBAMAZEPINE</td><td>CARBAMAZEPINE</td><td>2004/13.1/4309</td><td>09/22/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>MEDICAMEN BIOTECH LIMITED;  </td><td>MEDICAMEN BIOTECH LIMITED</td><td>MEDICAMEN BIOTECH LIMITED</td>
	</tr><tr>
		<td>CARBAMAZEPINE</td><td>CARBAMAZEPINE</td><td>95/13.1/2945</td><td>06/26/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CARBOL</td><td>CARBOPLATIN</td><td>2016/9.4/5150</td><td>01/08/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>450 MG/ 45 ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>CARBOL</td><td>CARBOPLATIN</td><td>2017/9.4/5379</td><td>05/22/2017</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/15ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>CARBOPLATIN MYLAN</td><td>CARBOPLATIN</td><td>2018/9.4/5736</td><td>11/12/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED (OTL)</td><td>MYLAN LABORATORIES LIMITED (OTL)</td>
	</tr><tr>
		<td>CARBOTEEN</td><td>CARBOPLATIN</td><td>2023/9.4/6470</td><td>08/22/2023</td><td>08/22/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>450MG/45ML</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>CARBOTEEN</td><td>CARBOPLATIN</td><td>2023/9.4/6469</td><td>08/22/2023</td><td>08/22/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150 MG/ML</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>CARBOXY METHYL CELLULOSE SODIUM </td><td>CARBOXY METHYL CELLULOSE SODIUM</td><td>2018/19.1/5605</td><td>04/23/2018</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACY MEDICINES (P.)</td><td>5MG/ML</td><td>AMANTA HEALTHCARE LTD;  </td><td>AMANTA HEALTHCARE LTD</td><td>AMANTA HEALTHCARE LTD</td>
	</tr><tr>
		<td>CARCA-3.125</td><td>CARVEDILOL</td><td>2015/12.3.2/5012</td><td>04/14/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>3.125 MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CARCA-6.25</td><td>CARVEDILOL</td><td>2015/12.3.2./5013</td><td>04/14/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>6.25 MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CARDIZ</td><td>TELMISARTAN</td><td>2017/12.3.5/5437</td><td>10/11/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CARDIZ</td><td>TELMISARTAN</td><td>2017/12.3.5/5438</td><td>10/11/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CARDIZ-CO</td><td>HYDROCHLOROTHIAZIDE; TELMISARTAN</td><td>2017/12.3.5/5440</td><td>10/11/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 80MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>NEW AVAKASH INTERNATIONAL</td><td>NEW AVAKASH INTERNATIONAL</td>
	</tr><tr>
		<td>CARDIZ-CO</td><td>HYDROCHLOROTHIAZIDE; TELMISARTAN</td><td>2017/12.3.5/5439</td><td>10/11/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 40MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CARDURA XL</td><td>DOXAZOSIN</td><td>2001/12.3.1/3952</td><td>10/03/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>4MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  PFIZER PHARMACEUTICALS LLC;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>CARDURA XL</td><td>DOXAZOSIN</td><td>2001/12.3.1/3953</td><td>10/03/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>8MG</td><td>PFIZER PHARMACEUTICALS LLC;  PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>CARFALONE</td><td>EPLERENONE</td><td>2024/1.2.1/6773</td><td>11/25/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>MARCYRL PHARMACEUTICAL INDUSTRIES;  </td><td>MARCYRL PHARMACEUTICAL INDUSTRIES</td><td>MARCYRL PHARMACEUTICAL INDUSTRIES</td>
	</tr><tr>
		<td>CASODEX</td><td>BICALUTAMIDE</td><td>99/9.4/3553</td><td>06/15/1999</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>CORDEN PHARMA GMBH;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>CASPOFUNGIN MYLAN</td><td>CASPOFUNGIN</td><td>2018/7.12/5727</td><td>11/02/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/VIAL</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED (OTL)</td><td>MYLAN LABORATORIES LIMITED (OTL)</td>
	</tr><tr>
		<td>CASPOFUNGIN MYLAN</td><td>CASPOFUNGIN</td><td>2018/7.12/5728</td><td>11/02/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>70MG/VIAL</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED (OTL)</td><td>MYLAN LABORATORIES LIMITED (OTL)</td>
	</tr><tr>
		<td>CASPRIN</td><td>&nbsp;</td><td>2025/2.1/6811</td><td>01/10/2025</td><td>01/09/2030</td><td>&nbsp;</td><td>PHARMACY MEDICINES (P.)</td><td>&nbsp;</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>CATAFLAM</td><td>DICLOFENAC POTASSIUM</td><td>91/3.1/2531</td><td>05/08/1991</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>NOVARTIS PHARMA SERVICES AG;  NOVARTIS;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>CEEPRO</td><td>CIPROFLOXACIN HYDROCHLORIDE</td><td>2021/19.1.1/6111</td><td>03/19/2021</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.3%W/V</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CEFACLOR</td><td>CEFACLOR</td><td>2003/7.2.2/4154</td><td>05/23/2003</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CEFACLOR</td><td>CEFACLOR</td><td>2003/20.1.1/4101</td><td>04/02/2003</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CEFACLOR</td><td>CEFACLOR</td><td>2003/7.2.2/4153</td><td>05/23/2003</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CEFAMOR</td><td>CEFALEXIN MONOHYDRATE</td><td>2003/7.2.2/4200</td><td>10/13/2003</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CEFTAZIDIME</td><td>CEFTAZIDIME</td><td>2013/7.2.2/4780</td><td>06/14/2013</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>KARNATAKA ANTIB &amp; PHARMA LTD;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CEFTRIAXONE SODIUM </td><td>CEFTRIAXONE SODIUM</td><td>2017/7.2.2/5352</td><td>03/28/2017</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>SWISS PARENTERALS PVT.LTD;  </td><td>SWISS EXPORT PVT</td><td>SWISS EXPORT PVT</td>
	</tr><tr>
		<td>CEFTRIAXONE SODIUM</td><td>CEFTRIAXONE SODIUM</td><td>2004/7.2.2/4292</td><td>08/05/2004</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/VIAL</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CEFTRIAXONE SODIUM</td><td>CEFTRIAXONE SODIUM</td><td>2008/7.2/4516</td><td>03/06/2008</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>KARNATAKA ANTIB &amp; PHARMA LTD;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CEFTURE</td><td>CEFTRIAXONE SODIUM</td><td>2021/7.2.2/6206</td><td>11/18/2021</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1GRAM</td><td>INJECT CARE PARENTERALS PVT LTD;  </td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td><td>INJECT CARE PARENTERALS PVT LTD</td>
	</tr><tr>
		<td>CEFUROXIME SODIUM</td><td>CEFUROXIME SODIUM</td><td>2017/7.2.2/5354</td><td>04/13/2017</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>750 MG</td><td>SWISS EXPORT PVT;  </td><td>SWISS EXPORT PVT</td><td>SWISS EXPORT PVT</td>
	</tr><tr>
		<td>CELEBIB 100</td><td>CELECOXIB</td><td>2020/3.1/6050</td><td>11/04/2020</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CELEBIB 200</td><td>CELECOXIB</td><td>2020/3.1/6051</td><td>11/04/2020</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CELECOXIB</td><td>CELECOXIB</td><td>2024/3.1/6762</td><td>11/14/2024</td><td>&nbsp;</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>INVENTIA HEALTHCARE PVT LTD;  </td><td>COSPHARM INVESTMENTS</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CELECOXIB ASCENDIS 100</td><td>CELECOXIB</td><td>2024/3.1/6756</td><td>11/07/2024</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100mg</td><td>KOPRAN LTD;  </td><td>ASCENDIS PHARMA (PTY) LTD</td><td>ASCENDIS PHARMA (PTY) LTD</td>
	</tr><tr>
		<td>CELECOXIB ASCENDIS 200</td><td>CELECOXIB</td><td>2024/3.1/6757</td><td>11/07/2024</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200mg</td><td>KOPRAN LTD;  </td><td>ASCENDIS PHARMA (PTY) LTD</td><td>ASCENDIS PHARMA (PTY) LTD</td>
	</tr><tr>
		<td>CELETOR 200</td><td>CELECOXIB</td><td>2020/3.1/6024</td><td>07/22/2020</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>CELOFEN</td><td>CELECOXIB</td><td>2018/3.1/5565</td><td>02/09/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>CELPROTEC</td><td>MISOPROSTOL</td><td>2017/21.6/5415</td><td>08/10/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG</td><td>ACME FORMULATION PVT LTD (HORMONE BLOCK);  ACME FORMULATION PVT LTD (HORMONE BLOCK);  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CENOXIB  200</td><td>CELECOXIB</td><td>2022/3.1/6322</td><td>08/29/2022</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>CELOGEN PHARMA PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CEPACOL COUGH DISCS</td><td>BENZOCAINE; DEXTROMETHORPHAN; CETYLPYRIDINIUM CHLORIDE</td><td>76/20.3.6/702</td><td>09/22/1976</td><td>12/31/2027</td><td>TROCHE/LOZENGE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.5; 5; 1.25MG</td><td>ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>CEPACOL COUGH LINCTUS</td><td>CETYLPYRIDINIUM CHLORIDE; DEXTROMETHORPHAN; DOXYLAMINE SUCCINATE; SODIUM CITRATE</td><td>76/22.2.2/703</td><td>09/22/1976</td><td>12/31/2027</td><td>LINCTUS; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2.5; 30; 6; 500MG</td><td>ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>CEPACOL PLUS ORIGINAL LOZENGE</td><td>CETYLPYRIDINIUM CHLRORIDE; BENZOCAINE</td><td>79/20.3.5/866</td><td>08/13/1979</td><td>12/31/2027</td><td>LOZENGES</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>10; 1.4MG</td><td>ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  DATLABS PRIVATE LIMITED;  UNIQUE PHARMACEUTICAL LABORATORIES;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>CEPACOL THROAT LOZENGES</td><td>BENZYL ALCOHOL; CETYLPYRIDINIUM</td><td>76/20.3.4/704</td><td>09/22/1976</td><td>12/31/2027</td><td>TROCHE/LOZENGE; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>6.5; 1.47MG</td><td>ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  UNIQUE PHARMACEUTICAL LABORATORIES;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>CEPHALEXIN</td><td>CEFALEXIN MONOHYDRATE</td><td>2002/7.2.2/4086</td><td>12/12/2002</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CEPHALEXIN</td><td>CEFALEXIN MONOHYDRATE</td><td>2002/7.2.2/4085</td><td>12/12/2002</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CERAZETTE</td><td>&nbsp;</td><td>2025/21.2.2/6902</td><td>03/27/2025</td><td>03/26/2030</td><td>&nbsp;</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>&nbsp;</td><td>N.V ORGANON ;  </td><td>N.V ORGANON </td><td>N.V ORGANON </td>
	</tr><tr>
		<td>CEROXIM</td><td>CEFUROXIME AXETIL</td><td>2017/7.2.2/5410</td><td>08/08/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>CEROXIM</td><td>CEFUROXIME AXETIL</td><td>2017/7.2.2/5409</td><td>09/08/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>CERVARIX</td><td>HUMAN PAPILLOMA VIRUS TYPES 16; 7; 18 (RECOMBINANT) </td><td>2012/18.2/4739</td><td>08/07/2012</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20; 20MCG</td><td>GLAXOSMITHKLINE S.A (PTY) LTD;  </td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td>
	</tr><tr>
		<td>CETICIT</td><td>CETIRIZINE DIHYDROCHLORIDE</td><td>2020/5/6068</td><td>12/14/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10MG</td><td>ADCOCK INGRAM LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>CETRIMIDE SOLUTION</td><td>CETRIMIDE </td><td>82/14.1.4/5876</td><td>02/22/1982</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>1%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CHIRORAB</td><td>RABIES VIRUS (PURIFIED CHICK-EMBRYO CELL)</td><td>87/18.2/2047</td><td>01/28/1987</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5IU</td><td>CHIRON BEHRING GMBH &amp; CO;  CHIRON BEHRING VACCINES PVT LTD;  </td><td>CHIRON BEHRING VACCINES PVT LTD</td><td>CHIRON BEHRING VACCINES PVT LTD</td>
	</tr><tr>
		<td>CHLORAMPHENICOL</td><td>CHLORAMPHENICOL</td><td>95/7.2.5/2901</td><td>03/30/1995</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CHLORAMPHENICOL</td><td>CHLORAMPHENICOL</td><td>2001/7.2.5/3912</td><td>04/02/2001</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CHLORAMPHENICOL SODIUM SUCCINATE</td><td>CHLORAMPHENICOL SODIUM SUCCINATE</td><td>2019/7.2.5/5886</td><td>06/20/2019</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CHLORAMPHENICOL SODIUM SUCCINATE</td><td>CHLORAMPHENICOL SODIUM SUCCINATE</td><td>78/7.2.5/1109</td><td>03/25/1977</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CHLORMINE</td><td>CHLORPHENIRAMINE MALEATE</td><td>2023/5/6429</td><td>06/30/2023</td><td>06/30/2028</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>2 MG/5ML</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CHLORNICOL</td><td>CHLORAMPHENICOL</td><td>77/19.1.1/939</td><td>08/04/1977</td><td>12/31/2027</td><td>OINTMENT; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1%M/M</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CHLORNICOL</td><td>CHLORAMPHENICOL</td><td>86/7.2.5/1978</td><td>06/17/1987</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CHLORNICOL</td><td>CHLORAMPHENICOL</td><td>86/7.2.5/1977</td><td>06/17/1986</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CHLOROP</td><td>CHLORAMPHENICOL</td><td>2023/7.2.5/6537</td><td>12/13/2023</td><td>12/13/2028</td><td>OINTMENT; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/G</td><td>SM PHARMACEUTICALS;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CHLOROQUIN PHOSPHATE</td><td>CHLOROQUINE PHOSPHATE</td><td>7/20.2.6/912</td><td>10/08/1979</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>CHLORPHENIRAMINE</td><td>CHLORPHENIRAMINE MALEATE</td><td>2006/5/4408</td><td>02/20/2006</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>4MG</td><td>S KANT HEALTHCARE LTD;  </td><td>S K AGE EXPORTS</td><td>S K AGE EXPORTS</td>
	</tr><tr>
		<td>CHLORPROMAZINE HYDROCHLORIDE</td><td>CHLORPROMAZINE HYDROCHLORIDE</td><td>78/13.2.3/1037</td><td>05/01/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>DATLABS PRIVATE LIMITED;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>CHLORPROMAZINE HYDROCHLORIDE</td><td>CHLORPROMAZINE HYDROCHLORIDE</td><td>89/13.2.3/2296</td><td>08/25/1989</td><td>12/31/2027</td><td>ELIXIR; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/5ML</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>WALLACE LABORATORIES PVT LTD</td>
	</tr><tr>
		<td>CHLORPROMAZINE HYDROCHLORIDE</td><td>CHLORPROMAZINE HYDROCHLORIDE</td><td>78/13.2.3/1038</td><td>05/01/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>DATLABS PRIVATE LIMITED;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>CHOATS CLEER RUB</td><td>CAMPHOR; MENTHOL; METHYLSALICYLATE</td><td>75/22.3/456</td><td>03/18/1975</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>5; 0.5; 1.5; 2; 2; 1; 0.1; 4.5G</td><td>GRANITESIDE CHEMICALS (PVT) LTD;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>BAYRIDGE ENTERPRISES LTD</td>
	</tr><tr>
		<td>CHOATS EXTRACT OF LETTUCE</td><td>TOLUBALSAM; HONEY PURIFIED</td><td>76/22.2.5/610</td><td>05/04/1976</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>80; 400; 0.32; 1.5; 12; 195MG</td><td>GRANITESIDE CHEMICALS (PVT) LTD;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>BAYRIDGE ENTERPRISES LTD</td>
	</tr><tr>
		<td>CILOX 200</td><td>OFLOXACIN</td><td>2001/7.2.5/3945</td><td>07/02/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>CILOXAN</td><td>CIPROFLOXACIN</td><td>99/19.1.1/3585</td><td>08/26/1999</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3 MG/ML</td><td>S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>CIMETIDINE 400 FC</td><td>CIMETIDINE</td><td>95/16.7/2922</td><td>05/05/1995</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>400MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>CIPLADON</td><td>PARACETAMOL</td><td>2018/2.1/5523</td><td>01/11/2018</td><td>12/31/2027</td><td>TABLET, EFFERVESCENT; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>1000MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>CIPOLOX</td><td>CIPROFLOXACIN HYDROCHLORIDE</td><td>2001/7.2.5/3984</td><td>11/16/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CIPRIND - 250</td><td>CIPROFLOXACIN HYDROCHLORIDE</td><td>2003/7.2.5/4222</td><td>11/28/2003</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>INDOCO REMEDIES LTD;  </td><td>INDOCO REMEDIES LTD</td><td>INDOCO REMEDIES LTD</td>
	</tr><tr>
		<td>CIPRIND - 500</td><td>CIPROFOXACIN HYDROCHLORIDE</td><td>2002/7.2.5/4055</td><td>07/12/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>INDOCO REMEDIES LTD;  </td><td>INDOCO REMEDIES LTD</td><td>INDOCO REMEDIES LTD</td>
	</tr><tr>
		<td>CIPROBAY</td><td>CIPROFLOXACIN</td><td>94/7.2.5/2874</td><td>11/01/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>BAYER AG;  GLAXO-WELLCOME;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>CIPROBAY SUSPENSION </td><td>CIPROFLOXACIN</td><td>2018/7.2.5/5544</td><td>01/29/2018</td><td>12/31/2027</td><td>GRANULE, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5%</td><td>BAYER HEALTHCARE S.R.L;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>CIPRODAC</td><td>CIPROFLOXACIN HYDROCHLORIDE</td><td>99/7.2.5/3561</td><td>07/14/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CADILA PHARMACEUTICALS LTD;  </td><td>CADILA PHARMACEUTICALS LTD</td><td>CADILA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CIPROFLOXACIN LACTATE</td><td>CIPROFLOXACIN LACTATE</td><td>2006/7.2.5/4448</td><td>09/21/2006</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.2% W/V</td><td>AMANTA HEALTHCARE LTD;  </td><td>AMANTA HEALTHCARE LTD</td><td>AMANTA HEALTHCARE LTD</td>
	</tr><tr>
		<td>CIPROVAR</td><td>CIPROFLOXACIN HYDROCHLORIDE</td><td>2001/7.2.5/3965</td><td>09/04/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CIPROVAR</td><td>CIPROFLOXACIN HYDROCHLORIDE</td><td>2002/7.2.5/4065</td><td>09/04/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CIPROX</td><td>CIPROFLOXACIN LACTATE</td><td>2010/7.2.5/4310</td><td>10/08/2004</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.2%</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED;  </td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED</td>
	</tr><tr>
		<td>CIPROXIN-250</td><td>CIPROFLOXACIN HYDROCHLORIDE</td><td>2001/7.2.5/3975</td><td>10/22/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>UMEDICA LABORATORIES PVT. LTD;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>CIPROXIN-500</td><td>CIPROFLOXACIN HYDROCHLORIDE</td><td>2004/7.2.5/4243</td><td>03/09/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>UMEDICA LABORATORIES PVT. LTD;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>CIPYNE</td><td>CODEINE PHOSPHATE; IBUPROFEN; PARACETAMOL; </td><td>2016/2.2/5224</td><td>06/16/2016</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10; 200; 250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CIS-ATRACURIUM 10MG/5ML</td><td>&nbsp;</td><td>2025/1.3/6839</td><td>01/28/2025</td><td>01/27/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CIS-ATRACURIUM 20MG/10ML</td><td>&nbsp;</td><td>2025/1.3/6840</td><td>01/28/2025</td><td>01/27/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CIS-ATRACURIUM 5MG/2.5ML</td><td>&nbsp;</td><td>2025/1.3/6838</td><td>01/28/2025</td><td>01/27/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CITAFINE  1000</td><td>GEMCITABINE</td><td>2016/9.2.2/5222</td><td>06/08/2016</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000 MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CITAFINE 200</td><td>GEMCITABINE</td><td>2016/9.2.2/5221</td><td>06/08/2016</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200 MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CITAL</td><td>DISODIUM HYDROGEN CITRATE</td><td>2005/23.5/4387</td><td>09/07/2005</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.37G/5ML</td><td>INDOCO REMEDIES LTD;  </td><td>INDOCO REMEDIES LTD</td><td>INDOCO REMEDIES LTD</td>
	</tr><tr>
		<td>CITRO SODA</td><td>CITRIC ACID; SODIUM BICARBONATE; SODIUM CITRATE; TARTARIC ACID</td><td>73/16.1/0137</td><td>07/23/1973</td><td>12/31/2027</td><td>GRANULE, EFFERVESCENT; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>702.22; 1716; 613; 857,771MG</td><td>ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>CLACEE 250</td><td>CLARITHROMYCIN</td><td>98/7.2.5/3407</td><td>08/21/1998</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>ABBOTT SPA;  ABBOTT LABS S.A (PTY) LTD;  </td><td>ABBOTT LABS S.A (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>CLACEE 500</td><td>CLARITHROMYCIN</td><td>98/7.2.5/3334</td><td>05/26/1998</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>ABBOTT SPA;  ABBOTT LABS S.A (PTY) LTD;  </td><td>ABBOTT LABS S.A (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>CLARANTA-500</td><td>CLARITHROMYCIN</td><td>2013/7.2.5/4759</td><td>01/11/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>AJANTA PHARMA;  </td><td>AJANTA PHARMA</td><td>AJANTA PHARMA</td>
	</tr><tr>
		<td>CLARIGEN 500</td><td>CLARITHROMYCIN</td><td>2023/7.2.5/6434</td><td>07/19/2023</td><td>07/19/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>CELOGEN GENERIC PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CLARIMAX</td><td>CLARITHROMYCIN</td><td>2022/7.2.5/6290</td><td>06/17/2022</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>IMMACULE LIFESCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CLAVICURE</td><td>AMOXYCILLIN TRIHYDRATE; POTASSIUM CLAVULANATE</td><td>2024/7.1.2/6748</td><td>11/14/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>875; 125MG</td><td>MEDOPHARM PRIVATE LTD;  </td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td>
	</tr><tr>
		<td>CLEDOMOX 625</td><td>AMOXICILLIN; CLAVULANATE POTASSIUM</td><td>2019/7/5934</td><td>10/08/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>625 MG</td><td>MEDOPHARM PRIVATE LTD;  </td><td>MEDOPHARM</td><td>MEDOPHARM</td>
	</tr><tr>
		<td>CLEDOMOX-1000</td><td>AMOXYCILLIN TRIHYDRATE; POTASSIUM CLAVULANATE</td><td>2019/7.1.2/5810</td><td>03/20/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>875; 125MG</td><td>MEDOPHARM PRIVATE LTD;  </td><td>COSPHARM INVESTMENTS</td><td>MEDOPHARM PRIVATE LTD</td>
	</tr><tr>
		<td>CLEXANE 20</td><td>ENOXAPARIN SODIUM</td><td>2005/10.2/4342</td><td>01/31/2005</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/0.2ML</td><td>AVENTIS PHARMA PROPHARM;  </td><td>AVENTIS PHARMA</td><td>AVENTIS PHARMA</td>
	</tr><tr>
		<td>CLINDAMYCIN</td><td>CLINDAMYCIN</td><td>2000/7.2.5/3687</td><td>03/03/2000</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CLINDAMYCIN 300MG/2ML COSPHARM</td><td>&nbsp;</td><td>2025/7.2.5/6920</td><td>04/11/2025</td><td>04/10/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CLINDAMYCIN 600MG/4ML COSPHARM</td><td>CLINDAMYCIN PHOSPHATE</td><td>2024/7.2.5/6691</td><td>08/28/2024</td><td>&nbsp;</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CLOFAZIMINE</td><td>CLOFARABINE</td><td>2023/7.4/6473</td><td>08/24/2023</td><td>08/24/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>OXALIS LABS;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CLOGABA 10</td><td>CLOBAZAM</td><td>2025/13.1/6835</td><td>01/24/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>CLOGABA 20</td><td>CLOBAZAM</td><td>2025/13.1/6836</td><td>01/24/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>CLOPI 75</td><td>CLOPIDOGREL BISULPHATE</td><td>2021/10.5/6102</td><td>02/18/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CLOPIDOGREL 75MG PD</td><td>CLOPIDOGREL</td><td>2021/10.5/6132</td><td>05/19/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75MG</td><td>UNICHEM LABORATORIES LTD;  KRKA POLSKA SP. ZOO;  KRKA-FARMA D.O.O;  KRKA D.D, NOVO MESTO;  </td><td>PHARMA DYNAMICS PTY LTD</td><td>PHARMA DYNAMICS PTY LTD</td>
	</tr><tr>
		<td>CLOPIDOGREL IMPACT</td><td>CLOPIDOGREL</td><td>2024/10.5/6750</td><td>11/01/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>SANOFI WINTHROP INDUSTRIES;  SANOFI WINTHROP INDUSTRIE;  </td><td>SANOFI - AVENTIS</td><td>SANOFI  WINTHROP INDUSTRIE</td>
	</tr><tr>
		<td>CLORIMED-4</td><td>CHLORPHENIRAMINE MALEATE</td><td>2024/5/6765</td><td>11/19/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>4MG</td><td>MEDICAMEN BIOTECH LIMITED;  </td><td>MEDICAMEN BIOTECH LIMITED</td><td>MEDICAMEN BIOTECH LIMITED</td>
	</tr><tr>
		<td>CLOSCRIPT</td><td>CLOTRIMAZOLE</td><td>96/14.1.3/3050</td><td>01/22/1996</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1% W/W</td><td>PHARMANOVA (PVT) LTD;  </td><td>MULLER & PHIPPS</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>CLOSCRIPT VAGINAL CREAM</td><td>CLOTRIMAZOLE</td><td>96/14.17/3049</td><td>01/22/1996</td><td>12/31/2027</td><td>CREAMS</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1% W/W</td><td>PHARMANOVA (PVT) LTD;  </td><td>MULLER & PHIPPS</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>CLOTRIDERM</td><td>CLOTRIMAZOLE</td><td>2000/14.13/3810</td><td>11/10/2000</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1% W/W</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CLOTRILIN</td><td>CLOTRIMAZOLE</td><td>2023/14.17/6446</td><td>07/20/2023</td><td>07/20/2028</td><td>INSERTS</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100MG</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CLOTRILIN</td><td>CLOTRIMAZOLE</td><td>2023/14.1.3/6447</td><td>07/20/2023</td><td>07/20/2028</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1%</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CLOTRILIN-V</td><td>CLOTRIMAZOLE</td><td>2023/14.17/6448</td><td>07/20/2023</td><td>07/20/2028</td><td>CREAMS</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2%</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CLOXACILLIN</td><td>CLOXACILLIN</td><td>95/7.1.2/2946</td><td>07/05/1995</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CLOXACILLIN</td><td>CLOXACILLIN SODIUM</td><td>95/7.1.2/2903</td><td>04/03/1995</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CLOXACILLIN</td><td>CLOXACILLIN SODIUM</td><td>95/7.1.2/2902</td><td>04/03/1995</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CLOXACILLIN SODIUM</td><td>CLOXACILLIN SODIUM</td><td>2001//7.1.2/3883</td><td>01/23/2001</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CLOXACILLIN SODIUM</td><td>CLOXACILLIN SODIUM</td><td>2001/7.1.2/3882</td><td>01/23/2001</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CLOXACILLIN SODIUM</td><td>CLOXACILLIN SODIUM</td><td>2002/7.1.2/4053</td><td>06/28/2002</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>UMEDICA LABORATORIES PVT. LTD;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>CLOXACILLIN SODIUM</td><td>CLOXACILLIN SODIUM</td><td>2011/7.1.2/4702</td><td>08/18/2011</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>KARNATAKA ANTIB &amp; PHARMA LTD;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CLOXACILLIN SODIUM</td><td>CLOXACILLIN SODIUM</td><td>2008/7.1.2/4537</td><td>07/11/2008</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>KARNATAKA ANTIB &amp; PHARMA LTD;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CLOZAREM</td><td>CLOZAPINE</td><td>2025/13.2.2/6852</td><td>04/02/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>CLOZAREM</td><td>CLOZAPINE</td><td>2025/13.2.2/6851</td><td>02/04/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>COAL TAR OINTMENT</td><td>COAL TAR</td><td>82/14.6.1/5877</td><td>01/19/1982</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>6.25%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>COARTEM</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2015/7.5/5078</td><td>07/30/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80; 480MG</td><td>NOVARTIS PHARMACEUTICALS CORPORATION;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>COARTEM</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2000/7.5/3664</td><td>02/07/2000</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120MG</td><td>NOVARTIS PHARMACEUTICAL CORPORATION;  NOVARTIS PHARMACEUTICAL CORPORATION;  NOVARTIS PHARMA S.P.A Y;  NOVARTIS PHARMA GMBH;  NOVARTIS PHARMACEUTICALS CORPORATION;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>COARTEM</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2017/7.5/5327</td><td>02/16/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120MG</td><td>NOVARTIS;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>CO-CODAMOL</td><td>CODEINE PHOSPHATE; PARACETAMOL</td><td>93/2.2/2825</td><td>12/17/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 8MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CODEINE PHOSPHATE</td><td>CODEINE PHOSPHATE</td><td>84/2.1/1816</td><td>06/12/1984</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CO-DIOVAN</td><td>HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2016/12.3.5/5191</td><td>04/13/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25; 160MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMA SPA AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>CO-DIOVAN</td><td>HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2016/12.3.5/5190</td><td>04/13/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 160MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMA SPA AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>COFSYL CLEAR</td><td>GUAIFENESIN; TERBUTALINE</td><td>2024/22.2.5/6749</td><td>11/01/2024</td><td>&nbsp;</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>100MG/8MG//2.5MG</td><td>Cospharm Investments Zimbabwe;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>COFSYL DM</td><td>GUAIFENESIN; DEXTROMETHORPHAN HYDROBROMIDE; PARACETAMOL</td><td>2024/22.2.5/6553</td><td>01/31/2024</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>250; 100; 10 MG/5ML</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>COFSYL DRY</td><td>DEXTROMETHORPHAN HYDROBROMIDE</td><td>2023/22.2.1/6527</td><td>12/05/2023</td><td>12/05/2028</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>15 MG/5ML</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>COFSYL ORIGINAL</td><td>&nbsp;</td><td>2025/22.2.5/6931</td><td>04/25/2025</td><td>04/24/2030</td><td>&nbsp;</td><td>PHARMACY MEDICINES (P.)</td><td>&nbsp;</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>COLCAPS</td><td>CAFFEINE; CHLORPHENILAMINE MALEATE; MEPIRAMINE MALEATE; PHENYLPROPANOLAMINE; PHENYLEPHRINE HYDROCHLORIDE; SALICYLAMIDE</td><td>74/22.2.5/0265</td><td>07/24/1974</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>40; 1.5; 7.8; 5.75; 9.25; 240MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>COLCAPS</td><td>DEXTROMETHORPHAN; PARACETAMOL; PROMETHAZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE</td><td>80/22.2.5/1341</td><td>09/02/1980</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10; 120; 6.5; 25MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>COLCHICINE</td><td>COLCHICINE</td><td>95/3.2/2993</td><td>09/09/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.5MG</td><td>ASPEN PORT ELIZABETH (PTY) LIMIITED;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LTD</td>
	</tr><tr>
		<td>COLDEEZE</td><td>BENZYLCONIUM CHLORIDE; PHENYLEPHRINE HYDROCHLORIDE; THENYLDIAMINE HYDROCHLORIDE</td><td>76/20.2.4/749</td><td>09/15/1976</td><td>12/31/2027</td><td>SPRAY, METERED; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.02; 0.5; 0.1G</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>COLFED</td><td>PSEUDOEPHEDINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE</td><td>2020/22.2.5/6061</td><td>12/08/2020</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>30; 1.25MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>COLICAID DROPS</td><td>DILL OIL; FENNEL OIL; SIMETHICONE EMULSION</td><td>2024/28.1/6676</td><td>07/30/2024</td><td>12/31/2027</td><td>LIQUID</td><td>PHARMACY MEDICINES (P.)</td><td>4.51; 0.67; 40MG/ML</td><td>MEYER ORGANICS PRIVATE LIMITED;  </td><td>MEYER ORGANICS PRIVATE LIMITED</td><td>MEYER ORGANICS PRIVATE LIMITED</td>
	</tr><tr>
		<td>COMBE FIVE (LIQUID) -SINGLE DOSE</td><td>BORDETELLA PERTUSSIS; DIPTHERIA TOXOID; HAEMOPHILLUS; HEPATITIS B; TETANUS TOXOID</td><td>2018/18.2/5663</td><td>07/31/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4IU; 30IU; 11MCG; 12.5MCG; 60IU</td><td>BIOLOGICAL E. LIMITED;  </td><td>M/S BIOLOGICAL E, LTD</td><td>BIOLOGICAL E. LIMITED</td>
	</tr><tr>
		<td>COMBE FIVE (LIQUID)-TEN DOSE</td><td>BORDETELLA PERTUSSIS; DIPTHERIA TOXOID; HAEMOPHILLUS; HEPATITIS B; TETANUS TOXOID</td><td>2018/18.2/5662</td><td>07/31/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4IU; 30IU; 11MCG; 12.5MCG;  60IU</td><td>BIOLOGICAL E. LIMITED;  </td><td>BIOLOGICAL E. LIMITED</td><td>BIOLOGICAL E. LIMITED</td>
	</tr><tr>
		<td>COMBIART</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2016/7.5/5164</td><td>01/27/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120 MG</td><td>STRIDES SHASUN LIMITED;  </td><td>STRIDES ARCOLAB LTD</td><td>STRIDES ARCOLAB LTD</td>
	</tr><tr>
		<td>COMBIART-DT</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2019/7.5/5840</td><td>05/23/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120MG</td><td>STRIDES ARCOLAB LTD;  </td><td>STRIDES ARCOLAB LTD</td><td>STRIDES ARCOLAB LTD</td>
	</tr><tr>
		<td>COMBIGAN</td><td>BRIMONIDINE TARTRATE; TIMOLOL MALEATE</td><td>2015/19.10/5003</td><td>03/30/2015</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2; 5MG/ML</td><td>ALLERGAN INC;  </td><td>ABBVIE PTY LTD</td><td>ABBVIE PTY LTD</td>
	</tr><tr>
		<td>COMBIWAVE SF</td><td>FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE</td><td>2016/22.1.4/5269</td><td>06/15/2016</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25; 125MCG</td><td>GLENMARK PHARAMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>COMBIWAVE SF 250</td><td>FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE</td><td>2016/22.1.14/5270</td><td>09/15/2016</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250 MCG</td><td>GLEMARK PHARMACEUTICAL LTD;  GLENMARK PHARAMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>COMPOUND SODIUM LACTATE</td><td>SODIUM LACTATE; SODIUM CHLORIDE; POTASSIUM CHLORIDE; CALCIUM CHLORIDE</td><td>2017/23.2.1/5340</td><td>03/07/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.006; 0.003G</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED</td>
	</tr><tr>
		<td>COMPOUND SODIUM LACTATE</td><td>COMPOUND SODIUM LACTATE</td><td>2013/23.2.1/4782</td><td>06/24/2013</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3.2; 6; 0.4; 0.27G</td><td>ACULIFE HEALTHCARE PRIVATE LTD;  </td><td>ACULIFE HEALTHCARE PRIVATE LTD</td><td>ACULIFE HEALTHCARE PRIVATE LTD</td>
	</tr><tr>
		<td>CONCENTRATED HAEMODIALYSIS SOLUTION (WITH POTASSIUM)</td><td>CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE </td><td>84/23.3.2/1784</td><td>03/09/1984</td><td>12/31/2027</td><td>SOLUTION; INTRAPERIOTONEAL</td><td>PHARMACY MEDICINES (P.)</td><td>8.22; 35; 2.14; 3.92; 166.6; 214G</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>CONTIFLO OD</td><td>TAMSULOSIN HYDROCHLORIDE</td><td>2006/12.3.1/4454</td><td>11/10/2006</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.4MG</td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>CONTRASAFE</td><td>MEDROXYPROGESTERONE ACETATE</td><td>2018/21.2.3/5760</td><td>12/18/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>CONTREZ</td><td>DROSPIRENONE; ETHINYLESTRADIOL</td><td>2023/21.2.1/6523</td><td>12/05/2023</td><td>12/05/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>3; 0.02 MG</td><td>OMAN PHARMACEUTICAL PRODUCTS CO.,LLC;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>CONTREZIN</td><td>DROSPERINONE; ETHINYLESTRADIOL</td><td>2023/21.2.1/6524</td><td>12/05/2023</td><td>12/05/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>3; 0.03 MG</td><td>OMAN PHARMACEUTICAL PRODUCTS CO.,LLC;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>CONTROL PILL</td><td>ETHINYLESTRADIOL; NORGESTREL</td><td>2006/21.2.1/4452</td><td>10/25/2006</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.03; 0.3MG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>CONTROL-L</td><td>ETHINYL ESTRADIOL; FERROUS FUMARATE; LEVONORGESTREL</td><td>2014/21.2.1/4923</td><td>08/19/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.15; 0.03; 75MG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>COOL MINT LISTERINE</td><td>ETHANOL; THYMOL</td><td>96/20.3.4/3044</td><td>01/19/1996</td><td>12/31/2027</td><td>SOLUTION/MOUTHWASH; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>4.58; 12.78MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  WARNER-LAMBERT (PTY) LTD;  JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>CORBIS-H 10</td><td>BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE</td><td>2021/12.3.5/6133</td><td>05/21/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 6.25MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>CORBIS-H 5</td><td>BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE</td><td>2021/12.3.5/6134</td><td>05/21/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 6.25MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>CORILIEF</td><td>DIPHENHYDRAMINE HYDROCHLORIDE; PARACETAMOL; PSEUSOEPHEDRINE HYDROCHLORIDE</td><td>2016/22.2.5/5281</td><td>09/21/2016</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 12.5; 22.5 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CORILIEF 5 FLU</td><td>DIPHENHYDRAMINE HYDROCHLORIDE; PARACETAMOL; PSEUSOEPHEDRINE HYDROCHLORIDE</td><td>2024/22.2.5/6565</td><td>02/29/2024</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>1000; 25; 45 MG/20ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CORILIEF DAY AND NIGHT</td><td>CHLOPHENIRAMINE MALEATE; PARACETAMOL; PSEUDOEPHEDRINE HYDROCHLORIDE</td><td>2020/22.2.5/6017</td><td>07/20/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 30; 2; 500; 30MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CORILIEF DRY COUGH SYRUP</td><td>HYDROBROMIDE</td><td>2016/22.2.1/5236</td><td>07/27/2016</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>15 MG/5 ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CORILIEF EXTRA-STRONG</td><td>CODEINE PHOSPHATE; CHLORPHENIRAMINE MALEATE; PARACETAMOL; PSEUDOEPHEDRINE HYDROCHLORIDE</td><td>2021/22.2.5/6157</td><td>07/28/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2; 10; 500; 30MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CORILIEF NON DROWSY</td><td>PARACETAMOL; PSEUDOEPHEDRINE</td><td>2019/22.2.5/5933</td><td>10/03/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 30MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>CORILIEF SINUS </td><td>CHLORPHENIRAMINE MALEATE; PARACETAMOL; PSEUDOEPHEDRINE HYDROCHLORIDE </td><td>2020/22.2.5/5996</td><td>04/16/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2; 500; 30MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>COROLOR</td><td>TICAGRELOR</td><td>2024/10.5/6732</td><td>10/21/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>90MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>CORSODYL MOUTHWASH MINT</td><td>CHLORHEXIDINE GLUCONATE</td><td>97/20.3.4/3136</td><td>02/27/1997</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>2MG/ML</td><td>SMITHKLINE BEECHAM PHARM PTY LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD</td><td>GLAXOSMITHKLINE</td>
	</tr><tr>
		<td>CORSODYL MOUTHWASH ORIGIONAL</td><td>CHLORHEXIDINE GLUCONATE</td><td>99/20.3.4/3480</td><td>01/29/1999</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>2MG/ML</td><td>DATLABS PRIVATE LIMITED;  GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD;  </td><td>GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD</td><td>GLAXOSMITHKLINE</td>
	</tr><tr>
		<td>CORT 10</td><td>HYDROCORTISONE</td><td>2025/17.1/6869</td><td>02/17/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>RENATA LIMITED ;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>CORT 20</td><td>HYDROCORTISONE</td><td>2025/17.1/6799</td><td>01/06/2025</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>RENATA LIMITED ;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>CORVADIL 10</td><td>AMLODIPINE BESYLATE</td><td>2020/12.6/6040</td><td>10/06/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>CORVADIL-5</td><td>AMLODIPINE BESYLATE</td><td>2008/12.6/4528</td><td>04/17/2008</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>COSAMIDE</td><td>LACOSAMIDE</td><td>2015/13.1/5101</td><td>11/03/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>COSAMIDE</td><td>LACOSAMIDE</td><td>2015/13.1/5102</td><td>11/06/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>CO-TRIMOXAZOLE</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>90/7.2.3/2342</td><td>03/12/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4OO; 80MG</td><td>DATLABS PRIVATE LIMITED;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>COTRINOL</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>92/7.2.3/2725</td><td>09/22/1992</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>240MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS (PVT) LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>COTRINOL</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>92/7.2.3/2724</td><td>09/22/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>480MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  GAMMA PHARMACEUTICALS ;  </td><td>PLUS FIVE PHARMACEUTICALS (PVT) LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>COTRIZOLE</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>91/7.2.3/2559</td><td>11/19/1991</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>240MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>COTRIZOLE</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>91/7.2.3/2572</td><td>12/19/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>480MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>COTRIZOLE DS</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>2002/7.23/4038</td><td>03/19/2002</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>960MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>COUGH STOP MIXTURE</td><td>COUGH STOP MIXTURE</td><td>89/22.2.5/2297</td><td>08/25/1989</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>12.5MG/140MG</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>WALLACE LABORATORIES PVT LTD</td>
	</tr><tr>
		<td>CP- AMLODIPINE 5</td><td>AMLODIPINE BESYLATE</td><td>2022/12.6/6232</td><td>01/21/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>ACME FORMULATION PVT LTD (HORMONE BLOCK)</td>
	</tr><tr>
		<td>CP- BENZYLPENICILLIN 1 MEGA</td><td>BENZYL PENICILLIN SODIUM</td><td>2024/7.1.1/6673</td><td>07/26/2024</td><td>&nbsp;</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1 000 000 UNITS</td><td>INJECT CARE PARENTERALS PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP- BENZYLPENICILLIN 5 MEGA</td><td>BENZYL PENICILLIN SODIUM</td><td>2024/7.1.1/6674</td><td>07/26/2024</td><td>&nbsp;</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 000 000 UNITS</td><td>INJECT CARE PARENTERALS PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-ADRENALINE INJECTION</td><td>&nbsp;</td><td>2025/12.7/6873</td><td>02/18/2025</td><td>02/17/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-AMLODIPINE 10</td><td>AMLODIPINE BESYLATE</td><td>2022/12.6/6233</td><td>01/21/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>ACME FORMULATION PVT LTD (HORMONE BLOCK)</td>
	</tr><tr>
		<td>CP-ATRACURIUM</td><td>ATRACURIUM BESYLATE</td><td>2024/1.3/6667</td><td>07/15/2024</td><td>&nbsp;</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/2ML</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-AZITHROMYCIN 500</td><td>AZITHROMYCIN</td><td>2019/7.2.5/5850</td><td>06/04/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-CARBOPLATIN 150</td><td>CARBOPLATIN</td><td>2023/9.4/6509</td><td>11/17/2023</td><td>11/17/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150 MG/15ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-CARBOPLATIN 450</td><td>CARBOPLATIN</td><td>2023/9.4/6510</td><td>11/17/2023</td><td>11/17/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>450 MG/45ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-CEFAZOLIN 1000</td><td>CEFAZOLIN SODIUM</td><td>2021/7.2.2/6094</td><td>02/04/2021</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1GRAM</td><td>SWISS PARENTERALS PVT.LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-CEFOTAXIME 1000</td><td>CEFOTAXIME SODIUM</td><td>2021/7.2.2/6199</td><td>10/22/2021</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>SWISS PARENTERALS PVT.LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-CEFTAZIDIME 1000</td><td>CEFTAZIDIME</td><td>2022/7.2.2/6356</td><td>11/16/2022</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1 GRAM</td><td>SWISS PARENTERALS PVT.LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-CEFTRIAXONE 250</td><td>CEFTRIAXONE SODIUM</td><td>2019/7.2.2/5930</td><td>09/20/2019</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>SWISS PARENTERALS PVT.LTD;  </td><td>SWISS EXPORT PVT</td><td>SWISS EXPORT PVT</td>
	</tr><tr>
		<td>CP-CEFUROXIME 250</td><td>CEFUROXIME AXETIL</td><td>2018/7.2.2/5682</td><td>09/07/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>NECTAR LIFESCIENCES LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-CEFUROXIME 500</td><td>CEFUROXIME AXETIL</td><td>2018/7.2.2/5683</td><td>09/07/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>NECTAR LIFESCIENCES LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-CISPLATIN 10</td><td>CISPLATIN</td><td>2024/9.4/6734</td><td>10/21/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/10ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-CISPLATIN 50</td><td>CISPLATIN</td><td>2024/9.4/6735</td><td>10/21/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/50ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-CLOTRIMAZOLE</td><td>CLOTRIMAZOLE</td><td>2022/14.17/6259</td><td>03/08/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100 MG</td><td>INTERMED;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-CLOTRIMAZOLE</td><td>CLOTRIMAZOLE</td><td>2022/14.1.3/6280</td><td>04/13/2022</td><td>12/31/2027</td><td>CREAMS</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>10MG/G</td><td>INTERMED;  COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-COLCHICINE 0.5</td><td>&nbsp;</td><td>2025/3.2/6955</td><td>05/13/2025</td><td>05/12/2030</td><td>&nbsp;</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>&nbsp;</td><td>RENATA LIMITED ;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-DOCETAXEL 120</td><td>DOCETAXEL TRIHYDRATE</td><td>2023/9.4/6478</td><td>10/04/2023</td><td>10/04/2028</td><td>LIQUID</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120 MG/3ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-DOCETAXEL 20</td><td>DOCETAXEL TRIHYDRATE</td><td>2023/9.4/6476</td><td>09/04/2023</td><td>09/04/2028</td><td>LIQUID</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20 MG/0.5ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-DOCETAXEL 80</td><td>DOCETAXEL TRIHYDRATE</td><td>2023/9.4/6477</td><td>10/04/2023</td><td>10/04/2028</td><td>LIQUID</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80 MG/2ML</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-EPIRUBICIN</td><td>EPIRUBICIN</td><td>2024/9.4/6794</td><td>12/12/2024</td><td>&nbsp;</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS SOUTH AFRICA </td>
	</tr><tr>
		<td>CP-ESOMEPRAZOLE 20</td><td>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</td><td>2023/16.7/6424</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>ACME FORMULATION PVT LTD (HORMONE BLOCK)</td>
	</tr><tr>
		<td>CP-ESOMEPRAZOLE 40</td><td>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</td><td>2023/16.7/6536</td><td>12/13/2023</td><td>12/13/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-FLUPHENAZINE</td><td>FLUPHENAZINE DECANOATE</td><td>2024/13.2.3/6653</td><td>06/25/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>CIRON DRUGS AND PHARMACEUTICALS PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-GLYCERIN</td><td>GLYCERIN</td><td>2021/16.5/6197</td><td>10/22/2021</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.2GRAM</td><td>BLISS GVS PHARMA LIMITED;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-GLYCERIN</td><td>GLYCERIN</td><td>2021/16.5/6196</td><td>10/22/2021</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2GRAM</td><td>BLISS GVS PHARMA LIMITED;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-KETOLAC 10</td><td>KETOROLAC TROMETHAMINE</td><td>2025/3.1/6827</td><td>01/17/2025</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/ML</td><td>STERIL-GENE LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-KETOLAC 30</td><td>KETOROLAC TROMETHAMINE</td><td>2025/3.1/6828</td><td>01/17/2025</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30 MG/ML</td><td>STERIL-GENE LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-LEVOTHYROXINE 50</td><td>LEVOTHYROXINE SODIUM</td><td>2024/17.8.1/6556</td><td>02/09/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MCG</td><td>ACME GENERICS LLP;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-NEX</td><td>ESOMEPRAZOLE SODIUM</td><td>2024/16.7/6597</td><td>05/06/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>42.5MG</td><td>IMMACULE LIFESCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-OMEP</td><td>OMEPRAZOLE</td><td>2023/16.7/6495</td><td>10/26/2023</td><td>10/26/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/VIAL</td><td>IMMACULE LIFESCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-OXYLINE </td><td>OXYMETAZOLINE HYDROCHLORIDE</td><td>2021/20.2.4/6173</td><td>09/07/2021</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.05%W/V</td><td>GENERAL PHARMACEUTICALS LIMITED;  </td><td>COSPHARM INVESTMENTS</td><td>GENERAL PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CP-OXYLINE </td><td>OXYMETAZOLINE HYDROCHLORIDE</td><td>2021/20.2.4/6172</td><td>09/07/2021</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.025%W/V</td><td>GENERAL PHARMACEUTICALS LIMITED;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>GENERAL PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>CP-OXYLINE FORTE</td><td>OXYMETAZOLINE HYDROCHLORIDE</td><td>2024/20.2.4/6764</td><td>11/18/2024</td><td>&nbsp;</td><td>SPRAY, METERED; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.5MG/ML</td><td>LABORATORIES CINFA, S.A.;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-OXYTOCIN 5 IU</td><td>OXYTOCIN</td><td>2022/21.1.1/6355</td><td>11/16/2022</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5IU/ML</td><td>STERIL-GENE LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-OXYTOXIN 10 IU</td><td>OXYTOCIN</td><td>2020/21.1.1/6047</td><td>10/26/2020</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10IU/ML</td><td>STERIL-GENE LIFE SCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-PARACETAMOL</td><td>PARACETAMOL</td><td>2024/2.1/6578</td><td>04/03/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>ACME FORMULATION PVT LTD;  COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-PRANOX</td><td>PANTOPRAZOLE SODIUM SESQUIHYDRATE</td><td>2024/16.7/6796</td><td>12/12/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/ML</td><td>IMMACULATE LIFESCIENCES PVT. LTD. ;  </td><td>COSPHARM INVESTMENTS</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CP-SERTRALINE 50</td><td>SERTRALINE HYDROCHLORIDE</td><td>2025/13.2.1/6891</td><td>03/06/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>PINNACLE LIFE SCIENCE PVT. LTD. ;  Cospharm Investments Zimbabwe;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>CP-SUXAMETHONIUM</td><td>SUXAMETHONIUM CHLORIDE</td><td>2025/1.3/6874</td><td>02/24/2025</td><td>02/23/2030</td><td>AEROSOL; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MCG;25MCG</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-TADALAFIL 20</td><td>&nbsp;</td><td>2025/31/6961</td><td>05/27/2025</td><td>05/26/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>UMEDICA LABORATORIES PVT. LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>CP-TRAMADOL</td><td>TRAMADOL HYDROCHLORIDE</td><td>2019/2.1/5938</td><td>10/14/2019</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CREAM E45</td><td>PARAFIN SOFT WHITE; LIQUID PARAFIN; WOOL FAT</td><td>2016/14.4/5231</td><td>12/20/1981</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>14.5; 12.6; 1.0 G</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD;  ADCOCK INGRAM LTD;  PHARMACEUTICAL CONTRACTORS (PTY) LTD;  RECKITT BENCKISSER PHARMACEUTICALS PTY LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>RECKITT BENKISER HEALTHCARE INTERNATIONAL LTD</td>
	</tr><tr>
		<td>CREON 10000</td><td>PANCREATIN</td><td>2018/16.8.1/5659</td><td>07/27/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>ABBOTT LABORATORIES GMBH;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES GMBH</td>
	</tr><tr>
		<td>CREON 25000</td><td>PANCREATIN</td><td>2018/16.8.1/5660</td><td>07/27/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>ABBOTT LABORATORIES GMBH;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES GMBH</td>
	</tr><tr>
		<td>CREON 40 000</td><td>PANCREATIN</td><td>2018/16.8.1/5645</td><td>07/05/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>ABBOTT LABORATORIES GMBH;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES GMBH</td>
	</tr><tr>
		<td>CRESTOR 10MG</td><td>ROSUVASTATIN CALCIUM</td><td>2017/12.8/5407</td><td>08/07/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>ASTRAZENECA UK LIMITED;  IPR PHARMACEUTICALS INC.;  </td><td>ASTRAZENECA UK LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>CRESTOR 20MG</td><td>ROSUVASTATIN CALCIUM</td><td>2017/12.8/5408</td><td>08/07/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>IPR PHARMACEUTICALS INC.;  ASTRAZENECA UK LIMITED;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>CRESTOR 5MG</td><td>ROSUVASTATIN CALCIUM</td><td>2017/12.8/5406</td><td>08/07/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>IPR PHARMACEUTICALS INC.;  ASTRAZENECA UK LIMITED;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>CUREDOL</td><td>TRAMADOL HYDROCHLORIDE</td><td>2022/2.1/6305</td><td>07/25/2022</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td>
	</tr><tr>
		<td>CURON</td><td>ROCURONIUM BROMIDE</td><td>2022/1.3/6224</td><td>01/13/2022</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>IMMACULE LIFESCIENCES PVT LTD;  </td><td>COSPHARM INVESTMENTS</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>CUROX</td><td>ROXITHROMYCIN</td><td>2001/7.2.5/3922</td><td>07/09/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>CYANIDE ANTIDOTE A</td><td>CITRIC ACID; FERROUS SULPHATE; SODIUM CARBONATE</td><td>84/35/1423</td><td>04/30/1985</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>300MG;15.8G; 6G</td><td>CAPS PVT LTD;  LANCASTER INDUSTRIAL PVT LTD;  </td><td>GEDDES LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CYCLIZINE HYDROCHLORIDE</td><td>CYCLIZINE HYDROCHLORIDE</td><td>93/16.2/2751</td><td>01/12/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>CYCLOKAPRON</td><td>TRANEXAMIC ACID</td><td>75/10.4/574</td><td>12/17/1975</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1G/ML</td><td>PHARMACIA NV/S.A;  PFIZER INCORPORATION;  PFIZER MANUFACTURING;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>CYCLOKAPRON</td><td>TRANEXAMIC ACID</td><td>5/8.1/523</td><td>12/17/1975</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5G</td><td>PHARMACIA &amp; UPJOHN S.P.A.;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>CYCLOPAM</td><td>DICYCLOMINE HYDROCHLORIDE; SIMETHICOME</td><td>2006/16.4/4423</td><td>05/16/2006</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10; 40MG/5ML</td><td>INDOCO REMEDIES LTD;  INDOCO REMEDIES LIMITED;  </td><td>INDOCO REMEDIES LTD</td><td>INDOCO REMEDIES LTD</td>
	</tr><tr>
		<td>CYCLOSERINE </td><td>CYCLOSERINE</td><td>2021/7.3/6113</td><td>03/19/2021</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>CYCLOSERINE</td><td>CYCLOSERINE</td><td>2009/7.3/4548</td><td>03/04/2009</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>MACLEODS PHARMACEUTICALS LTD;  MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>CYCLOVAX</td><td>ACYCLOVIR</td><td>96/7.13/3192</td><td>12/19/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>CYTARINE</td><td>CYTARABINE</td><td>2010/9.2/4615</td><td>03/29/2010</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>CYTOCRISTIN AQUEOUS</td><td>VINCRISTINE SULPHATE</td><td>2011/9.3.1/4663</td><td>02/14/2011</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>CYVAC</td><td>R21 MALARIA ANTIGEN</td><td>2024/18.2/6711</td><td>11/30/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MCG/0.5ML</td><td>SERUM INSTITUTE OF INDIA PVT LTD;  </td><td>SERUM INSTITUTE OF INDIA PVT LTD</td><td>SERUM INSTITUTE OF INDIA PVT LTD</td>
	</tr><tr>
		<td>CYVAC</td><td>R21 MALARIA ANTIGEN</td><td>2024/18.2/6710</td><td>09/30/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG/0.5ML</td><td>SERUM INSTITUTE OF INDIA PVT LTD;  </td><td>SERUM INSTITUTE OF INDIA PVT LTD</td><td>SERUM INSTITUTE OF INDIA PVT LTD</td>
	</tr><tr>
		<td>DABIFIB 110</td><td>DABIGATRAN ETEXILATE</td><td>2022/10.2/6227</td><td>01/13/2022</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>110MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>DABIFIB 150</td><td>DABIGATRAN ETEXILATE</td><td>2022/10.2/6226</td><td>01/13/2022</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>DABIFIB 75</td><td>DABIGATRAN ETEXILATE</td><td>2022/10.2/6228</td><td>01/13/2022</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>DAISY-30</td><td>DESOGESTREL; ETHINYL ESTRADIOL</td><td>2013/21.2.1/4798</td><td>09/02/2013</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>150; 30MCG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>DAKTARIN</td><td>MICONAZOLE NITRATE</td><td>80/20.3.6/1327</td><td>03/31/1980</td><td>12/31/2027</td><td>GEL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2%</td><td>SPECPHARM HOLDINGS PRIVATE LIMITED;  </td><td>JANSSEN PHARMACEUTICA (PTY) LTD</td><td>JANSSEN PHARMACEUTICA</td>
	</tr><tr>
		<td>DALACIN C PALMITATE</td><td>CLINDAMYCIN PALMITATE HYDROCHLORIDE</td><td>73/7.25/0125</td><td>06/04/1973</td><td>12/31/2027</td><td>GRANULE, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>CATALENT PHARMA SOLUTIONS; LLC;  PHARMACIA &amp; UPJOHN;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>DALACIN C PHOSPHATE</td><td>CLINDAMYCIN PHOSPHATE</td><td>3/20.1.1/126</td><td>09/24/1973</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML</td><td>PHARMACIA NV/S.A;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>DAPAGLIFLOZIN 10 COSPHARM</td><td>DAPAGLIFLOZIN</td><td>2025/17.7/6868</td><td>02/13/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>INVENTIA HEALTHCARE PVT LTD;  </td><td>COSPHARM INVESTMESTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>DAPAGLIFLOZIN 5 COSPHARM</td><td>DAPAGLIFLOZIN</td><td>2025/17.7/6867</td><td>02/13/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>INVENTIA HEALTHCARE PVT LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>DAPAONE 10</td><td>DAPAGLIFLOZIN</td><td>2024/17.7/6661</td><td>07/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>DAPAONE 5</td><td>DAPAGLIFLOZIN</td><td>2024/17.7/6660</td><td>07/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>DAPIRING</td><td>DAPIVIRINE</td><td>2021/7.13/6148</td><td>07/06/2021</td><td>12/31/2027</td><td>RING: VAGINAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/RING</td><td>QPHARMA AB;  </td><td>INTERNATIONAL PARTNERSHIP FOR MICROBICIDES INC. IPM</td><td>INTERNATIONAL PARTNERSHIP FOR MICROBICIDES INC. IPM</td>
	</tr><tr>
		<td>DAPOXEM 30</td><td>DAPOXETINE</td><td>2017/31/5341</td><td>03/09/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>DAPZIN 10-M</td><td>DAPAGLIFLOZIN/ METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6721</td><td>10/02/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10; 500MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>DAPZIN 10-M PLUS</td><td>DAPAGLIFLOZIN/ METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6722</td><td>10/21/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10; 1000MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>DAPZIN 5-M PLUS</td><td>DAPAGLIFLOZIN/ METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6719</td><td>10/02/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5; 500MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>DAPZIN 5-M PLUS</td><td>DAPAGLIFLOZIN/ METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6720</td><td>10/02/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5; 1000MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>DAPZIN-10</td><td>DAPAGLIFLOZIN PROPANEDIOL</td><td>2023/17.7/6482</td><td>09/27/2023</td><td>09/27/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>DAPZIN-5</td><td>DAPAGLIFLOZIN PROPANEDIOL</td><td>2023/17.7/6481</td><td>09/27/2023</td><td>09/27/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>DARITOR-15</td><td>DARIFENACIN HYDROBROMIDE</td><td>2024/21.7/6585</td><td>04/12/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>DARITOR-7.5</td><td>DARIFENACIN HYDROBROMIDE</td><td>2024/21.7/6586</td><td>04/12/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>7.5MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>DARROWS SOLUTION</td><td>POTASIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE</td><td>2017/23.2.1/5499</td><td>12/11/2017</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.57; 3.96; 5.84G</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>DARUNAVIR</td><td>DARUNAVIR</td><td>2020/7.13/5962</td><td>01/23/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>DARUNAVIR</td><td>DARUNAVIR</td><td>2020/7.13/5961</td><td>01/23/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>DARUNAVIR </td><td>DARUNAVIR</td><td>2020/7.13/5960</td><td>01/23/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>CIPLA LIMITED;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>DARUNAVIR</td><td>DARUNAVIR</td><td>2020/7.13/5963</td><td>01/23/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>800MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>DARUNAVIR AND RITONAVIR TABLETS 800MG/100MG</td><td>DARUNAVIR; RITONAVIR</td><td>2022/7.13/6351</td><td>11/15/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>800/100MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>DARUNAVIR; RITONAVIR</td><td>DARUNAVIR; RITONAVIR</td><td>2018/7.13/5739</td><td>11/19/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400; 50MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DARUNAVIR; RITONAVIR</td><td>DARUNAVIR; RITONAVIR</td><td>2022/7.13/6283</td><td>05/30/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400; 50MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>DATVITAMIN SYRUP</td><td>MULTIVITAMINS</td><td>77/23.4/986</td><td>11/03/1977</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>0.042; 0.0077; 0.0015; 0.002G; 2800IU</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>DAWNEX</td><td>FLUOXETINE HYDROCHLORIDE</td><td>2000/13.2.1/3753</td><td>08/10/2000</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>DAXOTEL</td><td>DOCETAXEL</td><td>2008/9.4/4542</td><td>12/10/2008</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/ML</td><td>FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>DAXOTEL</td><td>DOCETAXEL</td><td>2008/9.4/4545</td><td>12/10/2008</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG/2ML</td><td>FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>DECALETS</td><td>BENZOCAINE; DEQUALINIUM CHLORIDE  </td><td>81/20.3.5/5980</td><td>12/18/1981</td><td>12/31/2027</td><td>TROCHE/LOZENGE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.25; 2.5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>DECLOT 0.5</td><td>WARFARIN SODIUM</td><td>2025/10.2/6850</td><td>02/03/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>DEEP RELIEF</td><td>IBUPROFEN</td><td>2023/3.1/6397</td><td>05/22/2023</td><td>05/22/2028</td><td>GEL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>50MG/G</td><td>THE MENTHOLATUM CO LTD;  </td><td>MENTHOLATUM R.S.A PTY LTD</td><td>MENTHOLATUM R.S.A PTY LTD</td>
	</tr><tr>
		<td>DEFETOR 250</td><td>DEFERASIROX</td><td>2023/10.7/6426</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>DEFETOR-125</td><td>DEFERASIROX</td><td>2023/10.7/6427</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>DEFETOR-500</td><td>DEFERASIROX</td><td>2023/10.7/6425</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>DEKSTOMID</td><td>DEXMEDETOMIDINE HYDROCHLORIDE</td><td>2024/1.1/6689</td><td>08/23/2024</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG/2ML</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>DELSTRIGO</td><td>DORAVIRINE; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2024/7.13/6550</td><td>01/29/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100, 300, 300MG</td><td>MSD INTERNATIONAL GMBH;  </td><td>MSD (PTY) LTD</td><td>MSD (PTY) LTD</td>
	</tr><tr>
		<td>DELTAPRIM</td><td>DAPSONE; PYRIMETHAMINE</td><td>73/7.5/112</td><td>05/18/1973</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>12.5; 100MG</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>DELTAPRIM PAEDIATRIC</td><td>DAPSONE; PYRIMETHAMINE</td><td>75/7.5/507</td><td>07/29/1975</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>25; 3.125MG</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>DEPLATT</td><td>CLOPIDOGREL BISULPHATE</td><td>2012/10.5/4742</td><td>08/10/2012</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>DEPO - MEDROL (1ML)</td><td>METHYLPREDNISOLONE ACETATE</td><td>77/3.4/848</td><td>03/03/1977</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/ML</td><td>PFIZER MANUFACTURING;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>DEPO MEDROL</td><td>METHYLPREDNISOLONE ACETATE</td><td>C/3.1/198</td><td>07/01/1972</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG/ML</td><td>PHARMACIA NV/S.A;  </td><td>PHARMACIA & UPJOHN</td><td>PHARMACIA NV/S.A</td>
	</tr><tr>
		<td>DEPO-MEDROL (2ML)</td><td>METHYLPREDNISOLONE ACETATE</td><td>2019/3.4/5895</td><td>07/30/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/ML</td><td>PFIZER MANUFACTURING;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>DEPO-PROVERA</td><td>MEDROXYPROGESTERONE ACETATE</td><td>2/21.8.2/25</td><td>08/24/1972</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG/ML</td><td>PFIZER MANUFACTURING;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>DERIVA AQUEOUS GEL</td><td>ADAPALENE</td><td>2004/14.5.1/4237</td><td>01/19/2004</td><td>12/31/2027</td><td>GEL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.1% WW</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>DERMAPAL - CALAMINE CREAM</td><td>CALAMINE; ZINC OXIDE</td><td>2015/14.19/5144</td><td>12/17/2015</td><td>12/31/2027</td><td>LOTION; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>15/5 % W/W</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>DERMAPAL - CALAMINE CREAM</td><td>CALAMINE; ZINC OXIDE</td><td>2015/14.19/5143</td><td>12/17/2015</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>4/3 % W/W</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>DERMAPAL - G& I</td><td>GLYCERINE; ICHTHAMMOL</td><td>2015/14.1.2/5141</td><td>12/17/2015</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>10% W/W</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>DERMAPAL - SSD CREAM</td><td>SILVER SULFADIAZINE</td><td>2015/14.1.2/5142</td><td>12/17/2015</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1% W/W</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>DERMAPAL - WHITFIELD'S OINTMENT</td><td>COMPOUND BENZOIC ACID</td><td>2015/14.1.3/5146</td><td>12/17/2015</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>6 %</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>DERMAPAL - WINTERGREEN OINTMENT</td><td>METHYL SALICYLATE</td><td>2015/14.19/5145</td><td>12/17/2015</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>50% W/W</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>DERMOCIN</td><td>MUPIROCIN</td><td>2017/14.1.1/5489</td><td>12/05/2017</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2% W/W</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>DERMOLIN</td><td>CLOBETASOL PROPIONATE</td><td>2020/14.2.1/6048</td><td>11/03/2020</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.05%W/W</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>DERMOVIDONE</td><td>POVIDONE IODINE</td><td>2016/14.1.4/5201</td><td>04/27/2016</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100 MG/ML</td><td>GALENTIC PHARMA, PVT LTD;  </td><td>GALENTIC PHARMA (INDIA) PVT LTD</td><td>GALENTIC PHARMA (INDIA) PVT LTD</td>
	</tr><tr>
		<td>DERVACORT</td><td>HYDROCORTISONE</td><td>91/14.2.1/2533</td><td>05/08/1991</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1%</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>DERVACORT</td><td>HYDROCORTISONE</td><td>91/14.2.1/2532</td><td>09/20/1991</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1%</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>DESCOVY</td><td>EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>2017/7.13/5445</td><td>10/13/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/10MG</td><td>PATHEON INC;  ROTTENDORF PHARMA GMBH,;  GILEAD SCIENCES INC;  MILLMOUNT HEALTHCARE LTD;  </td><td>GILEAD SCIENCES INC</td><td>GILEAD SCIENCES INC</td>
	</tr><tr>
		<td>DESCOVY</td><td>EMITRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>2017/7.13/5446</td><td>10/13/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 25MG</td><td>PATHEON INC;  MILLMOUNT HEALTHCARE LTD;  GILEAD SCIENCES LIMITED;  GILEAD SCIENCES INC;  ROTTENDORF PHARMA GMBH,;  </td><td>GILEAD SCIENCES INC</td><td>GILEAD SCIENCES INC</td>
	</tr><tr>
		<td>DESLAFAXOR 100 (EXTENDED RELEASE)</td><td>DESVENLAFAXINE SUCCINATE</td><td>2021/13.2.1/6084</td><td>01/20/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>DESLAFAXOR 50 (EXTENDED RELEASE)</td><td>DESVENLAFAXINE SUCCINATE</td><td>2021/13.2.1/6083</td><td>01/20/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>DESLORATIDINE 5 COSPHARM</td><td>DESLORATIDINE</td><td>2025/5/6815</td><td>01/14/2025</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>LABORATORIES LESVI S.L;  </td><td>COSPHARM INVESTMENTS SOUTH AFRICA </td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>DESOGESTREL/ETHINYL ESTRADIOL</td><td>DESOGESTREL; ETHINYL ESTRADIOL</td><td>2018/21.2.1/5545</td><td>01/29/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.15MG/0.03MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED</td><td>LUPIN LIMITED</td>
	</tr><tr>
		<td>DESTRA 20</td><td>DESOGESTREL; ETHINYL ESTRADIOL</td><td>2023/21.2.1/6413</td><td>06/20/2023</td><td>06/20/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.15; 0.02MG</td><td>CYNDEA PHARMA S.L;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>DESTRA 30</td><td>DESOGESTREL; ETHINYL ESTRADIOL</td><td>2023/21.2.1/6404</td><td>04/21/2023</td><td>04/21/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.15; 0.03MG</td><td>CYNDEA PHARMA S.L;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>DETTOL</td><td>CHLOROXYLENOL</td><td>2019/14.1.4/5826</td><td>09/17/1981</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>4.8G/100ML</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD</td>
	</tr><tr>
		<td>DEULOKS 60</td><td>DULOXETINE HYDROCHLORIDE</td><td>2018/13.2.1/5653</td><td>07/23/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>60MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>DEVODIL 200</td><td>SULPIRIDE</td><td>98/13.2.3/3361</td><td>06/22/1998</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>DEXAMETHASONE SODIUM PHOSPHATE</td><td>DEXAMETHASONE SODIUM PHOSPHATE</td><td>2024/17.1/6723</td><td>10/11/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4MG/ML</td><td>CIRON DRUGS AND PHARMACEUTICALS PVT LTD;  </td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td>
	</tr><tr>
		<td>DEXIGLOFOZIN</td><td>DAPAGLIFLOZIN PROPANEDIOL</td><td>2024/17.7/6669</td><td>07/18/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>ZETA  PHARMA;  </td><td>ZETA PHARMA FOR PHARMACEUTICAL INDUSTRIES</td><td>ZETA PHARMA FOR PHARMACEUTICAL INDUSTRIES</td>
	</tr><tr>
		<td>DEXIGLOFOZIN</td><td>DAPAGLIFLOZIN</td><td>2024/17.7/6670</td><td>07/18/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>ZETA  PHARMA;  </td><td>ZETA PHARMA FOR PHARMACEUTICAL INDUSTRIES</td><td>ZETA PHARMA FOR PHARMACEUTICAL INDUSTRIES</td>
	</tr><tr>
		<td>DEXONE</td><td>DEXAMETHASONE SODIUM PHOSPHATE</td><td>92/17.1/2637</td><td>05/18/1992</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG/ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>DEXONE</td><td>DEXAMETHASONE</td><td>94/17.1/2832</td><td>03/30/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>DEXPURE</td><td>DEXRABEPRAZOLE SODIUM</td><td>2017/16.7/5393</td><td>07/13/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>DEXTROSE</td><td>DEXTROSE</td><td>92/23.2.1/2666</td><td>06/24/1992</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5%</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM CRITICAL CARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>DEXTROSE 10%</td><td>DEXTROSE</td><td>2017/23.2.1/5454</td><td>10/30/2017</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10%W/V</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM CRITICAL CARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>DEXTROSE 5% FRESENIUS</td><td>DEXTROSE</td><td>2003/23.2.1/4188</td><td>08/27/2003</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50G/1000ML</td><td>INTRAMED (PTY) LTD;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>DEXTROSE 50% (20ML) FRESENIUS</td><td>DEXTROSE</td><td>2006/23.2.2/4437</td><td>07/10/2006</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10G/20ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>DEXTROSE 50% FRESENIUS</td><td>DEXTROSE</td><td>2010/23.2.2/4650</td><td>10/25/2010</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25G/50ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>DEXTROSE MONOHYDRATE 50%</td><td>DEXTROSE</td><td>77/23.2.1/0982</td><td>11/03/1977</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>55G/100ML</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>DIABEND</td><td>GLICLAZIDE</td><td>2001/17.7/3957</td><td>07/20/2001</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80MG</td><td>BAL PHARMA;  BAL PHARMA LTD;  </td><td>SKY PHARMACEUTICALS LTD</td><td>BAL PHARMA</td>
	</tr><tr>
		<td>DIANE 35</td><td>CYPROTERONE ACETATE; ETHINYLOESTRADIOL</td><td>90/21.2.1/2396</td><td>10/10/1990</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2; 0.035MG</td><td>BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  BAYER AG, BERLIN;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>DIANEAL WITH  1.5% DEXTROSE</td><td>CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE; MAGNESIUM CHLORIDE</td><td>73/23.3.1/181</td><td>10/29/1973</td><td>12/31/2027</td><td>SOLUTION; INTRAPERIOTONEAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.026G; 1.5G; 0.05G; 0.56G; 0.015G</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>DIANEAL WITH 4.25% DEXTROSE</td><td>CALCIUM CHLORIDE; DEXTROSE; SODIUM CHLORIDE; SODIUM LACTATE; MAGNESIUM CHLORIDE</td><td>73/23.3.1/183</td><td>10/29/1973</td><td>12/31/2027</td><td>SOLUTION; INTRAPERIOTONEAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.026; 4.50; 0.56; 0.50; 0.015G/100ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>DIAZEPAM</td><td>DIAZEPAM</td><td>89/13.2.2/2229</td><td>01/05/1989</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>&nbsp;</td>
	</tr><tr>
		<td>DICHLOR-12.5</td><td>CHLORTHALIDONE</td><td>2017/12.5.1/5360</td><td>04/04/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5 MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DICHLOR-25</td><td>CHLORTHALIDONE</td><td>2017/12.5.1/5359</td><td>04/04/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25 MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DICLOFENAC</td><td>DICLOFENAC SODIUM</td><td>2008/3.1/4533</td><td>07/02/2008</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>LINCOLN PHARMACEUTICALS LTD;  </td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td><td>LINCOLN PARENTERAL LIMITED</td>
	</tr><tr>
		<td>DICLOFENAC</td><td>DICLOFENAC SODIUM</td><td>2012/3.1/4752</td><td>09/27/2012</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>KARNATAKA ANTIB &amp; PHARMA LTD;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>DICLOFENAC SODIUM</td><td>DICLOFENAC SODIUM</td><td>2000/3.1/3763</td><td>08/28/2000</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>BAL PHARMA;  BAL PHARMA LTD;  </td><td>BAL PHARMA</td><td>BAL PHARMA</td>
	</tr><tr>
		<td>DICLOFENAC SODIUM</td><td>DICLOFENAC SODIUM</td><td>2001/3.1/3891</td><td>02/26/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>DICLORAN</td><td>DICLOFENAC DIETHYLAMINE</td><td>2024/3.1/6765</td><td>11/19/2024</td><td>12/31/2027</td><td>GEL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>10% W/W</td><td>UNIQUE PHARMACEUTICAL LABORATORIES;  </td><td>RAINBOW PHARMACEUTICALS</td><td>UNIQUE PHARM LABS </td>
	</tr><tr>
		<td>DICLOZED</td><td>DICLOFENAC SODIUM</td><td>2016/3.1/5277</td><td>09/16/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75 MG</td><td>SAKAR HEALTHCARE PVT LTD;  </td><td>SAKAR HEALTHCARE PVT LTD</td><td>SAKAR HEALTHCARE PVT LTD</td>
	</tr><tr>
		<td>DICLOZOR</td><td>DICLOFENAC</td><td>2024/3.1/6782</td><td>12/10/2024</td><td>&nbsp;</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25mg/ml</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>ZORWAY EXIM PVT LTD</td><td>ZORWAY EXIM PVT LTD</td>
	</tr><tr>
		<td>DICURE</td><td>DICLOFENAC SODIUM</td><td>2025/3.1/6930</td><td>04/25/2025</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td>
	</tr><tr>
		<td>DIGESTIF RENNIE</td><td>CALCIUM CARBONATE; MAGNESIUM CARBONATE</td><td>94/16.1/2875</td><td>11/14/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>80; 680 MG</td><td>ROCHE PRODUCTS PTY LTD;  HOFFMAN LA ROCHE;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  ROCHE PRODUCTS FRANCE;  </td><td>BAYER (PTY) LTD</td><td>BAYER (PTY) LTD</td>
	</tr><tr>
		<td>DIGESTIF RENNIE (SPEARMINT)</td><td>CALCIUM CARBONATE; MAGNESIUM CARBONATE</td><td>95/16.1/2896</td><td>02/15/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>80; 680 MG</td><td>ROCHE PRODUCTS PTY LTD;  HOFFMAN LA ROCHE;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  ROCHE PRODUCTS FRANCE;  </td><td>BAYER (PTY) LTD</td><td>BAYER (PTY) LTD</td>
	</tr><tr>
		<td>DIKLORON </td><td>DICLOFENAC SODIUM</td><td>2024/3.1/6677</td><td>07/30/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>DEVA HOLDINGS;  </td><td>ACCESS PHARMACEUTICALS</td><td>DEVA HOLDINGS A.S</td>
	</tr><tr>
		<td>DIKLORON </td><td>DICLOFENAC DIETHYLAMMONIUM</td><td>2024/3.1/6601</td><td>05/09/2024</td><td>12/31/2027</td><td>GEL</td><td>PHARMACY MEDICINES (P.)</td><td>1.16% W/W</td><td>DEVA HOLDINGS A.S;  </td><td>DEVA HOLDINGS A.S</td><td>DEVA HOLDINGS A.S</td>
	</tr><tr>
		<td>DILINCT DRY COUGH</td><td>HYDROBROMIDE</td><td>2006/22.2.1/4441</td><td>08/16/2006</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>15MG/5ML</td><td>ADCOCK INGRAM LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>DIOVAN</td><td>VALSARTAN</td><td>2002/12.3.5/4034</td><td>02/08/2002</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>160MG</td><td>NOVARTIS PHARMA STEIN AG;  </td><td>NOVARTIS PHARMA STEIN AG</td><td>NOVARTIS PHARMA STEIN AG</td>
	</tr><tr>
		<td>DIOVAN</td><td>VALSARTAN</td><td>2002/12.3.5/4033</td><td>02/08/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80MG</td><td>NOVARTIS PHARMA STEIN AG;  </td><td>NOVARTIS PHARMA STEIN AG</td><td>NOVARTIS PHARMA STEIN AG</td>
	</tr><tr>
		<td>DIPHENHYDRAMINE HYDROCHLORIDE</td><td>DIPHENHYDRAMINE HYDROCHLORIDE</td><td>89/5/2295</td><td>08/25/1989</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>12.5MG/5ML</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>WALLACE LABORATORIES PVT LTD</td>
	</tr><tr>
		<td>DIPHENHYDRAMINE HYDROCHLORIDE</td><td>DIPHENHYDRAMINE HYDROCHLORIDE</td><td>89/5/2230</td><td>01/05/1989</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>25MG</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>&nbsp;</td>
	</tr><tr>
		<td>DIPTATRIS 10/160/12.5MG</td><td>&nbsp;</td><td>2025/12.3.5/6896</td><td>03/13/2025</td><td>03/12/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DIPTATRIS 10/160/25MG</td><td>&nbsp;</td><td>2025/12.3.5/6897</td><td>03/13/2025</td><td>03/12/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DIPTATRIS 10/320/25MG</td><td>&nbsp;</td><td>2025/12.3.5/6898</td><td>03/06/2025</td><td>03/05/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DIPTATRIS 5/160/12.5</td><td>&nbsp;</td><td>2025/12.3.5/6894</td><td>03/13/2025</td><td>03/12/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DIPTATRIS 5/160/25</td><td>&nbsp;</td><td>2025/12.3.5/6895</td><td>03/13/2025</td><td>03/12/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DIPTHERIA; HAEMOPHILUS TYPE B; HEPATITIS B; PERTUSSIS; TETANUS</td><td>DIPTHERIA;  HAEMOPHILUS TYPE B; HEPATITIS B; PERTUSSIS; TETANUS</td><td>2021/18.2/6160</td><td>07/27/2021</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5ML (10 DOSE)</td><td>BIOLOGICAL E. LIMITED;  </td><td>M/S BIOLOGICAL E, LTD</td><td>M/S BIOLOGICAL E, LTD</td>
	</tr><tr>
		<td>DIPTHERIA; HAEMOPHILUS TYPE B; HEPATITIS B; PRTUSSIS; TETANUS</td><td>DIPTHERIA;  HAEMOPHILUS TYPE B; HEPATITIS B; PERTUSSIS; TETANUS</td><td>2021/18.2/6159</td><td>07/27/2021</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5ML</td><td>BIOLOGICAL E. LIMITED;  </td><td>M/S BIOLOGICAL E, LTD</td><td>M/S BIOLOGICAL E, LTD</td>
	</tr><tr>
		<td>DISPRIN</td><td>ASPIRIN</td><td>77/2.1/900</td><td>04/14/1977</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>300MG</td><td>RECKITT BENCKISER HEALTHCARE UK LIMITED;  </td><td>RECKITT BENKISER PHARMACEUTICALS</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>DISPRIN EXTRA-RECKITT STRENGTH</td><td>ASPIRIN</td><td>2024/2.1/6745</td><td>10/31/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500MG</td><td>RECKITT BENCKISER HEALTHCARE PRIVATE LIMITED;  RECKITT BENCKISER HEALTHCARE (UK) LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>DIUREN</td><td>FUROSEMIDE</td><td>2006/22.5.1/4405</td><td>01/17/2006</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>DIZAM</td><td>DIAZEPAM</td><td>77/13.02.02/944</td><td>08/04/1977</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>CAPS PVT LTD;  </td><td>CAPS INTERNATIONAL EST</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>DIZAM</td><td>DIAZEPAM</td><td>73/13.02.02/0130</td><td>06/19/1973</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/2ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>DOBUTAMINE FRESENIUS</td><td>DOBUTAMINE HYDROCHLORIDE</td><td>2011/12.7/4700</td><td>08/05/2011</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/20ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>DOCETAXEL MYLAN</td><td>DOCETAXEL</td><td>2019/9.3/5908</td><td>08/21/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED (OTL)</td><td>MYLAN LABORATORIES LIMITED (OTL)</td>
	</tr><tr>
		<td>DOCETAXEL MYLAN</td><td>DOCETAXEL</td><td>2019/9.3/5909</td><td>08/21/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED (OTL)</td><td>MYLAN LABORATORIES LIMITED (OTL)</td>
	</tr><tr>
		<td>DOLEX</td><td>IBUPROFEN</td><td>87/3.1/2123</td><td>11/12/1987</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>DOLEX</td><td>IBUPROFEN</td><td>87/3.1/2122</td><td>11/12/1987</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>DOLIO SABIN ONE AND THREE (ORAL)</td><td>POLIOMYELITIS VIRUS TYPES 1,3 (LIVE, INACTIVATED; ORAL) </td><td>2016/18.2/5223</td><td>06/14/2016</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10^6; 10^5.8CCID50</td><td>GLAXOSMITHKLINE BIOLOGICALS S. A.;  GLAXOSMITHKLINE  BIOLOGICALS;  </td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td>
	</tr><tr>
		<td>DOLUTEGRAVIR</td><td>DOLUTEGRAVIR</td><td>2018/7.13/5675</td><td>08/16/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR</td><td>DOLUTEGRAVIR</td><td>2018/7.13/5738</td><td>11/19/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>DOLUTEGRAVIR</td><td>DOLUTEGRAVIR</td><td>2018/7.13/5632</td><td>06/27/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>DOLUTEGRAVIR</td><td>DOLUTEGRAVIR</td><td>2018/7.13/5756</td><td>12/17/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>AUROBINDO PHARMA LTD;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR</td><td>DOLUTEGRAVIR</td><td>2022/7.13/6320</td><td>08/26/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD;  </td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD</td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD</td>
	</tr><tr>
		<td>DOLUTEGRAVIR (SODIUM)</td><td>DOLUTEGRAVIR</td><td>2019/7.13/5946</td><td>12/06/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR ; EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFANAMIDE</td><td>2024/7.13/6755</td><td>11/07/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 200; 25 MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>DOLUTEGRAVIR SODIUM</td><td>DOLUTEGRAVIR SODIUM</td><td>2019/7.13/5923</td><td>09/13/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR SODIUM</td><td>DOLUTEGRAVIR SODIUM</td><td>2024/7.13/6567</td><td>03/14/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>STRIDES PHARMA SCIENCE LIMITED;  </td><td>STRIDES PHARMA SCIENCE LIMITED</td><td>STRIDES PHARMA SCIENCE LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR SODIUM</td><td>DOLUTEGRAVIR SODIUM</td><td>2022/7.13/6359</td><td>12/06/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR(SODIUM); LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2024/7.13/6548</td><td>01/24/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>DOLUTEGRAVIR EMTRICITABINE TENOFOVIR ALAFENAMIDE</td><td>2022/7.13/6321</td><td>08/26/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 200; 25MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>DOLUTEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFANAMIDE</td><td>2023/7.13/6493</td><td>10/26/2023</td><td>10/26/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 200; 25MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2018/7.13/5698</td><td>09/21/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>AUROBINDO PHARMA LTD;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2020/7.13/5992</td><td>03/12/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2019/7.13/5803</td><td>03/18/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2019/7.13/5834</td><td>05/14/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2019/7.13/5910</td><td>08/22/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>CIPLA LIMITED (GOA UNIT VII);  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2019/7.13/5885</td><td>06/12/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300 MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2021/7.13/6127</td><td>05/05/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>CIPLA QUALITY CHEMICAL INDUSTRIES LIMITED;  </td><td>CIPLA QUALITY CHEMICAL INDUSTRIES LIMITED</td><td>CIPLA QUALITY CHEMICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMERATE</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2024/7.13/6609</td><td>05/16/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD;  </td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD</td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD</td>
	</tr><tr>
		<td>DOMADOL</td><td>TRAMADOL HYDROCHLORIDE</td><td>2018/2.1/5557</td><td>02/06/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DOMADOL PLUS</td><td>PARACETAMOL; TRAMADOL HYDROCHLORIDE</td><td>2017/2.2/5387</td><td>06/20/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>325; 37.5MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DOMSTAL</td><td>DOMPERIDONE</td><td>2000/16.2/3698</td><td>03/16/2000</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>DOPATAB M250</td><td>METHYLDOPA</td><td>2004/12.3.3/4285</td><td>07/05/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250MG</td><td>HOVID SDN BDH;  </td><td>TANTURE INVESTMENTS</td><td>HOVID SDN BDH</td>
	</tr><tr>
		<td>DORZIM</td><td>DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE</td><td>2020/19.10. /6044</td><td>10/22/2020</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2; 0.5%</td><td>INDOCO REMEDIES LIMITED;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>DOVAL</td><td>&nbsp;</td><td>2025/13.2.2/6950</td><td>05/08/2025</td><td>05/07/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>WRAPSA PACKAGING &amp; MANUF.;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>DOVPROLA</td><td>PRETOMANID </td><td>2021/7.3/6139</td><td>06/09/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DOXICAP</td><td>DOXYCYCLINE</td><td>92/7.2.4/2599</td><td>03/16/1992</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>DOXOL 80</td><td>DOCETAXEL</td><td>2016/9.4/5276</td><td>09/16/2016</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80 MG/ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>DOXSYN</td><td>CAFFEINE; CODEINE PHOSPHATE; DOXYLAMINE SUCCINATE; PARACETAMOL</td><td>2010/2.2/4633</td><td>06/10/2010</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>30; 10; 5; 450MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>MULLER & PHIPPS</td><td>PLASPHARMA PRIVATE LTD</td>
	</tr><tr>
		<td>DOXYCLIN</td><td>DOXYCYCLINE HYDROCHLORIDE</td><td>72/7.2.4/38</td><td>04/20/1972</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>DOXYCYCLINE</td><td>DOXYCYCLINE</td><td>95/7.2.4/2994</td><td>09/14/1995</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>DOXYCYCLINE</td><td>DOXYCYCLINE HYCLATE</td><td>2010/7.2.5/4645</td><td>09/07/2010</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>DUELOKS 30</td><td>DULOXETINE HYDROCHLORIDE</td><td>2018/13.2.1/5654</td><td>07/23/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>30MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>DUOTRAV</td><td>TIMOLOL MALEATE; TRAVOPROST</td><td>2014/19.10/4824</td><td>01/17/2014</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40; 5MG</td><td>ALCON CUSI S. E.;  S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>DUPHASTON</td><td>DYDROGESTERONE</td><td>2017/17.4/5400</td><td>07/25/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>ABBOTT BIOLOGICALS PRIVATE LIMITED;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES SA (PTY) LTD</td>
	</tr><tr>
		<td>DURART 600</td><td>DARUNAVIR</td><td>2018/7.13/5650</td><td>07/10/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>DURO-TUSS</td><td>BROMHEXINE HYDROCHLORIDE; SALBUTAMOL SULPHATE</td><td>2015/22.2.5/5131</td><td>12/10/2015</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4; 2MG/5ML</td><td>INOVA PHARMACEUTICALS  PTY LTD;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  ENSIGN LABORATIES LTD;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>DUSDATALIN</td><td>MEBEVERINE HYDROCHLORIDE</td><td>2018/16.4/5559</td><td>02/07/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>135 MG</td><td>MYLAN LABOROTORIES;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES SA (PTY) LTD</td>
	</tr><tr>
		<td>EAR DROPS</td><td>ACRIFLAVINE; GLYCEROL; SODIUM CARBONATE</td><td>82/20.1.4/5880</td><td>01/19/1982</td><td>12/31/2027</td><td>SOLUTION/DROPS; OTIC</td><td>PHARMACY MEDICINES (P.)</td><td>0.63; 33.3; 4.58%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ECODERM</td><td>ECONAZOLE NITRATE</td><td>2003/14.3/4190</td><td>09/11/2003</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1% M/M</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ECONAZOLE NITRATE</td><td>ECONAZOLE NITRATE</td><td>2001/14.1.3/3897</td><td>03/01/2001</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1 % W/W</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>EC-PRAM</td><td>ESCITALOPRAM</td><td>2018/13.2.1/5524</td><td>01/11/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>E-DOL</td><td>TRAMADOL HYDROCHLORIDE</td><td>2018/2.1/5618</td><td>05/29/2018</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG/ML</td><td>SAKAR HEALTHCARE PVT LTD;  </td><td>SAKAR HEALTHCARE PVT LTD</td><td>SAKAR HEALTHCARE PVT LTD</td>
	</tr><tr>
		<td>EDURANT</td><td>RILPIVIRINE</td><td>2014/7.13/4960</td><td>12/18/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25 MG</td><td>JANSSEN-CILAG SPA;  ASPEN SVP PTY LTD;  </td><td>JANSSEN PHARMACEUTICA</td><td>JANSSEN PHARMACEUTICA</td>
	</tr><tr>
		<td>EFAMAT</td><td>EFAVIRENZ</td><td>2009/7.13/4557</td><td>05/12/2009</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>EFAVIRENZ</td><td>EFAVIRENZ</td><td>2018/7.13/5577</td><td>03/01/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>STRIDES ARCOLAB LTD;  </td><td>STRIDES ARCOLAB LTD</td><td>STRIDES ARCOLAB LTD</td>
	</tr><tr>
		<td>EFAVIRENZ</td><td>EFAVIRENZ</td><td>2018/7.13/5576</td><td>03/01/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>STRIDES ARCOLAB LTD;  </td><td>STRIDES ARCOLAB LTD</td><td>STRIDES ARCOLAB LTD</td>
	</tr><tr>
		<td>EFAVIRENZ</td><td>EFAVIRENZ</td><td>2015/7.13/5016</td><td>04/27/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600 MG</td><td>AURO BINDO PHARMA LTD;  AUROBINDO PHARMA LTD;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2010/7.13/4649</td><td>09/28/2010</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 200; 300MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMERATE</td><td>EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2015/7.13/5051</td><td>06/05/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 200; 300 MG</td><td>AUROBINDO;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>EFAVIRENZ; LAMIVUDINE ; TENOFOVIR DISOPROXIL FUMARATE</td><td>EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2023/7.13/6449</td><td>07/20/2023</td><td>07/20/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400; 300; 300MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2021/7.13/6210</td><td>11/22/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400; 300; 300M</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2021/7.13/6093</td><td>02/04/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 300; 300MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMERATE</td><td>2020/7.13/5986</td><td>03/09/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400; 300; 300MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ELECTRAL</td><td>GLUCOSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM CITRATE</td><td>2016/23.1.1/5296</td><td>11/25/2016</td><td>12/31/2027</td><td>POWDER, SOLUBLE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>13.5; 1.5; 2.6; 2.9G</td><td>FDC LIMITED;  FDC LTD;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>ELIQUIS</td><td>APIXABAN</td><td>2014/10.2/4897</td><td>06/23/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>BRISTOL-MYERS SQUAIBB COMPANY;  BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>ELIQUIS</td><td>APIXABAN</td><td>2014/10.2/4896</td><td>06/23/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2.5 MG</td><td>BRISTOL-MYERS SQUAIBB COMPANY;  BRISTOL-MYERS SQUIBB MANUFACTURING COMPANY;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>ELOVAC-B</td><td>HEPATITIS B VIRUS</td><td>2019/18.2/5796</td><td>03/08/2019</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20UG/ML</td><td>HUMAN BIOLOGICS INSTITUTE, INDIAN IMMUNOLOGICALS LIMITED;  </td><td>HUMAN BIOLOGICALS INSTITUTE</td><td>HUMAN BIOLOGICALS INSTITUTE</td>
	</tr><tr>
		<td>ELOVERA CREAM</td><td>ALOE EXTRACT; VITAMIN E ACETATE</td><td>2001/14.19/3991</td><td>12/05/2001</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>105; 0.5% W/W</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ELTROXIN</td><td>LEVOTHYROXINE</td><td>2017/17.8.1/5414</td><td>08/08/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MCG</td><td>ASPEN BAD OLDESLOE GmBH;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LTD</td>
	</tr><tr>
		<td>ELTROXIN NEW FORMULATION</td><td>LEVOTHYROXINE SODIUM PENTAHYDRATE</td><td>2017/17.8.1/5413</td><td>08/08/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MCG</td><td>ASPEN BAD OLDESLOE GmBH;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LTD</td>
	</tr><tr>
		<td>EMFANEF</td><td>EFAVIRENZ; EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>2025/7.13/6871</td><td>04/04/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400; 200; 25MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>EMITON</td><td>METOCLOPRAMIDE HYDROCHLORIDE</td><td>2023/16.2/6491</td><td>10/26/2023</td><td>10/26/2028</td><td>LIQUID</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>5 MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE</td><td>EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE</td><td>2021/17.7/6073</td><td>12/17/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25; 1000MG</td><td>CIPLA LIMITED;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE</td><td>EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE</td><td>2021/17.7/6070</td><td>12/17/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 1000MG</td><td>CIPLA LIMITED;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE</td><td>EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE</td><td>2021/17.7/6072</td><td>12/17/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 1000MG</td><td>CIPLA LIMITED;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE</td><td>EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE</td><td>2021/17.7/6071</td><td>12/17/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 1000MG</td><td>CIPLA LIMITED;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>EMTRICITABINE ; TENOFOVIR ALAFENAMIDE</td><td>EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>2023/7.13/6485</td><td>10/04/2023</td><td>10/04/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 25MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>EMTRICITABINE ; TENOFOVIR DISOPROXIL FUMARATE</td><td>EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2020/7.13/6062</td><td>12/09/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 300MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS </td><td>EMITRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>2024/7.13/6648</td><td>06/20/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 25MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>EMTRICITABINE; TENOFOVIR  DISOPROXIL FUMARATE</td><td>EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2022/7.13/6282</td><td>05/30/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 300 MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>EMTRICITABINE; TENOFOVIR  DISOPROXIL FUMARATE</td><td>EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2013/7.13/4791</td><td>08/09/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 300MG</td><td>HETERO DRUGS LTD;  </td><td>HETERO DRUGS LTD</td><td>HETERO DRUGS LTD</td>
	</tr><tr>
		<td>EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>2021/7.13/6213</td><td>12/14/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 25MG</td><td>CIPLA LIMITED (GOA UNIT VII);  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>2023/7.13/6382</td><td>02/22/2023</td><td>02/22/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 25MG</td><td>ANNORA PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>EMTRICITABINE; TENOFOVIR ALAFENAMIDE</td><td>2018/7.13/5740</td><td>11/19/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 25MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2021/7.13/6104</td><td>02/18/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 300MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>EMTRICITABINE;TENOFOVIR DISOPROXIL FUMARATE</td><td>EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2016/7.13/5180</td><td>03/18/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 300 MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>EMULSIFYING OINTMENT BP</td><td>EMULSIFYING WAX; LIQUID PARFFIN; PARAFFIN SOFT WHITE</td><td>82/14.14/5881</td><td>01/19/1982</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>30; 20; 50%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ENAPRIL 10</td><td>ENALAPRIL MALEATE</td><td>2020/12.3.5/5954</td><td>01/17/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>INTAS PHARMACEUTICALS LTD;  INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ENAPRIL 5</td><td>ENALAPRIL MALEATE</td><td>2020/12.3.5/5953</td><td>01/17/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ENCIFER</td><td>IRON SUCROSE</td><td>2011/10.1.1/4686</td><td>05/30/2011</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ENHANCIN</td><td>AMOXICILLIN; CLAVULANATE POTASSIUM</td><td>2004/7.1.2/4282</td><td>07/01/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>875; 125MG</td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>ENHANCIN</td><td>AMOXICILLIN; CLAVULANATE POTASSIUM</td><td>2001/7.1.2/3923</td><td>07/02/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500; 125MG</td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>ENO ACTIVE FRUIT SALT (REGULAR)</td><td>CITRIC ACID; SODIUM BICARBONATE; SODIUM CARBONATE </td><td>82/16.1/1606</td><td>07/23/1982</td><td>12/31/2027</td><td>GRANULE, EFFERVESCENT; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>25MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  SMITHLINE BEECHAM;  </td><td>GROUP LABS S.A PTY LTD</td><td>BEECHAM RESEARCH INTERNATIONAL</td>
	</tr><tr>
		<td>ENO ACTIVE FRUIT SALT-ORANGE FLAVOUR</td><td>CITRIC ACID; SODIUM BICARBONATE; SODIUM CARBONATE </td><td>98/16.1/3288</td><td>01/05/1998</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>2.16; 2.29; 0.5 G</td><td>SMITHLINE BEECHAM;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD;  </td><td>GLAXOSMITHKLINE</td><td>GROUP LABORATORIES SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>ENO ACTIVE FRUIT SALTS -LEMON FLAVOUR</td><td>CITRIC ACID; SODIUM BICARBONATE; SODIUM CARBONATE </td><td>82/16.1/1607</td><td>07/23/1982</td><td>12/31/2027</td><td>POWDER, SOLUBLE; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>2.16; 2.29; 0.50GRAM</td><td>GLAXOSMITHKLINE CONSUMER HEALTHCARE S.A. (PTY) LTD;  </td><td>GLAXOSMITHKLINE CONSUMER HEALTHCARE S.A. (PTY) LTD</td><td>GLAXOSMITHKLINE CONSUMER HEALTHCARE S.A. (PTY) LTD</td>
	</tr><tr>
		<td>ENOPAXARIN SODIUM IMPACT</td><td>ENOXAPARIN SODIUM</td><td>98/10.2/3313</td><td>03/24/1998</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/ML</td><td>AVENTIS PHARMA PROPHARM;  AVENTIS PHARMA SA;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>AVENTIS PHARMA</td>
	</tr><tr>
		<td>ENOXAPARIN SODIUM</td><td>ENOXAPARIN SODIUM</td><td>2023/10.2/6458</td><td>08/09/2023</td><td>08/09/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/0.4ML</td><td>GLAND PHARMA LTD;  </td><td>ARAVAS PHARMACEUTICALS</td><td>GLAND PHARMA LTD</td>
	</tr><tr>
		<td>ENOXAPARIN SODIUM</td><td>ENOXAPARIN SODIUM</td><td>2023/10.2/6459</td><td>08/09/2023</td><td>08/09/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80 MG/0.8ML</td><td>GLAND PHARMA LTD;  </td><td>ARAVAS PHARMACEUTICALS</td><td>GLAND PHARMA LTD</td>
	</tr><tr>
		<td>ENOXAPARIN SODIUM IMPACT</td><td>ENOXAPARIN SODIUM</td><td>2005/10.2/4344</td><td>01/31/2005</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG</td><td>AVENTIS PHARMA PROPHARM;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>AVENTIS PHARMA</td>
	</tr><tr>
		<td>ENOXAPARIN SODIUM IMPACT</td><td>ENOXAPARIN SODIUM</td><td>2005/10.2/4343</td><td>01/31/2005</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60MG/0.6ML</td><td>AVENTIS PHARMA PROPHARM;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>AVENTIS PHARMA</td>
	</tr><tr>
		<td>ENSEDOL</td><td>CODEINE PHOSPHATE; IBUPROFEN; PARACETAMOL</td><td>2015/2.2/5111</td><td>11/12/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>250; 200; 10MG</td><td>PHARMANOVA PVT LTD;  </td><td>PHARMANOVA PVT LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>ENSPRYNG</td><td>SATRALIZUMAB</td><td>2024/9.7/6572</td><td>03/14/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120MG/ML</td><td>CHUGAI PHARMA MANUFACTURING CO., LTD (CPMC);  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>ENTAC</td><td>RANITIDINE HYDROCHLORIDE</td><td>2017/16.7/5403</td><td>08/07/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/2ML</td><td>NEON LABORATORIES LIMITED;  </td><td>WMT PHARMACEUTICALS PVT LTD</td><td>NEON LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ENTAMIZOLE</td><td>DILOXANIDE FUROATE; METRONIDAZOLE</td><td>83/7.6/1743</td><td>10/04/1983</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250/200 MG</td><td>BOOTS CO LTD, NOTTINGHAM, UK;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABS LTD</td>
	</tr><tr>
		<td>ENVAS-10</td><td>ENALAPRIL MALEATE</td><td>2001/12.3.1/3962</td><td>10/16/2001</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>CADILA PHARMACEUTICALS LTD;  </td><td>CADILA PHARMACEUTICALS LTD</td><td>CADILA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ENVUTEG</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR ALAFENAMIDE</td><td>2022/7.13/6256</td><td>02/23/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 25 MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>ENZYSTAL P</td><td>PANCREATIN</td><td>2024/16.8.1/6561</td><td>02/15/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>116.170MG</td><td>TORRENT PHARM LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>EPANUTIN</td><td>PHENYTOIN SODIUM</td><td>2000/13.1/3700</td><td>03/16/2000</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>PFIZER PHARMACEUTICALS LLC;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>EPHEDRINE HYDROCHLORIDE</td><td>EPHEDRINE HYDROCHLORIDE</td><td>2019/12.7/5811</td><td>03/25/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG/ML</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED;  </td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td>
	</tr><tr>
		<td>EPHEDRINE NASAL DROPS BPC</td><td>EPHEDRINE HYDROCHLORIDE</td><td>82/20.2.4/5948</td><td>01/19/1982</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.5%W/V</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>EPIBALIN ER 165</td><td>PREGABALIN</td><td>2023/13.1/6418</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>165MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>EPIBALIN ER 82.5</td><td>PREGABALIN</td><td>2023/13.1/6417</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>82.5MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>EPICARB</td><td>CARBAMAZEPINE</td><td>89/13.1/2242</td><td>04/25/1989</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>EPICEPHIN</td><td>CEFTRIAXONE SODIUM</td><td>2024/7.2.2/6655</td><td>07/05/2024</td><td>&nbsp;</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (EIPICO);  </td><td>EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (EIPICO)</td><td>EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (EIPICO)</td>
	</tr><tr>
		<td>EPIGABALIN 100</td><td>PREGABALIN</td><td>2020/13.1/5966</td><td>01/23/2020</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>MSN LABORATORIES PRIVATE LIMITED, FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>EPIGABALIN 150</td><td>PREGABALIN</td><td>2020/13.1/5967</td><td>01/23/2020</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG</td><td>MSN LABORATORIES PRIVATE LIMITED, FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>EPIGABALIN 25</td><td>PREGABALIN</td><td>2020/7.13/5964</td><td>01/23/2020</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>MSN LABORATORIES PRIVATE LIMITED, FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>EPIGABALIN 50</td><td>PREGABALIN</td><td>2020/13.1/5965</td><td>01/23/2020</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>MSN LABORATORIES PRIVATE LIMITED, FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>EPIMATE</td><td>TOPIRAMATE</td><td>2015/13.1/5118</td><td>11/19/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>EPIMATE 25</td><td>TOPIRAMATE</td><td>2015/13.1/5116</td><td>11/16/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>EPIMATE 50</td><td>TOPIRAMATE</td><td>2015/13.1/5117</td><td>11/19/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>EPIVULEX </td><td>SODIUM VALPROATE</td><td>2021/13.1/6128</td><td>05/07/2021</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG/ML</td><td>G.L. PHARMA GMBH ;  G.L. PHARMA GMBH ;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>EPIZITHRO</td><td>AZITHROMYCIN DIHYDRATE</td><td>2024/7.2.5/6656</td><td>07/05/2024</td><td>&nbsp;</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (EIPICO);  </td><td>EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (EIPICO)</td><td>EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (EIPICO)</td>
	</tr><tr>
		<td>EPIZOLONE DEPOT</td><td>METHYL PREDNISOLONE</td><td>2023/17.1/6506</td><td>11/13/2023</td><td>11/13/2028</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40 MG/2ML</td><td>EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (EIPICO);  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>EPNONE 25</td><td>EPLERENONE</td><td>2015/12.5.1/5073</td><td>07/29/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>EPNONE 50</td><td>EPLERENONE</td><td>2015/12.5.1/5074</td><td>07/29/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>EQUEMOTE</td><td>SULPIRIDE</td><td>87/13.2.1/2070</td><td>05/05/1987</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>EQUISIN</td><td>EXEMESTANE</td><td>2024/9.5.2/6554</td><td>01/31/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>EIRGEN PHARMA LTD;  </td><td>EQUITY PHARMACEUTICALS (PTY) LTD</td><td>EQUITY PHARMACEUTICALS (PTY) LTD</td>
	</tr><tr>
		<td>ERESTZ</td><td>EMTRICITABINE; RILPIVIRINE; TENOFOVIR DISOPROXIL FUMERATE</td><td>2023/7.13/6373</td><td>02/07/2023</td><td>02/07/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 25; 300MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>ERLOCIP 100</td><td>ERLOTINIB</td><td>2021/9.4/6188</td><td>10/07/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>CIPLA LIMITED (GOA UNIT VII);  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ERLOCIP 150</td><td>ERLOTINIB HYDROCHLORIDE</td><td>2021/9.4/6189</td><td>10/07/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ERLOCIP 25</td><td>ERLOTINIB</td><td>2021/9.4/6187</td><td>10/07/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>CIPLA LIMITED (GOA UNIT VII);  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ERLOTYK 150</td><td>ERLOTINIB HYDROCHLORIDE</td><td>2024/9.4/6668</td><td>07/22/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>EROMEL</td><td>ERYTHROMYCIN ETHYLSUCCINATE</td><td>E/20.1/96</td><td>05/08/1973</td><td>12/31/2027</td><td>GRANULE, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>EROMEL</td><td>ERYTHROMYCIN STEARATE</td><td>73/7.2.5/85</td><td>02/26/1973</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>DATLABS PRIVATE LIMITED;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>EROMEL</td><td>ERYTHROMYCIN</td><td>86/7.2.5/2013</td><td>10/17/1986</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>DATLABS PRIVATE LIMITED;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>ERYTHROMYCIN ESTOLATE</td><td>ERYTHROMYCIN ESTOLATE</td><td>2003/7.2.5/4209</td><td>11/11/2003</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125 MG/5ML</td><td>MEDICAMEN BIOTECH LIMITED;  </td><td>MEDICAMEN BIOTECH LIMITED</td><td>MEDICAMEN BIOTECH LIMITED</td>
	</tr><tr>
		<td>ESLICARBATOL 200</td><td>ESLICARBAZEPINE</td><td>2025/13.1/6813</td><td>02/17/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>ESLICARBATOL 400</td><td>ESLICARBAZEPINE</td><td>2025/13.1/6651</td><td>02/17/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>TORRENT PHARMACEUTICAL LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>ESLICARBATOL 600</td><td>ESLICARBAZEPINE</td><td>2025/13.1/6652</td><td>02/17/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>TORRENT PHARMACEUTICAL LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>ESLICARBATOL 800</td><td>ESLICARBAZEPINE</td><td>2025/13.1/6666</td><td>02/17/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>800MG</td><td>TORRENT PHARMACEUTICAL LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>ESMOBLOC 10MG/ML</td><td>ESMOLOL HYDROCHLORIDE</td><td>2024/12.3.2/6657</td><td>07/10/2024</td><td>&nbsp;</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>POLIFARMA ILAC SAN. VETIC. A.S. ;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>ESOMAC 20 MUPS</td><td>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</td><td>2022/16.7/6273</td><td>04/07/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20 MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ESOMAC 40 MUPS</td><td>ESOMEPRAZOLE MAGNESIUM DIHYDRATE</td><td>2022/16.7/6274</td><td>04/07/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40 MG</td><td>CIPLA LIMITED;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>ESOPREX 20</td><td>ESOMEPRAZOLE MAGNESIUM</td><td>2021/16.7/6116</td><td>04/06/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>ESOPREX 40</td><td>ESOMEPRAZOLE MAGNESIUM</td><td>2021/16.7/6117</td><td>04/06/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>ESOZ-20</td><td>ESOMEPRAZOLE MAGNESIUM</td><td>2004/16.5.6/4234</td><td>01/19/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20MG</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ESOZ-40</td><td>ESOMEPRAZOLE MAGNESIUM</td><td>2004/16.5.6/4235</td><td>01/19/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ETHAMBUTOL HYDROCHLORIDE</td><td>ETHAMBUTOL HYDROCHLORIDE</td><td>2019/7.3/5784</td><td>02/18/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ETHAMBUTOL;  ISONIAZID; PYRAZINAMIDE; RIFAMPICIN</td><td>ETHAMBUTOL HYDROCHLORIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN</td><td>2008/7.3/4520</td><td>04/10/2008</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>275; 75; 400; 150MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ETHIONAMIDE</td><td>ETHIONAMIDE</td><td>2008/7.3/4523</td><td>04/10/2008</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ETHOSUXIMIDE</td><td>ETHIONAMIDE</td><td>2025/13.1/6802</td><td>01/06/2025</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250 MG</td><td>SOFTGEL HEALTHCARE PVT. LTD.;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>ETOCIN 250</td><td>ERYTHROMYCIN STEARATE</td><td>2003/7.2.5/4199</td><td>10/10/2003</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ETOCOXX</td><td>ETORICOXIB</td><td>2017/3.1/5491</td><td>12/07/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>60MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>ETOCOXX</td><td>ETORICOXIB</td><td>2017/3.1/5492</td><td>12/07/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>90MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>ETOFLAM 120</td><td>ETORICOXIB</td><td>2018/3.1/5656</td><td>07/25/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>ETOFLAM 60</td><td>ETORICOXIB</td><td>2018/3.1/5658</td><td>07/25/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>ETOFLAM 90</td><td>ETORICOXIB</td><td>2018/3.1/5657</td><td>07/25/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>90MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>ETOVA-400</td><td>ETODOLAC</td><td>2017/3.1/5385</td><td>06/19/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>ETROBAX 60</td><td>ETORICOXIB</td><td>2021/3.1/6207</td><td>11/19/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>60MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ETROBAX 90</td><td>ETORICOXIB</td><td>2021/3.1/6208</td><td>11/19/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>90MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ETROCIN</td><td>ERYTHROMYCIN</td><td>92/7.2.5/2740</td><td>10/27/1992</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ETROCIN</td><td>ERYTHROMICIN</td><td>94/7.2.5/2855</td><td>09/02/1994</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>EUCORUB</td><td>UNICORN CAMPHOR RUB</td><td>72/22.3/27</td><td>04/13/1972</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>15.56; 0.61; 2.77; 0.16; 0.12; 0.62G</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>EXAPINE</td><td>ENOXAPARIN SODIUM</td><td>2023/10.2/6465</td><td>08/16/2023</td><td>08/16/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/0.4ML</td><td>WADI EL NEEL BENTA FOR PHARMACEUTICALS AND MEDICAL DEVICES (WNB);  </td><td>ORANGE HEALTH P/L</td><td>WADI EL NEEL BENTA FOR PHARMACEUTICALS AND MEDICAL DEVICES (WNB)</td>
	</tr><tr>
		<td>EXAPINE</td><td>ENOXAPARIN SODIUM</td><td>2023/10.2/6466</td><td>08/16/2023</td><td>08/16/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG/0.8ML</td><td>WADI EL NEEL BENTA FOR PHARMACEUTICALS AND MEDICAL DEVICES (WNB);  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>EXEDRAL</td><td>EXEMESTANE</td><td>2019/9.5.2/5942</td><td>11/21/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>EXEMEX 25</td><td>EXEMESTANE</td><td>2023/9.5.2/6461</td><td>08/21/2023</td><td>08/21/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>GENEPHARM S.A.;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>EXFORGE</td><td>AMLODIPINE BESYLATE; VALSARTAN</td><td>2013/12.3.5/4766</td><td>03/06/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5; 160MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVO-NORDISK A/S;  NOVARTIS FARMACEUTICA SA;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>EXFORGE</td><td>AMLODIPINE BESYLATE; VALSARTAN</td><td>2013/12.3.47/4765</td><td>03/06/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5; 80MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA SA;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>EXFORGE</td><td>AMLODIPINE BESYLATE; VALSARTAN</td><td>2013/12.3.5/4767</td><td>03/06/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10; 160MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA SA;  NOVARTIS ANIMAL HEALTH;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>EXFORGE HCT</td><td>AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2016/12.3.5/5188</td><td>04/13/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 12.5; 160MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA SA;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>EXFORGE HCT</td><td>AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2017/12.3.5/5433</td><td>09/19/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 25; 160MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA S.A;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>EXFORGE HCT</td><td>AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2017/12.3.5/5431</td><td>09/19/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 25; 320MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA SA;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>EXFORGE HCT</td><td>AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2016/12.3/5189</td><td>05/11/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 12.5; 160 MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMA SPA AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>EXFORGE HCT </td><td>AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2017/12.3.5/5432</td><td>09/19/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 160; 25MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA S.A;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>EXLUTON </td><td>LYNESTRENOL</td><td>E/21.8.2/181</td><td>09/17/1974</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.5MG</td><td>N.V ORGANON ;  ORGANON LABS LTD;  </td><td>ORGANON SOUTH AFRICA (PTY) LTD.</td><td>N.V ORGANON </td>
	</tr><tr>
		<td>EXOCIN</td><td>OFLOXACIN</td><td>96/19.1.1/3184</td><td>11/18/1996</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3MG/ML</td><td>ALLERGAN PHARMACEUTICALS;  ALLERGAN PHARMACEUTICALS IRELAND;  </td><td>ABBVIE PTY LTD</td><td>ABBVIE PTY LTD</td>
	</tr><tr>
		<td>EXPELINCT GUAIFENESIN</td><td>GUAIFENESIN</td><td>2004/22.2.2/4296</td><td>09/09/2004</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG/10ML</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>EYE - GENE EYE DROPS</td><td>PHENYLEPHRINE HYDROCHLORIDE</td><td>76/19.9/0658</td><td>07/01/1976</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>0.043G/100ML</td><td>ASPEN SA OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LTD</td>
	</tr><tr>
		<td>FAMILIA</td><td>ETHINYL ESTRADIOL; FERROUS FUMARATE; LEVONORGESTREL</td><td>2022/21.2.1/6253</td><td>02/22/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>30 MCG; 75 MG; 150 MCG</td><td>MYLAN LABORATORIES LIMITED;  MYLAN LABORATORIES LIMITED;  </td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td>
	</tr><tr>
		<td>FAMYTEC</td><td>MISOPROSTOL</td><td>2024/21.6/6698</td><td>09/12/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>FASLODEX</td><td>FULVESTRANT </td><td>2021/9.7/6076</td><td>01/13/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>VETTER PHARMA-FERTGUNG GMBH;  ASTRA ZENECA LIMITED;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRAZENECA UK LIMITED</td>
	</tr><tr>
		<td>FEBINNO 40</td><td>FEBUXOSTAT</td><td>2024/3.2/6781</td><td>05/12/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>RV LIFESCIENCES LIMITED ;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>FEBINNO 80</td><td>FEBUXOSTAT</td><td>2024/3.2/6780</td><td>05/12/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG</td><td>RV LIFESCIENCES LIMITED ;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>FEBRAMOL</td><td>PARACETAMOL</td><td>2014/2.1/4854</td><td>02/26/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/ML</td><td>AMANTA HEALTHCARE LTD;  </td><td>AMANTA HEALTHCARE LTD</td><td>AMANTA HEALTHCARE LTD</td>
	</tr><tr>
		<td>FEBUTOR 40</td><td>FEBUXOSTAT</td><td>2024/3.2/6625</td><td>06/06/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>TORRENT PHARMACEUTICAL LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>FEBUTOR 80</td><td>FEBUXOSTAT</td><td>2024/3.2/6626</td><td>06/06/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG</td><td>TORRENT PHARMACEUTICAL LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>FEDALOC 30MG SR</td><td>NIFEDIPINE</td><td>2024/12.6/6664</td><td>07/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>30MG</td><td>VALPHARMA INTERNATIONAL S.P.A GIAMBATTISTA;  </td><td>PHARMA DYNAMICS PTY LTD</td><td>PHARMA DYNAMICS PTY LTD</td>
	</tr><tr>
		<td>FEDALOC 60MG SR</td><td>NIFEDIPINE</td><td>2024/12.6/6665</td><td>07/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>60MG</td><td>VALPHARMA INTERNATIONAL S.P.A GIAMBATTISTA;  </td><td>PHARMA DYNAMICS PTY LTD</td><td>PHARMA DYNAMICS PTY LTD</td>
	</tr><tr>
		<td>FEGEM 100 PLUS</td><td>FOLIC ACID; IRON HYDROXIDE</td><td>2003/10.1/4089</td><td>01/08/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>350MCG; 100MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>FELIZ S 10</td><td>ESCITALOPRAM OXALATE</td><td>2014/13.2.1/4924</td><td>08/20/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10 MG</td><td>TORRENT PHARMACEUTICALS;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>FEMARA</td><td>LETROZOLE</td><td>2015/9.5.2/5110</td><td>11/10/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5 MG</td><td>NOVARTIS PHARMA SERVICES AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>FEMIGEL</td><td>OESTRADIOL HEMIHYDRATE</td><td>95/17.3/2927</td><td>05/08/1995</td><td>12/31/2027</td><td>GEL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.5MG</td><td>BESINS ISCOVESCO LABORATORIES;  </td><td>MEDI CHALLENGE (PTY) LTD</td><td>BESINS ISCOVESCO LABORATORIES</td>
	</tr><tr>
		<td>FEMPRO</td><td>LETROZOLE</td><td>2023/9.5.2/6463</td><td>08/11/2023</td><td>08/11/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>CIPLA LIMITED (GOA UNIT VII);  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>FENTANYL  (2ML)</td><td>FENTANYL CITRATE</td><td>2018/4.1/5705</td><td>10/01/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>50MCG/ML</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA;  </td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td>
	</tr><tr>
		<td>FENTANYL (10ML)</td><td>FENTANYL CITRATE</td><td>2018/4.1/5706</td><td>10/01/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>50MCG/ML</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA;  </td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td>
	</tr><tr>
		<td>FENTANYL FRESENIUS</td><td>FENTANYL CITRATE</td><td>2006/4.1/4435</td><td>07/10/2006</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>100MCG/2ML</td><td>BODENE;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>FERRIMED</td><td>IRON POLYMALTOSE; PYRIDOXIME HYDROCHLORIDE; CYANOCOBALAMINE</td><td>75/10.1.4/439</td><td>01/24/1975</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MG; 10MG; 5MCG/5ML </td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FERRIMED</td><td>IRON POLYMALTOSE; FOLIC ACID</td><td>75/10.1.4/438</td><td>01/24/1975</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>&nbsp;</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FERROUS SULPHATE CO</td><td>COOPER SULPHATE; FERROUS SULPHATE; MANGANESE SULPHATE</td><td>93/10.1.4/2785</td><td>04/27/1993</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2.5; 200; 2.5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FIBROSAL</td><td>POVIDONE IODINE</td><td>76/14.15/766</td><td>10/19/1976</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1; 1; 5% W/W</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FIRIALTA</td><td>FINERENONE</td><td>2023/12.5.1/6513</td><td>11/21/2023</td><td>11/21/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>FIRIALTA</td><td>FINERENONE</td><td>2023/12.5.1/6512</td><td>11/21/2023</td><td>11/21/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>FLAIROF</td><td>ROFLUMILAST</td><td>2025/22.1.1/6834</td><td>01/24/2025</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MCG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>FLEXIVIAL</td><td>POTASSIUM CHLORIDE</td><td>2017/23.2.2/5349</td><td>03/23/2017</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML</td><td>FRESENIUS KABI ESPANA;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>FLOMIST</td><td>FLUTICASONE DIPROPIONATE</td><td>2004/20.2.2/4301</td><td>09/14/2004</td><td>12/31/2027</td><td>SPRAY, METERED; NASAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MCG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>FLUCLOXACILLIN SODIUM</td><td>FLUCLOXACILLIN SODIUM</td><td>2001/7.1.2/3896</td><td>03/16/2001</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>FLUCONAZOLE</td><td>FLUCONAZOLE</td><td>2016/7.12/5168</td><td>02/17/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200 MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>FLUCONAZOLE</td><td>FLUCONAZOLE</td><td>2002/7.12/4076</td><td>11/11/2002</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>FLUCONAZOLE</td><td>FLUCONAZOLE</td><td>2003/7.12/4093</td><td>01/16/2003</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>FLUCYTOSINE</td><td>FLUCYTOSINE</td><td>2024/7.12/6737</td><td>10/22/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>FLUKEN 200</td><td>FLUCONAZOLE</td><td>2003/7.12/4096</td><td>02/12/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>FDC LTD;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>FLUMED</td><td>CHLORPHENIRAMINE MALEATE; PARACETAMOL; PHENYLEHRINE HYDROCHLORIDE</td><td>2015/22.2.5/5080</td><td>08/05/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 2; 10 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>FLUMED</td><td>CHLORPHENIRAMINE MALEATE; PARACETAMOL; PHENYLEHRINE HYDROCHLORIDE</td><td>2015/22.2.5/5079</td><td>08/05/2015</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>FLUMEL</td><td>CHLORPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE; PARACETAMOL</td><td>75/22.2.5/544</td><td>10/13/1975</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2; 500; 10MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FLUSTOP</td><td>DIPHENHYDRAMINE HYDROCHLORIDE; PARACETAMOL; PHENYLEPHRINE HYDROCHLORIDE</td><td>78/22.02.05/1120</td><td>06/09/1978</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10; 400; 5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FML LIQUIFILM</td><td>FLUOROMETHOLONE</td><td>2000/19.2.1/3694</td><td>03/10/2000</td><td>12/31/2027</td><td>SUSPENSION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG/ML</td><td>ALLERGAN PHARMACEUTICALS;  ALLERGAN PHARMACEUTICALS (PTY) LTD;  </td><td>ABBVIE PTY LTD</td><td>ABBVIE PTY LTD</td>
	</tr><tr>
		<td>FOLIC ACID</td><td>FOLIC ACID</td><td>91/10.1.2/2521</td><td>09/04/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FORXIGA</td><td>DAPAGLIFLOZIN PROPANEDIOL</td><td>2018/17.7/5578</td><td>03/06/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>ASTRAZENECA UK LIMITED;  </td><td>ASTRAZENECA UK LIMITED</td><td>ASTRAZENECA UK LIMITED</td>
	</tr><tr>
		<td>FORXIGA</td><td>DAPAGLIFLOZIN PROPANEDIOL</td><td>2018/17.7/5579</td><td>03/06/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10 MG</td><td>ASTRAZENECA UK LIMITED;  </td><td>ASTRAZENECA UK LIMITED</td><td>ASTRAZENECA UK LIMITED</td>
	</tr><tr>
		<td>FOSAPREPITANT DIMEGLUMINE</td><td>FOSAPREPITANT DIMEGLUMINE</td><td>2025/16.2/6831</td><td>01/17/2025</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>ASPIRO PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>FOSENEMA</td><td>SODIUM PHOSPHATE</td><td>98/16.5.4/3398</td><td>07/29/1998</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>9; 24G/150ML</td><td>ADCOCK INGRAM CRITICAL CARE;  DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>FRAXONE</td><td>CEFTRIAXONE SODIUM</td><td>2024/7.2.2/6763</td><td>11/15/2024</td><td>&nbsp;</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>CSPC ZHONGNUO PHARMACEUTICAL (SHIJIIAZHUANG);  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>FRESENIUS PROPOVEN</td><td>PROPOFOL</td><td>2017/1.1/5495</td><td>08/12/2017</td><td>12/31/2027</td><td>EMULSIONS; INJECTABLE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>FRESENIUS KABI AUSTRIA GMBH,;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>FRESH BURST LISTERINE</td><td>ETHANOL; THYMOL</td><td>2020/20.3.4/5983</td><td>03/03/2020</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>4.54ML; 12.78MG/20ML</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  JOHNSON &amp; JOHNSON (PTY) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>FRUDIS</td><td>FUROSEMIDE</td><td>2019/12.5.1/5797</td><td>03/11/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>SAKAR HEALTHCARE PVT LTD;  </td><td>SAKAR HEALTHCARE PVT LTD</td><td>SAKAR HEALTHCARE PVT LTD</td>
	</tr><tr>
		<td>FRUGEX</td><td>FUROSEMIDE</td><td>75/12.5.1/572</td><td>12/17/1975</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FRUMIDE</td><td>FUROSEMIDE</td><td>2018/12.5.1/5684</td><td>09/07/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/2ML</td><td>STERIL-GENE LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>FRUSIDE</td><td>FUROSEMIDE</td><td>91/12.5.1/2503</td><td>03/13/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>FULPHILA</td><td>PEGFILGRASTIM </td><td>2019/10/5772</td><td>01/25/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>6; 0.6MG/ML</td><td>BIOCON LIMITED;  </td><td>BIOSIMILARS NEWCO LIMITED</td><td>BIOSIMILARS NEWCO LIMITED</td>
	</tr><tr>
		<td>FUNGEX</td><td>UNDECYLENIC ACID ALKYLOLAMIDE</td><td>2001/14.1.3/3977</td><td>10/24/2001</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>5% W/W</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FUNGEX</td><td>BORIC ACID; TRICLOSAN; UNDECENOIC ACID; ZINC OXIDE</td><td>74/14.1.3/364</td><td>11/27/1974</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>160; 2; 200; 200MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>FUNGICON-150</td><td>FLUCONAZOLE</td><td>2001/7.12/3964</td><td>09/04/2001</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>FUNGICON-50</td><td>FLUCONAZOLE</td><td>2001/7.12/3963</td><td>09/04/2001</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>FUNGISTOP TOPICAL</td><td>ECONAZOLE NITRATE</td><td>2006/14.1.3/4406</td><td>01/17/2006</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1% W/W</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>FUROCSEM</td><td>CEFUROXIME AXETIL</td><td>2018/7.2.2/5601</td><td>04/12/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>NECTAR LIFESCIENCES LTD;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>FUROCSEM</td><td>CEFUROXIME AXETIL</td><td>2018/7.2.2/5600</td><td>04/12/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>NECTAR LIFESCIENCES LTD;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>FUROSEMIDE</td><td>FUROSEMIDE</td><td>2020/12.5.1/5987</td><td>03/10/2020</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>COSPHARM INVESTMENTS</td><td>AKUMS DRUG & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>FUROSEMIDE</td><td>FUROSEMIDE</td><td>2014/12.5.2/4890</td><td>06/12/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG/ML</td><td>KARNATAKA ANTIBIOTICS &amp; PHARMACEUTICALS;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>FUROSEMIDE FRESENIUS</td><td>FUROSEMIDE</td><td>2006/12.5.1/4421</td><td>05/15/2006</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG/2ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>FYCOMPA  2MG</td><td>PERAMPANEL</td><td>2020/13.1/5988</td><td>03/12/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG</td><td>EISAI MANUAFCTURING LIMITED (EML);  KAWASHIMA FACTORY, EISAI CO., LTD;  </td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td>
	</tr><tr>
		<td>FYCOMPA 4MG</td><td>PERAMPANEL</td><td>2020/13.1/5989</td><td>03/12/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4MG</td><td>KAWASHIMA FACTORY, EISAI CO., LTD;  EISAI MANUAFCTURING LIMITED (EML);  </td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td>
	</tr><tr>
		<td>FYCOMPA 6MG</td><td>PERTUZUMAB</td><td>2020/13.1/5990</td><td>03/12/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>6MG</td><td>KAWASHIMA FACTORY, EISAI CO., LTD;  EISAI MANUAFCTURING LIMITED (EML);  </td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td>
	</tr><tr>
		<td>FYCOMPA 8MG</td><td>PERTUZUMAB</td><td>2020/13.1/5991</td><td>03/12/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>8MG</td><td>EISAI MANUAFCTURING LIMITED (EML);  KAWASHIMA FACTORY, EISAI CO., LTD;  </td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td>
	</tr><tr>
		<td>FYTOSID</td><td>ETOPOSIDE</td><td>2001/9.4/3976</td><td>10/24/2001</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>GACET-125</td><td>PARACETAMOL</td><td>2016/2.1/5174</td><td>03/18/2016</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>125 MG</td><td>BLISS GVS PHARMA LTD;  </td><td>BLISS GVS PHARMA LIMITED</td><td>BLISS GVS PHARMA LIMITED</td>
	</tr><tr>
		<td>GALENICOS BENZYL BENZOATE</td><td>BENZYL BENZOATE</td><td>2022/14.1.5/6293</td><td>06/21/2022</td><td>12/31/2027</td><td>LOTION; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>25%W/V</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>GALENICOS BETACLEANSE</td><td>POVIDONE IODINE</td><td>2023/14.1.4/6487</td><td>10/17/2023</td><td>10/17/2028</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>10 %W/W</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>GALENICOS BETA-CLEANSE LOTION</td><td>POVIDONE IODINE</td><td>2022/14.1.4/6292</td><td>06/21/2022</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>10%W/V</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>GALENICOS BURN CREAM</td><td>SILVER SULFADIAZINE</td><td>2023/14.1.2/6396</td><td>04/03/2023</td><td>04/03/2028</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1% W/W</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>GALENICOS CP-BENZOIC ACID</td><td>BENZOIC ACID; SALICYLIC ACID</td><td>2023/14.1.3/6369</td><td>02/17/2023</td><td>02/17/2028</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>6%; 3% W/W</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>GALENICOS CP-CALAMINE</td><td>CALAMINE; ZINC OXIDE</td><td>2022/14.19/6294</td><td>06/21/2022</td><td>12/31/2027</td><td>LOTION; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>15; 5%W/V</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>GALENICOS CP-SULPHUR</td><td>SULPHUR</td><td>2023/14.1.5/6368</td><td>01/26/2023</td><td>01/26/2028</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>10% W/W</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>GALENICOS GLYCERINE &ICHTHAMMOL</td><td>GLYCERINE; ICHTHAMMOL</td><td>2022/14.1.4/6326</td><td>09/06/2022</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>10%W/W</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>GALVUS</td><td>VILDAGLIPTIN</td><td>2015/17.7/5027</td><td>05/14/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA S.A;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>GALVUS MET</td><td>METFORMIN HYDROCHLORIDE; VILDAGLIPTIN</td><td>2015/17.7/5029</td><td>05/14/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50; 850 MG</td><td>NOVARTIS PHARMA STEIN AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>GALVUS MET</td><td>METFORMIN HYDROCHLORIDE; VILDAGLIPTIN</td><td>2015/17.7/5030</td><td>05/14/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50; 1000 MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS SINGAPORE PHARMACEUTICAL MANF PTC LT;  NOVARTIS PHARMA PRODUCTIONS GMGH;  NOVARTIS;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>GALVUS MET</td><td>METFORMIN HYDROCHLORIDE; VILDAGLIPTIN</td><td>2015/17.7/5028</td><td>05/14/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50; 500 MG</td><td>NOVARTIS PHARMA SERVICES AG;  NOVARTIS PHARMA PRODUCTIONS GMGH;  NOVARTIS SINGAPORE PHARMACEUTICAL MANF PTC LT;  NOVARTIS PHARMA STEIN AG;  NOVARTIS;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>GAMMA BENZENE HEXACHLORIDE IN LIQUID PARAFFIN</td><td>GAMMA BENZENE HEXACHLORIDE; LIQIUD PARAFFIN</td><td>82/14.1.5/5879</td><td>01/19/1982</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>1%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>GANFORT</td><td>BIMATOPROST; TIMOLOL MALEATE</td><td>2014/19.10/4961</td><td>12/18/2014</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>0.30; 6.8MG</td><td>ALLERGAN PHARMACEUTICALS;  </td><td>ABBVIE PTY LTD</td><td>ABBVIE PTY LTD</td>
	</tr><tr>
		<td>GARDASIL</td><td>HUMAN PAPILLOMA VIRUS VACCINE TYPES 6, 11, 16, 18</td><td>2014/18.2/4958</td><td>12/11/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20; 40; 40; 20 MCG</td><td>MERCK SHARP &amp; DOHME BV;  MERCK SHARP &amp; DOHME CORP;  EUROFINS LANCASTER LABORATORIES INC;  BAXTER PHARMACEUTICAL SOLUTIONS LLC;  PATHEON ITALIA S.P.A ;  </td><td>MSD (PTY) LTD</td><td>MSD (PTY) LTD</td>
	</tr><tr>
		<td>GASTRIGEL</td><td>ALUMINIUM HYDROXIDE MAGNESIUM; DICYCLOMINE HYDROCHLORIDE; DIMETHICOME; SODIUM LAURYL SULPHATE</td><td>81/16.1/5845</td><td>12/18/1981</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>325; 1.75; 17.5; 8MG</td><td>CAPS PVT LTD;  </td><td>CAPS INTERNATIONAL EST</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>GAVISCON ADVANCE PEPPERMINT</td><td>CALCIUM CARBONATE; SODIUM ALGINATE; SODIUM BICARBONATE</td><td>2022/16.1/6315</td><td>08/03/2022</td><td>12/31/2027</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200; 1000; 200MG/10ML</td><td>RECKITT BENCKISER HEALTHCARE UK LIMITED;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISER HEALTHCARE UK LIMITED</td>
	</tr><tr>
		<td>GAVISCON ADVANCED LIQUID ANISEED</td><td>SODIUM ALGINATE</td><td>2013/16.1/4819</td><td>12/19/2013</td><td>12/31/2027</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>150; 180; 200; 500; 600MG</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD</td>
	</tr><tr>
		<td>GAVISCON DOUBLE ACTION </td><td>CALCIUM CARBONATE; SODIUM ALGINATE; SODIUM BICARBONATE</td><td>2017/16.1/5473</td><td>11/01/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>187.5; 250; 106.5 MG</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>GAVISCON DOUBLE ACTION</td><td>CALCIUM CARBONATE; SODIUM ALGINATE; SODIUM BICARBONATE</td><td>2017/16.1/5462</td><td>10/30/2017</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>325; 213; 500MG</td><td>RECKITT BENCKISER HEALTHCARE UK LIMITED;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>GAVISCON LIQUID ANISEED</td><td>SODIUM ALGINATE</td><td>2013/16.1/4820</td><td>12/20/2013</td><td>12/31/2027</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500; 267; 160MG/5ML</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD</td>
	</tr><tr>
		<td>GAVISCON LIQUID PEPPERMINT</td><td>CALCIUM CARBONATE; SODIUM ALGINATE; SODIUM BICARBONATE</td><td>2013/16.1/4821</td><td>12/20/2013</td><td>12/31/2027</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500MG</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD</td>
	</tr><tr>
		<td>GC-METFORMIN SR 1000</td><td>METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6611</td><td>05/27/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1000MG</td><td>VERGO PHARMA RESEARCH LABORATORIES;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>GRANITESIDE CHEMICALS (PVT) LTD</td>
	</tr><tr>
		<td>GC-METFORMIN SR 500</td><td>METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6610</td><td>05/27/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500 MG</td><td>VERGO PHARMA RESEARCH LABORATORIES;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>GRANITESIDE CHEMICALS (PVT) LTD</td>
	</tr><tr>
		<td>G-COSPE</td><td>PYRIMETHAMINE; SULFADOXINE</td><td>2025/7.5/6854</td><td>02/04/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25;500MG</td><td>GUILIN PHARAMCEUTICAL CO. LTD;  </td><td>SHANGHAI FOSUN PHARMACEUTICAL DEVELOPMENT CO</td><td>YIFANG WU </td>
	</tr><tr>
		<td>GCP ANTISEPTIC LIQUID</td><td>FLUMETHRIN</td><td>77/14.1.4/925</td><td>07/01/1977</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>5.00; 1.75; 0.95; 0.50MG/ML</td><td>GRANITESIDE CHEMICALS (PVT) LTD;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>BAYRIDGE ENTERPRISES LTD</td>
	</tr><tr>
		<td>GCP OINTMENT</td><td>DIGOXIN</td><td>&nbsp;</td><td>12/31/1981</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>&nbsp;</td><td>GRANITESIDE CHEMICALS (PVT) LTD;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>BAYRIDGE ENTERPRISES LTD</td>
	</tr><tr>
		<td>GEES LINCTUS</td><td>MORPHINE; SQUILL OXYMEL</td><td>2006/22.2.1/4419</td><td>05/05/2006</td><td>12/31/2027</td><td>LINCTUS; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>33.33; 33.33; 100%</td><td>CAPS PVT LTD;  LANCASTER INDUSTRIAL PVT LTD;  </td><td>GEDDES LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>GEES LINCTUS (OPIATE SQUILL LINCTUS)</td><td>MORPHINE; SQUILL OXYMEL</td><td>2002/22.2.1/4048</td><td>05/30/2002</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.83MG/5ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>GEFITINIB</td><td>GEFITINIB </td><td>2022/9.4/6260</td><td>03/09/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250 MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>GELOFUSINE</td><td>GELATIN SUCCINYL</td><td>2004/11.1/4265</td><td>05/03/2004</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4% W/V</td><td>B. BRAUN MEDICAL;  B.BRAUN MELSUNGEN AG;  </td><td>B.BRAUN MELSUNGEN AG</td><td>B.BRAUN MELSUNGEN AG</td>
	</tr><tr>
		<td>GEMCITABINE HYDROCHLORIDE</td><td>GEMCITABINE HYDROCHLORIDE</td><td>2021/9.2.2/6077</td><td>01/13/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/ML</td><td>INTAS PHARMACEUTICALS LIMITED;  INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>GEMLIFE</td><td>GEMCITABINE</td><td>2018/9.2.2/5548</td><td>01/30/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>GEMTERO</td><td>GEMCITABINE HYDROCHLORIDE</td><td>2015/9.2.2/4989</td><td>03/19/2015</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200 MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GEMTERO</td><td>GEMCITABINE HYDROCHLORIDE</td><td>2015/9.2.2/4990</td><td>03/19/2015</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GENPAYNE</td><td>CODEINE PHOSPHATE; IBUPROFEN; PARACETAMOL; </td><td>2016/2.2/5239</td><td>08/02/2016</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>250; 200; 10MG</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>GENTAMYCIN FRESENIUS</td><td>GENTAMICIN SULPHATE</td><td>2010/7.2.1/4610</td><td>03/26/2010</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG/2ML</td><td>BODENE;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>GENTAMYCIN SULPHATE</td><td>GENTAMICIN SULPHATE</td><td>95/7.2.1/2885</td><td>01/16/1995</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>GENTIAN VIOLET SOLUTION</td><td>CRYSTAL VIOLET </td><td>81/14.1.4/5870</td><td>10/19/1981</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1%</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>GEPATRIN</td><td>CEFTRIAXONE SODIUM</td><td>2003/7.2.2/4141</td><td>05/13/2003</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>KARNATAKA ANTIBIOTICS &amp; PHARMACEUTICALS;  </td><td>GENERA INC</td><td>GEPACH INTERNATIONAL LTD</td>
	</tr><tr>
		<td>GERMSTOP </td><td>POVIDONE IODINE</td><td>2020/14.1.4/5985</td><td>03/06/2020</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>10%M/M</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>GERMSTOP </td><td>POVIDONE IODINE</td><td>2020/14.1.4/5984</td><td>03/06/2020</td><td>12/31/2027</td><td>SOLUTION/MOUTHWASH; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1%M/V</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>GIAGRA 100</td><td>SILDENAFIL CITRATE</td><td>2014/31/4877</td><td>05/08/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>HETERO LABS LTD;  HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GIAGRA 50</td><td>SILDENAFIL CITRATE</td><td>2014/31/4883</td><td>05/15/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>HETERO LABS LTD;  HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GIGAPYN</td><td>CODEINE PHOSPHATE; PARACETAMOL</td><td>98/2.2/3439</td><td>10/28/1998</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 8 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>GILL ANTI-DANDRUFF SHAMPOO</td><td>ZINC PYRITHIONE</td><td>85/14.7/1952</td><td>01/10/1985</td><td>12/31/2027</td><td>SHAMPOO; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1%M/V</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>GLAMIDE</td><td>GLIBENCLAMIDE</td><td>2003/17.7/4203</td><td>10/17/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>GLENDES</td><td>DESLORATIDINE</td><td>2018/5/5754</td><td>12/17/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>GLENMARK PHARMACEUTICAL LIMITED;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>GLEVATE</td><td>CLOBETASOL PROPIONATE</td><td>2005/14.2.1/4372</td><td>06/17/2005</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.05 % W/W</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>GLIBENCLAMIDE</td><td>GLIBENCLAMIDE</td><td>2004/17.7/4308</td><td>09/22/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>MEDICAMEN BIOTECH LIMITED;  </td><td>MEDICAMEN BIOTECH LIMITED</td><td>MEDICAMEN BIOTECH LIMITED</td>
	</tr><tr>
		<td>GLIMULIN-2</td><td>GLIMEPIRIDE</td><td>2004/17.7/4236</td><td>01/19/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>GLINSIP 100</td><td>SITAGLIPTIN</td><td>2023/17.7/6437</td><td>06/30/2023</td><td>06/30/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>ANNORA PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GLINSIP 25</td><td>SITAGLIPTIN PHOSPHATE</td><td>2023/17.7/6435</td><td>06/30/2023</td><td>06/30/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>ANNORA PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GLINSIP 50</td><td>SITAGLIPTIN</td><td>2023/17.7/6436</td><td>06/30/2023</td><td>06/30/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>ANNORA PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GLITISOL 5</td><td>GLIBENCLAMIDE</td><td>99/17.7/3621</td><td>11/02/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>GLIVEC</td><td>IMATINIB MESYLATE</td><td>2015/9.4/5085</td><td>09/17/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400 MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS PHARMA PRODUCTIONS GMGH;  NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD;  SOLVIAS AG;  NOVARTIS RINGASKIDDY LTD;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>GLIVEC</td><td>IMATINIB MESYLATE</td><td>2015/9.4/5084</td><td>09/17/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS PHARMA PRODUCTIONS GMGH;  NOVARTIS PHARMA GMBH;  SOLVIAS AG;  NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD;  NOVARTIS RINGASKIDDY LTD;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>GLUCIVIA XR</td><td>METFORMIN HYDROCHLORIDE</td><td>2025/17.7/6929</td><td>04/17/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1000MG</td><td>PINNACLE LIFE SCIENCE PVT. LTD. ;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>GLUCOPECT</td><td>DEXTROSE; KAOLIN; LACTIC ACID; PECTIN; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM HYDROXIDE</td><td>6/11.9/567</td><td>07/20/1976</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>934MG; 44MG; 26.7MG; 40MG; 22.3MG; 2.2G; 0.047ML</td><td>GULF DRUG COMPANY;  </td><td>GULF DRUG COMAPANY</td><td>GULF DRUG COMPANY (PVT) LTD</td>
	</tr><tr>
		<td>GLUCOSE 5% B.BRAUN </td><td>DEXTROSE MONOHYDRATE</td><td>&nbsp;</td><td>&nbsp;</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5 G/50ML</td><td>B.BRAUN INTERGRATED PHARMACEUTICAL PLANT;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>GLUCOSE 5% B.BRAUN 200ML</td><td>GLUCOSE</td><td>2024/23.2.1/6777</td><td>11/28/2024</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5 G/50ML</td><td>B.BRAUN INTERGRATED PHARMACEUTICAL PLANT;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>GLUCOSE INJECTION</td><td>DEXTROSE</td><td>98/23.2.1/3464</td><td>05/20/1999</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5% W/V</td><td>AUTOSTERILE;  AUTOSTERILE NAMIBIA (PTY) LTD;  </td><td>AUTOSTERILE</td><td>AUTOSTERILE</td>
	</tr><tr>
		<td>GLUSIS 1000ER</td><td>METFORMIN</td><td>2017/17.7/5337</td><td>03/22/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>GLUSIS 500 ER</td><td>METFORMIN</td><td>2017/17.7/5336</td><td>03/22/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>GLYCERIN AND ROSE WATER</td><td>GLYCERIN; ROSE WATER</td><td>81/14.14/5866</td><td>10/22/1981</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>50%</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>GLYCERINE ADULT</td><td>GLYCERIN</td><td>2018/16.5.2/5586</td><td>03/12/2018</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>2.4G</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>GLYCERINE CHILDREN</td><td>GLYCERIN</td><td>2017/16.5.2/5422</td><td>09/07/2017</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>1.26G</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>GLYCINORM-80</td><td>GLICLAZIDE</td><td>2003/17.7/4179</td><td>07/31/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>GLYCOPYRRONIUM BROMIDE</td><td>GLYCOPYRRONIUM BROMIDE</td><td>2019/6.2/5892</td><td>07/19/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG/ML</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA;  </td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td>
	</tr><tr>
		<td>GLYDA 10</td><td>&nbsp;</td><td>2025/17.7/6825</td><td>01/17/2025</td><td>01/16/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GLYDA 5</td><td>&nbsp;</td><td>2025/17.7/6824</td><td>01/17/2025</td><td>01/16/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GOAB 10</td><td>SOLIFENACIN SUCCINATE</td><td>2024/21.7/6643</td><td>06/14/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GOAB 5</td><td>SOLIFENACIN SUCCINATE</td><td>2024/21.7/6642</td><td>06/14/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>GOFEN 400</td><td>IBUPROFEN</td><td>2021/3.1/6120</td><td>04/28/2021</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>MEGA LIFESCIENCES PUBLIC COMPANY LIMITED;  </td><td>MEGA LIFESCIENCES PUBLIC COMPANY LIMITED</td><td>MEGA LIFESCIENCES PUBLIC COMPANY LIMITED</td>
	</tr><tr>
		<td>GOLDGESIC</td><td>CAFFEINE; CODEINE PHOSPHATE; MEPROBAMATE; PARACETAMOL</td><td>96/2.2/3123</td><td>07/01/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>32; 5; 150; 320MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>MULLER & PHIPPS</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>GOLDGESIC</td><td>CODEINE PHOSPHATE; PARACETAMOL; PROMETHAZINE</td><td>96/2.2/3122</td><td>07/01/1996</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5; 120; 6.5MG/5ML</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>GOLDGESTANT</td><td>CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE</td><td>96/22.2.5/3121</td><td>07/01/1996</td><td>12/31/2027</td><td>ELIXIR; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2; 2.5; 2.5 MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>MULLER & PHIPPS</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>G-OUT </td><td>COLCHICINE</td><td>2021/3.2/6079</td><td>01/13/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.5MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>G-OUT PLUS</td><td>COLCHICINE</td><td>2024/3.2/6693</td><td>10/10/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>GOUTSEAL-40</td><td>FEBUXOSTAT</td><td>2018/3.2/5641</td><td>06/28/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>ACME FORMULATION PVT LTD (HORMONE BLOCK);  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>GOUTSEAL-80</td><td>FEBUXOSTAT</td><td>2018/3.2/5640</td><td>06/28/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG</td><td>ACME FORMULATION PVT LTD (HORMONE BLOCK);  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>GRAND-PA ADVANCE</td><td>PARACETAMOL</td><td>2014/2.1/4945</td><td>10/16/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500MG</td><td>GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD;  </td><td>GLAXOSMITHKLINE CONSUMER HEALTHCARE S.A. (PTY) LTD</td><td>GLAXOSMITHKLINE CONSUMER HEALTHCARE S.A. (PTY) LTD</td>
	</tr><tr>
		<td>GRANDPA HEADACHE POWDERS</td><td>ASPIRIN; CAFFEINE; PARACETAMOL</td><td>75/2.2/440</td><td>02/03/1975</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>453.6; 64.8; 324 MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  SMITHLINE BEECHAM;  </td><td>GROUP LABS S.A PTY LTD</td><td>GROUP LABS S.A PTY LTD</td>
	</tr><tr>
		<td>GRANDPA HEADACHE TABLETS</td><td>ASPIRIN; CAFFEINE; PARACETAMOL</td><td>2013/2.2/4787</td><td>07/10/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>226; 32; 162 MG</td><td>GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD;  </td><td>GLAXOSMITHKLINE SOUTH AFRICA (PTY) LTD</td><td>GLAXOSMITHKLINE</td>
	</tr><tr>
		<td>GRANITRYL 1MG/1ML</td><td>GRANISETRON HYROCHLORIDE</td><td>2024/16.2/6774</td><td>11/27/2024</td><td>&nbsp;</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG/1ML</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>GRAYS COUGH SYRUP</td><td>HONEY; PINE TAR</td><td>95/22.5.5/3017</td><td>11/09/1995</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>MULTIPLE</td><td>PHARMANOVA (PVT) LTD;  </td><td>MULLER & PHIPPS</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>GRAYS GRIPE WATER</td><td>GRIPE WATER</td><td>95/16.1/3024</td><td>11/09/1995</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1; 0.05; 0.08; 0.0059; 0.0109; 0.0028G</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>GRAYS MILK OF MAGNESIA</td><td>MAGNESIUM HYDROXIDE</td><td>95/16.1/3023</td><td>11/09/1995</td><td>12/31/2027</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>8.1% W/W /5ML</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>GRAYS NYONGOCID</td><td>ALUMINIUM HYDROXIDE</td><td>2019/16.1/5932</td><td>11/20/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>216MG</td><td>PHARMANOVA PVT LTD;  </td><td>PHARMANOVA PVT LTD</td><td>PHARMANOVA (PVT) LTD HOLDINGS LTD</td>
	</tr><tr>
		<td>GRAYS PARACETAMOL TABLETS</td><td>PARACETAMOL</td><td>75/2.1/466</td><td>04/14/1975</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>PHARMANOVA (PVT) LTD;  CADILA PHARMACEUTICALS LIMITED;  PHARMANOVA PVT LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>GRAYS PEPPERMINT AND HONEY COUGH SYRUP</td><td>GUAIFENESIN</td><td>2018/22.2.2/5711</td><td>10/09/2018</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG/5ML</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>GREENWOOD PYNMOL</td><td>PARACETAMOL</td><td>2024/2.1/6539</td><td>01/09/2024</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>120 MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>GRISEOFULVIN 125</td><td>GRISEOFULVIN</td><td>99/7.12/3479</td><td>01/29/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>GRISEON</td><td>GRISEOFULVIN</td><td>92/7.12/2721</td><td>09/22/1992</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>GRISEON</td><td>GRISEOFULVIN</td><td>92/7.12/2722</td><td>09/22/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>GRISORAL</td><td>GRISEOFULVIN</td><td>98/7.12/3397</td><td>07/29/1998</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250MG</td><td>BAL PHARMA;  BAL PHARMA LTD;  </td><td>BAL PHARMA</td><td>BAL PHARMA</td>
	</tr><tr>
		<td>GUAIPHENESIN BETAMINT</td><td>GUAIFENESIN</td><td>2005/22.2.2/4339</td><td>01/27/2005</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100MG/5ML</td><td>ECOMED MANUFACTURING (PVT) LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>GULF GRIPE MIXTURE</td><td>GRIPE WATER</td><td>95/16.1/3006</td><td>10/19/1995</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>2.5; 87.5MG</td><td>GULF DRUG CO;  GULF DRUG COMPANY (PVT) LTD;  GEDDES LTD;  </td><td>GULF DRUG COMAPANY</td><td>D A B PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>GYNOCIDE</td><td>ECONAZOLE NITRATE</td><td>99/14.17/3527</td><td>05/18/1999</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>&nbsp;</td><td>1% W/W</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>GYNO-MICOVAR</td><td>MICONAZOLE NITRATE</td><td>99/14.17/3569</td><td>07/16/2000</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>&nbsp;</td><td>2% W/W</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>HAEM UP INJECTION</td><td>IRON SUCROSE</td><td>2015/10.1.1/5133</td><td>12/14/2015</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/ML</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>HAEMACCEL</td><td>POLYGELINE</td><td>1976/11.1/699</td><td>09/23/1976</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>35G/L</td><td>PIRAMAL HEALTH CARE LIMITED;  </td><td>PIRAMAL HEALTHCARE LIMITED</td><td>PIRAMAL PHARMA LIMITED</td>
	</tr><tr>
		<td>HALAVEN</td><td>ERIBULIN MESYLATE</td><td>2021/9.7/6078</td><td>01/13/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.44MG/ML</td><td>BSP PHARMACEUTICALS S.P.A;  NERPHARMA S.R.L;  </td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td><td>EISAI PHARMACEUTICALS AFRICA (PTY0 LTD.,</td>
	</tr><tr>
		<td>HALF STRENGTH DARROWS SOLN WITH DETROSE 10%</td><td>DARROW'S HALF STRENGTH (WITH DEXTROSE) </td><td>97/23.2.1/3207</td><td>03/27/1997</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10% M/V</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM CRITICAL CARE</td>
	</tr><tr>
		<td>HALF STRENGTH DARROWS SOLUTION WITH 5 % DEXTROSE FRESENIUS (1000ML)</td><td>DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE</td><td>2019/23.2.1/5917</td><td>09/02/2019</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 1.30; 2; 2.95G/1000ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>HALF STRENGTH DARROWS SOLUTION WITH 5% DEXTROSE FRESENIUS (500ML)</td><td>DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE</td><td>2019/23.2.1/5916</td><td>09/02/2019</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25; 0.65; 1; 1.475G/500ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>HALF STRENGTH DARROWS SOLUTION WITH DEXTROSE 2.5%</td><td>DARROW'S HALF STRENGTH (WITH DEXTROSE) </td><td>92/23.2.1/2667</td><td>06/24/1992</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5%</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>HALF STRENGTH DARROWS SOLUTION; DEXTROSE FRESENIUS (200ML)</td><td>DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE</td><td>2003/23.2.1/4192</td><td>10/03/2003</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10; 0.26; 0.40; 0.59G / 200ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>HALF STRENGTH DARROWS WITH 5% GLUCOSE</td><td>DARROW'S HALF STRENGTH (WITH DEXTROSE) </td><td>98/23.2.1/3466</td><td>03/22/2001</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.2; 0.13; 5% W/W</td><td>AUTOSTERILE;  AUTOSTERILE NAMIBIA (PTY) LTD;  </td><td>AUTOSTERILE</td><td>AUTOSTERILE</td>
	</tr><tr>
		<td>HALF-STRENGTH DARROWS WITH GLUCOSE 5%</td><td>DARROW'S HALF STRENGTH (WITH DEXTROSE) </td><td>2002/23.2.1/4080</td><td>11/03/2002</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3; 2; 1.3; 100G</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM CRITICAL CARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>HALOTHANE BP</td><td>HALOTHANE</td><td>97/1.1/3134</td><td>02/27/1997</td><td>12/31/2027</td><td>LIQUID</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100%V/V</td><td>PIRAMAL ENTERPRISES LIMITED;  </td><td>PIRAMAL ENTERPRISES LIMITED</td><td>PIRAMAL PHARMA LIMITED</td>
	</tr><tr>
		<td>HCQS</td><td>HYDROXY CHLOROQUINE SULPHATE</td><td>2018/7.5/5678</td><td>08/27/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>IPCA LABORATORIES LIMITED;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABORATORIES LIMITED</td>
	</tr><tr>
		<td>HCT/AMILORIDE CO</td><td>AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE</td><td>90/12.5.1/2395</td><td>09/05/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50; 5MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>HELIGO 500</td><td>TINIDAZOLE; CLARITHROMYCIN; LANSOPRAZOLE </td><td>2022/16.7/6360</td><td>12/07/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500; 500; 30MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>HEMATONIC</td><td>FERRIC AMMONIUM CITRATE; FOLIC ACID; VITAMIN B12; VITAMIN B6; ZINC SULPHATE</td><td>2016/24.5/5228</td><td>06/24/2016</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200; 0.5; 1.5; 1.455MG; 50MCG</td><td>S KANT HEALTHCARE LTD;  </td><td>SK AGE EXPORTS</td><td>S KANT HEALTHCARE LTD</td>
	</tr><tr>
		<td>HEMLIBRA </td><td>EMICIZUMAB</td><td>2019/10/5813</td><td>03/29/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>105MG/0.7ML</td><td>CHUGAI PHARMA MANUFACTURING CO., LTD (CPMC);  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>HEMLIBRA</td><td>EMICIZUMAB</td><td>2019/10/5815</td><td>03/29/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG/ML</td><td>CHUGAI PHARMA MANUFACTURING CO., LTD (CPMC);  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>HEMLIBRA </td><td>EMICIZUMAB</td><td>2019/10/5814</td><td>03/29/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60MG/0.4ML</td><td>CHUGAI PHARMA MANUFACTURING CO., LTD (CPMC);  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>HEMLIBRA</td><td>EMICIZUMAB</td><td>2019/10/5812</td><td>03/29/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML</td><td>CHUGAI PHARMA MANUFACTURING CO., LTD (CPMC);  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>HENKA 30</td><td>DULOXETINE HYDROCHLORIDE</td><td>2024/13.2.1/6583</td><td>04/11/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>30MG</td><td>HETERO LABS LIMITED;  HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>HENKA 60</td><td>DULOXETINE HYDROCHLORIDE</td><td>2024/13.2.1/6584</td><td>04/11/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>60MG</td><td>HETERO LABS LIMITED;  HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>HEPALIN </td><td>HEPARIN SODIUM</td><td>2023/10.2/6494</td><td>10/26/2023</td><td>10/26/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5000 IU/ML</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>HEPANIR</td><td>HEPARIN SODIUM</td><td>2024/10.2/6654</td><td>07/01/2024</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5000 IU/ML</td><td>ACULIFE HEALTHCARE PVT LTD;  </td><td>ACULIFE HEALTHCARE PRIVATE LTD</td><td>ACULIFE HEALTHCARE PRIVATE LTD</td>
	</tr><tr>
		<td>HEPARIN SODIUM FRESENIUS</td><td>HEPARIN SODIUM</td><td>2011/10.2/4658</td><td>01/17/2011</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5000IU/ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>HEPARIN SODIUM PANPHARMA</td><td>HEPARIN SODIUM</td><td>99/10.2/3530</td><td>05/20/1999</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5000 IU/ML</td><td>PANPHARMA GMBH;  </td><td>PANPHARMA GMBH</td><td>PANPHARMA GMBH</td>
	</tr><tr>
		<td>HERCEPTIN</td><td>TRASTUZUMAB</td><td>2014/9.7/4830</td><td>01/21/2014</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>440MG</td><td>F. HOFFMAN LA ROCHE LTD;  GENETECH INC.;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>HERCEPTIN SC</td><td>TRASTUZUMAB</td><td>2017/9.7/5512</td><td>12/20/2017</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>120MG/ML</td><td>ROCHE DIAGNOSTICS GMBH;  F. HOFFMAN LA ROCHE LTD;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN LA ROCHE LTD</td>
	</tr><tr>
		<td>HERPERAX</td><td>ACYCLOVIR</td><td>98/7.13/3295</td><td>03/17/1998</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>HETEROLAXA</td><td>SODIUM PICOSULFATE; MAGNESIUM OXIDE; ANHYDROUS CITRIC ACID</td><td>2023/16.5.2/6401</td><td>04/21/2023</td><td>04/21/2028</td><td>POWDER, SOLUBLE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG; 3.5G; 12G</td><td>ANNORA PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>HETSOLID 110</td><td>DABIGATRAN ETEXILATE</td><td>2025/10.2/6939</td><td>05/05/2025</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>110 MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>HETSOLID 150</td><td>DABIGATRAN ETEXILATE</td><td>2025/10.2/6940</td><td>05/05/2025</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>HETSOLID 75</td><td>DABIGATRAN ETEXILATE</td><td>2025/10.2/6938</td><td>05/05/2025</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>HEXAXIM</td><td>BORDETELLA PERTUSIS; DIPHERIA TOXOID; HEPATITIS; POLIOVIRUS; TETANUS TOXOID</td><td>2015/18.2/5072</td><td>07/28/2015</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5 ML</td><td>SANOFI PASTEUR S. A;  SANOFI PASTEUR S. A;  GRUPPO LEPETIT SRL;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>HIDRASEC</td><td>RACECADOTRIL</td><td>2014/16.6/4955</td><td>11/25/2014</td><td>12/31/2027</td><td>BALSAM</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>LABORATOIRES SOPHARTEX;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>BIOPROJECT PHARMA</td>
	</tr><tr>
		<td>HIDRASEC CHILDREN</td><td>RACECADOTRIL</td><td>2014/16.6/4954</td><td>11/25/2014</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30 MG</td><td>SOPHARTEX;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>BIOPROJECT PHARMA</td>
	</tr><tr>
		<td>HIDRASEC INFANTS</td><td>RACECADOTRIL</td><td>2014/16.6/4953</td><td>11/05/2014</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>ABBOTT LABORATORIES SA (PTY) LTD;  BIOPROJECT PHARMA;  SOPHARTEX;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>BIOPROJECT PHARMA</td>
	</tr><tr>
		<td>HISTACET</td><td>CETIRIZINE HYDROCHLORIDE</td><td>2021/5/6174</td><td>09/08/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>10MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>HISTACET</td><td>CETIRIZINE HYDROCHLORIDE</td><td>2017/5/5484</td><td>11/08/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>5MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>HISTALIX</td><td>AMMONIUM CHLORIDE; CODEINE PHOSPHATE; DIPHENYLHYDRAMINE HYDROCHLORIDE</td><td>76/22.2.5/649</td><td>05/25/1976</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>90; 9; 10MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>HISTALIX-D</td><td>AMMONIUM CHLORIDE; DEXTROMETHORPHANE; DIPHENHYDRAMINE HYDROCHLORIDE</td><td>93/22.2.5/2783</td><td>04/15/1993</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>9; 10; 90MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>HISTAVERT 16</td><td>BETAHISTINE DIHYDROCHLORIDE</td><td>2024/5/6767</td><td>11/19/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>16MG</td><td>PULSE PHARMACEUTICALS PVT LTD ;  </td><td>COSPHARM INVESTMENTS South Africa</td><td>COSPHARM INVESTMENTS South Africa</td>
	</tr><tr>
		<td>HISTAVERT 24</td><td>BETAHISTINE DIHYDROCHLORIDE</td><td>2024/5/6768</td><td>11/19/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>24MG</td><td>PULSE PHARMACEUTICALS PVT LTD ;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>HISTAVERT 8</td><td>BETAHISTINE DIHYDROCHLORIDE</td><td>2024/5/6766</td><td>11/19/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>8MG</td><td>PULSE PHARMACEUTICALS PVT LTD ;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>HULIO (0.8ML)</td><td>ADALIMUMAB</td><td>2020/9.6/6001</td><td>05/27/2020</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/0.8ML</td><td>TERUMO YAMAGUCHI D&amp;D CORPORATION;  </td><td>MYLAN PHARMACEUTICALS PVT LTD</td><td>MYLAN PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>HULIO (1ML)</td><td>ADALIMUMAB</td><td>2020/9.6/6000</td><td>05/27/2020</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/0.8ML</td><td>TERUMO YAMAGUCHI D&amp;D CORPORATION;  </td><td>MYLAN PHARMACEUTICALS PVT LTD</td><td>MYLAN PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>HYAN</td><td>LEVONORGESTREL</td><td>2016/21.2.2/5294</td><td>11/15/2016</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.03MG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>HYDROCHLOROTHIAZIDE</td><td>HYDROCHLOROTHIAZIDE</td><td>94/12.5.1/2834</td><td>04/07/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM</td><td>HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM</td><td>2017/12.3.5/5425</td><td>09/11/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50; 12.5MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>JUBILANT ORGANOSYS LIMITED</td>
	</tr><tr>
		<td>HYDROCORTISONE</td><td>HYDROCORTISONE</td><td>2023/14.2.1/6498</td><td>10/26/2023</td><td>10/26/2028</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1 %W/W</td><td>INTERMED;  </td><td>INTERMED</td><td>INTERMED</td>
	</tr><tr>
		<td>HYDROCORTISONE</td><td>HYDROCORTISONE</td><td>91/14.2.1/2499</td><td>09/09/1991</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1%</td><td>CAPS PVT LTD;  </td><td>CAPS INTERNATIONAL EST</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>HYDROCORTISONE CREAM</td><td>HYDROCORTISONE</td><td>1982/14.2.1/5864</td><td>01/19/1982</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>10MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>HYDROCORTISONE SODIUM SUCCINATE</td><td>HYDROCORTISONE SODIUM SUCCINATE</td><td>2020/17.1/5968</td><td>02/03/2020</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>HYDROLIN</td><td>HYDROCORTISONE ACETATE</td><td>2024/19.2.1/6579</td><td>04/09/2024</td><td>&nbsp;</td><td>SUSPENSION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1%W/V</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>HYDROLIN</td><td>&nbsp;</td><td>2025/14.2.1/6951</td><td>05/08/2025</td><td>05/07/2030</td><td>&nbsp;</td><td>PHARMACY MEDICINES (P.)</td><td>&nbsp;</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>HYDROXYUREA</td><td>HYDROXYCARBAMIDE</td><td>2022/31/6244</td><td>02/04/2022</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>HAUPT PHARMA AMAREG GMBH;  </td><td>NORVATIS PHARMA AG </td><td>SANDOZ S.A PTY LTD</td>
	</tr><tr>
		<td>HYDROXYUREA 100</td><td>HYDROXYCARBAMIDE</td><td>2023/31/6406</td><td>05/12/2023</td><td>05/12/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>HAUPT PHARMA AMAREG GMBH;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>SANDOZ PHARMACEUTICALS D.D.</td>
	</tr><tr>
		<td>HYDROXYUREA 1000</td><td>HYDROXYCARBAMIDE</td><td>2023/31/6407</td><td>05/12/2023</td><td>05/12/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>HAUPT PHARMA AMAREG GMBH;  </td><td>NORVATIS PHARMA AG </td><td>SANDOZ PHARMACEUTICALS D.D.</td>
	</tr><tr>
		<td>HYOSCINE BUTYLBROMIDE</td><td>HYOSCINE BUTYLBROMIDE</td><td>96/16.4/3022</td><td>04/17/1996</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>HYOSPASMOL</td><td>HYOSCINE BUTYLBROMIDE</td><td>91/16.4/2563</td><td>12/09/1991</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>ASPEN SA OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>HYOSPASMOL</td><td>HYOSCINE BUTYLBROMIDE</td><td>99/16.4/3577</td><td>07/21/1999</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>HYPERPHEN-50</td><td>HYDRALAZINE HYDROCHLORIDE</td><td>92/12.3.1/2608</td><td>04/09/1992</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>ASPEN SA OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>HYPNOMIDATE</td><td>ETOMIDATE</td><td>83/13.3/1257</td><td>08/08/1979</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG/ML</td><td>GLAXOSMITHKLINE S. P. A;  </td><td>PIRAMAL CRITICAL CARE SOUTH AFRICA (PTY) LTD</td><td>PIRAMAL CRITICAL CARE SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>HYPOTENS</td><td>METHYLDOPA</td><td>83/12.3.3/1670</td><td>02/02/1983</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>HYPOTONE</td><td>METHYLDOPA</td><td>92/12.3.3/2603</td><td>04/06/1992</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250MG</td><td>ASPEN SA OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>I PILL</td><td>LEVONORGESTREL</td><td>2016/21.2.2/5254</td><td>10/11/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1.5MG</td><td>CIPLA LIMITED;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>I.N.H.</td><td>ISONIAZID</td><td>81/7.3/5847</td><td>11/27/1981</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>IBICAR 100</td><td>&nbsp;</td><td>2025/22.1.3/6953</td><td>05/09/2025</td><td>05/08/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>GLEMARK PHARMACEUTICAL LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>IBICAR 200</td><td>&nbsp;</td><td>2025/22.1.3/6954</td><td>05/09/2025</td><td>05/08/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>GLENMARK PHARAMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>IBICAR 50</td><td>&nbsp;</td><td>2025/22.1.3/6952</td><td>05/09/2025</td><td>05/08/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>GLENMARK PHARAMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>IBRANCE</td><td>PALBOCICLIB</td><td>2023/9.5.2/6502</td><td>11/02/2023</td><td>11/02/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>IBRANCE</td><td>PALBOCICLIB</td><td>2023/9.5.2/6503</td><td>11/02/2023</td><td>11/02/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>IBRANCE</td><td>PALBOCICLIB</td><td>2023/9.5.2/6504</td><td>11/02/2023</td><td>11/02/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>IBUCET</td><td>IBUPROFEN; PARACETAMOL</td><td>2017/2.2/5326</td><td>03/08/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200; 250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>IBUCET MENSTRUAL</td><td>IBUPROFEN; PARACETAMOL</td><td>2018/2.2/5536</td><td>01/25/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200; 250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>IBUN</td><td>IBUPROFEN</td><td>2021/3.1/6101</td><td>02/18/2021</td><td>12/31/2027</td><td>GEL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>5%W/W</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>IBUPROFEN</td><td>IBUPROFEN</td><td>2002/3.1/4069</td><td>09/12/2002</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>IBUPROFEN</td><td>IBUPROFEN</td><td>2004/3.1/4253</td><td>02/18/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>IBUPROFEN</td><td>IBUPROFEN</td><td>2000/3.1/3742</td><td>07/19/2000</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>BAL PHARMA;  BAL PHARMA LTD;  </td><td>BAL PHARMA</td><td>BAL PHARMA</td>
	</tr><tr>
		<td>IBUPROFEN</td><td>IBUPROFEN</td><td>2004/3.1/4254</td><td>02/18/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>IBUPROFEN</td><td>IBUPROFEN</td><td>89/3.1/2271</td><td>06/05/1989</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>IBUPROFEN</td><td>IBUPROFEN</td><td>2002/3.1/4066</td><td>09/05/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>IBUPROFEN</td><td>IBUPROFEN</td><td>2002/3.1/4067</td><td>09/05/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>IBUPROFEN</td><td>IBUPROFEN</td><td>89/3.1/1807</td><td>06/05/1989</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>IBUPROFEN</td><td>IBUPROFEN</td><td>95/3.1/3015</td><td>11/03/1995</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>IBUSPAN</td><td>IBUPROFEN</td><td>2003/3.1/4155</td><td>05/27/2003</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG</td><td>SM PHARMACEUTICALS;  </td><td>SM PHARMACEUTICALS</td><td>SM PHARMACEUTICALS</td>
	</tr><tr>
		<td>IBUSPAN</td><td>IBUPROFEN</td><td>2003/3.1/4156</td><td>05/27/2003</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>SM PHARMACEUTICALS;  </td><td>SM PHARMACEUTICALS</td><td>SM PHARMACEUTICALS</td>
	</tr><tr>
		<td>ICHTHAMMOL GLYCERIN BPC</td><td>GLYCEROL; ICHTHAMMOL</td><td>82/14.1.4/5883</td><td>01/19/1982</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>90; 10%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>IFIMOL IV</td><td>PARACETAMOL</td><td>2025/2.1/6924</td><td>04/14/2025</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>UNIQUE PHARM LABS ;  </td><td>RAINBOW PHARMACEUTICALS</td><td>RAINBOW PHARMACEUTICALS</td>
	</tr><tr>
		<td>IKLEER</td><td>PHENYLEPHRINE HYDROCHLORIDE; PHENAZONE </td><td>75/19.9/502</td><td>07/18/1975</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACY MEDICINES (P.)</td><td>12; 1MG/ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ILEVRO</td><td>NEPAFENAC</td><td>2024/19.1/6789</td><td>12/11/2024</td><td>12/31/2027</td><td>SUSPENSION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3 MG/ML</td><td>ALCON-COUVREUR n.v.;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>IMAREM</td><td>IMATINIB MESYLATE</td><td>2023/9.4/6409</td><td>05/17/2023</td><td>05/17/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>IMAREM</td><td>IMATINIB MESYLATE</td><td>2023/9.4/6408</td><td>05/17/2023</td><td>05/17/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>IMATIB</td><td>IMATINIB MESYLATE</td><td>2021/9.4/6097</td><td>02/05/2021</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>IMATIB</td><td>IMATINIB MESYLATE</td><td>2021/9.4/6096</td><td>02/05/2021</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>IMATIS 100 MG</td><td>IMATINIB</td><td>2017/9.4/5346</td><td>03/10/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>DEVA HOLDINGS A.S. ONCOLYTICS PRODUCTION SITE;  </td><td>KEY ONCOLOGICS (PYT) LTD</td><td>KEY ONCOLOGICS (PYT) LTD</td>
	</tr><tr>
		<td>IMMUNOREL 5G</td><td>HUMAN IMMUNOGLOBULIN</td><td>2022/18.1.3/6225</td><td>01/13/2022</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5%</td><td>RELIANCE LIFE SCIENCES (PVT) LTD;  </td><td>WMT PHARMACEUTICALS</td><td>RELIANCE LIFE SCIENCES (PVT) LTD</td>
	</tr><tr>
		<td>IMMUNOX</td><td>CEFTRIAXONE SODIUM</td><td>2010/7.2.2/4625</td><td>01/29/2010</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1 GRAM</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>IMPLANON NXT</td><td>ETONOGESTREL</td><td>2014/21.2.4/4918</td><td>08/15/2014</td><td>12/31/2027</td><td>IMPLANT; SUBCUTANEOUS</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>68 MG</td><td>NUVIS.AN ANALYTICAL SERVICES GMBH;  N.V.ORGANON;  SYNERGY HEALTH EDE B. V. SOEVEREINSTRAAT 2;  </td><td>ORGANON SOUTH AFRICA (PTY) LTD.</td><td>MSD PTY LTD</td>
	</tr><tr>
		<td>INACTIVATED POLIOMYELITIS VACCINE TYPES 1,2,3</td><td>POLIOMYELITIS  (TYPES 1,2,3; INACTIVATED)</td><td>2016/18.2/5227</td><td>06/20/2016</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40; 8; 32 D ANTIGEN</td><td>BILTHOVEN BIOLOGICALS B.V,;  </td><td>BILTHOVEN BIOLOGICALS B.V,</td><td>BILTHOVEN BIOLOGICALS B.V,</td>
	</tr><tr>
		<td>INACTIVATED POLIOMYELITIS VACCINE TYPES 1,2,3</td><td>POLIOMYELITIS  (TYPES 1,2,3; INACTIVATED)</td><td>2016/18.2/5226</td><td>06/22/2016</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40; 8; 32 D ANTIGEN</td><td>BILTHOVEN BIOLOGICALS B.V,;  </td><td>BILTHOVEN BIOLOGICALS B.V,</td><td>BILTHOVEN BIOLOGICALS B.V,</td>
	</tr><tr>
		<td>INBEC</td><td>ABACAVIR; DOLUTEGRAVIR; LAMIVUDINE</td><td>2021/7.13/6181</td><td>10/01/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 50; 300MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>INDOMETHACIN</td><td>INDOMETHACIN</td><td>92/3.1/2619</td><td>04/28/1992</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>INDOMETHACIN</td><td>INDOMETHACIN</td><td>2002/3.1/4012</td><td>01/14/2002</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>UMEDICA LABORATORIES PVT. LTD;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>INDOMETHACIN</td><td>INDOMETHACIN</td><td>89/3.1/2274</td><td>06/06/1989</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>DATLABS PRIVATE LIMITED;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>INFEX</td><td>NYSTATIN</td><td>81/14.17/1478</td><td>12/13/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100000IU</td><td>SCANPHARM A/S;  CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>INFLUVAC</td><td>INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED)</td><td>2016/18.2/5264</td><td>09/09/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15; 15; 15MCG/ML</td><td>ABBOTT BIOLOGICALS PRIVATE LIMITED;  ABBOTT BIOLOGICALS B.V;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>SKY PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>INJECTA-FEM</td><td>MEDROXYPROGESTERONE ACETATE</td><td>2022/21.2.3/6297</td><td>06/28/2022</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML</td><td>INCEPTA PHARMACEUTICALS (PTY) LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>INN0GRA</td><td>SILDENAFIL</td><td>2017/31/5389</td><td>06/29/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>HETERO DRUGS LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>INNIKRA</td><td>PREGABALIN</td><td>2017/13.1/5502</td><td>12/14/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>INNIKRA</td><td>PREGABALIN</td><td>2017/13.1/5503</td><td>12/14/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>INNIKRA</td><td>PREGABALIN</td><td>2017/13.1/5504</td><td>12/14/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>INNOFER</td><td>IRON SUCROSE</td><td>2017/10.1.1/5463</td><td>10/30/2017</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG;5ML</td><td>GLOBAL REMEDIES (PVT) LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>INNOFLAM 100</td><td>CELECOXIB</td><td>2021/3.1/6167</td><td>08/18/2021</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>INNOFLAM 200</td><td>CELECOXIB</td><td>2021/3.1/6168</td><td>08/18/2021</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>INNOGRA</td><td>SILDENAFIL</td><td>2017/31/5390</td><td>06/29/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>HETERO DRUGS LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>INNOKLOD  5</td><td>APIXABAN</td><td>2024/10.2/6628</td><td>06/06/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>M/S NATCO PHARMA LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>INNOKLOD 2.5</td><td>APIXABAN</td><td>2024/10.2/6627</td><td>06/06/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>M/S NATCO PHARMA LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>INNOLON</td><td>MOXIFLOXACIN HYDROCHLORIDE</td><td>2017/7.3/5480</td><td>11/06/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>HETERO LABS LTD,;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>INNOXIME</td><td>CEFIXIME</td><td>2018/7.2.2/5609</td><td>05/03/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>NECTAR LIFESCIENCES LTD;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>INNOZINC 20</td><td>ZINC SULPHATE MONOHYDRATE</td><td>2024/16.6/6619</td><td>06/05/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>20MG</td><td>MEDICAMEN BIOTECH LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>INSPRA 25</td><td>EPLERENONE</td><td>2025/12.5.1/6914</td><td>04/08/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>VIATRIS PHARMACEUTICALS ;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEALTHCARE (PTY) LTD</td>
	</tr><tr>
		<td>INSPRA 50</td><td>EPLERENONE</td><td>2025/12.5.1/6915</td><td>04/08/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>VIATRIS PHARMACEUTICALS ;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEALTHCARE (PTY) LTD</td>
	</tr><tr>
		<td>INSTGRA</td><td>DOLUTEGRAVIR SODIUM</td><td>2019/7.13/5770</td><td>01/04/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>INSULIDD N</td><td>INSULIN ISOPHANE</td><td>2004/17.6/4284</td><td>07/01/2004</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100IU/ML</td><td>M. J. BIOPHARMA;  </td><td>M. J. BIOPHARMA (PVT) LTD</td><td>M. J. BIOPHARMA (PVT) LTD</td>
	</tr><tr>
		<td>INSULIDD-R</td><td>SOLUBLE INSULIN (HUMAN INSULIN)</td><td>2004/17.6/4295</td><td>09/02/2004</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100IU/ML</td><td>M. J. BIOPHARMA;  </td><td>M. J. BIOPHARM (PVT) LTD</td><td>M. J. BIOPHARM (PVT) LTD</td>
	</tr><tr>
		<td>INSULIN GLARGINE IMPACT SOLOSTAR</td><td>INSULIN GLARGINE</td><td>2024/17.6/6747</td><td>11/14/2024</td><td>&nbsp;</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100IU/ML</td><td>SANOFI-AVENTIS;  </td><td>SANOFI HEALTHCARE INDIA PRIVATE LIMITED</td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>INTAXEL</td><td>PACLITAXEL</td><td>2007/9.4/4470</td><td>01/16/2007</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG/5ML</td><td>FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>INTAXEL</td><td>PACLITAXEL</td><td>2007/9.4/4471</td><td>01/16/2007</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/17ML</td><td>FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>INTELENCE</td><td>ETRAVIRINE</td><td>2016/7.13/5159</td><td>01/26/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25 MG</td><td>JANSSEN-CILAG SPA;  </td><td>JANSSEN-CILAG INTERNATIONAL</td><td>JANSSEN-CILAG INTERNATIONAL</td>
	</tr><tr>
		<td>INTELENCE</td><td>ETRAVIRINE</td><td>2015/7.13/5001</td><td>03/16/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>JANSSEN-CILAG SPA;  </td><td>JANSSEN-CILAG INTERNATIONAL NV</td><td>PHARMACARE LTD</td>
	</tr><tr>
		<td>IODINE TINCTURE</td><td>IODINE TICTURE</td><td>81/14.1.4/5872</td><td>10/19/1981</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>25G/1000ML</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>IOTIM</td><td>TIMOLOL MALEATE</td><td>2000/19.10/3690</td><td>03/06/2000</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG/100ML</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>IPOPRIN 2</td><td>POMALIDOMIDE</td><td>2024/9.6/6639</td><td>06/13/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>IRBIS 150</td><td>IRBESARTAN</td><td>2014/12.3.5/4921</td><td>08/15/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>IRBIS 300</td><td>IRBESARTAN</td><td>2014/12.3.5/4922</td><td>08/15/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>300 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>IRBIS-HT</td><td>HYDROCHLOROTHIAZIDE; IRBESARTAN</td><td>2018/12.3.5/5668</td><td>08/08/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 150MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>IRBIS-HT</td><td>HYDROCHLOROTHIAZIDE; IRBESARTAN</td><td>2018/12.3.5/5669</td><td>08/08/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 300MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>IRINOTECAN MYLAN</td><td>IRINOTECAN HYDROCHLORIDE</td><td>2023/9.4/6379</td><td>02/22/2023</td><td>02/22/2028</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20 MG/ML</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>IRINOTEL</td><td>IRINOTECAN HYDROCHLORIDE</td><td>2007/9.3/4473</td><td>01/16/2007</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/5ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>IRINOTEL 40MG</td><td>IRINOTECAN HYDROCHLORIDE</td><td>2007/9.3/4472</td><td>01/16/2007</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/2ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>IRITERO 100</td><td>&nbsp;</td><td>2025/9.4/6957</td><td>05/16/2025</td><td>05/15/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>IRITERO 40</td><td>&nbsp;</td><td>2025/9.4/6956</td><td>05/16/2025</td><td>05/15/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ISENTRESS</td><td>RALTEGRAVIR</td><td>2014/7.13/4914</td><td>08/13/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>MSD MERCK MAN DIV;  MSD B V HAARLEM;  ZHEJIANG HAUAHAI PHARMACEUTICAL CO LTD;  MSD TECHNOLOGY PVT LTD;  MSD PTY LTD;  </td><td>MSD PTY LTD</td><td>MSD PTY LTD</td>
	</tr><tr>
		<td>ISENTRESS</td><td>RALTEGRAVIR</td><td>2014/7.13/4963</td><td>12/19/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>PATHEON PHARMACEUTICALS INC;  MSD B V HAARLEM;  </td><td>MSD PTY LTD</td><td>MSD PTY LTD</td>
	</tr><tr>
		<td>ISENTRESS</td><td>RALTEGRAVIR</td><td>2014/7.13/4962</td><td>12/19/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25 MG</td><td>MSD B V HAARLEM;  PATHEON PHARMACEUTICALS INC;  </td><td>MSD PTY LTD</td><td>MSD PTY LTD</td>
	</tr><tr>
		<td>ISOFLURANE (100ML)</td><td>ISOFLURANE</td><td>2011/1.1/4671</td><td>03/25/2011</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100%W/V</td><td>PIRAMAL ENTERPRISES LIMITED;  </td><td>PIRAMAL ENTERPRISES LIMITED</td><td>PIRAMAL PHARMA LIMITED</td>
	</tr><tr>
		<td>ISOFLURANE (250ML)</td><td>ISOFLURANE</td><td>2011/1.1/4672</td><td>03/25/2011</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100%W/V</td><td>PIRAMAL ENTERPRISES LIMITED;  </td><td>PIRAMAL ENTERPRISES LIMITED</td><td>PIRAMAL PHARMA LIMITED</td>
	</tr><tr>
		<td>ISONAZID; PYRIDOXINE HYDROCHLORIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>ISONIAZID; PYRIDOXINE HYDROCHLORIDE; SULPHAMETHOXAZOLE; TRIMETHOPRIM</td><td>2023/7.15/6484</td><td>10/02/2023</td><td>10/02/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 25; 800; 160MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>ISONIAZID</td><td>ISONIAZID</td><td>95/7.3/2918</td><td>04/25/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ISONIAZID</td><td>ISONIAZID</td><td>2010/7.3/4580</td><td>02/08/2010</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ISONIAZID</td><td>ISONIAZID</td><td>2016/7.3/5210</td><td>05/26/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300 MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ISONIAZID</td><td>ISONIAZID</td><td>78/7.3/967</td><td>11/02/1982</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>ISONIAZID</td><td>ISONIAZID</td><td>2020/7.3/6027</td><td>08/07/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>ISONIAZID</td><td>ISONIAZID</td><td>2020/7.3/6026</td><td>08/07/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ISONIAZID</td><td>ISONIAZID</td><td>2023/7.3/6444</td><td>07/18/2023</td><td>07/18/2028</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>ISONIAZID</td><td>ISONIAZID</td><td>2010/7.3/4579</td><td>02/08/2010</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ISONIAZID</td><td>ISONIAZID</td><td>2023/7.3/6390</td><td>03/23/2023</td><td>03/23/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>OXALIS LABS;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ISONIAZID;  PYRAZINAMIDE; RIFAMPICIN</td><td>ISONIAZID; PYRAZINAMIDE; RIFAMPICIN</td><td>2018/7.3/5643</td><td>07/03/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 150; 75MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ISONIAZID; RIFAMPICIN</td><td>ISONIAZID; RIFAMPICIN</td><td>2023/7.3/6462</td><td>08/21/2023</td><td>08/21/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 75MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>ISONIAZID; RIFAPENTINE</td><td>ISONIAZID; RIFAPENTINE </td><td>2023/7.3/6528</td><td>12/05/2023</td><td>12/05/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 300MG</td><td>MACLEODS PHARMACEUTICALS LIMITED  AT OXALIS LABS;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ISOPTIN SR</td><td>VERAPAMIL HYDROCHLORIDE</td><td>97/12.6/3277</td><td>10/30/1997</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>240 MG</td><td>KNOLL GERMANY;  NORISTAN LABS DIV OF NORISTAN LTD;  BOOTS CO LTD, NOTTINGHAM, UK;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>ISOPTO ATROPINE</td><td>ATROPINE SULPHATE</td><td>98/19.5/3378</td><td>07/17/1998</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1% W/V</td><td>ALCON-COUVREUR n.v.;  </td><td>ALCON PHARM LTD</td><td>ALCON PHARM LTD</td>
	</tr><tr>
		<td>ITRAZOLE 100</td><td>ITRACONAZOLE</td><td>2023/7.12/6363</td><td>01/04/2023</td><td>01/04/2028</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>IVABEAT 5</td><td>IVABRADINE</td><td>2019/12.1/5836</td><td>05/20/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>IVABEAT 7.5</td><td>IVABRADINE</td><td>2019/12.1/5837</td><td>05/20/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>7.5MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>IVATOR 5</td><td>&nbsp;</td><td>2025/12.1/6909</td><td>04/04/2025</td><td>04/03/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>TORRENT PHARMACEUTICAL LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>IVATOR 7.5</td><td>&nbsp;</td><td>2025/12.1/6910</td><td>04/04/2025</td><td>04/03/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>TORRENT PHARMACEUTICAL LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>IVIXONE</td><td>CEFTRIAXONE SODIUM</td><td>2018/7.2.2/5547</td><td>01/30/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>IXAROLA 10</td><td>RIVAROXABAN</td><td>2023/10.2/6398</td><td>04/14/2023</td><td>04/14/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>BAYER AG;  BAYER HEALTHCARE MANUFACTURING S.R.L.;  BAYER BITTERFELD GMBH;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>IXAROLA 15</td><td>RIVAROXABAN</td><td>2023/10.2/6399</td><td>04/14/2023</td><td>04/14/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15 MG</td><td>BAYER AG;  BAYER BITTERFELD GMBH;  BAYER HEALTHCARE MANUFACTURING S.R.L.;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>IXAROLA 20</td><td>RIVAROXABAN</td><td>2023/10.2/6400</td><td>04/14/2023</td><td>04/14/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>JADELLE SINE INSERTER</td><td>LEVONORGESTREL</td><td>2003/21.2.4/4098</td><td>02/12/2003</td><td>12/31/2027</td><td>IMPLANT; SUBCUTANEOUS</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>LEIRAS OY;  BAYER OY;  </td><td>BAYER (PTY) LTD</td><td>BAYER PHARM AG</td>
	</tr><tr>
		<td>JANUMET</td><td>SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE</td><td>2015/17.7/5000</td><td>03/19/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50; 1000 MG</td><td>PATHEON PUERTO RICO INC;  AESICA QUEENBOROUGH LTD;  MSD INTERNATIONAL GMBH SINGAPORE BRANCH;  MERCK SHARP &amp; DOHME BV;  </td><td>MSD (PTY) LTD</td><td>MSD (PTY) LTD</td>
	</tr><tr>
		<td>JANUMET</td><td>SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE</td><td>2015/17.7/4999</td><td>03/13/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50; 850 MG</td><td>MERCK SHARP &amp; DOHME BV;  PATHEON PUERTO RICO INC;  AESICA QUEENBOROUGH LTD;  MSD INTERNATIONAL GMBH SINGAPORE BRANCH;  </td><td>MSD (PTY) LTD</td><td>MSD (PTY) LTD</td>
	</tr><tr>
		<td>JANUVIA</td><td>SITAGLIPTIN</td><td>2014/17.7/4940</td><td>10/15/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 MG</td><td>ORGANON PHARMA (UK) LIMITED;  </td><td>MSD PTY LTD</td><td>MSD PTY LTD</td>
	</tr><tr>
		<td>JANUVIA</td><td>SITAGLIPTIN</td><td>2014/17.7/4939</td><td>10/15/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>ORGANON PHARMA (UK) LIMITED;  </td><td>MSD PTY LTD</td><td>MSD PTY LTD</td>
	</tr><tr>
		<td>JINK</td><td>ZINC GLUCONATE</td><td>2023/16.6/6365</td><td>01/20/2023</td><td>01/20/2028</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>20 MG/5ML</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>JINK</td><td>ZINC SULPHATE</td><td>2023/16.6/6442</td><td>07/17/2023</td><td>07/17/2028</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>20MG</td><td>LINCOLN PHARMACEUTICALS LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>JITRIT-5</td><td>TOFACITINIB</td><td>2025/3.3/6808</td><td>01/10/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>JOVAN T 20</td><td>TADALAFIL</td><td>2015/31/5129</td><td>12/02/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20 MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>KAMAGRA-100</td><td>SILDENAFIL CITRATE</td><td>2008/21.8/4526</td><td>04/14/2008</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>AJANTA PHARMA;  </td><td>AJANTA PHARMA</td><td>AJANTA PHARMA</td>
	</tr><tr>
		<td>KAMAGRA-50</td><td>SILDENAFIL CITRATE</td><td>2008/21.8/4527</td><td>04/14/2008</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>AJANTA PHARMA;  </td><td>AJANTA PHARMA</td><td>AJANTA PHARMA</td>
	</tr><tr>
		<td>KANAMYCIN</td><td>KANAMYCIN SULPHATE</td><td>91/7.2.1/2506</td><td>06/12/1991</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>KAOLIN AND MORPHINE MIXTURE</td><td>CHLOROFORM; KAOLIN LIGHT;   MORPHINE HYDROCHLORIDE; SODIUM BICARBONATE</td><td>82/16.6/5976</td><td>01/19/1982</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>4V/V; 20%M/V; 5%M/V</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>KAPETRAL</td><td>CAPECITABINE</td><td>2020/9.2.2/6014</td><td>07/10/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>KAPETRAL 150</td><td>CAPECITABINE</td><td>2020/9.2.2/6034</td><td>09/08/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>KARVIL 25</td><td>CARVEDILOL</td><td>2015/12.3.2/5065</td><td>07/10/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>TORRENT PHARMACEUTICALS LTD;  TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>KARVIL 6.25MG</td><td>CARVEDILOL</td><td>2015/12.3.2/5064</td><td>07/10/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>6.25MG</td><td>TORRENT PHARMACEUTICALS LTD;  TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>KAVIDEZA DISTAB</td><td>ABACAVIR SULPHATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE</td><td>2024/7.3/6718</td><td>10/01/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60; 5; 30 MG</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>KCHECK</td><td>CALCITONIN</td><td>2023/23.4/6460</td><td>08/09/2023</td><td>08/09/2028</td><td>POWDER</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15G</td><td>STANFORD LABORATORIES PVT;  </td><td>LA RENON HEALTHCARE PRIVATE LIMITED</td><td>LA RENON HEALTHCARE PRIVATE LIMITED</td>
	</tr><tr>
		<td>KEFLOXA  250</td><td>CEFUROXIME AXETIL</td><td>2016/7.2.2/5172</td><td>03/15/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250 MG</td><td>MEDREICH LTD;  </td><td>MYLAN PHARMACEUTICALS LTD</td><td>MYLAN PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>KEFLOXA 500</td><td>CEFUROXIME</td><td>2016/7.2.2/5173</td><td>03/15/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>MEDREICH LTD;  </td><td>MYLAN PHARMACEUTICALS LTD</td><td>MYLAN PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>KEMOCARB</td><td>CARBOPLATIN</td><td>2007/9.4/4466</td><td>01/16/2007</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/15ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>KEMOCARB</td><td>CARBOPLATIN</td><td>2007/9.4/4467</td><td>01/16/2007</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>450MG/45ML</td><td>DABUR PHARMA LTD;  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>KEPPROLIN</td><td>LEVETIRACETAM</td><td>2024/13.1/6547</td><td>01/23/2024</td><td>&nbsp;</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/ML</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>KETAMINE FRESENIUS</td><td>KETAMINE HYDROCHLORIDE</td><td>2004/1.1/4281</td><td>07/01/2004</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/ML</td><td>INTRAMED (PTY) LTD;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>KETOCONAZOLE</td><td>KETOCONAZOLE</td><td>93/7.12/2752</td><td>01/12/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>KETOCONAZOLE</td><td>KETOCONAZOLE</td><td>98/7.12/3440</td><td>10/28/1998</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>KIDDISLEEP SYRUP</td><td>DIPHENHYDRAMINE HYDROCHLORIDE; PARACETAMOL</td><td>5/2.9/389</td><td>11/23/1976</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10; 120MG/5ML</td><td>PFIZER INC;  </td><td>LEMEX PRODUCTS PVT LTD</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>KIDDY SOOTHING</td><td>DIPHENHYDRAMINE HYDROCHLORIDE; PARACETAMOL</td><td>5/2.9/388</td><td>11/23/1976</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>120; 10MG/5ML</td><td>PFIZER INC;  </td><td>LEMEX PRODUCTS PVT LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>KIDDYCOUGH</td><td>AMONIUM CHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE; MENTHOL</td><td>87/10.1/1596</td><td>05/27/1987</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>110; 12; 0.8 MG/5ML</td><td>PFIZER INC;  </td><td>LEMEX PRODUCTS PVT LTD</td><td>LEMEX PRODUCTS PVT LTD</td>
	</tr><tr>
		<td>KIDDYGUM</td><td>BENZOCAINE</td><td>6/4/560</td><td>01/14/1977</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2.6% W/W</td><td>PFIZER INC;  </td><td>LEMEX PRODUCTS PVT LTD</td><td>LEMEX PRODUCTS PVT LTD</td>
	</tr><tr>
		<td>KIRSTY</td><td>INSULIN ASPART</td><td>2024/17.6/6662</td><td>07/11/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100IU/ML</td><td>BIOCON SDN. BDN (930330);  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>KIRSTY</td><td>INSULIN ASPART</td><td>2024/17.6/6663</td><td>07/11/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100IU/ML</td><td>BIOCON SDN. BDN (930330);  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>KLACID IV</td><td>CLARITHROMYCIN</td><td>2001/7.2.5/3956</td><td>10/24/2001</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>ABBOTT FRANCE R.S.A;  ABBOTT LABS S.A (PTY) LTD;  </td><td>ABBOTT LABS S.A (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>KLACID P125</td><td>CLARITHROMYCIN</td><td>2000/7.2.5/3797</td><td>11/02/2000</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>ABBOTT SPA;  ABBOTT LABORATORIES LTD;  </td><td>ABBOTT LABS S.A (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>KLACID P250</td><td>CLARITHROMYCIN</td><td>2000/7.2.5/3798</td><td>11/02/2000</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>ABBOTT SPA;  ABBOTT LABORATORIES LTD;  </td><td>ABBOTT LABS S.A (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>KLACID XL</td><td>CLARITHROMYCIN</td><td>98/7.2.5/3451</td><td>11/16/1998</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>ABBOTT SPA;  ABBOTT LABORATORIES LTD;  </td><td>ABBOTT LABS S.A (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>KOCITAF</td><td>DOLUTEGRAVIR EMTRICITABINE TENOFOVIR ALAFENAMIDE</td><td>2018/7.13/5725</td><td>11/02/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 200; 25MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>KOMEFAN 140</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2014/7.5/4943</td><td>10/15/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120 MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>KONAZOL </td><td>KETOCONAZOLE</td><td>2024/14.1.3/6564</td><td>02/29/2024</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2%W/W</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>KORANDIL 10</td><td>ENALAPRIL MALEATE</td><td>99/12.3.5/3599</td><td>10/01/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>KORANDIL 20</td><td>ENALAPRIL MALEATE</td><td>99/12.3.5/3600</td><td>10/01/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>KOSOREX</td><td>GUAIFENESIN</td><td>2011/22.2.2/4708</td><td>09/30/2011</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>50 MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>KOSOREX STRONG</td><td>GUAIFENESIN</td><td>2015/22.2.2/4964</td><td>01/06/2015</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>KRYXANA 200MG</td><td>RIBOCICLIB SUCCINATE</td><td>2024/9.7/6771</td><td>11/21/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>NOVARTIS SINGAPORE PHARMACEUTICAL MANF PTC LT;  LEK PHARMACEUTICALS D.D.;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>LAFEKS 150</td><td>VENLAFAXINE HYDROCHLORIDE</td><td>2024/13.2.1/6646</td><td>06/14/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150 MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>LAFEKS 37.5</td><td>VENLAFAXINE HYDROCHLORIDE</td><td>2024/13.2.1/6644</td><td>06/14/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>37.5 MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>LAFEKS 75</td><td>VENLAFAXINE HYDROCHLORIDE</td><td>2024/13.2.1/6645</td><td>06/14/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75 MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>LAMISIL</td><td>TERBINAFINE</td><td>96/7.12/3076</td><td>04/15/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>NORVATIS PHARMA AG ;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>LAMITOR-25</td><td>LAMOTRIGINE</td><td>2005/13.1/4460</td><td>11/24/2006</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>LAMITOR-50</td><td>LAMOTRIGINE</td><td>2006/13.1/4461</td><td>11/24/2006</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>LAMIVUDINE</td><td>LAMIVUDINE</td><td>2015/7.13/5019</td><td>04/17/2015</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LAMIVUDINE</td><td>LAMIVUDINE</td><td>2004/7.13/4290</td><td>08/04/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>LAMIVUDINE</td><td>LAMIVUDINE</td><td>2005/7.13/4404</td><td>12/12/2005</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>&nbsp;</td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>LAMIVUDINE ORAL SOLUTION</td><td>LAMIVUDINE</td><td>2014/7.13/4912</td><td>07/16/2014</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>AUROBINDO;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2020/7.13/6067</td><td>12/14/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 300MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2022/7.13/6361</td><td>12/08/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 300MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMERATE </td><td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2017/7.13/5402</td><td>08/07/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 300MG</td><td>CIPLA LIMITED;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMERATE</td><td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2020/7.13/6005</td><td>06/18/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 300MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>LAMIVUDINE; ZIDOVUDINE</td><td>LAMIVUDINE; ZIDOVUDINE</td><td>2018/7.13/5573</td><td>03/01/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150; 300MG</td><td>STRIDES ARCOLAB LTD;  </td><td>STRIDES ARCOLAB LTD</td><td>STRIDES ARCOLAB LTD</td>
	</tr><tr>
		<td>LAMIVUDINE; ZIDOVUDINE</td><td>LAMIVUDINE; ZIDOVUDINE</td><td>2013/7.13/4818</td><td>12/19/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150; 300 MG</td><td>HETERO DRUGS LTD;  HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LAMIVUDINE; ZIDOVUDINE</td><td>LAMIVUDINE; ZIDOVUDINE</td><td>2018/7.13/5758</td><td>12/17/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150; 300MG</td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD;  </td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD</td><td>SHANGHAI DESANO BIO-PHARMACEUTICAL CO., LTD</td>
	</tr><tr>
		<td>LAMIVUDINE; ZIDOVUDINE DISPERSIBLE</td><td>LAMIVUDINE; ZIDOVUDINE</td><td>2015/7.13/5105</td><td>11/06/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30; 60 MG</td><td>MYLAN LAB LTD;  MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>LAMIVUDINE;ZIDOVUDINE</td><td>LAMIVUDINE; ZIDOVUDINE</td><td>2017/7.13/5350</td><td>03/23/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30; 60MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>LAMODEP 100</td><td>LAMOTRIGINE</td><td>2021/13.1/6177</td><td>09/08/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>LAMODEP 25</td><td>LAMOTRIGINE</td><td>2021/13.1/6175</td><td>09/08/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>LAMODEP 50</td><td>LAMOTRIGINE</td><td>2021/13.1/6176</td><td>09/08/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>LAN-30</td><td>LANSOPRAZOLE</td><td>2002/16.7/4010</td><td>01/02/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>30MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LANOXIN</td><td>DIGOXIN</td><td>2017/12.4/5421</td><td>09/07/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>0.25MG</td><td>ASPEN BAD OLDESLOE GmBH;  ASPEN PORT ELIZABETH (PTY) LIMIITED;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LTD</td>
	</tr><tr>
		<td>LANTUS</td><td>INSULIN GLARGINE</td><td>2014/17.6/4911</td><td>07/15/2014</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 IU/ML</td><td>S.ANOFI-AVENTUS DEUTSCHLAND GMBH;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>LARINATE - 6</td><td>ARTESUNATE</td><td>2021/7.5/6190</td><td>10/07/2021</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60MG/VIAL</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABORATORIES LIMITED</td>
	</tr><tr>
		<td>LASTINEM</td><td>IMIPENEM; CILASTATIN</td><td>2017/7.2.5/5388</td><td>06/23/2017</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500; 500MG</td><td>VENUS REMEDIES LTD;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LATANOPOST EYE DROPS</td><td>LATANOPOST</td><td>2018/19.10/5568</td><td>02/15/2018</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.005%W/V</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>LATANOPROST; TIMOLOL EYE DROPS</td><td>LATANOPROST; TIMOLOL</td><td>2018/19.10. /5720</td><td>11/01/2018</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.05; 6.8MG</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>LAXALINK</td><td>LACTULOSE</td><td>2019/16.5.4/5843</td><td>05/27/2019</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>3.35G/5ML</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>LDNIL-10</td><td>ROSUVASTATIN CALCIUM</td><td>2016/12.8/5255</td><td>09/09/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>LDNIL-20</td><td>ROSUVASTATIN CALCIUM</td><td>2016/12.8/5256</td><td>09/09/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>LEFNO-20</td><td>LEFLUNOMIDE</td><td>2019/3.3/5899</td><td>07/30/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>IPCA LABORATORIES LTD;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABS LTD</td>
	</tr><tr>
		<td>LEFRA-20</td><td>LEFLUNOMIDE</td><td>2007/3.3/4477</td><td>01/12/2007</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>TORRENT PHARMACEUTICALS;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>LEMSLIM</td><td>CAFFEINE; EPHEDRINE HYDROCHLORIDE</td><td>82/16.9.1/1620</td><td>10/20/1982</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>45; 16MG</td><td>DATLABS PRIVATE LIMITED;  D A B PHARMACEUTICALS PVT LTD;  </td><td>LEMEX PRODUCTS PVT LTD</td><td>LEMEX PRODUCTS PVT LTD</td>
	</tr><tr>
		<td>LENIOL</td><td>PARACETAMOL</td><td>2021/2.1/6212</td><td>12/13/2021</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED;  </td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED</td>
	</tr><tr>
		<td>LENOSIDE 10</td><td>LENALIDOMIDE</td><td>2020/9.4/6002</td><td>05/28/2020</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>LENOSIDE 15</td><td>LENALIDOMIDE</td><td>2020/9.4/6003</td><td>05/28/2020</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>LENOSIDE 25</td><td>LENALIDOMIDE</td><td>2020/9.4/6004</td><td>05/28/2020</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>LETERO</td><td>LETROZOLE</td><td>2015/9.5.2/5043</td><td>05/14/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LETRAM</td><td>LEVETIRACETAM</td><td>2016/13.1/5215</td><td>05/27/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500 MG</td><td>HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LETRASAN</td><td>LETROZOLE</td><td>2017/9.1/5343</td><td>02/21/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>DEVA HOLDINGS A.S. ONCOLYTICS PRODUCTION SITE;  </td><td>KEY ONCOLOGICS (PYT) LTD</td><td>&nbsp;</td>
	</tr><tr>
		<td>LETROZOLE</td><td>LETROZOLE</td><td>2021/9.5.2/6106</td><td>03/19/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMA SPA AG;  PIEFFE DEPOSITI S.R.L;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>LEVCET 5</td><td>LEVOCETIRIZINE DIHYDROCHLORIDE</td><td>2024/5/6797</td><td>12/19/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>SAI MIRRA INNOPHARM PVT LTD;  </td><td>N2SA LIMITED</td><td>N2SA LIMITED</td>
	</tr><tr>
		<td>LEVEMIR FLEXPEN</td><td>INSULIN DETEMIR</td><td>2014/17.6/4826</td><td>01/17/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 IU/ML</td><td>NOVO-NORDISK A/S;  NOVO NORDISK A/S;  NOVO NORDISK  A/S;  NOVO NORDISK PRODUCAO;  NOVO NORDISK PHARMACEUTIQUE;  </td><td>NOVO NORDISK KENYA LIMITED</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>LEVIN - 500</td><td>LEVOFLOXACIN</td><td>2015/7.2.5/5045</td><td>05/27/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LEVOMAC</td><td>LEVOFLOXACIN</td><td>2011/7.2.5/4710</td><td>11/16/2011</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LEVOMAC 250</td><td>LEVOFLOXACIN HEMIHYDRATE</td><td>2018/7.2.5/5741</td><td>11/21/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>LEVONORGESTREL; ETHINYL ESTRADIOL</td><td>ETHINYL ESTRADIOL; LEVONORGESTREL</td><td>2018/21.2.1/5597</td><td>04/12/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.15; 0.03MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED</td><td>LUPIN LIMITED</td>
	</tr><tr>
		<td>LEVOPLANT</td><td>LEVONORGESTREL</td><td>2018/17.4/5556</td><td>02/02/2018</td><td>12/31/2027</td><td>IMPLANT; SUBCUTANEOUS</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>SHANGHAI DAHUA PHARMACEUTICAL CO. LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>SHANGHAI DAHUA PHARMACEUTICAL CO. LTD</td>
	</tr><tr>
		<td>LEVOX</td><td>LEVOFLOXACIN</td><td>2015/7.2.5/4971</td><td>01/19/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>750 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>LEVOX</td><td>LEVOFLOXACIN HEMIHYDRATE</td><td>2016/7.2.5/5290</td><td>10/06/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>LEVOZIN </td><td>LEVOCETIRIZINE DIHYDROCHLORIDE</td><td>2023/5/6452</td><td>08/04/2023</td><td>08/04/2028</td><td>SYRUP; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2.5MG/5ML</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>LEVULEX 500</td><td>LEVETIRACETAM</td><td>2024/13.1/6658</td><td>07/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>PULSE PHARMACEUTICALS PVT LTD ;  COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>LEVULEX 750</td><td>LEVETIRACETAM</td><td>2024/13.1/6659</td><td>07/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>750MG</td><td>PULSE PHARMACEUTICALS PVT LTD ;  Cospharm Investments Zimbabwe;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>LICAN 2%</td><td>LIGNOCAINE HYDROCHLORIDE</td><td>2019/1.2.1/5800</td><td>03/14/2019</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2%</td><td>SAKAR HEALTHCARE PVT LTD;  </td><td>SAKAR HEALTHCARE PVT LTD</td><td>SAKAR HEALTHCARE PVT LTD</td>
	</tr><tr>
		<td>LIDOCAINE HRDYOCHLORIDE 1MG/50ML SOLUTION FOR INJECTION</td><td>LIDOCAINE HYDROCHLORIDE</td><td>2024/1.2.1/6758</td><td>11/12/2024</td><td>&nbsp;</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1mg/50mlmg/ml</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>LIDOCAINE HYDROCHLORIDE</td><td>LIDOCAINE HYDROCHLORIDE</td><td>2017/1.2.1/5419</td><td>08/17/2017</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2%W/V</td><td>LINCOLN PHARMACEUTICALS LTD;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>LIDOCAINE HYDROCHLORIDE</td><td>LIDOCAINE HYDROCHLORIDE</td><td>2017/1.2.2/5471</td><td>10/31/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>AMANTA HEALTHCARE LTD;  </td><td>AMANTA HEALTHCARE LTD</td><td>AMANTA HEALTHCARE LTD</td>
	</tr><tr>
		<td>LIGNOCAINE AND ADRENALINE</td><td>ADRENALINE ACID TARTRATE; LIGNOCAINE HYDROCHLORIDE</td><td>89/1.2.1/2289</td><td>08/09/1989</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.4; 400MG/20ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>LIGNOCAINE HYDROCHLORIDE</td><td>LIGNOCAINE HYDROCHLORIDE</td><td>89/1.2.1/2303</td><td>10/12/1989</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2%M/V</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>LIGNOCAINE HYDROCHLORIDE FRESENIUS</td><td>LIGNOCAINE HYDROCHLORIDE</td><td>2010/1.2.1/4608</td><td>03/26/2010</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2% W/V</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>LIGNOTOX</td><td>LIGNOCAINE HYDROCHLORIDE</td><td>91/1.2.1/2470</td><td>04/09/1991</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2%</td><td>CAPS PVT LTD;  AUTOSTERILE;  AUTOSTERILE;  AUTOSTERILE;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>LIGNOX</td><td>LIDOCAINE HYDROCHLORIDE</td><td>2005/1.2.1/4366</td><td>05/13/2005</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2%</td><td>INDOCO REMEDIES LIMITED;  </td><td>INDOCO REMEDIES LTD</td><td>INDOCO REMEDIES LTD</td>
	</tr><tr>
		<td>LINEZOLID</td><td>LINEZOLID</td><td>2020/7.3/6025</td><td>08/07/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>LINEZOLID</td><td>LINEZOLID</td><td>2022/7.3/6362</td><td>12/12/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>LINOXID</td><td>LINEZOLID</td><td>2022/7.3/6304</td><td>07/07/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>LIPITAS 20</td><td>ATORVASTATIN CALCIUM</td><td>2004/12.8/4256</td><td>02/17/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>INTAS PHARMACEUTICALS LTD;  INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LIPITOR</td><td>ATORVASTATIN CALCIUM</td><td>200/12.8/3657</td><td>01/25/2000</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>GOEDECKE AG;  WARNWR-LAMBERT;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>LIPITOR</td><td>ATORVASTATIN CALCIUM</td><td>2000/12.8/3658</td><td>01/25/2000</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>GOEDECKE AG;  WARNWR-LAMBERT;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>LIPOFIX-20</td><td>ATORVASTATIN CALCIUM</td><td>2011/12.8/4685</td><td>05/26/2011</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>BAL PHARMA;  BAL PHARMA LTD;  </td><td>BAL PHARMA</td><td>BAL PHARMA</td>
	</tr><tr>
		<td>LIRAPYN</td><td>PREGABALIN</td><td>2016/13.1/5195</td><td>01/06/2016</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150 MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>LIRAPYN</td><td>PREGABALIN</td><td>2016/13.1/5194</td><td>01/06/2016</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75 MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>LITHIUM  CARBONATE</td><td>LITHIUM CARBONATE</td><td>93/13.2.3/2791</td><td>06/01/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>LIZOMAC</td><td>LINEZOLID</td><td>2018/7.3/5516</td><td>01/09/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600 MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LOCKIT</td><td>LOPERAMIDE</td><td>98/16.6/3351</td><td>06/22/1998</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2MG</td><td>BROWN &amp; BURK PHARM PVT LTD;  MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>LODIP 5</td><td>AMLODIPINE BESYLATE</td><td>2022/12.6/6284</td><td>05/30/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>SAI MIRRA INNOPHARM PVT LTD;  </td><td>N2SA LIMITED</td><td>N2SA LIMITED</td>
	</tr><tr>
		<td>LOFEN</td><td>DICLOFENAC DIETHYLAMINE</td><td>2018/3.1/5750</td><td>12/12/2018</td><td>12/31/2027</td><td>GEL</td><td>PHARMACY MEDICINES (P.)</td><td>1%</td><td>BAL PHARMA LTD;  </td><td>BAL PHARMA LIMITED</td><td>BAL PHARMA LIMITED</td>
	</tr><tr>
		<td>LOFNAC 50</td><td>DICLOFENAC SODIUM</td><td>2024/3.1/6636</td><td>06/12/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>BLISS GVS PHARMA LIMITED;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>LOGYNON ED</td><td>ETHINYLOESTRADIOL; LEVONORGESTREL</td><td>81/21.2.1/1419</td><td>07/02/1981</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.03; 0.05MG</td><td>BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  </td><td>BAYER (PTY) LTD</td><td>BAYER PHARM AG</td>
	</tr><tr>
		<td>LOMANOR</td><td>AMLODIPINE BESYLATE</td><td>2012/12.6/4716</td><td>01/16/2012</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>PFIZER PHARMACEUTICALS;  R-PHARM GERMANY GMBH;  </td><td>VIATRIS SOUTH AFRICA (PVT) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>LOMANOR</td><td>AMLODIPINE BESYLATE</td><td>2012/12.6/4717</td><td>01/16/2012</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>PFIZER PHARMACEUTICALS;  R-PHARM GERMANY GMBH;  </td><td>VIATRIS SOUTH AFRICA (PVT) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>LOMOH-40</td><td>ENOXAPARIN SODIUM</td><td>2011/10.2/4668</td><td>03/15/2011</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LONGRIDE</td><td>DAPOXETINE</td><td>2017/31/5342</td><td>03/09/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>LOPERAMIDE</td><td>LOPERAMIDE</td><td>95/16.6/2913</td><td>04/24/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>LOPINAVIR; RITONAVIR</td><td>LOPINAVIR; RITONAVIR</td><td>2015/7.13/5123</td><td>11/20/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 50 MG</td><td>AUROBINDO;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>LOPINAVIR; RITONAVIR</td><td>LOPINAVIR; RITONAVIR</td><td>2015/7.13/5122</td><td>11/20/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100; 25MG</td><td>AUROBINDO;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>LOPINAVIR; RITONAVIR</td><td>LOPINAVIR; RITONAVIR</td><td>2022/7.13/6352</td><td>11/15/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 50MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>LOPINAVIR; RITONAVIR</td><td>LOPINAVIR; RITONAVIR</td><td>2014/7.13/4864</td><td>03/13/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG; 50MG</td><td>HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LOPINAVIR; RITONAVIR </td><td>LOPINAVIR; RITONAVIR</td><td>2017/7.13/5353</td><td>04/13/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100; 25MG</td><td>HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LOPINAVIR; RITONAVIR</td><td>LOPINAVIR; RITONAVIR</td><td>2022/7.13/6353</td><td>11/15/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100; 25MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>LORATIN</td><td>LORATIDINE</td><td>2004/5/4298</td><td>09/09/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>CIPLA LTD;  CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>LORVAS SR</td><td>INDAPAMIDE</td><td>2014/12.5.1/4879</td><td>05/13/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.5 MG</td><td>TORRENT PHARMACEUTICALS LTD;  TORRENT PHARM LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>LOSACLO</td><td>HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM</td><td>2018/12.3.5/5755</td><td>12/17/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 50MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>LOSAGEN-100</td><td>LOSARTAN POTASSIUM</td><td>2013/12.3.5/4773</td><td>04/03/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LOSAGEN-50</td><td>LOSARTAN POTASSIUM</td><td>2013/12.3.5/4772</td><td>04/03/2013</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LOSAR*-50</td><td>LOSARTAN POTASSIUM</td><td>2008/12.3.5/4525</td><td>04/14/2008</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>LOSAR-25</td><td>LOSARTAN POTASSIUM</td><td>2008/12.3.5/4524</td><td>04/14/2008</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25 MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>LOSARTAS-50</td><td>LOSARTAN POTASSIUM</td><td>2003/12.3.5/4102</td><td>04/02/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LOZARCO 100/25</td><td>HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM</td><td>2022/12.3.5/6318</td><td>08/19/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100; 25MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>L-PROSTIM</td><td>LATANOPOST</td><td>2020/19.9/6046</td><td>10/22/2020</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MCG/5GRAM</td><td>INDOCO REMEDIES LIMITED;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LUCOZOL</td><td>LULICONAZOLE </td><td>2023/14.1.3/6497</td><td>10/26/2023</td><td>10/26/2028</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1%W/W</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>LUKAST</td><td>MONTELUKAST</td><td>2017/22.1.1/5335</td><td>02/08/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>HETERO DRUGS LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LUKUST</td><td>MONTELUKAST</td><td>2017/22.1.1/5334</td><td>03/08/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>4 MG</td><td>HETERO DRUGS LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LUMARTEM</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2009/7.5/4574</td><td>09/11/2009</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120MG</td><td>CIPLA LTD;  CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>LUMARTEM DT</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2018/7.5/5701</td><td>10/01/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20MG/120MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>LUMECOAT</td><td>SUCRALFATE</td><td>2025/16.7/6807</td><td>01/10/2025</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G/10ML</td><td>ANNORA PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>LUMERAX DT 20/120</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2020/7.5/6063</td><td>12/09/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABORATORIES LIMITED</td>
	</tr><tr>
		<td>LUMET</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2018/7.5/5570</td><td>02/16/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120MG</td><td>CIPLA QUALITY CHEMICAL INDUSTRIES LIMITED;  </td><td>QUALITY CHEMICAL INDUSTRIES (QCIL)</td><td>CIPLA QUALITY CHEMICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>LUMITER</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2014/7.5/4919</td><td>08/15/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120 MG</td><td>MACLEODS PHARMACEUTICALS LTD;  MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>LUMITER 80/480</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2021/7.5/6099</td><td>02/16/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>80; 480MG</td><td>OXALIS LABS;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>LUMITER DT</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2019/7.5/5912</td><td>08/23/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120MG</td><td>OXALIS LABS;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>LURATA 40</td><td>LURASIDONE HYDROCHLORIDE</td><td>2022/13.2.3/6217</td><td>12/15/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>LURATA 80</td><td>LURASIDONE HYDROCHLORIDE</td><td>2021/13.2.3/6218</td><td>12/15/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>LUSIA-F</td><td>ETHINYLESTRADIOL; NORGESTREL</td><td>2004/21.2.1/4239</td><td>01/21/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.3; 0.03 MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>LYRICA</td><td>PREGABALIN</td><td>2016/13.1/5306</td><td>12/13/2016</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>LYRICA</td><td>PREGABALIN</td><td>2016/13.1/5304</td><td>12/13/2016</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>LYRICA</td><td>PREGABALIN</td><td>2016/13.1/5305</td><td>12/13/2016</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>M.M.T</td><td>ALUMINIUM HYDROXIDE; MAGNESIUM TRISILICATE</td><td>2002/16.1/4071</td><td>09/22/2002</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>250; 120MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  GAMMA PHARMACEUTICALS ;  </td><td>PLUS FIVE PHARMACEUTICALS (PVT) LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>M.S.A.</td><td>ACRIFLAVINE; MERCUROCHROME; SULPHANILAMIDE; ZINC OXIDE</td><td>81/14.1.4/5901</td><td>12/15/1981</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1.0; 1.0; 50; 100MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MABTHERA 100</td><td>RITUXIMAB</td><td>2016/9.7/5175</td><td>03/15/2016</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>ROCHE DIAGNOSTICS GMBH;  GENENTECH INC;  </td><td>ROCHE PRODUCTS</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>MABTHERA 500</td><td>RITUXIMAB</td><td>2016/9.7/5176</td><td>03/15/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/ML</td><td>ROCHE DIAGNOSTICS GMBH;  GENENTECH INC;  </td><td>ROCHE PRODUCTS</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>MABTHERA SC 1400</td><td>RITUXIMAB</td><td>2017/9.7/5511</td><td>12/20/2017</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1400; 11.7MG/ML</td><td>F. HOFFMAN LA ROCHE LTD;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>MAGNESIUM SULPHATE  (10ML)</td><td>MAGNESIUM SULPHATE</td><td>2021/13.1/6138</td><td>06/03/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50%W/V</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED;  </td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td>
	</tr><tr>
		<td>MAGNESIUM SULPHATE  (5ML)</td><td>MAGNESIUM SULPHATE</td><td>2021/13.1/6137</td><td>06/03/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50%W/V</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED;  </td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td>
	</tr><tr>
		<td>MAGNESIUM TRISILICATE COMPOUND</td><td>MAGNESIUM TRISILICATE COMPOUND</td><td>90/16.1/2370</td><td>05/15/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>250MG</td><td>LANCASTER INDUSTRIAL PVT LTD;  </td><td>LANCASTER INDUSTRIAL PVT LTD</td><td>LANCASTER GROUP</td>
	</tr><tr>
		<td>MAGNEVIST</td><td>GADOPENTETIC ACID DIMESGUMINE SALT</td><td>2001/15.2/3996</td><td>12/05/2001</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>469.01MG/ML</td><td>BAYER AG, BERLIN;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>MAGPRAZ 20</td><td>ESOMEPRAZOLE</td><td>2023/16.7/6530</td><td>12/07/2023</td><td>12/07/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>MAGPRAZ 40</td><td>ESOMEPRAZOLE</td><td>2023/16.7/6531</td><td>12/07/2023</td><td>12/07/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>MAGSPEC</td><td>MAGNESIUM SULPHATE</td><td>2024/24.4.1/6592</td><td>04/23/2024</td><td>&nbsp;</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50%W/V</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>MAINTALYTE WITH GLUCOSE</td><td>MAINTELYTE (WITH GLUCOSE)</td><td>98/23.3.1/3467</td><td>05/02/2002</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10% W/V</td><td>AUTOSTERILE;  </td><td>AUTOSTERILE</td><td>AUTOSTERILE</td>
	</tr><tr>
		<td>MAINTELYTE</td><td>MAINTELYTE</td><td>2004/23.2.1/4242</td><td>02/10/2004</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.05; 1.86; 0.51G</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>MALACURE</td><td>PYRIMETHAMINE; SULFADOXINE</td><td>2022/7.5/6222</td><td>01/04/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>500; 25MG</td><td>S KANT HEALTHCARE LTD;  </td><td>S K AGE EXPORTS</td><td>S KANT HEALTHCARE LTD</td>
	</tr><tr>
		<td>MALAQUIN</td><td>CHLOROQUINE PHOSPHATE</td><td>87/7.5/2053</td><td>03/26/1987</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MALASONE</td><td>DAPSONE; PYRIMETHAMINE</td><td>5/29.1.6/547</td><td>06/05/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100; 12.5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MANNITOL</td><td>MANNITOL</td><td>2005/23.2.1/4332</td><td>01/06/2005</td><td>12/31/2027</td><td>SOLUTION; IRRIGATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td> 5%W/V</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM CRITICAL CARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>MANNITOL FRESENIUS 5%</td><td>MANNITOL</td><td>2021/21.8/6086</td><td>01/21/2021</td><td>12/31/2027</td><td>SOLUTION; IRRIGATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5%W/V</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>MANNITOLFRESENIUS 20%</td><td>MANNITOL</td><td>2021/23.2.1/6085</td><td>01/21/2021</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20%W/V</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>MARIPRIST</td><td>MIFEPRISTONE; MISOPROSTOL</td><td>2020/21.8/6043</td><td>10/14/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG; 200MCG</td><td>ACME FORMULATION PVT LTD;  </td><td>POPULATION SERVICES ZIMBABWE</td><td>PULSE MEDICLA CARE PVT LTD</td>
	</tr><tr>
		<td>MARVELON 28</td><td>DESOGESTREL; ETHINYL ESTRADIOL</td><td>85/18.8/1481</td><td>09/10/1986</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>0.0150; 0.030MG</td><td>N.V ORGANON ;  </td><td>ORGANON SOUTH AFRICA (PTY) LTD.</td><td>N.V ORGANON </td>
	</tr><tr>
		<td>MATIS</td><td>IMATINIB MESYLATE</td><td>2017/9.4/5347</td><td>03/10/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>DELTA HOLDINGS A.S.;  </td><td>KEY ONCOLOGICS (PYT) LTD</td><td>KEY ONCOLOGICS (PYT) LTD</td>
	</tr><tr>
		<td>MAVIK</td><td>TRANDOLAPRIL</td><td>98/12.3.5/3413</td><td>08/27/1998</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG</td><td>UNIPHAR;  KNOLL GERMANY;  NORISTAN LABS DIV OF NORISTAN LTD;  BOOTS CO LTD, NOTTINGHAM, UK;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>MAVIK</td><td>TRANDOLAPRIL</td><td>98/12.3.5/3438</td><td>10/22/1998</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5MG</td><td>KNOLL GERMANY;  USIPHAR;  BOOTS CO LTD, NOTTINGHAM, UK;  </td><td>ABBOTT LABORATORIES SA (PTY) LTD</td><td>ABBOTT LABORATORIES</td>
	</tr><tr>
		<td>MAXIDEX</td><td>DEXAMETHASONE</td><td>98/19.2.1/3364</td><td>06/30/1998</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG/ML</td><td>ALCON-COUVREUR n.v.;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>MAXITROL</td><td>DEXAMETHASONE; NEOMYCIN SULPHATE; POLYMYXIN B SULPHATE</td><td>98/19.2.2/3322</td><td>04/02/1998</td><td>12/31/2027</td><td>OINTMENT; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG/3500; 6000IU/G</td><td>S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>MAXITROL</td><td>DEXAMETHASONE; NEOMYCIN SULPHATE; POLYMYXIN B</td><td>98/19.2.2/3365</td><td>06/30/1998</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG/3500; 6000 IU/ML</td><td>S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>MDICORVAL 200/6</td><td>BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE</td><td>2025/22.1.4/6862</td><td>02/12/2025</td><td>&nbsp;</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 6MCG</td><td>MDI PHARMA;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA,</td>
	</tr><tr>
		<td>MDIOCORVAL 100/6</td><td>BUDESONIDE; FORMOTEROL FUMARATE DIHYDRATE</td><td>2025/22.1.4/6861</td><td>02/12/2025</td><td>&nbsp;</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100; 6 MCG</td><td>MDI PHARMA;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>MEASLES AND RUBELLA VACCINE (10 DOSES)</td><td>MEASLES; RUBELLA (LIVE ATTENUATED)</td><td>2023/18.2/6508</td><td>11/16/2023</td><td>11/16/2028</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000; 1000CCID50</td><td>M/S BIOLOGICAL E LIMITED;  </td><td>M/S BIOLOGICAL E, LTD</td><td>BIOLOGICAL E. LIMITED</td>
	</tr><tr>
		<td>MEASLES AND RUBELLA VACCINE (5 DOSES)</td><td>MEASLES; RUBELLA (LIVE ATTENUATED)</td><td>2023/18.2/6507</td><td>11/16/2023</td><td>11/16/2028</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000; 1000CCID50</td><td>M/S BIOLOGICAL E LIMITED;  </td><td>M/S BIOLOGICAL E, LTD</td><td>BIOLOGICAL E. LIMITED</td>
	</tr><tr>
		<td>MEDAXONE</td><td>CEFTRIAXONE SODIUM</td><td>2023/7.2.2/6456</td><td>08/08/2023</td><td>08/08/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2G/VIAL</td><td>MEDOCHEMIE LTD FACTORY C;  </td><td>MEDOCHEMIE LTD</td><td>MEDOCHEMIE LTD</td>
	</tr><tr>
		<td>MEDICAL OXYGEN GAS</td><td>OXYGEN</td><td>2024/31/6700</td><td>10/17/2024</td><td>12/31/2027</td><td>GAS; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>99.5%V/V</td><td>VERIFY ENGINEERING PLC;  </td><td>VERIFY ENGINEERING PLC T/A VE GASES</td><td>VERIFY ENGINEERING PLC T/A VE GASES</td>
	</tr><tr>
		<td>MEDI-FLU</td><td>CAFFEINE ANHYDROUS;CHLORPHENIRAMINE MALEATE;PARACETAMOL;PHENYLEPHRINE HYDROCHLORIDE</td><td>2025/22.2.5/6820</td><td>01/14/2025</td><td>01/13/2030</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>30mg;2mg;500mg;10mg</td><td>EVERTOGEN LIFE SCIENCES LIMITED;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>MEDI-LOSARTAN 100</td><td>LOSARTAN POTASSIUM</td><td>2015/12.3.5/4984</td><td>02/19/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>JUBILANT GENERIC LIMITED</td>
	</tr><tr>
		<td>MEDI-LOSARTAN 25</td><td>LOSARTAN POTASSIUM</td><td>2015/12.3.5/4982</td><td>02/19/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>JUBILANT GENERIC LIMITED</td>
	</tr><tr>
		<td>MEDI-LOSARTAN 50</td><td>LOSARTAN POTASSIUM</td><td>2015/12.3.5/4983</td><td>02/19/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>JUBILANT GENERIC LIMITED</td>
	</tr><tr>
		<td>MEDI-OLANZAPINE</td><td>OLANZAPINE</td><td>2015/13.2.3/5055</td><td>06/17/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>JUBILANT GENERIC LIMITED</td>
	</tr><tr>
		<td>MEDI-OLANZAPINE</td><td>OLANZAPINE</td><td>2015/13.2.3/5053</td><td>06/17/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>JUBILANT GENERIC LIMITED</td>
	</tr><tr>
		<td>MEDI-VALSARTAN</td><td>VALSARTAN</td><td>2016/12.3.5/5197</td><td>04/27/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>JUBILANT GENERICS SCIENCE LTD</td>
	</tr><tr>
		<td>MEDI-VALSARTAN</td><td>VALSARTAN</td><td>2016/12.3.5/5198</td><td>04/27/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>160 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>JUBILANT GENERICS SCIENCE LTD</td>
	</tr><tr>
		<td>MED-LEMON HOT MEDICATION -CHERRY MENTHOL</td><td>ASPRIN; ASCORBIC ACID; CAFFEINE; MENTHOL </td><td>74/22.2.5/238</td><td>04/22/1974</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10; 800; 50; 14.4MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  SMITHLINE BEECHAM;  </td><td>GROUP LABS S.A PTY LTD</td><td>SMITHKLINE BEECHAM PHARM PTY LTD</td>
	</tr><tr>
		<td>MED-LEMON HOT MEDICATION WITH VITAMIN C</td><td>ASPRIN; ASCORBIC ACID; CAFFEINE </td><td>99/22.2.5/3497</td><td>03/24/1999</td><td>12/31/2027</td><td>POWDER/SATCHETS; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>800; 45; 50MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  SMITHKLINE BEECHAM PHARM PTY LTD;  </td><td>GROUP LABS S.A PTY LTD</td><td>SMITHKLINE BEECHAM CONSUMER HEALTHCARE</td>
	</tr><tr>
		<td>MED-LEMON HOT MEDICATION-LEMON MENTHOL W/VIT C</td><td>ASPRIN; ASCORBIC ACID; CAFFEINE; MENTHOL </td><td>99/2.2/3635</td><td>12/20/1999</td><td>12/31/2027</td><td>POWDER/SATCHETS; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>800; 45; 50; 2.6 MG</td><td>GLAXOSMITHKLINE CONSUMER HEALTHCARE S.A. (PTY) LTD;  </td><td>GROUP LABS S.A PTY LTD</td><td>SKB PTY LTD</td>
	</tr><tr>
		<td>MEDOCEF (1G)</td><td>CEFOPERAZONE SODIUM</td><td>2024/7.2.2/6649</td><td>06/20/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1GRAM</td><td>MEDOCHEMIE LTD FACTORY C;  </td><td>MEDOCHEMIE LTD</td><td>MEDOCHEMIE LTD</td>
	</tr><tr>
		<td>MEDOCEF (2G)</td><td>CEFOPERAZONE SODIUM</td><td>2024/7.2.2/6650</td><td>06/20/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2G</td><td>MEDOCHEMIE LTD FACTORY C;  </td><td>MEDOCHEMIE LTD</td><td>MEDOCHEMIE LTD</td>
	</tr><tr>
		<td>MEDOGEN</td><td>MEDROXYPROGESTERONE ACETATE</td><td>2022/21.2.3/6298</td><td>06/29/2022</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML</td><td>INCEPTA PHARMACEUTICALS (PTY) LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>MEDOX MULTIVITAMIN</td><td>MULTIVITAMIN</td><td>88/24.3/2150</td><td>02/09/1988</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>1500IU; 1MG; 2MG; 20MG; 200IU; 5MG</td><td>CAPS PVT LTD;  </td><td>CAPS INTERNATIONAL EST</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDOX SUPER 12 + 12</td><td>MULTIVITAMIN; MULTIMINERAL</td><td>77/22.5/980</td><td>11/03/1977</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>MULTIINGREDIENT</td><td>CAPS PVT LTD;  </td><td>CAPS INTERNATIONAL EST</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDOX VITAMIN A</td><td>VITAMIN A ACETATE</td><td>86/24.1.1/2015</td><td>10/10/1986</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDOX VITAMIN B</td><td>VITAMIN B COMPLEX</td><td>88/24.2/2148</td><td>02/09/1988</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2; 2.0; 0.5; 1MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDOX VITAMIN B FORTE</td><td>VITAMIN B COMPLEX FORTE</td><td>88/24.2/2149</td><td>02/09/1988</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50; 10; 15; 15MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDOX VITAMIN B12</td><td>CYANOCOBALAMIN</td><td>86/10.1.3/2017</td><td>10/10/1986</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100MCG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDOX VITAMIN B12</td><td>CYANOCOBALAMIN</td><td>86/22.1/1530</td><td>10/10/1986</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MCG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDOX VITAMIN C</td><td>ASCORBIC ACID</td><td>81/24.1.3/1440</td><td>06/22/1981</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDOX VITAMIN C</td><td>ASCORBIC ACID</td><td>81/24.1.3/1382</td><td>02/25/1981</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDOX VITAMIN C FORTE</td><td>ASCORBIC ACID</td><td>76/24.1.3/1383</td><td>11/26/1976</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEDWIN</td><td>MEDROXYPROGESTERONE ACETATE</td><td>2025/21.2.3/6826</td><td>01/14/2025</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML</td><td>EUGIA PHARMA SPECIALITIES LIMITED;  </td><td>EUGIA PHARMA SPECIALTIES LIMITED</td><td>EUGIA PHARMA SPECIALTIES LIMITED</td>
	</tr><tr>
		<td>MEGALIS 10</td><td>TADALAFIL</td><td>2025/31/6937</td><td>04/30/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>MEKARD</td><td>DOBUTAMINE HYDROCHLORIDE</td><td>2023/12.7/6511</td><td>11/21/2023</td><td>11/21/2028</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250 MG/20ML</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>MELANOV MR 60</td><td>GLICLAZIDE</td><td>2025/17.7/6830</td><td>01/17/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>60MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>MEMENTOR</td><td>MEMANTINE HYDROCHLORIDE</td><td>2017/13.1/5325</td><td>03/08/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>MENTHIES PEPPERMINT & MENTHOL COUGH SYRUP</td><td>MENTHOL; PEPPERMINT OIL</td><td>98/22.2.1/3453</td><td>11/26/1998</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>0.4% M/M</td><td>GULF DRUG CO;  GULF DRUG COMPANY (PVT) LTD;  VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>GULF DRUG COMAPANY</td><td>GULF DRUG COMPANY (PVT) LTD</td>
	</tr><tr>
		<td>MENTHOLATUM DEAP HEAT SPRAY</td><td>2-HYDROXYETHYL SALICYLATE; ETHYL SALICYLATE; METHYL NICOTINATE; METHYL SALICYLATE</td><td>2018/14.15/5611</td><td>05/08/2018</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>4.95; 1.59; 0.99; 4.95 MG</td><td>WRAPSA PACKAGING &amp; MANUF.;  </td><td>MENTHOLATUM R.S.A PTY LTD</td><td>MENTHOLATUM R.S.A PTY LTD</td>
	</tr><tr>
		<td>MENTHOLATUM DEEP HEAT RUB</td><td>MENTHOLATUM DEEP HEAT RUB</td><td>92/14.15/1583</td><td>10/27/1992</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td> 12.80%; 5.91%; 1.97%;1.47%</td><td>MENTHOLATUM (THE) CO LTD;  THE MENTHOLATUM CO LTD;  </td><td>MENTHOLATUM R.S.A PTY LTD</td><td>THE MENTHOLATUM CO LTD</td>
	</tr><tr>
		<td>MENTIN</td><td>MEMANTINE HYDROCHLORIDE</td><td>2018/13/5642</td><td>06/29/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MEPYRAMINE ELIXIR</td><td>MEPYRAMINE MALEATE</td><td>82/5/5852</td><td>01/19/1982</td><td>12/31/2027</td><td>ELIXIR; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>0.5%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEPYRAMINE MALEATE</td><td>MEPYRAMINE</td><td>82/14.3/5855</td><td>01/19/1982</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>2%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEPYRAMINE MALEATE</td><td>MEPYRAMINE MALEATE</td><td>96/14.3/3151</td><td>08/29/1996</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2% W/W</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>MERCUROCHROME</td><td>MERCUROCHROME</td><td>81/14.1.4/5859</td><td>10/19/1981</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>2%</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>MERCUROCHROME SOLUTION</td><td>MERCUROCHROME</td><td>82/14.1.4/5865</td><td>01/19/1982</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>2%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MERONEM 500</td><td>MEROPENEM TRIHYDRATE</td><td>99/7.2.5/3548</td><td>06/15/1999</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>DAINIPPON  SUMMITOMO PHARMA CO. LTD;  DAINIPPON  SUMMITOMO PHARMAC CO. LTD;  AC DOBFAR S.P.A;  </td><td>PFIZER SOUTH AFRICA (PTY) LTD</td><td>PFIZER LIMITED</td>
	</tr><tr>
		<td>METACAIN 2%</td><td>LIGNOCAINE HYDROCHLORIDE</td><td>2016/1.2.2/5240</td><td>08/02/2016</td><td>12/31/2027</td><td>GEL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20 MG</td><td>GALENTIC PHARMA P/L;  </td><td>GALENTIC PHARMA (INDIA) PVT LTD</td><td>GALENTIC PHARMA (INDIA) PVT LTD</td>
	</tr><tr>
		<td>METFIN</td><td>METFORMIN HYDROCHLORIDE</td><td>2003/17.7/4107</td><td>04/16/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>METFOR 500</td><td>METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6576</td><td>04/03/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>METFOR 850</td><td>METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6577</td><td>04/03/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>850MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>METFORGRAN XR 1000</td><td>METFORMIN HYDROCHLORIDE</td><td>2022/17.7/6331</td><td>10/05/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1000MG</td><td>PT FERRON PAR PHARMACEUTICALS;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>PT DEXA MEDICA</td>
	</tr><tr>
		<td>METFORGRAN XR 750</td><td>METFORMIN HYDROCHLORIDE</td><td>2022/17.7/6330</td><td>10/05/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>750MG</td><td>PT FERRON PAR PHARMACEUTICALS;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>PT DEXA MEDICA</td>
	</tr><tr>
		<td>METFORMIN</td><td>METFORMIN HYDROCHLORIDE</td><td>95/17.7/3029</td><td>11/12/1995</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>METFORMIN</td><td>METFORMIN HYDROCHLORIDE</td><td>2006/17.7/4427</td><td>05/15/2006</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>METHOCID</td><td>INDOMETHACIN</td><td>80/3.2/1201</td><td>06/14/1982</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>METHOTREXATE</td><td>METHOTREXATE</td><td>2024/9.2.1/6779</td><td>11/28/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5 MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>METHOTREXATE-LERDELE</td><td>METHOTREXATE</td><td>94/9.2.1/2829</td><td>02/01/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>HAUPT PHARMA;  EXCELLA GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>METHYL PREDNISOLONE</td><td>METHYL PREDNISOLONE</td><td>2023/17.1/6505</td><td>11/13/2023</td><td>11/13/2028</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40 MG/ML</td><td>EGYPTIAN INTERNATIONAL PHARMACEUTICAL INDUSTRIES CO. (EIPICO);  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>METHYL SALICYCATE OINTMENT BPC</td><td>METHYL SALICYLATE</td><td>82/14.15/5853</td><td>01/19/1982</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>50%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>METOCLOPRAMIDE</td><td>METOCLOPRAMIDE HYDROCHLORIDE</td><td>90/16.2/2405</td><td>10/03/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>&nbsp;</td><td>10MG</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>WALLACE LABORATORIES PVT LTD</td>
	</tr><tr>
		<td>METOCLOPRAMIDE HYDROCHLORIDE</td><td>METOCLOPRAMIDE HYDROCHLORIDE</td><td>2023/16.2/6492</td><td>10/26/2023</td><td>10/26/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>METRICASON 250/25MCG</td><td>FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE</td><td>2025/22.1.4/6880</td><td>02/25/2025</td><td>02/24/2030</td><td>AEROSOL; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MCG;25MCG</td><td>MDI PHARMA;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>METRICASON 50/25MCG</td><td>FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE</td><td>2025/22.1.4/6878</td><td>02/25/2025</td><td>02/24/2030</td><td>AEROSOL; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MCG;25MCG</td><td>MDI PHARMA;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>METRICASONE 125/25MCG</td><td>FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE</td><td>2025/22.1.4/6879</td><td>02/25/2025</td><td>02/24/2030</td><td>AEROSOL; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MCG;25MCG</td><td>MDI PHARMA;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>METRIS</td><td>METRONIDAZOLE</td><td>2005/7.6/4358</td><td>03/23/2005</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5% W/V</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED;  </td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED</td>
	</tr><tr>
		<td>METROGEL V</td><td>METRONIDAZOLE</td><td>2000/14.17/3648</td><td>01/07/2000</td><td>12/31/2027</td><td>GEL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>37.5G/5G</td><td>DPT LABORATORIES LTD;  INOVA PHARMACEUTICALS PTY LTD;  ENSIGN LABORATIES LTD;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  M &amp; L LABORATORY SERVICES;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>METRONIDAZOLE</td><td>METRONIDAZOLE</td><td>2017/7.6/5455</td><td>11/16/1981</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>METRONIDAZOLE</td><td>METRONIDAZOLE</td><td>2006/7.6/4447</td><td>09/21/2006</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG/100ML</td><td>AMANTA HEALTHCARE LTD;  </td><td>AMANTA HEALTHCARE LTD</td><td>AMANTA HEALTHCARE LTD</td>
	</tr><tr>
		<td>METRONIDAZOLE</td><td>METRONIDAZOLE</td><td>97/7.6/3199</td><td>02/27/1997</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>METRONIDAZOLE</td><td>METRONIDAZOLE</td><td>92/7.6/2682</td><td>07/30/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>METTA SR</td><td>METFORMIN HYDROCHLORIDE</td><td>2013/17.6/4774</td><td>03/04/2013</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>METZOR PR 1000</td><td>METFORMIN HYDROCHLORIDE</td><td>2023/17.7/6393</td><td>03/29/2023</td><td>03/29/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1000MG</td><td>INVENTIA HEALTHCARE PVT LTD;  </td><td>ZORWAY EXIM PVT LTD</td><td>ZORWAY EXIM PVT LTD</td>
	</tr><tr>
		<td>MEURI</td><td>DESOGESTREL; ETHINYL ESTRADIOL</td><td>2018/21.2.1/5655</td><td>07/25/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>150; 30MCG</td><td>MYLAN LABORATORIES;  </td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td>
	</tr><tr>
		<td>MEZENOL</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>75/7.2.3/478</td><td>05/05/1975</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>480MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEZENOL</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>75/7.2.3/479</td><td>05/05/1975</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>240MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEZENOL DS</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>78/7.2.3/1007</td><td>03/08/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>960MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MEZENOL PAEDIATRIC</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>92/7.2.3/2638</td><td>05/18/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120 MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>M-FLOX</td><td>MOXIFLOXACIN</td><td>2015/7.3/5067</td><td>07/10/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>MIBZO</td><td>BORTEZOMIB</td><td>2019/9.7/5798</td><td>03/11/2019</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3.5MG/VIAL</td><td>MSN LABORATORIES PRIVATE LIMITED, FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>MICONAZOLE</td><td>MICONAZOLE NITRATE</td><td>2007/14.1.3/4509</td><td>12/14/2007</td><td>12/31/2027</td><td>GEL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MICONAZOLE NITRATE</td><td>MICONAZOLE NITRATE</td><td>95/14.1.3/2916</td><td>04/25/1995</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2% M/M</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MICONAZOLE NITRATE</td><td>MICONAZOLE NITRATE</td><td>2019/14.1.3/5782</td><td>02/13/2019</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>21MG</td><td>BAL PHARMA LTD;  </td><td>BAL PHARMA LIMITED</td><td>BAL PHARMA LIMITED</td>
	</tr><tr>
		<td>MICONAZOLE NITRATE & HYDROCORTISONE ACETATE</td><td>HYDROCORTISONE; MICONAZOLE NITRATE</td><td>2001/14.1/3908</td><td>03/11/2001</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>10; 20MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MICORT</td><td>HYDROCORTISONE; MICONAZOLE NITRATE</td><td>91/14.2.2/2535</td><td>05/08/1991</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>10; 20MG/G</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>MICOVAR</td><td>MICONAZOLE ORAL GEL</td><td>2000/14.1.3/3656</td><td>01/21/2000</td><td>12/31/2027</td><td>GEL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2% M/M</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>MICOVAR CREAM</td><td>HYDROCORTISONE; MICONAZOLE NITRATE</td><td>91/14.1.3/2534</td><td>09/19/1991</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2%</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>MICRODOX</td><td>DOXYCYCLINE HYDROCHLORIDE</td><td>97/7.2.4/3216</td><td>05/09/1997</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>MICROFLOX-500</td><td>CIPROFLOXACIN HYDROCHLORIDE</td><td>2004/7.2.5/4245</td><td>02/10/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>MICRO NOVA PHARMACEUTICALS;  </td><td>MICRO NOVA PHARMACEUTICALS</td><td>MICRO NOVA PHARMACEUTICALS</td>
	</tr><tr>
		<td>MICROGYNON 30</td><td>ETHINYLOESTRADIOL; LEVENORGESTREL</td><td>87/21.2.1/2037</td><td>11/20/1987</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.15; 0.03 MG</td><td>SCHERING AG;  ROCHE PRODUCTS PTY LTD;  BAYER PHARM AG;  BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>MICROLAX</td><td>SODIUM CITRATE; SODIUM LAURYL SULFOACETATE; SORBITOL</td><td>2023/16.5.5/6367</td><td>01/25/2023</td><td>01/25/2028</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>90; 12.9; 893 MG /1ML</td><td>FAMAR ORLEANS;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>MICROLUT</td><td>LEVONORGESTREL</td><td>87/21.2.2/2125</td><td>11/18/1987</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.03MG</td><td>BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>MICROMOX</td><td>MOXIFLOXACIN HYDROCHLORIDE</td><td>2025/19.1.1/6819</td><td>01/17/2025</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5% W/V</td><td>MICRO LABS ;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>MIFEPRISTONE 200 MG TABLETS; MISOPROSTOL 200 MCG VAGINAL TABLETS</td><td>MIFEPRISTONE; MISOPROSTOL</td><td>2022/21.8/6219</td><td>12/15/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG;200MCG</td><td>CHINA RESOURCES ZIZHU PHARMACEUTUCALS CO LTD;  </td><td>CHINA RESOURCES ZIZHU PHARMACEUTUCALS CO LTD</td><td>CHINA RESOURCES ZIZHU PHARMACEUTUCALS CO LTD</td>
	</tr><tr>
		<td>MIFESO</td><td>MIFEPRISTONE; MISOPROSTOL</td><td>2023/21.8/6388</td><td>03/20/2023</td><td>03/20/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG; 200MCG</td><td>ACME FORMULATION PVT LTD (HORMONE BLOCK);  </td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td>
	</tr><tr>
		<td>MIGRIL</td><td>CAFFEINE; CYCLIZINE; ERGOTAMINE TARTRATE</td><td>&nbsp;</td><td>12/04/1981</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100; 50; 2MG</td><td>GLAXO-WELLCOME;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  INOVA PHARMACEUTICALS  PTY LTD;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>3M PHARMACEUTICALS</td>
	</tr><tr>
		<td>MINULET</td><td>ETHINYLOESTRADIOL; GESTODENE</td><td>91/21.2.1/2443</td><td>02/22/1991</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.075; 0.03 MG</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  LEDERLE LABS;  HERMAN PHARMA AND COMPANY;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>MIRCERA</td><td>METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA</td><td>2014/10.1/4836</td><td>01/20/2014</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MCG/0.3 ML</td><td>F. HOFFMAN LA ROCHE LTD;  ROCHE DIAGNOSTICS GMBH;  VETTER PHARMA-FERTGUNG GMBH;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>MIRCERA</td><td>METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA</td><td>2014/10.1/4835</td><td>01/20/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MCG/0.3ML</td><td>F. HOFFMAN LA ROCHE LTD;  ROCHE DIAGNOSTICS GMBH;  VETTER PHARMA-FERTGUNG GMBH;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>MIRCERA</td><td>METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA</td><td>2014/10.1/4837</td><td>01/20/2014</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG/0.3ML</td><td>ROCHE DIAGNOSTICS GMBH;  F. HOFFMAN LA ROCHE LTD;  VETTER PHARMA-FERTGUNG GMBH;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>MIRENA</td><td>LEVONORGESTREL</td><td>2022/21.2/6268</td><td>03/17/2022</td><td>12/31/2027</td><td>INTRAUTERINE DEVICE; INTRAUTERINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>52 MG</td><td>BAYER OY;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>MISOCLEAR</td><td>MISOPROSTOL</td><td>2017/21.6/5375</td><td>05/20/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG</td><td>ACME FORMULATION PVT LTD;  </td><td>POPULATION SERVICES ZIMBABWE</td><td>POPULATION SERVICES ZIMBABWE</td>
	</tr><tr>
		<td>MISOPROST-200</td><td>MISOPROSTOL</td><td>2010/16.7/4622</td><td>03/29/2010</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MCG</td><td>CIPLA LTD;  CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>MIST DIARRHOEA</td><td>CINNAMON OIL;  GINGER TINCTURE; KAOLIN LIGHT; PECTIN</td><td>93/16.6/5947</td><td>12/16/1993</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>0.12; 1.25; 12.5; 0.9%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MIST KAOLIN ET PECTIN</td><td>KAOLIN LIGHT; PECTIN</td><td>&nbsp;</td><td>01/19/1982</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>&nbsp;</td><td>CAPS PVT LTD;  LANCASTER INDUSTRIAL PVT LTD;  </td><td>GEDDES LTD</td><td>GEDDES LTD</td>
	</tr><tr>
		<td>MIZART PLUS 40/10</td><td>&nbsp;</td><td>2025/12.3.5/6904</td><td>03/28/2025</td><td>03/27/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MIZART PLUS 40/5</td><td>&nbsp;</td><td>2025/12.3.5/6903</td><td>03/28/2025</td><td>03/27/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MIZART PLUS 80/10</td><td>&nbsp;</td><td>2025/12.3.5/6906</td><td>03/28/2025</td><td>03/27/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MIZART PLUS 80/5</td><td>&nbsp;</td><td>2025/12.3.5/6905</td><td>03/28/2025</td><td>03/27/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MOISOL</td><td>HYDROXYPROYLMETHYLCELLULOSE</td><td>97/19.1/3284</td><td>11/24/1997</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACY MEDICINES (P.)</td><td>0.7% W/V</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>MOMATE NASAL SPRAY</td><td>&nbsp;</td><td>2025/20.2.2/6932</td><td>04/29/2025</td><td>04/28/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>GLENMARK PHARAMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>MONAN</td><td>MEROPENEM</td><td>2017/7.2.5/5345</td><td>03/22/2017</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>M. J. BIOPHARMA;  </td><td>M. J. BIOPHARM (PVT) LTD</td><td>M. J. BIOPHARM (PVT) LTD</td>
	</tr><tr>
		<td>MONAN</td><td>MEROPENEM</td><td>2017/7.2.5/5344</td><td>03/22/2017</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>M. J. BIOPHARMA;  </td><td>M. J. BIOPHARM (PVT) LTD</td><td>M. J. BIOPHARM (PVT) LTD</td>
	</tr><tr>
		<td>MONAST 10</td><td>MONTELUKAST SODIUM</td><td>2016/22.1.1/5148</td><td>01/06/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>MONTERA 10</td><td>MONTELUKAST SODIUM</td><td>2015/22.1.1/5041</td><td>05/14/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>COSPHARM INVESTMENTS PVT LIMITED</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION</td>
	</tr><tr>
		<td>MONTERA 4</td><td>MONTELUKAST SODIUM</td><td>2015/22.1.1/5039</td><td>06/14/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>COSPHARM INVESTMENTS PVT LIMITED</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION</td>
	</tr><tr>
		<td>MONTERA 5</td><td>MONTELUKAST SODIUM</td><td>2015/22.1.1/5040</td><td>06/14/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>COSPHARM INVESTMENTS PVT LIMITED</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION</td>
	</tr><tr>
		<td>MORPHINE SULPHATE</td><td>MORPHINE SULPHATE</td><td>93/4.1/2819</td><td>12/10/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>NARCOTIC MEDICINES, (N.)</td><td>10MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MORPHINE SULPHATE</td><td>MORPHINE SULPHATE</td><td>78/4.1/1068</td><td>05/18/1978</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>15MG/ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MORPHINE SULPHATE</td><td>MORPHINE SULPHATE</td><td>2020/4.1/6053</td><td>12/03/2020</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED;  </td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td><td>MACARTHYS LABORATORIES T/A MARTINDALE PHARMA LIMITED</td>
	</tr><tr>
		<td>MORPHINE SULPHATE FRESENIUS PF</td><td>MORPHINE SULPHATE</td><td>2006/4.1/4434</td><td>07/10/2006</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG/ML</td><td>BODENE;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>MORTIN</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>2000/7.2.3/3725</td><td>05/05/2000</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>480MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>MOTEX</td><td>ATROPINE SULPHATE; DIPHENOXYLATE HYDROCHLORIDE</td><td>84/16.6/1831</td><td>09/02/1984</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.025; 2.5MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>MOXIFLOXACIN</td><td>MOXIFLOXACIN HYDROCHLORIDE</td><td>2015/7.3/5134</td><td>12/14/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400 MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MOXIFLOXACIN</td><td>MOXIFLOXACIN</td><td>2014/7.3/4946</td><td>10/21/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400 MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>MOXIFLOXACIN</td><td>MOXIFLOXACIN</td><td>2022/7.3/6281</td><td>04/21/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400 MG</td><td>LUPIN LIMITED;  LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>MPLIFY</td><td>TADALAFIL</td><td>2018/21.8/5541</td><td>01/29/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MR STRONG 500</td><td>ASPRIN; CAFFEINE</td><td>75/2.2/553</td><td>10/15/1975</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500; 50MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MR STRONG 500</td><td>CHLOROFORM; ETHER; LIQUORICE; MENTHOL; SODIUM CITRATE</td><td>75/22.2.5/477</td><td>07/21/1992</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>5.8; 5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>MSAADA</td><td>DICLOFENAC SODIUM</td><td>2022/3.1/6328</td><td>09/30/2022</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>SAPPS PHARMACEUTICALS;  </td><td>SAPPS PHARMACEUTICALS</td><td>SAPPS PHARMACEUTICALS</td>
	</tr><tr>
		<td>MSAADA OVERNIGHT</td><td>DICLOFENAC SODIUM</td><td>2022/3.1/6329</td><td>09/30/2022</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>SAPPS PHARMACEUTICALS;  </td><td>SAPPS PHARMACEUTICALS</td><td>SAPPS PHARMACEUTICALS</td>
	</tr><tr>
		<td>MS-BAC</td><td>MAGNESIUM TRISILICATE</td><td>2001/16.1/3875</td><td>01/12/2001</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>250MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>MUSCOBLOC 50MG/5ML</td><td>ROCURONIUM BROMIDE</td><td>2025/1.3/6829</td><td>01/17/2025</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/5ML</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS </td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>MYCLAV</td><td>AMOXICILLIN; CLAVULANATE POTASSIUM</td><td>2016/7.1.2/5219</td><td>06/02/2016</td><td>12/31/2027</td><td>POWDER, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>228.5 MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MYCLAV</td><td>AMOXICILLIN; CLAVULANATE POTASSIUM</td><td>2016/7.1.2/5218</td><td>06/02/2016</td><td>12/31/2027</td><td>POWDER, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>156.25 MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MYCLAV-375</td><td>AMOXICILLIN; CLAVULANATE POTASSIUM</td><td>2004/7.1.2/4317</td><td>11/17/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250; 125MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MYCLAV-625</td><td>AMOXICILLIN; CLAVULANATE POTASSIUM</td><td>2006/7.1.2/4420</td><td>05/15/2006</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500; 125MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MYDEKLA 60</td><td>DACLATASVIR DIHYDROCHLORIDE</td><td>2019/7.13/5764</td><td>12/21/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MYHEP</td><td>SOFOSBUVIR</td><td>2017/7.13/5328</td><td>03/22/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MYHEP ALL</td><td>SOFOSBUVIR</td><td>2021/7.13/6200</td><td>10/26/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400; 100MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MYHEP DVIR</td><td>DECLATASVIR DIHYDROCHLORIDE AND SOFOSBUVIR</td><td>2021/7.13/6103</td><td>02/18/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60MG; 400MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>MYLTEGA DT</td><td>DOLUTEGRAVIR SODIUM</td><td>2021/7.13/6164</td><td>08/23/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10mg</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>MYPRODOL</td><td>CODEINE PHOSPHATE; IBUPROFEN; PARACETAMOL</td><td>2014/2.2/4884</td><td>06/02/2014</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>250; 200; 10 MG</td><td>ADCOCK INGRAM LIMITED;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>MYTREX</td><td>PEMETREXED</td><td>2018/9.2.1/5686</td><td>09/10/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED (OTL)</td><td>MYLAN LABORATORIES LIMITED (OTL)</td>
	</tr><tr>
		<td>MYZOMIB</td><td>BORTEZOMIB</td><td>2020/9.4/6018</td><td>07/20/2020</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3.5MG</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LAB LTD</td><td>MYLAN LABORATORIES LIMITED (OTL)</td>
	</tr><tr>
		<td>N/A</td><td>FLUCONAZOLE</td><td>2024/7.12/6787</td><td>12/10/2024</td><td>&nbsp;</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS (PVT) LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>N/A</td><td>FLUCONAZOLE</td><td>2024/7.12/6786</td><td>12/10/2024</td><td>&nbsp;</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>N/A</td><td>SILDENAFIL CITRATE</td><td>2024/21.8/6744</td><td>10/31/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>N/A</td><td>SILDENAFIL CITRATE</td><td>2024/31/6743</td><td>10/31/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>N/A</td><td>ZOPICLONE</td><td>2024/13.3/6702</td><td>09/20/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>7.5MG</td><td>CENTAUR LABS;  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>NALIDIXIC ACID</td><td>NALIDIXIC ACID</td><td>2004/7.2.5/4279</td><td>06/25/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>FDC LTD;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>NAPRODOX 10</td><td>DOXORUBICIN HYDROCHLORIDE</td><td>2020/9.3.2/6039</td><td>09/28/2020</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>NAPROD LIFE SCIENCES PVT LTD</td><td>NAPROD LIFE SCIENCES PVT LTD</td>
	</tr><tr>
		<td>NAPRODOX 50</td><td>DOXORUBICIN HYDROCHLORIDE</td><td>2020/9.3.2/6038</td><td>09/28/2020</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>NAPROD LIFE SCIENCES PVT LTD;  </td><td>NAPROD LIFE SCIENCES PVT LTD</td><td>NAPROD LIFE SCIENCES PVT LTD</td>
	</tr><tr>
		<td>NAPROSCRIPT 500</td><td>NAPROXEN</td><td>95/3.1/2992</td><td>12/22/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>500MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>MULLER & PHIPPS</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NAPROSCRIPT-250</td><td>NAPROXEN</td><td>95/3.1/2991</td><td>12/22/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>250MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>MULLER & PHIPPS</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NASEHALER</td><td>MOMETASONE FUROATE</td><td>2016/20.2.2/5292</td><td>11/03/2016</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MCG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>NEBICARD-5</td><td>NEBIVOLOL HYDROCHLORIDE</td><td>2014/12.3.2/4906</td><td>06/26/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>TORRENT PHARMACEUTICALS;  TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>NEBIEM</td><td>NEBIVOLOL HYDROCHLORIDE</td><td>2016/12.3.2/5260</td><td>09/09/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>NEBIEMS</td><td>NEBIVOLOL HYDROCHLORIDE</td><td>2016/12.3.2/5259</td><td>09/09/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>NELSTAC 150</td><td>RANITIDINE HYDROCHLORIDE</td><td>2021/12.3.5/6135</td><td>05/27/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG</td><td>CELOGEN GENERIC PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>CELOGEN GENERIC PVT LTD</td>
	</tr><tr>
		<td>NEODEXONE</td><td>DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULPHATE</td><td>74/14.2.2/380</td><td>11/28/1974</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1; 0.5% W/W</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>NEODEXONE</td><td>DEXAMETHASONE SODIUM PHOSPHATE; NEOMYCIN SULPHATE</td><td>74/19.2.2/381</td><td>11/29/1974</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1; 5MG/ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>NEODEXONE</td><td>DEXAMETHASONE; NEOMYCIN</td><td>87/19.2.2/2054</td><td>03/26/1987</td><td>12/31/2027</td><td>OINTMENT; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5; 5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>NEONATALYTE INJECTION WITH 10% DEXTROSE</td><td>CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM CHLORIDE;POTASSIUM CHLORIDE; PHOSPHORIC ACID; SODIUM LACTATE </td><td>89/23.2.1/2262</td><td>05/02/1989</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>367; 10; 102; 1.12; 367; 2.24MG/1000ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>NEOSTIGMINE METHYLSULPHATE FRESENIUS</td><td>NEOSTIGMINE METHYLSULPHATE</td><td>2011/1.3/4656</td><td>01/12/2011</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG/ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>NEOSTIGMINE METHYLSULPHATE FRESENIUS</td><td>NEOSTIGMINE METHYLSULPHATE</td><td>2011/1.3/4657</td><td>01/12/2011</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5MG/ML</td><td>BODENE;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>NEPEXTO</td><td>ETANERCEPT</td><td>2021/3.3/6153</td><td>07/22/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/ML</td><td>LUPIN LIMITED;  </td><td>MYLAN PHARMACEUTICALS PVT LTD</td><td>MYLAN PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>NEPEXTO</td><td>ETANERCEPT</td><td>2021/3.3/6152</td><td>07/22/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>LUPIN LIMITED (BIOTECH DIVISION);  </td><td>MYLAN PHARMACEUTICALS PVT LTD</td><td>MYLAN PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>NEPEXTO</td><td>ETANERCEPT</td><td>2021/3.3/6154</td><td>07/22/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/ML</td><td>LUPIN LIMITED;  </td><td>MYLAN PHARMACEUTICALS PVT LTD</td><td>MYLAN PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>NEPRIVAS 97/103</td><td>SACUBITRIL; VALSARTAN</td><td>2024/12.3.5/6795</td><td>12/12/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>97MG/103MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>NEUROGAB 150</td><td>PREGABALIN</td><td>2021/13.1/6114</td><td>03/19/2021</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>NEUROGAB 75</td><td>PREGABALIN</td><td>2021/13.1/6198</td><td>10/22/2021</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>NEUROPYN</td><td>PREGABALIN</td><td>2023/13.1/6410</td><td>05/22/2023</td><td>05/22/2028</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>NEUROPYN</td><td>PREGABALIN</td><td>2023/13.1/6385</td><td>03/07/2023</td><td>03/07/2028</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>NEUTAS</td><td>FILGRASTIM</td><td>2019/10.7/5849</td><td>06/04/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MCG/0.5ML</td><td>INTAS PHARMACEUTICALS LIMITED;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>NEUTRACID</td><td>MAGNESIUM TRISILICATE</td><td>93/16.1/2818</td><td>12/13/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>250MG - 120MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>NEUTRAGEL</td><td>ALUMINIUM HYDROXIDE PASTE; MAGNESIUM HYDROXIDE GEL; SIMETHICONE</td><td>2014/16.1/4892</td><td>06/23/2014</td><td>12/31/2027</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>400; 318.4; 50MG</td><td>ASTRAZENECA AB,;  VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>NEVANAC</td><td>NEPAFENAC</td><td>2022/19.10. /6269</td><td>03/17/2022</td><td>12/31/2027</td><td>SUSPENSION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1 MG/ML</td><td>S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>NEVIMUNE</td><td>NEVIRAPINE</td><td>2009/7.13/4571</td><td>06/25/2009</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/5ML</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>NEVIRAPINE</td><td>NEVIRAPINE</td><td>2017/7.13/5420</td><td>08/29/2017</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/5ML</td><td>AUROBINDO;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO</td>
	</tr><tr>
		<td>NEVIRAPINE</td><td>NEVIRAPINE</td><td>2004/7.13/4227</td><td>01/19/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>NEVIRAPINE</td><td>NEVIRAPINE</td><td>2005/7.13/4393</td><td>09/23/2005</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>CAPS PVT LTD;  CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>NEXAVAR 200</td><td>SORAFENIB TOSYLATE</td><td>2017/9.4/5494</td><td>12/07/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>BAYER HEALTHCARE S.R.L;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>NEXIROZOVA</td><td>ROSUVASTATIN CALCIUM</td><td>2024/12.8/6685</td><td>08/08/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20.80MG</td><td>ZETA  PHARMA;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>NEXIROZOVA</td><td>ROSUVASTATIN CALCIUM</td><td>2024/12.8/6684</td><td>08/08/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10.40MG</td><td>ZETA  PHARMA;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>NEXIUM</td><td>ESOMEPRAZOLE MAGNESIUM</td><td>2005/16.7/4349</td><td>02/04/2005</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>ASTRAZENECA AB;  </td><td>INDUSTRIAL CHEMICAL IMPORTERS</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>NEXIUM</td><td>ESOMEPRAZOLE MAGNESIUM</td><td>2005/16.7/4350</td><td>02/04/2005</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>ASTRAZENECA AB,;  </td><td>INDUSTRIAL CHEMICAL IMPORTERS</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>NEXIUM</td><td>ESOMEPRAZOLE SODIUM</td><td>2016/16.7/5167</td><td>02/02/2016</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40 MG</td><td>ASTRAZENECA AB,;  </td><td>ASTRAZENECA UK LTD</td><td>ASTRAZENECA UK LTD</td>
	</tr><tr>
		<td>NEXPRO</td><td>ESOMEPRAZOLE MAGNESIUM</td><td>2015/16.7/5044</td><td>05/26/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>NEXPRO 40</td><td>ESOMEPRAZOLE MAGNESIUM</td><td>2015/16.7/4996</td><td>03/19/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>NIFELAT</td><td>NIFEDIPINE</td><td>98/12.6/3305</td><td>03/09/1998</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>NIFELAT</td><td>NIFEDIPINE</td><td>92/12.1/2687</td><td>08/13/1992</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>NIL-ACYD</td><td>&nbsp;</td><td>2025/16.1/6949</td><td>05/08/2025</td><td>05/07/2030</td><td>&nbsp;</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>&nbsp;</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>NIMBEX </td><td>CISATRACURIUM BESYLATE</td><td>2014/1.3/4917</td><td>08/15/2014</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG/ML (10ML)</td><td>GLAXOSMITHKLINE S. P. A;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>NIMBEX</td><td>CISATRACURIUM BESYLATE</td><td>2014/1.3/4916</td><td>08/15/2014</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG/ML (5ML)</td><td>GLAXOSMITHKLINE S. P. A;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>NIMBEX </td><td>CISATRACURIUM BESYLATE</td><td>2014/1.3/4915</td><td>08/15/2014</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG/ML (2.5ML)</td><td>GLAXOSMITHKLINE S. P. A;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>NIMOTOP </td><td>NIMODIPINE</td><td>2018/12.3/5513</td><td>01/03/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>NIMOTOP IV</td><td>NIMODIPINE</td><td>2018/13.8/5520</td><td>01/10/2018</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>NIRFOL</td><td>PROPOFOL</td><td>2013/1.1/4775</td><td>04/04/2013</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 ML</td><td>NIRMA LTD (HEALTH DIVISION);  ACULIFE HEALTHCARE PRIVATE LTD;  </td><td>ACULIFE HEALTHCARE PRIVATE LTD</td><td>ACULIFE HEALTHCARE PRIVATE LTD</td>
	</tr><tr>
		<td>NIRMET</td><td>METRONIDAZOLE</td><td>2013/7.2.5/4789</td><td>08/01/2013</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG/100ML</td><td>NIRMA LIMITED (HEALTH DIVISION);  ACULIFE HEALTHCARE PRIVATE LTD;  </td><td>ACULIFE HEALTHCARE PRIVATE LTD</td><td>ACULIFE HEALTHCARE PRIVATE LTD</td>
	</tr><tr>
		<td>NIZACARD 1000</td><td>RANOLAZINE</td><td>2023/12.1/6441</td><td>07/11/2023</td><td>07/11/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>NIZACARD 500</td><td>RANOLAZINE</td><td>2023/12.1/6440</td><td>07/11/2023</td><td>07/11/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000 MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>NONE</td><td>VARENICLINE TARTRATE</td><td>2025/13.10/6928</td><td>04/17/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5MG</td><td>UNISON PHARMACEUTICALS PVT LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>NONE</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>2025/20.2.4/6890</td><td>03/06/2025</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.1%W/V</td><td>SKYMAP PHARMACEUTICALS PVT LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>NONE</td><td>ARTEMETHER; LUMEFANTRINE</td><td>2017/7.5/5320</td><td>01/11/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20; 120 MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABORATORIES LIMITED</td>
	</tr><tr>
		<td>NONE</td><td>BACLOFEN</td><td>2025/13.6/6926</td><td>04/24/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATIES LIMITED</td><td>UNICHEM LABORATIES LIMITED</td>
	</tr><tr>
		<td>NONE</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>2025/20.2.4/6889</td><td>03/06/2025</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.05%W/V</td><td>SKYMAP PHARMACEUTICALS PVT LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>NONE</td><td>DOLUTEGRAVIR SODIUM; LAMIVUDINE</td><td>2025/7.13/6908</td><td>04/04/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>NONE</td><td>&nbsp;</td><td>2025/16.2/6912</td><td>04/07/2025</td><td>04/06/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>SWISS PARENTERALS LTD;  </td><td>ARAVAS PHARMACEUTICALS</td><td>SWISS PARENTERAL LTD</td>
	</tr><tr>
		<td>NONE</td><td>BACLOFEN</td><td>2025/13.6/6927</td><td>04/24/2025</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATIES LIMITED</td><td>UNICHEM LABORATIES LIMITED</td>
	</tr><tr>
		<td>NONE</td><td>LEVOTHYROXINE SODIUM</td><td>2025/17.8.1/6863</td><td>02/13/2025</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MCG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>INTAS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>NONE</td><td>BRIMONIDINE TATRATE</td><td>2025/19.1/6917</td><td>04/10/2025</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.2 %W/V</td><td>INDOCO REMEDIES LIMITED;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>NONE</td><td>BENZYL PENICILLIN SODIUM</td><td>2025/7.1.1/6817</td><td>01/14/2025</td><td>&nbsp;</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3G</td><td>INJECTCARE PARENTERALS PVT LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>NONE</td><td>BENZYL PENICILLIN SODIUM</td><td>2025/7.1.1/6816</td><td>01/14/2025</td><td>&nbsp;</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>INJECTCARE PARENTERALS PVT LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>NONE</td><td>LEVOTHYROXINE SODIUM</td><td>2025/17.8.1/6865</td><td>02/13/2025</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MCG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>INTAS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>NONE</td><td>LEVOTHYROXINE SODIUM</td><td>2025/17.8.1/6864</td><td>02/13/2025</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MCG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>INTAS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>NONE</td><td>&nbsp;</td><td>2025/17.1/6911</td><td>04/07/2025</td><td>04/06/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>SWISS PARENTERALS LTD;  </td><td>ARAVAS PHARMACEUTICALS</td><td>SWISS PARENTERAL LTD</td>
	</tr><tr>
		<td>NONE</td><td>&nbsp;</td><td>2025/17.8.1/6866</td><td>02/13/2025</td><td>02/12/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>NONE</td><td>&nbsp;</td><td>2025/22.1.2/6943</td><td>05/07/2025</td><td>05/06/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>GLENMARK PHARMACEUTICALS LIMITED;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>NOPAYNE</td><td>ASPIRIN; CAFFEINE</td><td>91/2.2/2466</td><td>04/08/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>225/30 MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>NOPYN</td><td>PARACETAMOL</td><td>79/2.1/1247</td><td>05/02/1979</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>NORDITROPIN NORDIFLEX</td><td>SOMATROPIN</td><td>2021/17.11/6221</td><td>12/16/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/1.5ML</td><td>NOVO NORDISK A/S;  NOVO NORDISK A/S;  </td><td>NOVO-NORDISK A/S</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>NORDITROPIN NORDIFLEX</td><td>SOMATROPIN</td><td>2021/17.11/6220</td><td>12/16/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG/1.5ML</td><td>NOVO NORDISK A/S;  NOVO NORDISK A/S;  </td><td>NOVO-NORDISK A/S</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>NORFLEX </td><td>BENZYDAMINE HYDROCHLORIDE</td><td>2019/3.1/5778</td><td>02/05/2019</td><td>12/31/2027</td><td>GEL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>3G/100G</td><td>ENSIGN LABORATIES LTD;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>NORFLEX CO</td><td>ORPHENADRINE CITRATE; PARACETAMOL</td><td>77/2.2/837</td><td>02/15/1977</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>35; 450MG</td><td>INOVA PHARMACEUTICALS  PTY LTD;  ADCOCK INGRAM LIMITED;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>NORFLOXACIN</td><td>NORFLOXACIN</td><td>2000/7.2.5/3857</td><td>12/19/2000</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LTD</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>NORFLOXACIN</td><td>NORFLOXACIN</td><td>2004/7.2.5/4277</td><td>06/24/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>NORFLOXACIN</td><td>NORFLOXACIN</td><td>95/7.2.5/2919</td><td>04/28/1995</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>BROWN &amp; BURK PHARM PVT LTD;  MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>NORFLOXIN-400</td><td>NORFLOXACIN</td><td>98/7.2.5/3396</td><td>07/29/1998</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>UMEDICA LABORATORIES PVT. LTD;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>NORICOR 0.35</td><td>NORETHINDRONE ACETATE</td><td>2025/21.2.2/6872</td><td>02/18/2025</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.35MG</td><td>NAARI PHARMA PRIVATE LIMITED;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>NORLOX</td><td>NORFLOXACIN</td><td>2002/7.2.5/4021</td><td>02/08/2002</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>NORVASC</td><td>AMLODIPINE BESYLATE</td><td>90/12.3.1/2422</td><td>10/25/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>R-PHARM GERMANY GMBH;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>NORVASC</td><td>AMLODIPINE BESYLATE</td><td>90/12.3.1/2423</td><td>10/25/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>R-PHARM GERMANY GMBH;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>NOSIL 0.05%</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>2021/20.2.4/6088</td><td>01/29/2021</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.05%W/V</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>NOSIL 0.1%</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>2021/20.2.4/6089</td><td>01/29/2021</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.1%W/V</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>NOVABACT</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>94/7.2.3/2856</td><td>09/02/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>480MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>NOVACID</td><td>ALUMINIUM HYDROXIDE</td><td>97/16.1/3247</td><td>06/24/1997</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>216MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NOVADERM</td><td>BETAMETHASONE VALERATE</td><td>95/14.2.1/2917</td><td>04/25/1995</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1% M/M</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NOVADOL</td><td>PARACETAMOL</td><td>95/2.1/3018</td><td>11/09/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NOVADOL</td><td>PARACETAMOL</td><td>95/2.1/3019</td><td>11/09/1995</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>PHARMANOVA (PVT) LTD;  CADILA PHARMACEUTICALS LIMITED;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NOVADOL ASP</td><td>PARACETAMOL</td><td>2002/2.1/4011</td><td>01/14/2002</td><td>12/31/2027</td><td>ELIXIR; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>NOVADOL CHILDREN'S SIZE</td><td>PARACETAMOL</td><td>91/2.1/2507</td><td>06/12/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>125MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NOVADOL CO</td><td>CODEINE PHOSPHATE; PARACETAMOL</td><td>95/2.2/3020</td><td>11/09/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 8 MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NOVADOL-RAPID</td><td>PARACETAMOL</td><td>76/2.1/598</td><td>03/25/1976</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NOVADYST</td><td>NALIDIXIC ACID</td><td>95/7.2.5/3027</td><td>11/09/1995</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250MG/5ML</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>NOVADYST</td><td>NALIDIXIC ACID</td><td>95/7.2.5/3016</td><td>11/09/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>NOVAFEN FOR CHILDREN</td><td>IBUPROFEN</td><td>2016/3.1/5205</td><td>05/16/2016</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>100 MG</td><td>PHARMANOVA PVT LTD;  </td><td>PHARMANOVA PVT LTD</td><td>PHARMANOVA (PVT) LTD HOLDINGS LTD</td>
	</tr><tr>
		<td>NOVAFEN GEL</td><td>IBUPROFEN</td><td>2015/3.1/5063</td><td>07/01/2015</td><td>12/31/2027</td><td>GEL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>50 MG/G</td><td>PHARMANOVA PVT LTD;  </td><td>PHARMANOVA PVT LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>NOVAZOLE</td><td>METRONIDAZOLE</td><td>93/7.6/2806</td><td>09/16/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA (PVT) LTD</td><td>PHARMANOVA (PVT) LTD</td>
	</tr><tr>
		<td>NOVELLA</td><td>&nbsp;</td><td>2025/21.2.1/6832</td><td>01/22/2025</td><td>01/21/2030</td><td>&nbsp;</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>&nbsp;</td><td>HLL LIFECARE LIMITED;  </td><td>HLL LIFECARE LIMITED</td><td>HLL LIFECARE LIMITED</td>
	</tr><tr>
		<td>NOVOMIX 30 FLEXPEN</td><td>INSULIN ASPART</td><td>2014/17.6/4828</td><td>01/17/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 I.U/ML</td><td>TORRENT PHARMACEUTICALS LTD;  NOVO-NORDISK A/S;  NOVO NORDISK A/S;  NOVO NORDISK  A/S;  NOVO NORDISK A/S;  NOVO NORDISK PRODUCAO;  NOVO NORDISK PHARMACEUTIQUE;  </td><td>NOVO NORDISK KENYA LIMITED</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>NOVORAPID FLEXPEN</td><td>INSULIN ASPART</td><td>2014/17.6/4827</td><td>01/17/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 IU/ML</td><td>NOVO-NORDISK A/S;  NOVO NORDISK A/S;  NOVO NORDISK  A/S;  NOVO NORDISK A/S;  NOVO NORDISK PRODUCAO;  NOVO NORDISK PHARMACEUTIQUE;  </td><td>NOVO NORDISK KENYA LIMITED</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>NUELIN SA 250</td><td>THEOPHYLLINE</td><td>98/22.1.1/3447</td><td>11/04/1998</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250MG</td><td>INOVA PHARMACEUTICALS  PTY LTD;  ADCOCK INGRAM LIMITED;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS  PTY LTD</td>
	</tr><tr>
		<td>NUR - ISTERATE</td><td>NORETHISTERONE ENANTHATE</td><td>76/21.2.3/0674</td><td>07/14/1976</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/ML</td><td>ASPEN SVP PTY LTD;  BAYER AG, BERLIN;  </td><td>BAYER (PTY) LTD</td><td>BAYER PHARM AG</td>
	</tr><tr>
		<td>NUROFEN</td><td>IBUPROFEN</td><td>2015/3.1/5024</td><td>06/30/2015</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100 MG/5ML</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD</td>
	</tr><tr>
		<td>NUROFEN</td><td>IBUPROFEN</td><td>90/3.1/2414</td><td>10/17/1990</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG</td><td>BOOTS CO PTY LTD;  RECKITT BENKISER HEALTHCARE INTERNATIONAL LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>NUROFEN COLD AND FLU</td><td>IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE</td><td>2018/22.2.5/5571</td><td>03/01/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200; 30MG</td><td>RECKITT BENCKISER HEALTHCARE INTERNATIONAL;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>NUROFEN EXPRESS</td><td>IBUPROFEN</td><td>2018/3.1/5665</td><td>08/03/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>200MG</td><td>RECKITT BENCKISER HEALTHCARE INTERNATIONAL;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>NUROFEN EXPRESS</td><td>IBUPROFEN</td><td>2018/3.1/5664</td><td>08/03/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>RECKITT BENCKISER HEALTHCARE INTERNATIONAL;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>NUROFEN EXPRESS 400MG LIQUID CAPSULES</td><td>IBUPROFEN</td><td>2017/2.1/5472</td><td>10/31/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400 MG</td><td>RECKITT BENCKISER HEALTHCARE INTERNATIONAL;  BANNER PHARMACAPS EUROPE B.V.;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>NUROFEN FOR CHILDREN</td><td>IBUPROFEN</td><td>2015/3.1/5025</td><td>05/13/2015</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100 MG /5ML</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD</td>
	</tr><tr>
		<td>NUROFEN FOR CHILDREN</td><td>IBUPROFEN</td><td>2018/3.1/5674</td><td>08/15/2018</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200MG/5ML</td><td>RECKITT BENCKISER HEALTHCARE (UK) LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>NUROFEN PERIOD PAIN</td><td>IBUPROFEN</td><td>2019/3.1/5773</td><td>01/28/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>400MG</td><td>RECKITT BENCKISER HEALTHCARE INTERNATIONAL;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>NYSTACID</td><td>NYSTATIN</td><td>91/14.1.3/2541</td><td>10/15/1991</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>21.875MG/G</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>NYSTATIN</td><td>NYSTATIN</td><td>2004/14.17/4328</td><td>12/15/2004</td><td>12/31/2027</td><td>PESSARY; VAGINAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000000IU</td><td>SM PHARMACEUTICALS;  </td><td>SM PHARMACEUTICALS</td><td>SM PHARMACEUTICALS</td>
	</tr><tr>
		<td>NYSTATIN N DOME</td><td>NYSTATIN</td><td>95/7.12/2940</td><td>06/20/1995</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 000IU/ML</td><td>PHARMASOL LTD;  DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM</td><td>LAGAP PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>OCCUMOL</td><td>TIMOLOL</td><td>2010/19.10/4638</td><td>08/03/2010</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG/5ML</td><td>AMANTA HEALTHCARE LTD;  </td><td>AMANTA HEALTHCARE LTD</td><td>AMANTA HEALTHCARE LTD</td>
	</tr><tr>
		<td>OCTANATE 1000 IU</td><td>HUMAN COAGULATION FACTOR VIII</td><td>2022/10.4/6241</td><td>02/02/2022</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000 IU</td><td>OCTAPHARMA AB;  </td><td>OCTAPHARMA AG</td><td>OCTAPHARMA AG</td>
	</tr><tr>
		<td>OCTANATE 250 IU</td><td>HUMAN COAGULATION FACTOR VIII</td><td>2022/10.4/6239</td><td>02/02/2022</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250 IU</td><td>OCTAPHARMA AB;  </td><td>OCTAPHARMA AG</td><td>OCTAPHARMA AG</td>
	</tr><tr>
		<td>OCTANATE 500 IU</td><td>HUMAN COAGULATION FACTOR VIII</td><td>2022/10.4/6240</td><td>02/02/2022</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 IU</td><td>OCTAPHARMA AB;  </td><td>OCTAPHARMA AG</td><td>OCTAPHARMA AG</td>
	</tr><tr>
		<td>OCUDOR</td><td>DORZOLAMIDE</td><td>2019/19.10. /5896</td><td>07/30/2019</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2%</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>OCUDOR-T</td><td>DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE</td><td>2019/19.10. /5897</td><td>07/30/2019</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/5MG</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>ODYCIN</td><td>MOXIFLOXACIN HYDROCHLORIDE</td><td>2022/19.1.1/6249</td><td>02/08/2022</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG/ML</td><td>BEXIMCO PHARMACEUTICALS LTD;  </td><td>BEXIMCO PHARMACEUTICALS LTD</td><td>BEXIMCO PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>OFLOXACIN-UF</td><td>OFLOXACIN</td><td>2022/7.2.5/6238</td><td>02/02/2022</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG/ML</td><td>YURIA-PHARM LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>YURIA-PHARM LTD</td>
	</tr><tr>
		<td>OGIVRI</td><td>TRASTUZUMAB</td><td>2018/9.7/5680</td><td>08/29/2018</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>440MG</td><td>BIOCON LIMITED;  </td><td>BIOSIMILARS NEWCO LIMITED</td><td>BIOSIMILARS NEWCO LIMITED</td>
	</tr><tr>
		<td>OGIVRI</td><td>TRASTUZUMAB</td><td>2021/9.7/6090</td><td>02/01/2021</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/VIAL</td><td>BIOCON SPECIAL ECONOMIC ZONE;  </td><td>BIOSIMILARS NEWCO LIMITED</td><td>BIOSIMILARS NEWCO LIMITED</td>
	</tr><tr>
		<td>OLMEHEART 10</td><td>OLMESARTAN  MEDOXOMIL</td><td>2020/12.3.5/6020</td><td>07/20/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>OLMEHEART 20</td><td>OLMESARTAN MEDOXOMIL</td><td>2020/12.3.5/6021</td><td>07/20/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>OLMEHEART 40</td><td>OLMESARTAN  MEDOXOMIL</td><td>2020/12.3.5/6022</td><td>07/20/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>OLMEHEART 5</td><td>OLMESARTAN MEDOXOMIL</td><td>2020/12.3.5/6019</td><td>07/20/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>OLODIN</td><td>OLOPATADINE</td><td>2018/19.9/5757</td><td>12/17/2018</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.1%W/V</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>OMEPREFUL 40</td><td>OMEPRAZOLE</td><td>2024/16.7/6571</td><td>03/14/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS </td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>OMICAP</td><td>OMEPRAZOLE</td><td>2004/16.7/4246</td><td>02/10/2004</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>OMIZAC</td><td>OMEPRAZOLE</td><td>2003/16.7/4136</td><td>04/16/2003</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>OMIZINC 20</td><td>ZINC SULPHATE MONOHYDRATE</td><td>2023/24.4.1/6391</td><td>03/23/2023</td><td>03/23/2028</td><td>TABLET, EFFERVESCENT; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>20MG</td><td>THE ACME LABORATORIES LIMITED;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>OMLINK</td><td>OMEPRAZOLE</td><td>2022/16.7/6277</td><td>04/07/2022</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40 MG</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>OMNIPAQUE</td><td>IOHEXOL</td><td>92/15.2/2719</td><td>09/18/1992</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>350MG/ML</td><td>GE HEALTHCARE IRELAND LIMITED;  </td><td>GE HEALTHCARE AS</td><td>GE HEALTHCARE AS</td>
	</tr><tr>
		<td>OMNIPAQUE</td><td>IOHEXOL</td><td>92/15.2/2718</td><td>09/18/1992</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG/ML</td><td>GE HEALTHCARE IRELAND LIMITED;  </td><td>GE HEALTHCARE AS</td><td>GE HEALTHCARE AS NYCOVEIEN 1 </td>
	</tr><tr>
		<td>OMNIPOL 300</td><td>IOHEXOL</td><td>2024/15.2/6620</td><td>06/05/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG/ML</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS PVT LTD</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>OMNIPOL 350</td><td>IOHEXOL</td><td>2024/15.2/6621</td><td>06/05/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>350MG/ML</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS PVT LTD</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>ONDANSETRON FRESENIUS</td><td>ONDANSETRON HYRODROCHLORIDE</td><td>2016/16.2/5284</td><td>10/04/2016</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4MG/2ML</td><td>LABESFAL LABORATORIOS ALMIROS S.A;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>ONDANSETRON FRESENIUS</td><td>ONDANSETRON HYDROCHLORIDE</td><td>2016/16.2/5285</td><td>10/06/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>8 MG / 4 ML</td><td>LABESFAL LABORATORIOS ALMIROS S.A;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>ONDI</td><td>ONDANSETRON</td><td>2019/16.2/5807</td><td>03/20/2019</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG/ML</td><td>SAKAR HEALTHCARE PVT LTD;  </td><td>SAKAR HEALTHCARE PVT LTD</td><td>SAKAR HEALTHCARE PVT LTD</td>
	</tr><tr>
		<td>ONSETT</td><td>ONDANSETRON HYDROCHLORIDE</td><td>2018/16.2/5622</td><td>05/30/2018</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ONSETT 4</td><td>ONDANSETRON</td><td>2015/16.2/5091</td><td>10/08/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ONSETT 8</td><td>ONDANSETRON</td><td>2015/16/5092</td><td>10/08/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>8 MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>O-PAT</td><td>OLOPATADINE HYDROCHLORIDE</td><td>2020/19.9/6045</td><td>10/22/2020</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1MG/ML</td><td>INDOCO REMEDIES LIMITED;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ORACHLOR ORIGINAL</td><td>CHLORHEXIDINE GLUCONATE</td><td>2023/20.3.4/6370</td><td>02/03/2023</td><td>02/03/2028</td><td>SOLUTION/MOUTHWASH; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>2 MG/ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ORACHLOR PEPPERMINT</td><td>CHLORHEXIDINE GLUCONATE</td><td>2023/20.3.4/6371</td><td>02/03/2023</td><td>02/03/2028</td><td>SOLUTION/MOUTHWASH; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>0.2 % M/V</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ORAL REHYDRATION SALT</td><td>DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE: SODIUM CITRATE</td><td>2008/23.1.1/4529</td><td>04/14/2008</td><td>12/31/2027</td><td>POWDER, SOLUBLE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.6; 1.5; 2.9; 13.5G</td><td>FDC LTD;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>ORALAX TABLET</td><td>BISACODYL</td><td>73/16.5.2/202</td><td>11/30/1973</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ORAPEN</td><td>PHENOXYMETHYLPENICILLIN</td><td>76/7.1.1/693</td><td>08/25/1976</td><td>12/31/2027</td><td>GRANULE, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ORAPEN</td><td>PHENOXYMETHYLPENICILLIN</td><td>76/7.1.1/692</td><td>08/25/1976</td><td>12/31/2027</td><td>GRANULE, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ORAPEN</td><td>PHENOXYMETHYLPENICILLIN POTASSIUM</td><td>91/7.1.1/2465</td><td>04/09/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>OROFER</td><td>IRON III HYDROXIDE POLYMALTOSE COMPLEX; FOLIC ACID</td><td>2023/10.1.4/6455</td><td>08/08/2023</td><td>08/08/2028</td><td>CAPSULE</td><td>PHARMACY MEDICINES (P.)</td><td>100; 0.55MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>OROFER</td><td>IRON III HYDROXIDE POLYMALTOSE COMPLEX</td><td>2004/10.1.1/4249</td><td>02/12/2004</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50 MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>OROZAPIN 5</td><td>OLANZAPINE</td><td>2022/13.2.3/6323</td><td>08/29/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>GENEPHARM S.A.;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>OROZIPAN 10</td><td>OLANZAPINE</td><td>2022/13.2.3/6324</td><td>08/29/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>GENEPHARM S.A.;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>OTRIMIST X</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>2022/20.2.4/6276</td><td>04/07/2022</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.1%W/V</td><td>MERIDIAN ENTERPRISES PVT LTD ;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>SKY PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>OTRIMIST XP</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>2022/20.2.4/6275</td><td>04/07/2022</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.05 %W/V</td><td>MERIDIAN ENTERPRISES PVT LTD ;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>SKY PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>OTRIVIN</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>90/16.1/1919</td><td>07/10/1990</td><td>12/31/2027</td><td>SPRAY, METERED; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>1MG/ML</td><td>GSK CONSUMER HEALTH SA;  </td><td>GSK CONSUMER HEALTH SA</td><td>GSK CONSUMER HEALTH SA</td>
	</tr><tr>
		<td>OTRIVIN (ADULT)</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>90/20.2.4/2367</td><td>07/10/1990</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>1.0MG/ML</td><td>GSK CONSUMER HEALTH SA;  </td><td>GSK CONSUMER HEALTH SA</td><td>GSK CONSUMER HEALTH SA</td>
	</tr><tr>
		<td>OTRIVIN (PAEDIATEIC)</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>90/20.2.4/2368</td><td>07/10/1990</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.5MG/ML</td><td>GSK CONSUMER HEALTH SA;  </td><td>GSK CONSUMER HEALTH SA</td><td>GSK CONSUMER HEALTH SA</td>
	</tr><tr>
		<td>OTYCULF 250</td><td>FLUCYTOSINE</td><td>2022/7.12/6250</td><td>02/08/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250 MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>OTYCULF 500</td><td>FLUCYTOSINE</td><td>2022/7.12/6251</td><td>02/08/2022</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>OVA-MIT</td><td>CLOMIPHENE CITRATE</td><td>94/17.13/2877</td><td>11/14/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>OXEDEP</td><td>FLUOXETINE HYDROCHLORIDE</td><td>2001/13.2.1/3873</td><td>01/04/2001</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>TORRENT EXPORTS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>OXIFLED 400</td><td>MOXIFLOXACIN HYDROCHLORIDE</td><td>2015/7.13/5113</td><td>11/13/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400 MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>OXITAN 100MG</td><td>OXALIPLATIN</td><td>2010/9.4/4582</td><td>02/10/2010</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>DABUR PHARMA;  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>OXITAN 50</td><td>OXALIPLATIN</td><td>2010/9.4/4581</td><td>02/16/2010</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>OXOL</td><td>OXALIPLATIN</td><td>2017/9.4/5368</td><td>05/05/2017</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG/ 50 ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>OXOL</td><td>OXALIPLATIN</td><td>2012/9.4/4718</td><td>01/12/2012</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/25ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>OXYPROGEST</td><td>MEDROXYPROGESTERONE ACETATE</td><td>2024/21.2.3/6738</td><td>10/24/2024</td><td>&nbsp;</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML</td><td>ACDIMA INTERNATIONAL TRADING;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>OXYTOCIN PANPHARMA</td><td>OXYTOCIN</td><td>95/21.1.1/2958</td><td>07/20/1995</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 IU/ML</td><td>PANPHARMA GMBH;  </td><td>PANPHARMA GMBH</td><td>PANPHARMA GMBH</td>
	</tr><tr>
		<td>OZICLIDE MR</td><td>GLICLAZIDE</td><td>2017/17.7/5339</td><td>02/20/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>60MG</td><td>RANBAXY LAB  LTD;  </td><td>RANBAXY LAB LTD</td><td>RANBAXY LAB LTD</td>
	</tr><tr>
		<td>PACLITAXEL MYLAN </td><td>PACLITAXEL</td><td>2021/9.4/6143</td><td>06/14/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/16.7ML</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>PACLITAXEL MYLAN </td><td>PACLITAXEL</td><td>2021/9.4/6142</td><td>06/14/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG/5ML</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>PACLITAXEL MYLAN </td><td>PACLITAXEL</td><td>2021/9.4/6144</td><td>06/14/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG/50ML</td><td>MYLAN LABORATORIES LIMITED (OTL);  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>PACLITERO 100</td><td>PACLITAXEL</td><td>2016/9.4/5244</td><td>08/03/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>PACLITERO 30</td><td>PACLITAXEL</td><td>2016/9.4/5243</td><td>08/03/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30 MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>PACLITERO 300</td><td>PACLITAXEL</td><td>2016/9.4/5245</td><td>08/03/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG/50ML</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>PAGENAX</td><td>BROLUCIZUMAB</td><td>2023/9.7/6389</td><td>03/23/2023</td><td>03/23/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120 MG/ML</td><td>NOVARTIS PHARMA STEIN AG;  </td><td>NOVARTIS OVERSEAS INVESTMENTS AG</td><td>NOVARTIS OVERSEAS INVESTMENTS AG</td>
	</tr><tr>
		<td>PAIN-EEZE</td><td>ASPIRIN; CAFFEINE</td><td>95/2.2/3025</td><td>11/09/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>400; 24MG</td><td>PHARMANOVA (PVT) LTD;  </td><td>PHARMANOVA PVT LTD</td><td>PHARMANOVA HOLDINGS LTD</td>
	</tr><tr>
		<td>PAINOGESIC</td><td>&nbsp;</td><td>2025/2.1/6942</td><td>05/06/2025</td><td>05/05/2030</td><td>&nbsp;</td><td>PHARMACY MEDICINES (P.)</td><td>&nbsp;</td><td>WRAPSA PACKAGING &amp; MANUF.;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>PAINRID</td><td>PARACETAMOL; CAFFEINE ANHYDROUS; CODEINE PHOSPHATE; DIPHENHYDRAMINE</td><td>2021/2.2/6131</td><td>05/18/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50; 10; 5; 400MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>PALBOCICLIB PFIZER</td><td>PALBOCICLIB</td><td>2023/9.5.2/6499</td><td>11/02/2023</td><td>11/02/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>PALBOCICLIB PFIZER</td><td>PALBOCICLIB</td><td>2017/9.5.2/5505</td><td>12/20/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75 MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>PALBOCICLIB PFIZER</td><td>PALBOCICLIB</td><td>2017/9.5.2/5507</td><td>12/20/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>PALBOCICLIB PFIZER</td><td>PALBOCICLIB</td><td>2017/9.7/5506</td><td>12/20/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>PALBOCICLIB PFIZER</td><td>PALBOCICLIB</td><td>2023/9.5.2/6501</td><td>11/02/2023</td><td>11/02/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>PALBOCILIB PFIZER</td><td>PALBOCICLIB</td><td>2023/9.5.2/6500</td><td>11/02/2023</td><td>11/02/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>PALOHALT</td><td>PALONOSETRON HYDROCHLORIDE</td><td>2019/16/5906</td><td>08/19/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.25MG/5ML</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>PALONOTAS</td><td>PALONOSETRON HYDROCHLORIDE</td><td>2021/16/6195</td><td>10/22/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.05MG/ML</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>PANADENE</td><td>CODEINE PHOSPHATE; PARACETAMOL</td><td>77/2.2/953</td><td>08/19/1977</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 8MG</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAMS SA (PTY) LTD;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAMS SA (PTY) LTD</td><td>WINTHROP PRODUCTS INCORP</td>
	</tr><tr>
		<td>PANADO</td><td>PARACETAMOL</td><td>76/2.1/597</td><td>03/25/1976</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>ADCOCK INGRAMS SA (PTY) LTD;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>PANADO</td><td>PARACETAMOL</td><td>79/2.1/1228</td><td>03/27/1979</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  DATLABS PRIVATE LIMITED;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>PANADO PAEDIATRIC ALCOHOL; SUGAR FREE</td><td>PARACETAMOL</td><td>2003/2.1/4207</td><td>10/22/2003</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>120MG/5ML</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>PANAFCORT</td><td>PREDNISONE</td><td>2004/17.1/4274</td><td>06/24/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>PANAMOR 25</td><td>DICLOFENAC SODIUM</td><td>91/3.1/2561</td><td>12/09/1991</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>ASPEN PORT ELIZABETH (PTY) LIMIITED;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>PANAMOR AT-50</td><td>DICLOFENAC SODIUM</td><td>91/3.1/2562</td><td>12/09/1991</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>ASPEN SA OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>PANTAISOL 40MG</td><td>PANTOPRAZOLE SODIUM SESQUIHYDRATE</td><td>2025/16.7/6841</td><td>01/28/2025</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td><td>HLL LIFECARE LIMITED</td>
	</tr><tr>
		<td>PANTIN</td><td>PANTOPRAZOLE SODIUM SESQUIHYDRATE</td><td>2023/16.7/6421</td><td>06/29/2023</td><td>06/29/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/VIAL</td><td>ASPIRO PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>PANTIN 40</td><td>PANTOPRAZOLE SODIUM</td><td>2014/16.7/4848</td><td>02/11/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>PANTOPRAZOLE SODIUM SESQUIHYDRATE</td><td>PANTOPRAZOLE SODIUM SESQUIHYDRATE</td><td>2018/16.7/5620</td><td>05/29/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>BEXIMCO PHARMACEUTICALS (PVT) LTD;  </td><td>BEXIMCO PHARMACEUTICALS LTD</td><td>BEXIMCO PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>PANTOPRAZOLE SODIUM SESQUIHYDRATE</td><td>PANTOPRAZOLE SODIUM SESQUIHYDRATE</td><td>2018/16.7/5619</td><td>05/29/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20MG</td><td>BEXIMCO PHARMACEUTICALS (PVT) LTD;  </td><td>BEXIMCO PHARMACEUTICALS LTD</td><td>BEXIMCO PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>PANTOR 20</td><td>PANTOPRAZOLE SODIUM</td><td>2024/16.7/6593</td><td>04/23/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>PANTOR 40</td><td>PANTOPRAZOLE SODIUM</td><td>2024/16.7/6593</td><td>04/23/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>PARA T</td><td>PARACETAMOL; TRAMADOL HYDROCHLORIDE</td><td>2022/2.2/6248</td><td>02/07/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>37.5;325MG</td><td>ATHENA DRUG DELIVERY SOLUTIONS;  </td><td>TNINE PHARMACEUTICALS </td><td>TNINE PHARMACEUTICALS </td>
	</tr><tr>
		<td>PARACEROL</td><td>PARACETAMOL</td><td>2021/2.1/6211</td><td>12/07/2021</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>POLIFARMA ILAC SAN. VETIC. A.S. ;  </td><td>WMT PHARMACEUTICALS </td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>PARACET</td><td>PARACETAMOL</td><td>92/2.1/2726</td><td>09/22/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>PARACET</td><td>PARACETAMOL</td><td>2002/2.1/4070</td><td>09/22/2002</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>PARACETAMOL</td><td>PARACETAMOL</td><td>2000/2.1/3858</td><td>12/07/2000</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>BAL PHARMA;  BAL PHARMA LTD;  </td><td>BAL PHARMA</td><td>BAL PHARMA</td>
	</tr><tr>
		<td>PARACETAMOL</td><td>PARACETAMOL</td><td>2005/2.1/4397</td><td>10/07/2005</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>INDOCO REMEDIES LTD;  </td><td>INDOCO REMEDIES LTD</td><td>INDOCO REMEDIES LTD</td>
	</tr><tr>
		<td>PARACETAMOL</td><td>PARACETAMOL</td><td>2017/2.1/5456</td><td>10/30/2017</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>PARACETAMOL B. BRAUN</td><td>PARACETAMOL</td><td>2016/2.1/5171</td><td>02/18/2016</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/ML</td><td>B. BRAUN MEDICAL;  B. BRAUN MELSUNGEN AG;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>PARACETAMOL FRESENIUS</td><td>PARACETAMOL</td><td>2016/2.1/5278</td><td>09/20/2016</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>FRESENIUS KABI;  FRESENIUS KABI AUSTRIA GMBH,;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>PARACETAMOL FRESENIUS</td><td>PARACETAMOL</td><td>2016/2.1/5279</td><td>09/20/2016</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/ML</td><td>FRESENIUS KABI AUSTRIA GMBH,;  FRESENIUS KABI GERMANY GMBH;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>PARACETAMOL; IBUPROFEN</td><td>IBUPROFEN; PARACETAMOL</td><td>2024/2.2/6729</td><td>10/17/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 500MG</td><td>SOFTESULE PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>PARAPAED</td><td>PARACETAMOL</td><td>74/2.1/0216</td><td>01/10/1974</td><td>&nbsp;</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>GULF DRUG COMPANY;  </td><td>GULF DRUG COMPANY (PVT) LTD</td><td>GULF DRUG COMPANY (PVT) LTD</td>
	</tr><tr>
		<td>PARATRAM</td><td>PARACETAMOL; TRAMADOL HYDROCHLORIDE</td><td>2016/2.2/5163</td><td>01/27/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>37.5; 325 MG</td><td>ATHENA DRUG DELIVERY SOLUTIONS;  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>PARCODIN</td><td>CODEINE PHOSPHATE; PARACETAMOL</td><td>2017/2.2/5465</td><td>10/20/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500; 8MG</td><td>RUSAN PHARMA;  </td><td>RUSAN PHARMA LTD</td><td>RUSAN PHARMA LTD</td>
	</tr><tr>
		<td>PAREBEX</td><td>VITAMIN B COMPLEX</td><td>87/24.2/2103</td><td>08/06/1987</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PHARMACY MEDICINES (P.)</td><td>50; 2; 3; 20MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PARECON FORTE</td><td>CYANOCOBALAMIN</td><td>81/22.1.4/1385</td><td>01/20/1981</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PHARMACY MEDICINES (P.)</td><td>1MG/ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PATADAY</td><td>OLOPATADINE HYDROCHLORIDE</td><td>2024/19.9/6591</td><td>04/23/2024</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.22MG/ML</td><td>S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>PATANOL</td><td>OLOPATADINE HYDROCHLORIDE</td><td>2002/19.9/4020</td><td>02/08/2002</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.1%</td><td>ALCON LABORATORIES INCORPORATED, USA;  S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>PATIZRA</td><td>RANIBIZUMAB</td><td>2018/9.2/5733</td><td>11/06/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>NOVARTIS PHARMA STEIN AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>PAUSE </td><td>TRANEXAMIC ACID</td><td>2021/10.4/6069</td><td>12/15/2020</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG/5ML</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>PAUSE 500</td><td>TRANEXAMIC ACID</td><td>2022/10.4/6334</td><td>10/27/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>PAXOL</td><td>PACLITAXEL</td><td>2012/9.4/4725</td><td>02/06/2012</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/16.7ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>PCD C4 SYRUP</td><td>CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE</td><td>2020/22.1/6042</td><td>10/09/2020</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>0.5; 2.0; 120; 2.5MG/5ML</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>PCD CHESTY COUGH</td><td>AMMONIUM CHLORIDE; DIPHENHYDRAMINE HYDROCHLORIDE</td><td>2021/22.2.5/6130</td><td>05/18/2021</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>12.5; 125 MG</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>PCD DRY COUGH</td><td>DEXTROMETHORPHAN HYDROBROMIDE</td><td>2018/22.2.1/5702</td><td>10/01/2018</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>15MG/5ML</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>PENTACOL COLIC DROPS</td><td>SIMETHICONE</td><td>2020/16.1/6041</td><td>10/07/2020</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>50MG/ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS (PVT) LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>PENTALINK 40</td><td>PANTOPRAZOLE</td><td>2023/16.7/6538</td><td>12/14/2023</td><td>12/14/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>PEPALETS</td><td>CAFFEINE</td><td>79/13.7/1287</td><td>08/05/1979</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>136.8MG</td><td>DATLABS PRIVATE LIMITED;  D A B PHARMACEUTICALS PVT LTD;  </td><td>LEMEX PRODUCTS PVT LTD</td><td>LEMEX PRODUCTS PVT LTD</td>
	</tr><tr>
		<td>PERILIN</td><td>METOCLOPRAMIDE HYDROCHLORIDE</td><td>2023/16.2/6445</td><td>07/20/2023</td><td>07/20/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/2ML</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>PERILIN SOLUTION</td><td>METOCLOPRAMIDE HYDROCHLORIDE</td><td>2025/16.2/6803</td><td>01/07/2025</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>5MG/5ML</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>PERJETA</td><td>PERTUZUMAB</td><td>2019/9.7/5926</td><td>09/17/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>420MG/14ML</td><td>ROCHE DIAGNOSTICS GMBH;  F. HOFFMAN LA ROCHE LTD;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>F. HOFFMAN-LA ROCHE LTD</td>
	</tr><tr>
		<td>PETHIDINE</td><td>PETHIDINE HYDROCHLORIDE</td><td>91/4.1/2504</td><td>06/12/1991</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>100MG/2ML</td><td>CAPS PVT LTD;  </td><td>CAPS INTERNATIONAL EST</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PETHIDINE  </td><td>PETHIDINE HYDROCHLORIDE</td><td>2018/4.1/5709</td><td>10/01/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>100MG/2ML</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA;  </td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td>
	</tr><tr>
		<td>PETHIDINE</td><td>PETHIDINE HYDROCHLORIDE</td><td>2018/4.1/5708</td><td>10/01/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>50MG/ML</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA;  </td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td>
	</tr><tr>
		<td>PETHIDINE HYDROCHLORIDE FRESENIUS PF</td><td>PETHIDINE HYDROCHLORIDE</td><td>2006/4.1/4433</td><td>07/10/2006</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/2ML</td><td>BODENE;  BODENE;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>PHARMA-Q ADRENALINE</td><td>ADRENALINE ACID TARTRATE</td><td>98/12.7/3380</td><td>07/27/1998</td><td>12/31/2027</td><td>INJECTABLE; INJECTION, AMPOULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG/ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q ATROPINE</td><td>ATROPINE SULPHATE</td><td>2014/6.2/4832</td><td>01/20/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>IMG/ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q BUPIVACAINE SPINAL WITH DEXTROSE</td><td>BUPIVACAINE HYDROCHLORIDE</td><td>2000/1.2.1/3702</td><td>03/24/2000</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/4ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q DIAZEPAM</td><td>DIAZEPAM</td><td>98/13.2.2/3381</td><td>07/27/1998</td><td>12/31/2027</td><td>INJECTABLE; INJECTION, AMPOULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/2ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q DOPAMINE</td><td>DOPAMINE HYDROCHLORIDE</td><td>2000/12.7/3729</td><td>05/19/2000</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/5ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q FENTANYL</td><td>FENTANYL CITRATE</td><td>99/4.1/3539</td><td>06/07/1999</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>100MCG</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q FRUSEMIDE</td><td>FUROSEMIDE</td><td>2000/12.5.1/3731</td><td>08/16/2000</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/2ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q GENTAMICIN</td><td>GENTAMICIN SULPHATE</td><td>99/7.2.1/3595</td><td>09/27/1999</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG/2ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q GENTAMICIN</td><td>GENTAMICIN SULPHATE</td><td>98/7.2.1/3379</td><td>07/27/1998</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG/2ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q METOCLOPRAMIDE</td><td>METOCLOPRAMIDE HYDROCHLORIDE</td><td>2014/16.2/4880</td><td>05/14/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/2ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q MORPHINE</td><td>MORPHINE SULPHATE</td><td>98/4.1/3423</td><td>10/05/1998</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>10MG/ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q MORPHINE</td><td>MORPHINE SULPHATE</td><td>99/4.1/3476</td><td>01/13/1999</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>15MG/1ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q PETHIDINE</td><td>PETHIDINE HYDROCHLORIDE</td><td>2001/4.1/3910</td><td>03/28/2001</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>50MG/ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q PETHIDINE</td><td>PETHIDINE HYDROCHLORIDE</td><td>2001/4.1/3913</td><td>03/28/2001</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>100MG/2ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q SUXAMETHONIUM</td><td>SUXAMETHONIUM CHLORIDE</td><td>200/1.3/3843</td><td>11/30/2000</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/2ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q THEOPHYLLINE</td><td>THEOPHYLLINE ETHYLENE DIAMINE</td><td>98/22.1.1/3382</td><td>07/27/1998</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/10ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHARMA-Q-DEXAMETHASONE PHOSHATE</td><td>DEXAMETHASONE PHOSHATE</td><td>2013/17.1/4790</td><td>08/09/2013</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4MG/1ML</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS</td>
	</tr><tr>
		<td>PHENOBARBITONE</td><td>PHENOBARBITONE</td><td>91/13.1/2471</td><td>04/09/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>30MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PHENOBARBITONE</td><td>PHENOBARBITONE</td><td>96/13.1/3086</td><td>05/15/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>30MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>PHENOL EAR DROPS</td><td>PHENOL</td><td>82/20.1.1/5949</td><td>01/19/1982</td><td>12/31/2027</td><td>SOLUTION/DROPS; OTIC</td><td>PHARMACY MEDICINES (P.)</td><td>40%V/V</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PHENOXYMETHYL PENICILLIN</td><td>PHENOXYMETHYLPENICILLIN</td><td>98/71.1/3415</td><td>08/27/1998</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>PHENOXYMETHYL PENICILLIN</td><td>PHENOXYMETHYLPENICILLIN</td><td>96/7.1.1/3185</td><td>11/21/1996</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>PHENTOLEPT 250MG/5ML</td><td>&nbsp;</td><td>2025/13.1/6919</td><td>04/11/2025</td><td>04/10/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>PHENYTOIN SODIUM</td><td>PHENYTOIN SODIUM</td><td>81/13.1/5844</td><td>12/11/1981</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PHESGO</td><td>PERTUZUMAB; TRASTUZUMAB</td><td>2023/9.7/6394</td><td>03/29/2023</td><td>03/29/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 600 MG/ML</td><td>F. HOFFMAN LA ROCHE LTD;  </td><td>ROCHE PRODUCTS</td><td>F. HOFFMAN LA ROCHE LTD</td>
	</tr><tr>
		<td>PHESGO </td><td>PERTUZUMAB; TRASTUZUMAB</td><td>2023/9.7/6395</td><td>03/29/2023</td><td>03/29/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1200; 600MG/ML</td><td>F. HOFFMAN LA ROCHE LTD;  </td><td>ROCHE PRODUCTS</td><td>F. HOFFMAN LA ROCHE LTD</td>
	</tr><tr>
		<td>PHYTORAL</td><td>KETOCONAZOLE</td><td>2001/7.12/3967</td><td>09/04/2001</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>BROWN &amp; BURK PHARM PVT LTD;  MICRO LABS LIMITED;  </td><td>MICRO LABS LTD</td><td>MICRO LABS LTD</td>
	</tr><tr>
		<td>PIFELTRO</td><td>DORAVIRINE</td><td>2024/7.13/6551</td><td>01/29/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>MSD INTERNATIONAL GMBH;  </td><td>MSD (PTY) LTD</td><td>MSD (PTY) LTD</td>
	</tr><tr>
		<td>PIPRANIR-TZ</td><td>PIPERACILLIN; TAZOBACTAM</td><td>2018/7.1.2/5732</td><td>11/06/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4.5MG</td><td>ACULIFE HEALTHCARE PVT LTD;  </td><td>ACULIFE HEALTHCARE PVT LTD </td><td>ACULIFE HEALTHCARE PVT LTD </td>
	</tr><tr>
		<td>PLACLOP 75MG</td><td>&nbsp;</td><td>2025/10.5/6916</td><td>04/09/2025</td><td>04/08/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>N2SA LIMITED</td><td>N2SA LIMITED</td>
	</tr><tr>
		<td>PLAPAR</td><td>PARACETAMOL</td><td>2018/2.1/5616</td><td>05/22/2018</td><td>12/31/2027</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>PLATIFIRST</td><td>CISPLASTIN</td><td>2023/9.4/6414</td><td>06/29/2023</td><td>06/29/2028</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG/10ML</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>PLATIFIRST </td><td>CISPLATIN</td><td>2021/9.4/6147</td><td>07/02/2021</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG/50ML</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>PLATOL</td><td>CISPLATIN</td><td>2017/9.4/5423</td><td>09/05/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/100ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>PLUSCHLO</td><td>CHLOROQUINE PHOSPHATE</td><td>2003/7.5/4120</td><td>04/16/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>PLUSCHLO</td><td>CHLOROQUINE PHOSPHATE</td><td>2002/7.5/4068</td><td>09/06/2002</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>PLUSNOLE</td><td>METRONIDAZOLE</td><td>92/7.6/2723</td><td>09/22/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>PLUSNOLE</td><td>METRONIDAZOLE</td><td>2025/7.6/6814</td><td>01/14/2025</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/5ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS (PVT) LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>PODOPHYLLIN COMPOUND PAINT BPC 1973</td><td>BENZOIN; PODOPHYLLUM</td><td>82/14.8/5979</td><td>02/17/1982</td><td>12/31/2027</td><td>PAINT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>100ML; 0.150G</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>POLAMINOFEN</td><td>PARACETAMOL</td><td>2024/2.1/6624</td><td>06/11/2024</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>POLIFARMA ILAC SAN. VETIC. A.S. ;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>POLIFEKS LACTATED RINGER SOLUTION</td><td>CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE</td><td>2024/23.2.1/6623</td><td>06/06/2024</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.3; 0.4; 6.0; 3.0MG/ML</td><td>POLIFARMA ILAC SAN. VETIC. A.S. ;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>POLIFLEKS </td><td>SODIUM CHLORIDE</td><td>2023/23.2.1/6532</td><td>12/07/2023</td><td>12/07/2028</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.9%</td><td>POLIFARMA ILAC SAN. VETIC. A.S. ;  </td><td>WMT PHARMACEUTICALS </td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>POLI-RIN</td><td>HEPARIN SODIUM</td><td>2024/10.2/6598</td><td>05/06/2024</td><td>&nbsp;</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25000IU/5ML</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>POLIVY</td><td>POLATUZUMAB VEDOTIN</td><td>2024/9.7/6574</td><td>03/14/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>140MG</td><td>BSP PHARMACEUTICALS S.P.A;  </td><td>ROCHE PRODUCTS</td><td>F. HOFFMAN LA ROCHE LTD</td>
	</tr><tr>
		<td>POLIVY</td><td>POLATUZUMAB VEDOTIN</td><td>2024/9.7/6573</td><td>03/14/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG</td><td>F. HOFFMAN LA ROCHE LTD;  </td><td>ROCHE PRODUCTS</td><td>F. HOFFMAN LA ROCHE LTD</td>
	</tr><tr>
		<td>POL-MOXI</td><td>MOXIFLOXACIN HYDROCHLORIDE</td><td>2024/7.2.5/6555</td><td>02/09/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG/250ML</td><td>POLIFARMA ILAC SAN. VETIC. A.S. ;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>POLYGYL</td><td>METRONIDAZOLE</td><td>2024/7.2.5/6543</td><td>01/11/2024</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG/100ML</td><td>POLIFARMA ILAC SAN. VETIC. A.S. ;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>POLY-MXB</td><td>POLYMYXIN B SULPHATE</td><td>2018/7.2.5/5763</td><td>12/18/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500000IU</td><td>BHARAT SERUMS &amp; VACCINES LTD;  </td><td>BHARAT SERUMS & VACCINES LTD</td><td>BHARAT SERUMS & VACCINES LTD</td>
	</tr><tr>
		<td>PONSTAN</td><td>MEFENAMIC ACID</td><td>74/2.1/261</td><td>07/12/1974</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>250MG</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  GOEDECKE AG;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>PONSTAN</td><td>MEFENAMIC ACID</td><td>74/2.1/262</td><td>07/12/1974</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MG/5ML</td><td>WARNER-LAMBERT (PTY) LTD;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>WARNER-LAMBERT R.S.A.(PTY) LTD</td>
	</tr><tr>
		<td>POST SURGISOL SOLUTION FRESENIUS</td><td>DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE</td><td>2004/23.2.1/4305</td><td>09/16/2004</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100G; 510MLS; 1.86G; 2.05G</td><td>INTRAMED (PTY) LTD;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>POSTPIL</td><td>LEVONORGESTREL</td><td>2021/21.2.2/6194</td><td>10/20/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1.5MG</td><td>NAARI PHARMA PRIVATE LIMITED;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>POTASSIUM CHLORIDE</td><td>POTASSIUM CHLORIDE</td><td>2016/23.2.2/5158</td><td>01/21/2016</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>14.9G</td><td>B BRAUN MELSUNGEN PRODUCTION SITE;  B. BRAUN MEDICAL;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>POTASSIUM CITRATE MIXTURE</td><td>POTASSIUM CITRATE </td><td>82/23.5/5975</td><td>01/19/1982</td><td>12/31/2027</td><td>MIXTURE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>30%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>POTRELEASE TR</td><td>POTASSIUM CHLORIDE</td><td>2023/23.1.2/6443</td><td>07/17/2023</td><td>07/17/2028</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>600MG</td><td>SM PHARMACEUTICALS;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>POUR SODIUM CHLORIDE 0.9% B BRAUN</td><td>SODIUM CHLORIDE</td><td>2024/31/6760</td><td>11/13/2024</td><td>&nbsp;</td><td>SOLUTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1000ML</td><td>B.BRAUN INTERGRATED PHARMACEUTICAL PLANT;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>POUR WATER FOR IRRIGATION</td><td>WATER FOR IRRIGATION</td><td>2024/31/6759</td><td>11/13/2024</td><td>&nbsp;</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000ML</td><td>B.BRAUN INTERGRATED PHARMACEUTICAL PLANT;  </td><td>B. BRAUN MEDICAL</td><td>B. BRAUN AVITUM AG. SCHWARZENBERGER</td>
	</tr><tr>
		<td>POVICIDE</td><td>POVIDONE IODINE</td><td>2004/14.1..4/4262</td><td>04/06/2004</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>10% M/M</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>POVICIDE</td><td>POVIDONE IODINE</td><td>2003/14.1.4/4108</td><td>04/16/2003</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>10% M/V</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>POVICIDE MOUTHWASH AND GARGLE</td><td>POVIDONE IODINE</td><td>2019/14.1.4/5907</td><td>08/21/2019</td><td>12/31/2027</td><td>SOLUTION, GARGEL; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1%W/V</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>PRAZIQUANTEL</td><td>PRAZIQUANTEL</td><td>2011/7.7/4706</td><td>09/13/2011</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>600MG</td><td>UMEDICA LABORATORIES PVT. LTD;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>PRED FORTE</td><td>PREDNISOLONE ACETATE</td><td>96/19.2.1/3084</td><td>05/09/1996</td><td>12/31/2027</td><td>SUSPENSION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>ALLERGAN PHARMACEUTICALS;  </td><td>ABBVIE PTY LTD</td><td>ABBVIE PTY LTD</td>
	</tr><tr>
		<td>PREDNI</td><td>PREDNISOLONE ACETATE</td><td>2024/19.2.1/6569</td><td>03/14/2024</td><td>12/31/2027</td><td>SUSPENSION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1%W/V</td><td>LINCOLN PHARMACEUTICALS LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>PREDNISOLONE</td><td>PREDNISOLONE</td><td>93/17.1/2812</td><td>10/07/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PREDNISOLONE 5MG COSPHARM</td><td>PREDNISOLONE</td><td>2024/19.2.1/6754</td><td>11/07/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>CYNDEA PHARMA S.L;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS SOUTH AFRICA </td>
	</tr><tr>
		<td>PREGA 150</td><td>PREGABALIN</td><td>2018/13.1/5549</td><td>01/30/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG</td><td>HETERO LABS LIMITED;  HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>PREGA-75</td><td>PREGABALIN</td><td>2019/13.1/5900</td><td>07/31/2019</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75 MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>PREGABA</td><td>PREGABALIN</td><td>2017/13.1/5313</td><td>03/08/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150 MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>PREGABA</td><td>PREGABALIN</td><td>2017/13.1/5314</td><td>03/08/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75 MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>PREGBAGRAN 150</td><td>PREGABALIN</td><td>2024/13.1/6582</td><td>04/11/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>PT DEXA MEDICA;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>PT DEXA MEDICA</td>
	</tr><tr>
		<td>PREGBAGRAN 75</td><td>PREGABALIN</td><td>2024/13.1/6581</td><td>04/11/2024</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75MG</td><td>PT DEXA MEDICA;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>PT DEXA MEDICA</td>
	</tr><tr>
		<td>PREGEB 150</td><td>PRAGABALIN</td><td>2019/13.1/5809</td><td>03/20/2019</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>PREGEB 75</td><td>PREGABALIN</td><td>2019/13.1/5808</td><td>03/20/2019</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>PREGNATAL</td><td>VITAMINS; MINERALS</td><td>91/24.5/2026</td><td>05/23/1991</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>MULTIINGREDIENT</td><td>SCANPHARM A/S;  </td><td>SCANPHARM A/S</td><td>SCANPHARM A/S</td>
	</tr><tr>
		<td>PREGNON</td><td>LEVONORGESTREL</td><td>2010/21.2.2/4584</td><td>02/18/2010</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.75MG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>PREMARIN</td><td>CONJUGATED OESTROGENS</td><td>83/17.3/1752</td><td>12/02/1983</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.25MG</td><td>WYETH MEDICAL;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>PREMARIN</td><td>CONJUGATED OESTROGENS</td><td>86/17.03/2030</td><td>11/27/1986</td><td>12/31/2027</td><td>CREAMS</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.625MG/G</td><td>WYETH AYERST CANADA INC;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>PREMARIN</td><td>CONJUGATED OESTROGENS</td><td>83/17.3/1751</td><td>12/02/1983</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.625MG</td><td>WYETH MEDICAL;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>PREMARIN</td><td>CONJUGATED OESTROGENS</td><td>83/17.3/1750</td><td>12/02/1983</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>0.3MG</td><td>WYETH MEDICAL;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>PREMELLE</td><td>CONJUGATED OESTROGENS; MEDROXYPROGESTERONE ACETATE</td><td>2000/17.5/3800</td><td>11/15/2000</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>0.625; 2.5MG</td><td>WYETH-AYERST LABS INC;  WYETH MEDICAL;  TECHNIKON LABORATORIES;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>WYETH-AYERST INTERNATIONAL INC</td>
	</tr><tr>
		<td>PRESARTAN 100</td><td>LOSARTAN POTASSIUM</td><td>2015/12.3.5/4981</td><td>02/18/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 MG</td><td>IPCA LABORATORIES LIMITED;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>PRESARTAN H 50</td><td>HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM</td><td>2015/12.3.5/4980</td><td>02/18/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 50MG</td><td>IPCA LABORATORIES LIMITED;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABORATORIES LIMITED</td>
	</tr><tr>
		<td>PRESARTAN-25</td><td>LOSARTAN POTASSIUM</td><td>2004/12.3.5/4257</td><td>03/16/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>PRESARTAN-50</td><td>LOSARTAN POTASSIUM</td><td>2004/12.3.5/4258</td><td>03/16/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>PREVENAR 13</td><td>PNEUMOCOCCAL CONJUGATE 13 VALENT </td><td>2018/18.2/5747</td><td>12/07/2018</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2; 2.2; 2.2; </td><td>PFIZER MANUFACTURING;  PFIZER IRELAND PHARMACEUTICALS;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>PREVENAR 13</td><td>PNEUMOCOCCAL CONJUGATE 13 VALENT </td><td>2014/18.2/4856</td><td>02/28/2014</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5 ML</td><td>WYETH LEDERLE VACCINES;  BAXTER PHARMACEUTICAL;  PFIZER IRELAND PHARMACEUTICALS;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>PREZISTA</td><td>DARUNAVIR</td><td>2018/7.13/5716</td><td>10/12/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>JANSSEN ORTHO LLC;  </td><td>JANSSEN-CILAG INTERNATIONAL NV</td><td>JANSSEN-CILAG INTERNATIONAL NV</td>
	</tr><tr>
		<td>PREZISTA</td><td>DARUNAVIR</td><td>2013/7.13/4801</td><td>10/29/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600MG</td><td>JANSSEN ORTHO LLC;  JANSSEN-CILAG SPA;  ASPEN PHARMACARE;  </td><td>JANSSEN PHARMACEUTICA</td><td>PHARMACARE LTD</td>
	</tr><tr>
		<td>PREZISTA</td><td>DARUNAVIR</td><td>2016/7.13/5241</td><td>08/02/2016</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400 MG</td><td>JANSSEN ORTHO LLC;  JANSSEN-CILAG SPA;  </td><td>JANSSEN-CILAG INTERNATIONAL NV</td><td>JANSSEN-CILAG INTERNATIONAL NV</td>
	</tr><tr>
		<td>PREZISTA</td><td>DARUNAVIR</td><td>2018/7.13/5717</td><td>10/12/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>JANSSEN-CILAG INTERNATIONAL NV;  </td><td>JANSSEN-CILAG INTERNATIONAL NV</td><td>JANSSEN-CILAG INTERNATIONAL NV</td>
	</tr><tr>
		<td>PRIMACORT-100</td><td>HYDROCORTISONE SODIUM SUCCINATE</td><td>2008/17.1/4540</td><td>10/13/2008</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>MACLEODS PHARMACEUTICALS LTD;  MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>PRIMOLUT N</td><td>NORETHISTERONE ENANTHATE</td><td>78/17.4/1167</td><td>10/04/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>PROCAINE BENZYLPENICILLIN</td><td>PROCAINE BENZYLPENICILLIN</td><td>2015/7.1.1/5086</td><td>09/17/2015</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3000000IU</td><td>KARNATAKA ANTIB &amp; PHARMA LTD;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>PROCEDYL</td><td>CODEINE PHOSPHATE; EPHEDRINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE </td><td>2017/22.2.5/5477</td><td>11/02/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>9; 72; 3.6MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>PROCHLORPERAZINE MALEATE</td><td>PROCHLORPERAZINE MALEATE</td><td>90/16.2/2401</td><td>10/03/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>WALLACE LABORATORIES PVT LTD</td>
	</tr><tr>
		<td>PROCILLIN</td><td>PROCAINE BENZYLPENICILLIN</td><td>83/7.1.1/1707</td><td>06/02/1983</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PRODART 0.5</td><td>DUTASTERIDE</td><td>2021/17.12/6112</td><td>03/19/2021</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5MG</td><td>OLIVE HEALTHCARE ;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>PRODUTA 0.5</td><td>&nbsp;</td><td>2025/17.12/6804</td><td>01/13/2025</td><td>01/12/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>PROMETHAZINE HYDROCHLORIDE</td><td>PROMETHAZINE HYDROCHLORIDE</td><td>2002/5/4030</td><td>02/08/2002</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>PROMETHAZINE HYDROCHLORIDE FRESENIUS</td><td>PROMETHAZINE HYDROCHLORIDE</td><td>2005/5/4336</td><td>01/19/2005</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>PRONTA 1</td><td>LEVONORGESTREL</td><td>2018/21.2.2/5594</td><td>04/05/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1.5MG</td><td>MYLAN LABORATORIES LTD;  </td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td><td>POPULATION SERVICES INTERNATIONAL, SOUTH AFRICA</td>
	</tr><tr>
		<td>PROPAIN TABLETS</td><td>PROPAIN</td><td>77/2.2/909</td><td>07/01/1977</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50; 10; 5 400MG</td><td>ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAM</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>PROPOFOL - PF</td><td>PROPOFOL</td><td>2024/1.1/6595</td><td>05/02/2024</td><td>&nbsp;</td><td>EMULSIONS; INJECTABLE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/20ML</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>PROPOFOL-LIPURO 1%</td><td>PROPOFOL</td><td>2004/1.1/4289</td><td>07/28/2004</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>B.BRAUN MELSUNGEN AG;  </td><td>B.BRAUN MELSUNGEN AG</td><td>B.BRAUN MELSUNGEN AG</td>
	</tr><tr>
		<td>PROPRANOLOL HYDROCHLORIDE</td><td>PROPRANOLOL HYDROCHLORIDE</td><td>90/12.3.2/2399</td><td>08/28/1990</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>PROSTIN E2</td><td>DINOPROSTONE</td><td>J/19/8</td><td>03/29/1983</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5MG</td><td>SANICO NV;  </td><td>N.V. UPJOHN-PHARMACIA & UPJOHN</td><td>PHARMACIA NV/S.A</td>
	</tr><tr>
		<td>PROTAPHANE FLEXPEN</td><td>INSULIN HUMAN</td><td>2019/17.6/5890</td><td>06/27/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1001U/ML</td><td>NOVO NORDISK PRODUCAO;  NOVO NORDISK PHARMACEUTIQUE;  NOVO NORDISK A/S;  NOVO NORDISK  A/S;  NOVO-NORDISK A/S;  </td><td>NOVO NORDISK KENYA LIMITED</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>PROTAPHANE HM (GE)</td><td>BIO-SYNTHETIC HUMAN ISOPHANE INSULIN</td><td>86/17.6/1982</td><td>07/14/1986</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>100 IU/ML</td><td>NOVO-NORDISK A/S;  NOVO INDUSTRIES;  NOVO NORDISK PRODUCAO;  TEVA PHARMACEUTICAL WORKS PVT LTD;  NOVO NORDISK A/S;  NOVO NORDISK  A/S;  NOVO NORDISK PHARMACEUTICAL INDUSTRIES INC;  NOVO NORDISK PHARMACEUTIQUE;  </td><td>NOVO NORDISK KENYA LIMITED</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>PROVIRON</td><td>MESTEROLONE</td><td>87/17.2/2091</td><td>07/09/1987</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  BAYER AG, BERLIN;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>P-TAX 260</td><td>PACLITAXEL</td><td>2023/9.4/6534</td><td>12/08/2023</td><td>12/08/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>260MG/43.3ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>P-TAX 300</td><td>PACLITAXEL</td><td>2023/9.4/6535</td><td>12/08/2023</td><td>12/08/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG/50ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>PURINOL</td><td>ALLOPURINOL</td><td>72/3.2/32</td><td>04/17/1972</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PYCURE</td><td>PARACETAMOL</td><td>2022/2.1/6306</td><td>07/25/2022</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td>
	</tr><tr>
		<td>PYLOBACT</td><td>CLARITHROMYCIN; OMEPRAZOLE; TINIDAZOLE</td><td>2001/16.7/4002</td><td>12/17/2001</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250; 20; 500MG</td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>PYNGO</td><td>CAFFEINE ANHYDROUS; CODEINE PHOSPHATE; DOXYLAMINE SUCCINATE; PARACETAMOL</td><td>2017/2.2/5478</td><td>11/06/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>45; 10; 5; 450 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>PYNSTOP</td><td>CAFFEINE; CODEINE PHOSPHATE; PARACETEMOL; DOXYLAMINE SUCCINATE   </td><td>74/2.2/0253</td><td>07/01/1974</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>45; 10; 450; 5MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>RIO ETHICALS PTY LTD</td>
	</tr><tr>
		<td>PYRAZINAMIDE</td><td>PYRAZINAMIDE</td><td>92/7.3/2580</td><td>01/15/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>PYRAZINAMIDE</td><td>PYRAZINAMIDE</td><td>95/7.3/2956</td><td>07/20/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>PYRIDOXINE HYDROCHLORIDE</td><td>PYRIDOXINE HYDROCHLORIDE</td><td>2006/24.1.2/4409</td><td>02/20/2006</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>25MG</td><td>S KANT HEALTHCARE LTD;  </td><td>S K AGE EXPORTS</td><td>S K AGE EXPORTS</td>
	</tr><tr>
		<td>PYRIMON</td><td>DEXAMETHASONE; CHLORAPHENICOL</td><td>98/19.2.2/3375</td><td>07/17/1998</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1; 0.1%W/V</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>PYROSEAL</td><td>PARACETAMOL</td><td>2024/2.1/6552</td><td>01/31/2024</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>120 MG/5ML</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>PYROSEAL</td><td>PARACETAMOL</td><td>2024/2.1/6751</td><td>11/14/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500MG</td><td>I. GRANULES INDIA LIMITED;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>Q-TAB 100</td><td>QUETIAPINE FUMARATE</td><td>2019/13.2.3/5818</td><td>04/02/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>Q-TAB 200</td><td>QUETIAPINE FUMARATE</td><td>2019/13.2.3/5817</td><td>04/02/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>Q-TIB</td><td>ISONIAZID; PYRIDOXINE HYDROCHLORIDE; SULPHAMETHOXAZOLE; TRIMETHOPRIM</td><td>2017/7.3/5435</td><td>09/21/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 25; 800; 160MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>QUALICEF</td><td>CEFTRIAXONE SODIUM</td><td>2021/7.2.2/6105</td><td>02/18/2021</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1GRAM</td><td>INJECT CARE PARENTERALS PVT LTD;  </td><td>INJECTCARE PARENTERALS PVT LTD</td><td>INJECT CARE PARENTERALS PVT LTD</td>
	</tr><tr>
		<td>QUALIZIN </td><td>PROMETHAZINE HYDROCHLORIDE</td><td>2025/5/6842</td><td>01/29/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10MG</td><td>SUNGLOW LIFE SCIENCE PRIVATE LIMITED;  </td><td>RIDZ PHARMA</td><td>SUNGLOW LIFE SCIENCE PRIVATE LIMITED</td>
	</tr><tr>
		<td>QUALIZIN </td><td>PROMETHAZINE HYDROCHLORIDE</td><td>2025/5/6843</td><td>01/29/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>25MG</td><td>SUNGLOW LIFE SCIENCE PRIVATE LIMITED;  </td><td>RIDZ PHARMA</td><td>SUNGLOW LIFE SCIENCE PRIVATE LIMITED</td>
	</tr><tr>
		<td>QUARONTIN 625</td><td>AMOXYCILLIN TRIHYDRATE; CLAVULANIC ACID</td><td>2025/7.1.2/6857</td><td>02/10/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500; 125MG</td><td>MEDOPHARM PRIVATE LTD;  </td><td>RIDZ PHARMA</td><td>RIDZ PHARMA</td>
	</tr><tr>
		<td>QUARONTIN-1000</td><td>AMOXYCILLIN TRIHYDRATE; CLAVULANIC ACID</td><td>2025/7.1.2/6856</td><td>02/10/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>875; 125MG</td><td>MEDOPHARM PRIVATE LTD;  </td><td>RIDZ PHARMA</td><td>RIDZ PHARMA</td>
	</tr><tr>
		<td>QUETAMAC</td><td>QUETIAPINE FUMARATE</td><td>2019/13.2.3/5937</td><td>10/10/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>QUININE HYDROCHLORIDE</td><td>QUININE HYDROCHLORIDE</td><td>88/7.5/2199</td><td>09/12/1988</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG/ML</td><td>DATLABS PRIVATE LIMITED;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>QUININE SULPHATE</td><td>QUININE SULPHATE</td><td>2000/7.5/3861</td><td>12/21/2000</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>RAMGIC</td><td>TRAMADOL</td><td>2019/2.1/5783</td><td>02/18/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/ML</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>RANFERON-12</td><td>FERROUS FUMARATE, VITAMIN B12, VITAMIN C</td><td>99/10.1.4/3536</td><td>07/14/1999</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>112.5; 10; 305; 1.13; 5MG  </td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>RANITIDINE HYDROCHLORIDE</td><td>RANITIDINE HYDROCHLORIDE</td><td>2024/16.7/6733</td><td>10/21/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>SKYMAP PHARMACEUTICALS PVT LTD;  </td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td>
	</tr><tr>
		<td>RANOPHAGE OD</td><td>METFORMIN HYDROCHLORIDE</td><td>2011/17.7/4701</td><td>01/12/2012</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1000MG</td><td>RANBAXY LABORATORIES LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>RAPICLAV</td><td>AMOXYCILLIN TRIHYDRATE; CLAVULANIC ACID</td><td>2017/7.1.2/5470</td><td>10/31/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250; 62.5MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>RAPICLAV</td><td>AMOXYCILLIN TRIHYDRATE; POTASSIUM CLAVULANATE</td><td>2021/7.1.2/6178</td><td>09/08/2021</td><td>12/31/2027</td><td>POWDER, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125; 31.25MG/5ML</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABORATORIES LIMITED</td>
	</tr><tr>
		<td>RAPIDUCE</td><td>LACTULOSE</td><td>2023/16.5.4/6386</td><td>03/14/2023</td><td>03/14/2028</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>3.35MG/5ML</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>RAPIFEN</td><td>&nbsp;</td><td>2025/4.1/6901</td><td>03/11/2025</td><td>03/10/2030</td><td>&nbsp;</td><td>NARCOTIC MEDICINES, (N.)</td><td>&nbsp;</td><td>DEMO S.A PHARMACEUTICALS;  </td><td>PIRAMAL CRITICAL CARE SOUTH AFRICA (PTY) LTD</td><td>PIRAMAL CRITICAL CARE SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>RASATOR 0.5</td><td>RASAGILINE</td><td>2021/13.4/6126</td><td>05/04/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>RASATOR 1</td><td>RASAGILINE MESYLATE</td><td>2021/13.4/6125</td><td>05/04/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>RECOXITRO</td><td>ETORICOXIB</td><td>2025/3.1/6858</td><td>02/12/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60MGOFF</td><td>MARCYRL PHARMACEUTICAL INDUSTRIES;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>RECOXITRO</td><td>ETORICOXIB</td><td>2025/3.1/6860</td><td>02/12/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120MG</td><td>MARCYRL PHARMACEUTICAL INDUSTRIES;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>RECOXITRO 90</td><td>ETORICOXIB</td><td>2025/3.1/6859</td><td>02/12/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>90MG</td><td>MARCYRL PHARMACEUTICAL INDUSTRIES;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>REFPAIN</td><td>ACECLOFENAC; PARACETAMOL</td><td>2019/2/5935</td><td>10/08/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100; 500MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>REFPAIN PLAIN</td><td>ACECLOFENAC</td><td>2019/3.1/5816</td><td>03/29/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>ACME FORMULATION PVT LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>RELAXO</td><td>DICLOFENAC SODIUM</td><td>2018/3.1/5707</td><td>10/01/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG/3ML</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>RELCER</td><td>ALUMINIUM HYDROXIDE; DIMETHICONE; LIQUORICE; MAGNESIUM HYDROXIDDE</td><td>2001/16.1/3931</td><td>05/13/2009</td><td>12/31/2027</td><td>GEL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>6; 100; 400; 80MG</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>RELENZA</td><td>ZANAMIVIR</td><td>2002/7.13/4029</td><td>02/08/2002</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>GLAXO-WELCOME PRODUCTION;  </td><td>GLAXO-WELLCOME ZIMBABWE PVT LTD</td><td>GLAXO GROUP LTD</td>
	</tr><tr>
		<td>RELESTAT</td><td>EPINASTINE HYDROCHLORIDE</td><td>2014/19.9/4899</td><td>05/24/2014</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2 /5 MG/ML</td><td>ALLERGAN PHARMACEUTICALS;  </td><td>ABBVIE PTY LTD</td><td>ABBVIE PTY LTD</td>
	</tr><tr>
		<td>REMETHAN 25 EC</td><td>DICLOFENAC SODIUM</td><td>99/3.1/3620</td><td>11/02/1999</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>REMEVIA-100</td><td>SITAGLIPTIN</td><td>2024/17.7/6770</td><td>11/19/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>REMEVIA-50</td><td>SITAGLIPTIN</td><td>2024/17.7/6769</td><td>11/19/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>RENNIMED 10</td><td>ENALAPRIL MALEATE</td><td>2005/12.3.5/4400</td><td>11/15/2005</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>RENNIMED 20</td><td>ENALAPRIL MALEATE</td><td>2005/12.3.5/4401</td><td>11/15/2005</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>REPARIL-GEL</td><td>AESCIN; DIETHYLAMINE SALICYLATE</td><td>79/14.19/1256</td><td>08/08/1979</td><td>12/31/2027</td><td>GEL</td><td>PHARMACY MEDICINES (P.)</td><td>1; 5G</td><td>MADAUS DR &amp; CO;  PHARMASPEC CONSULTING LABORATORIES;  </td><td>VIATRIS SOUTH AFRICA (PVT) LTD</td><td>XIXIA PHARMACEUTICALS (PTY) LTD</td>
	</tr><tr>
		<td>RETROVIR S</td><td>ZIDOVUDINE</td><td>99/7.13/3555</td><td>06/17/1999</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/5ML</td><td>GLAXOSMITHKLINE INC;  GLAXO WELLCOME OPERATIONS;  </td><td>GLAXOSMITHKLINE ZIMBABWE (PVT) LTD</td><td>GLAXO GROUP LTD</td>
	</tr><tr>
		<td>REVAC-B</td><td>HEPATITIS B SURFACE ANTIGEN</td><td>2019/18.2/4087</td><td>12/18/2002</td><td>12/31/2027</td><td>LIQUID</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MCG/ML</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED;  </td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td>
	</tr><tr>
		<td>REVELOL-XL-50</td><td>METOPROLOL SUCCINATE</td><td>2013/12.3.2/4802</td><td>09/24/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>47.50 MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LIMITED</td><td>IPCA LABS LTD</td>
	</tr><tr>
		<td>REVOKE 1.5</td><td>LEVONORGESTREL</td><td>2014/21.2.2.2/4929</td><td>09/04/2012</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>1.50 MG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>REVOKE 72</td><td>LEVONORGESTREL</td><td>2014/21.2.2/4930</td><td>09/17/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>750 MCG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>REXAZONE</td><td>DEXAMETHASONE</td><td>2020/17.1/6006</td><td>06/25/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>8MG</td><td>RAFARM S.A;  </td><td>HAEMPHARMA PTY LTD</td><td>HAEMPHARMA PTY LTD</td>
	</tr><tr>
		<td>REXIGEN</td><td>PROPRANOLOL HYDROCHLORIDE</td><td>78/12.3.2/1101</td><td>06/07/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>REXIGEN</td><td>PROPRANOLOL HYDROCHLORIDE</td><td>78/12.3.2/1102</td><td>06/07/1978</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>RHOCLONE</td><td>ANTI-RHO- D IMMUNOGLOBIN</td><td>2021/18.1/6170</td><td>09/01/2021</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300 MCG</td><td>BHARAT SERUMS &amp; VACCINES LTD;  </td><td>BHARAT SERUMS & VACCINES LTD</td><td>BHARAT SERUMS & VACCINES LTD</td>
	</tr><tr>
		<td>RICOVIR</td><td>TENOFOVIR DISOPROXIL FUMARATE</td><td>2008/7.13/4536</td><td>07/07/2008</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>RICOVIR-EM</td><td>EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2011/7.13/4675</td><td>04/21/2011</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 300MG</td><td>MYLAN LABORATORIES LTD;  MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>RICOVIR-L</td><td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2010/7.13/4653</td><td>12/21/2010</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 300MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>RIDZ-HYOSCINE</td><td>HYOSCINE BUTYLBROMIDE</td><td>2024/16.4/6675</td><td>07/30/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>SUNGLOW LIFE SCIENCE PRIVATE LIMITED;  </td><td>RIDZ PHARMA</td><td>RIDZ PHARMA</td>
	</tr><tr>
		<td>RIFAMPICIN</td><td>RIFAMPICIN</td><td>95/7.3/2941</td><td>06/23/1995</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>RIFAMPICIN AND ISONIAZID</td><td>ISONIAZID; RIFAMPICIN</td><td>2020/7.3/5995</td><td>03/23/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75; 150MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>RIFAMPICIN AND ISONIAZID</td><td>ISONIAZID; RIFAMPICIN</td><td>2008/7.3/4522</td><td>04/10/2008</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75; 150MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>RIFAMPICIN; ISONIAZID</td><td>ISONIAZID; RIFAMPICIN</td><td>2018/7.3/5639</td><td>06/27/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75; 50MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>RIFAMPICIN; ISONIAZID; PYRAZINAMIDE; ETHAMBUTOL HYDROCHLORIDE</td><td>ETHAMBUTOL HYDROCHLORIDE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN</td><td>2019/7.3/5939</td><td>11/08/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>275; 75; 400; 150MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>RIFAMPIN; ISONIAZID; ETHAMBUTOL HYDROCHLORIDE</td><td>ETHAMBUTOL HYDROCHLORIDE; ISONIAZID; RIFAMPICIN</td><td>2019/7.3/5940</td><td>11/08/2019</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>275; 75; 150MG</td><td>LUPIN LIMITED;  </td><td>LUPIN LIMITED </td><td>LUPIN LIMITED </td>
	</tr><tr>
		<td>RIFAPENTINE</td><td>RIFAPENTINE</td><td>2024/7.3/6761</td><td>11/14/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>M/S OXALIS LABS;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>RINAVO</td><td>RITONAVIR</td><td>2011/7.13/4674</td><td>04/21/2011</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>RINGER LACTATE</td><td>RINGER'S LACTATE</td><td>98/23.2.1/3465</td><td>05/13/1999</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.6; 0.04; 0.32; 0.027%</td><td>AUTOSTERILE;  AUTOSTERILE NAMIBIA (PTY) LTD;  </td><td>AUTOSTERILE</td><td>AUTOSTERILE</td>
	</tr><tr>
		<td>RINGER LACTATE ADCOCARE</td><td>RINGER'S LACTATE</td><td>92/23.2.1/2665</td><td>06/24/1992</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5.94G; 0.396G; 0.267G; 3.17G PER 100ML</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM CRITICAL CARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>RINGER LACTATE SOLUTION FRESENIUS</td><td>CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE</td><td>2004/23.2.1/4306</td><td>09/16/2004</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.268; 0.4; 6; 3.25G/1000ML</td><td>INTRAMED (PTY) LTD;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>RINGERS LACTATE INFUSION B. BRAUN</td><td>CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE</td><td>2025/23.2.1/6846</td><td>01/31/2025</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.27; 0.4; 6.0; 3.2 G/1000ML</td><td>B.BRAUN INTERGRATED PHARMACEUTICAL PLANT;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>RINGERS LACTATE INFUSION B. BRAUN</td><td>CALCIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE</td><td>2025/23.2.1/6845</td><td>01/31/2025</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>54/80/1.2/0.64MG/200ML</td><td>B.BRAUN INTERGRATED PHARMACEUTICAL PLANT;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>RIROXATOR 10</td><td>RIVAROXABAN</td><td>2022/10.2/6245</td><td>02/07/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>RIROXATOR 15</td><td>RIVAROXABAN</td><td>2022/10.2/6246</td><td>02/07/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>RIROXATOR 20</td><td>RIVAROXABAN</td><td>2022/10.2/6247</td><td>02/07/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>RISPONSE 1</td><td>RISPERIDONE</td><td>2020/13.2.3/6011</td><td>07/03/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>RISPONSE 2</td><td>RISPERIDONE</td><td>2020/13.2.3/6012</td><td>07/03/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>RITALIN</td><td>METHYLPHENIDATE HYDROCHLORIDE</td><td>91/13.3/2573</td><td>12/19/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>NARCOTIC MEDICINES, (N.)</td><td>10MG</td><td>NOVARTIS PHARMACEUTICAL CORPORATION;  NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA SA;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>RITONAVIR</td><td>RITONAVIR</td><td>2015/7.13/5035</td><td>05/14/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>RIVA 10</td><td>RIVAROXABAN</td><td>2021/10.2/6182</td><td>10/01/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>RIVA 15</td><td>RIVAROXABAN</td><td>2021/10.2/6183</td><td>10/01/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>RIVA 20</td><td>RIVAROXABAN</td><td>2021/10.2/6184</td><td>10/01/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>RIVAMAX 10</td><td>RIVAROXABAN</td><td>2025/10.2/6887</td><td>03/06/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>KARLADE GLOBAL DMCC </td><td>KARLADE GLOBAL DMCC </td>
	</tr><tr>
		<td>RIVAMAX 20</td><td>RIVAROXABAN</td><td>2025/10.2/6888</td><td>03/06/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>KARLADE GLOBAL DMCC </td><td>KARLADE GLOBAL DMCC </td>
	</tr><tr>
		<td>RIVATAS 10</td><td>RIVAROXABAN</td><td>2021/10.2/6192</td><td>10/07/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>RIVATAS 20</td><td>RIVAROXABAN</td><td>2021/10.2/6191</td><td>10/07/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ROBOL -50</td><td>DOXORUBICIN HYDROCHLORIDE</td><td>2015/9.3.2/5099</td><td>10/19/2015</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>ROCEPHIN</td><td>CEFTRIAXONE SODIUM</td><td>84/20.1.1/1401</td><td>10/25/1984</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>HOFFMAN LA ROCHE;  F. HOFFMAN LA ROCHE LTD;  AKACIA HEALTHCARE PTY LTD;  </td><td>ROCHE PRODUCTS (PTY) LTD</td><td>EQUITY PHARM.(PTY) LTD</td>
	</tr><tr>
		<td>ROCETRAX</td><td>CEFTRIAXONE</td><td>2019/7.2.2/5888</td><td>06/24/2019</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>THEON PHARMACEUTICALS LIMITED;  </td><td>THEON PHARMACEUTICAL LIMITED</td><td>THEON PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>ROCETRAX</td><td>CEFTRIAXONE SODIUM</td><td>2017/7.2.2/5404</td><td>08/07/2017</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG/15ML</td><td>THEON PHARMACEUTICAL LTD;  </td><td>THEON PHARMACEUTICAL LIMITED</td><td>THEON PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>ROCETRAX</td><td>CEFTRIAXONE</td><td>2019/7.2.2/5887</td><td>06/24/2019</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>THEON PHARMACEUTICALS LIMITED;  </td><td>THEON PHARMACEUTICAL LIMITED</td><td>THEON PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>RONAPREVE</td><td>CASIRIVIMAB; IMDEVIMAB</td><td>2023/18.1/6475</td><td>08/31/2023</td><td>08/31/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>13332; 13332 MG/11.1ML</td><td>F. HOFFMAN LA ROCHE LTD;  </td><td>ROCHE PRODUCTS</td><td>ROCHE PRODUCTS</td>
	</tr><tr>
		<td>RONAPREVE</td><td>CASIRIVIMAB; IMDEVIMAB</td><td>2023/18.1/6474</td><td>08/31/2023</td><td>08/31/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 300 MG/2.5ML</td><td>GENENTECH INC;  CATALENT INDIANA;  </td><td>ROCHE PRODUCTS</td><td>F. HOFFMAN LA ROCHE LTD</td>
	</tr><tr>
		<td>RONEM</td><td>MEROPENEM</td><td>2017/7.2.5/5365</td><td>04/11/2017</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000 MG</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>RONEM</td><td>MEROPENEM</td><td>2017/7.2.5/5366</td><td>04/11/2017</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>ROPROATE</td><td>SODIUM VALPROATE</td><td>2025/13.1/6900</td><td>03/10/2025</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200 MG/5ML</td><td>ORBIT PHARMACEUTICALS PVT LTD;  </td><td>ROAR PHARMACEUTICALS PVT LTD</td><td>ROAR PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>ROSE WATER</td><td>ROSE OIL</td><td>81/14.19/5857</td><td>10/22/1981</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1ML</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>ROSUVASTATIN-UNICHEM 10</td><td>ROSUVASTATIN CALCIUM</td><td>2024/12.8/6714</td><td>09/30/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ROSUVASTATIN-UNICHEM 20</td><td>ROSUVASTATIN CALCIUM</td><td>2024/12.8/6715</td><td>09/30/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ROSUVASTATIN-UNICHEM 40</td><td>ROSUVASTATIN CALCIUM</td><td>2024/12.8/6716</td><td>09/30/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ROSUVASTATIN-UNICHEM 5</td><td>ROSUVASTATIN CALCIUM</td><td>2024/12.8/6713</td><td>10/03/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5mg</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ROTARIX</td><td>ROTAVIRUS RIX 4414 STRAIN</td><td>2013/18.2/4785</td><td>06/26/2013</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1.5 ML</td><td>GLAXOSMITHKLINE  BIOLOGICALS;  GLAXOSMITHKLINE BIOLOGICALS S. A.;  GLAXOSMITHKLINE BIOLOGICALS;  </td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td>
	</tr><tr>
		<td>ROTAVAC</td><td>ROTAVIRUS, STRAIN 116E</td><td>2023/18.2/6387</td><td>03/17/2023</td><td>03/17/2028</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10^5.0 FFU/0.5ML</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED;  </td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td>
	</tr><tr>
		<td>ROVAS 10</td><td>ROSUVASTATIN</td><td>2015/12.8/4986</td><td>03/02/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10 MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ROVAS 20</td><td>ROSUVASTATIN</td><td>2015/12.8/4985</td><td>02/19/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20 MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ROXICAM</td><td>PIROXICAM</td><td>92/3.1/2640</td><td>05/20/1992</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ROXICAM</td><td>PIROXICAM</td><td>92/3.1/2641</td><td>05/20/1992</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ROXITAN 20</td><td>PIROXICAM</td><td>98/3.1/3416</td><td>08/27/1998</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>ROZU 10</td><td>ROSUVASTATIN CALCIUM</td><td>2024/12.8/6559</td><td>02/09/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>ANTIBIOTICE SA;  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>ROZU 20</td><td>ROSUVASTATIN CALCIUM</td><td>2024/12.8/6560</td><td>02/09/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>ANTIBIOTICE SA;  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>ROZU 5</td><td>ROSUVASTATIN CALCIUM</td><td>2024/12.8/6558</td><td>02/09/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>ANTIBIOTICE SA;  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>RUBRAGEL</td><td>ALUMINIUM HYDROXIDE; MAGNESIUM OXIDE</td><td>77/16.1/0932</td><td>07/28/1977</td><td>12/31/2027</td><td>SUSPENSION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>400; 50; 50; 220; 25MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>RUPANASE 10</td><td>RUPATADINE FUMARATE</td><td>2019/5/5768</td><td>01/03/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>J. URIACH &amp; CIA SA;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>RUPANASE JUNIOUR</td><td>RUPATADINE FUMARATE</td><td>2019/5/5767</td><td>01/03/2019</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG/ML</td><td>ITALFARMACO SA, SAN RAFAEL;  </td><td>INOVA PHARMACEUTICALS PTY LTD</td><td>INOVA PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>RYALTRIS</td><td>OLOPATADINE; MOMETASONE FUROATE</td><td>2024/20.2.6/6602</td><td>05/09/2024</td><td>12/31/2027</td><td>SPRAY, METERED; NASAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 25MCG</td><td>GLENMARK PHARAMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK SPECIALITY S.A</td>
	</tr><tr>
		<td>RYTHROCAPS</td><td>ERYTHROMYCIN STEARATE</td><td>81/7.2.5/1476</td><td>08/18/1981</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>RYTHROCAPS</td><td>ERYTHROMYCIN ETHYLSUCCINATE</td><td>82/7.2.5/1541</td><td>03/15/1982</td><td>12/31/2027</td><td>GRANULE, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>RYTHROCAPS</td><td>ERYTHROMYCIN STEARATE</td><td>87/7.2.5/2065</td><td>03/20/1987</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>RYTHROCAPS</td><td>ERYTHROMYCIN ETHYLSUCCINATE</td><td>82/7.2.5/1540</td><td>03/13/1982</td><td>12/31/2027</td><td>GRANULE, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>RYZODEG FLEXTOUCH</td><td>INSULIN ASPART; INSULIN DEGLUDEC</td><td>2018/17.6/5696</td><td>09/14/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>180; 420NMOLE</td><td>NOVO-NORDISK A/S;  </td><td>NOVO-NORDISK A/S</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>SABAX FUROSEMIDE</td><td>FUROSEMIDE</td><td>2002/12.5.1/4074</td><td>10/16/2002</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG/2ML</td><td>ADCOCK INGRAM;  DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>SACUVAN 24/26</td><td>SACUBITRIL; VALSARTAN</td><td>2022/12.3.5/6342</td><td>11/04/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>24; 26MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>SACUVAN 49/51</td><td>SACUBITRIL; VALSARTAN</td><td>2022/12.3.5/6343</td><td>11/04/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>49; 51MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>SACUVAN 97/103</td><td>SACUBITRIL; VALSARTAN</td><td>2022/12.3.5/6344</td><td>11/04/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>97; 103MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>SAFERON</td><td>FOLIC ACID; IRON HYDROXIDE</td><td>2003/10.14/4103</td><td>04/03/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500MCG; 100MG</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SAFERON</td><td>IRON III HYDROXIDE POLYMALTOSE COMPLEX</td><td>2002/10.1.4/4054</td><td>07/08/2002</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MG/5ML</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SAFETELMI H</td><td>HYDROCHLOROTHIAZIDE; TELMISARTAN</td><td>2019/12.3.5/5927</td><td>09/17/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 40MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>SALAZOPYRIN</td><td>SULPHASALAZINE</td><td>76/3.3/0815</td><td>12/24/1976</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>PHARMACIA &amp;UPJOHN;  KEMWELL AB BJORKGATAN;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>SALBUTAMOL</td><td>SALBUTAMOL SULPHATE</td><td>89/22.1.1/2285</td><td>07/20/1989</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>4MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>SALINEX</td><td>FUROSEMIDE</td><td>2024/12.5.1/6785</td><td>12/10/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td><td>PHARMACURE DISTRIBUTORS (PVT) LTD</td>
	</tr><tr>
		<td>SAPPHIMOXY 1G</td><td>AMOXYCILLIN TRIHYDRATE; POTASSIUM CLAVULANATE</td><td>2025/7.1.2/6855</td><td>02/04/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>875; 125MG</td><td>MEDOPHARM PRIVATE LTD;  </td><td>PLANET PHARMACEUTICALS & CHEMICAL PVT LTD</td><td>LAXMIRATNA & SAPPHISUN PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>SAPPLAX</td><td>BISACODYL</td><td>2022/16.5.1/6303</td><td>07/06/2022</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>10MG</td><td>SAPPS PHARMACEUTICALS;  </td><td>SAPPS PHARMACEUTICALS</td><td>SAPPS PHARMACEUTICALS</td>
	</tr><tr>
		<td>SAPPS GLYCERINE</td><td>GLYCERINE</td><td>2022/16.5.1/6254</td><td>02/15/2022</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>1.35 GRAM</td><td>SAPPS PHARMACEUTICALS;  </td><td>SAPPS PHARMACEUTICALS</td><td>SAPPS PHARMACEUTICALS</td>
	</tr><tr>
		<td>SAVIBLEED</td><td>TRANEXAMIC ACID</td><td>2025/10.4/6822</td><td>01/15/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>MARCYRL PHARMACEUTICAL INDUSTRIES;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA,</td>
	</tr><tr>
		<td>SAVIBLEED 500MG/5ML</td><td>TRANEXAMIC ACID</td><td>2025/10.4/6823</td><td>01/15/2025</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG/5ML</td><td>SUNNY PHARMACEUTICALS;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA,</td>
	</tr><tr>
		<td>SCABOMA CREAM</td><td>BENZOCAINE; LINDANE</td><td>2003/14.1.5/4215</td><td>11/14/2003</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2; 1%</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SCANLUX </td><td>IOPAMIDOL</td><td>2022/15.2/6333</td><td>10/18/2022</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>370 MG/ML</td><td>SANOCHEMIA PHARMAZEUTIKA AG;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>MDI HEALTHCARE</td><td>TECMED PHARMA (PTY) LTD</td>
	</tr><tr>
		<td>SCANLUX </td><td>IOPAMIDOL</td><td>2022/15.2/6332</td><td>10/18/2022</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300 MG/ML</td><td>SANOCHEMIA PHARMAZEUTIKA AG;  PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>MDI HEALTHCARE</td><td>TECMED PHARMA (PTY) LTD</td>
	</tr><tr>
		<td>SECURE PILL</td><td>NORGESTREL</td><td>2006/21.2.2/4453</td><td>10/25/2006</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.075MG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>SECURE-L</td><td>LEVONORGESTREL</td><td>2017/21.2.2/5361</td><td>04/07/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>0.03 MG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>SEDAFOL</td><td>PROPOFOL</td><td>2023/1.1/6411</td><td>05/24/2023</td><td>05/24/2028</td><td>EMULSIONS; INJECTABLE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>ASPIRO PHARMA LIMITED ;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>SEDOL INJECTION</td><td>ETOPOSIDE</td><td>2013/9.4/4803</td><td>10/29/2013</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG/ 5ML</td><td>VENUS REMEDIES LTD;  </td><td>VENUS REMEDIES LTD</td><td>VENUS REMEDIES LTD</td>
	</tr><tr>
		<td>SEDRONEL 30</td><td>RISEDRONATE SODIUM</td><td>2022/31/6271</td><td>03/18/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>SEDRONEL 35</td><td>RISEDRONATE SODIUM</td><td>2022/31/6272</td><td>03/18/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>35 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>SEDRONEL 5</td><td>RISEDRONATE SODIUM</td><td>2022/31/6270</td><td>03/18/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>SEFIMAX</td><td>CEFEPIME HYDROCHLORIDE</td><td>2023/7.2.2/6522</td><td>12/05/2023</td><td>12/05/2028</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>VENUS REMEDIES LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SEFIXI 1000</td><td>CEFTRIAXONE SODIUM</td><td>2016/7.2.2/5274</td><td>09/15/2016</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>SAKAR HEALTHCARE PVT LTD;  </td><td>SAKAR HEALTHCARE PVT LTD</td><td>SAKAR HEALTHCARE PVT LTD</td>
	</tr><tr>
		<td>SEFTRIAX</td><td>CEFTRIAXONE SODIUM</td><td>2020/7.2.2/6037</td><td>09/15/2020</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1GRAM</td><td>INJECT CARE PARENTERALS PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SELTAVIR 30</td><td>OSELTAMIVIR PHOSPHATE</td><td>2024/7.13/6709</td><td>09/30/2024</td><td>&nbsp;</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>SELTAVIR 45</td><td>OSELTAMIVIR PHOSPHATE</td><td>2024/7.13/6707</td><td>09/30/2024</td><td>&nbsp;</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>45MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>SELTAVIR75</td><td>OSELTAMIVIR PHOSPHATE</td><td>2024/7.13/6708</td><td>09/30/2024</td><td>&nbsp;</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>SEMGLEE</td><td>INSULIN GLARGINE</td><td>2022/17.6/6257</td><td>02/23/2022</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 IU/ML</td><td>BIOCON SDN. BDN (930330);  </td><td>BIOCON SDN. BHD.</td><td>BIOCON SDN. BHD.</td>
	</tr><tr>
		<td>SENSITAMINE</td><td>CHLORPHENIRAMINE MALEATE</td><td>2003/5/4157</td><td>05/27/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>4MG</td><td>SM PHARMACEUTICALS;  </td><td>SM PHARMACEUTICALS</td><td>SM PHARMACEUTICALS</td>
	</tr><tr>
		<td>SEREGRA-100</td><td>SILDENAFIL CITRATE</td><td>2010/31/4644</td><td>09/07/2010</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>BAL PHARMA;  BAL PHARMA LTD;  </td><td>BAL PHARMA</td><td>BAL PHARMA</td>
	</tr><tr>
		<td>SEREGRA-50</td><td>SILDENAFIL CITRATE</td><td>2009/31/4569</td><td>06/24/2009</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>BAL PHARMA;  BAL PHARMA LTD;  </td><td>BAL PHARMA</td><td>BAL PHARMA</td>
	</tr><tr>
		<td>SEROCORT 125 INHALER (CFC FREE)</td><td>FLUTICASONE; SALMETEROL</td><td>2017/22.1.4/5430</td><td>09/18/2017</td><td>12/31/2027</td><td>AEROSOL; INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25; 125MCG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>SEROCORT 250 INHALER (CFC FREE)</td><td>FLUTICASONE PROPIONATE; SALMETEROL</td><td>2017/22.1.1/5338</td><td>02/14/2017</td><td>12/31/2027</td><td>AEROSOL; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25; 250MCG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>SEROQUEL XR 200</td><td>QUETIAPINE FUMARATE</td><td>2016/13.2.3/5233</td><td>07/19/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200 MG</td><td>ASTRA ZENECA PHARMACEUTICALS LP;  </td><td>LUYE PHARMA LIMITED (UK)</td><td>ASTRAZENECA UK LTD</td>
	</tr><tr>
		<td>SEROQUEL XR 300</td><td>QUETIAPINE FUMARATE</td><td>2016/13.2.3/5234</td><td>07/19/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>300 MG</td><td>ASTRA ZENECA PHARMACEUTICALS LP;  </td><td>LUYE PHARMA LIMITED (UK)</td><td>ASTRAZENECA UK LTD</td>
	</tr><tr>
		<td>SEROQUEL XR 50</td><td>QUETIAPINE FUMARATE</td><td>2016/13.2.3/5232</td><td>07/19/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>ASTRA ZENECA PHARMACEUTICALS LP;  </td><td>LUYE PHARMA LIMITED (UK)</td><td>ASTRAZENECA UK LTD</td>
	</tr><tr>
		<td>SEVCAR 400</td><td>SEVELAMER CARBONATE</td><td>2023/23.4/6520</td><td>12/01/2023</td><td>12/01/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SEVCAR 800</td><td>SEVELAMER CARBONATE</td><td>2023/23.4/6521</td><td>12/01/2023</td><td>12/01/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>800MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SEVOFLURANE</td><td>SEVOFLURANE</td><td>2011/1.1/4694</td><td>07/12/2011</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 %</td><td>PIRAMAL CRITICAL CARE INC;  </td><td>PIRAMAL CRITICAL CARE, INC</td><td>PIRAMAL CRITICAL CARE, INC</td>
	</tr><tr>
		<td>SHANCHOL</td><td>VIBRIO CHOLERAE</td><td>2017/18.2/5377</td><td>05/11/2017</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>21000IU</td><td>SHANTHA BIOTECHNICS (PVT) LTD;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>SHEBOX</td><td>MEBENDAZOLE</td><td>2022/7.7/6255</td><td>02/23/2022</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100 MG/5ML</td><td>INTERMED;  </td><td>INTERMED</td><td>INTERMED</td>
	</tr><tr>
		<td>SHRIZINE I</td><td>FLUPHENAZINE DECANOATE</td><td>2011/13.23/4712</td><td>11/18/2011</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>SM PHARMACEUTICALS;  </td><td>SM PHARMACEUTICALS</td><td>SM PHARMACEUTICALS</td>
	</tr><tr>
		<td>S-HYDRO</td><td>HYDROCORTISONE SODIUM SUCCINATE</td><td>2025/17.1/6899</td><td>04/09/2025</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>SWISS PARENTERALS LTD;  </td><td>SWISS PARENTERAL LTD</td><td>SWISS PARENTERAL LTD</td>
	</tr><tr>
		<td>SII BCG VACCINE BP (FREEZE DRIED)</td><td>BACILLUS CALMETTEGUERIN</td><td>2005/18.2/4402</td><td>11/30/2005</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1X10^5; 33X10^5 CFU/0.1ML</td><td>SERUM INSTITUTE OF INDIA PVT LTD;  </td><td>SERUM INSTITUTE OF INDIA PVT LTD</td><td>SERUM INSTITUTE OF INDIA PVT LTD</td>
	</tr><tr>
		<td>SII DIPTHERIA AND TETANUS VACCINE ADSORBED (PAEDIATRIC)</td><td>DIPTHERIA; TETANUS (ADSORBED)</td><td>96/18.2/3101</td><td>05/30/1996</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 12LF/ML</td><td>SERUM INSTITUTE OF INDIA PVT LTD;  </td><td>SERUM INSTITUTE OF INDIA PVT LTD</td><td>SERUM INSTITUTE OF INDIA PVT LTD</td>
	</tr><tr>
		<td>SII DIPTHERIA-TETANUS-PERTUSSIS VACCINE ADSORBED</td><td>DIPTHERIA; PERTUSIS; TETANUS (ADSORBED)</td><td>96/18.2/3100</td><td>05/30/1996</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50LF; 32IOU; 50LF</td><td>SERUM INSTITUTE OF INDIA PVT LTD;  </td><td>SERUM INSTITUTE OF INDIA PVT LTD</td><td>SERUM INSTITUTE OF INDIA PVT LTD</td>
	</tr><tr>
		<td>SII HEPATITIS-B (RDNA) (ADULT)</td><td>HEPATITIS B SURFACE ANTIGEN</td><td>2005/18.1/4395</td><td>09/23/2005</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MCG/ML</td><td>SERUM INSTITUTE OF INDIA PVT LTD;  </td><td>SERUM INSTITUTE OF INDIA PVT LTD</td><td>SERUM INSTITUTE OF INDIA PVT LTD</td>
	</tr><tr>
		<td>SII HEPATITIS-B (RDNA) (PAEDIATRIC)</td><td>HEPATITIS B SURFACE ANTIGEN</td><td>2005/18.1/4394</td><td>09/23/2005</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MCG</td><td>SERUM INSTITUTE OF INDIA PVT LTD;  </td><td>SERUM INSTITUTE OF INDIA PVT LTD</td><td>SERUM INSTITUTE OF INDIA PVT LTD</td>
	</tr><tr>
		<td>SII MEASLES; MUMPS; RUBELLA LIVE ATTENUATED VACCINE</td><td>MEASLES; MUMPS; RUBELLA (LIVE ATTENUATED) </td><td>96/18.2/3104</td><td>05/30/1996</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000; 5000; 1000 CCID50</td><td>SERUM INSTITUTE OF INDIA PVT LTD;  </td><td>SERUM INSTITUTE OF INDIA PVT LTD</td><td>SERUM INSTITUTE OF INDIA PVT LTD</td>
	</tr><tr>
		<td>SII TETANUS TOXOID VACCINE</td><td>TETANUS TOXOID (ADSORBED)</td><td>96/18.2/3102</td><td>05/30/1996</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>12LF/ML</td><td>SERUM INSTITUTE OF INDIA PVT LTD;  </td><td>SERUM INSTITUTE OF INDIA PVT LTD</td><td>SERUM INSTITUTE OF INDIA PVT LTD</td>
	</tr><tr>
		<td>SILBECOR</td><td>SILVER SULFADIAZINE</td><td>98/14.1.2/3422</td><td>09/30/1998</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.01G</td><td>LEK PHARMACEUTICAL &amp; CHEMICAL WORKS;  </td><td>BIOTECH LABS PTY LTD</td><td>LEK PHARMACEUTICAL & CHEMICAL WORKS</td>
	</tr><tr>
		<td>SILOTRIF 4</td><td>SILODOSIN</td><td>2022/21.7/6291</td><td>06/20/2022</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>SILVADEX</td><td>SILVER SULFADIAZINE</td><td>2015/14.1.2/5108</td><td>11/05/2015</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1 %</td><td>GALENTIC PHARMA, PVT LTD;  </td><td>GALENTIC PHARMA (INDIA) PVT LTD</td><td>GALENTIC PHARMA (INDIA) PVT LTD</td>
	</tr><tr>
		<td>SILVER SULPHADIAZINE</td><td>SILVER SULFADIAZINE</td><td>2010/14.1.2/4635</td><td>06/22/2010</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1% W/W</td><td>S KANT HEALTHCARE LTD;  </td><td>SK AGE EXPORTS</td><td>S K AGE EXPORTS</td>
	</tr><tr>
		<td>SILVER SULPHADIAZINE CREAM</td><td>SILVER SULPHADIAZINE </td><td>82/14.1.2/5982</td><td>01/19/1982</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.48%; 0.70%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>SIMBRINZA</td><td>BRINZOLAMIDE; BRIMONIDINE TARTRATE</td><td>2017/19.1/5324</td><td>03/22/2017</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10; 2MG</td><td>ALCON LABORATORIES;  S. A. ALCON-COUVREUR N. V;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>SIMLO-10</td><td>SIMVASTATIN</td><td>2001/12.8/4005</td><td>12/18/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>SIMLO-20</td><td>SIMVASTATIN</td><td>2002/12.8/4057</td><td>07/08/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>IPCA LABS LTD;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>SINUTAB ADULT NASAL SPRAY</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>2023/20.2.4/6526</td><td>12/05/2023</td><td>12/05/2028</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>1MG/ML</td><td>FAMAR ORLEANS;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON &JOHNSON GMBH, JOHNSON &JOHNSON PLATZ</td>
	</tr><tr>
		<td>SINUTAB ADULT NASAL SPRAY ADVANCE</td><td>XYLOMETAZOLINE HCL, DEXPANTHENOL</td><td>2020/20.2.4/6029</td><td>08/27/2020</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>50; 1MG</td><td>FAMAR HEALTH CARE SERVICES MADRID;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>SINUTAB CHILDRENS NASAL SPRAY</td><td>XYLOMETAZOLINE HYDROCHLORIDE</td><td>2023/20.2.4/6525</td><td>12/05/2023</td><td>12/05/2028</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.5MG/ML</td><td>FAMAR ORLEANS;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON &JOHNSON GMBH, JOHNSON &JOHNSON PLATZ</td>
	</tr><tr>
		<td>SINUTAB CHILDRENS NASAL SPRAY ADVANCE</td><td>XYLOMETAZOLINE HCL, DEXPANTHENOL</td><td>2020/20.2.4/6028</td><td>08/27/2020</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>50; 0.5MG</td><td>FAMAR HEALTH CARE SERVICES MADRID;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>SINUTAB SINUS PAIN NON-DROWSY</td><td>PARACETAMOL; PSEUDOEPHEDRINE</td><td>2016/22.2.5/5246</td><td>08/15/2016</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500; 30MG</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>SIRTURO</td><td>BEDAQUILINE</td><td>2021/7.3/6156</td><td>07/27/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>JANSSEN-CILAG INTERNATIONAL NV;  RECIPHARM PHARMASERVICES PRIVATE LIMITED;  </td><td>JANSSEN-CILAG INTERNATIONAL NV</td><td>JANSSEN-CILAG INTERNATIONAL NV</td>
	</tr><tr>
		<td>SITAGLIPTIN</td><td>SITAGLIPTIN</td><td>2024/17.7/6695</td><td>08/29/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50 MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>SITAZUCA 100</td><td>SITAGLIPTIN</td><td>2024/17.7/6696</td><td>08/29/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100 MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>SITAZUCA 25</td><td>SITAGLIPTIN</td><td>2024/17.7/6694</td><td>08/29/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25 MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>SKY PHARM - AZITHROMYCIN</td><td>AZITHROMYCIN</td><td>2014/7.2.5/4901</td><td>06/27/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>SKY PHARMACEUTICALS LTD</td><td>JUBILANT GENERICS SCIENCE LTD</td>
	</tr><tr>
		<td>SKY PHARM - CELECOXIB</td><td>CELECOXIB</td><td>2018/3.1/5617</td><td>05/29/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>KOPRAN LTD;  </td><td>SKY PHARMACEUTICALS LTD</td><td>KOPRAN LTD</td>
	</tr><tr>
		<td>SKY PHARM DAPA 5MG</td><td>DAPAGLIFLOZIN</td><td>2025/17.7/6968</td><td>05/23/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>INVENTIA HEALTHCARE PVT LTD;  </td><td>ADVENTURA INVESTMENTS LTD</td><td>INVENTIA HEALTHCARE PVT LTD</td>
	</tr><tr>
		<td>SKY PHARM- ESOMEPRAZOLE </td><td>ESOMEPRAZOLE MAGNESIUM</td><td>2018/16.7/5646</td><td>07/09/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>JUBILANT GENERICS LIMITED</td>
	</tr><tr>
		<td>SKY PHARM -NOCTE </td><td>ZOLPIDEM TARTRATE</td><td>2020/13.3/5969</td><td>02/11/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>ATHENA DRUG DELIVERY SOLUTIONS;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED</td>
	</tr><tr>
		<td>SKY PHARM- OTRIMIST</td><td>SODIUM CHLORIDE</td><td>2021/20.2.6/6186</td><td>10/06/2021</td><td>12/31/2027</td><td>SOLUTION/DROPS; NASAL</td><td>PHARMACY MEDICINES (P.)</td><td>0.65%W/V</td><td>MERIDIAN ENTERPRISES PVT LTD ;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>MERIDIAN ENTERPRISES PVT LTD </td>
	</tr><tr>
		<td>SKY PHARM- VALSARTAN</td><td>VALSARTAN</td><td>2019/12.3.5/5839</td><td>05/21/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>JUBILANT GENERICS SCIENCE LTD</td>
	</tr><tr>
		<td>SKY PHARMA DAPA 10MG</td><td>DAPAGLIFLOZIN</td><td>2025/17.7/6810</td><td>01/10/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>INVENTIA HEALTHCARE PVT LTD;  </td><td>ADVENTURA INVESTMENTS LTD</td><td>INVENTIA HEALTHCARE PVT LTD</td>
	</tr><tr>
		<td>SKY PHARM-DICLOFENAC </td><td>DICLOFENAC SODIUM</td><td>2018/14.15/5621</td><td>05/29/2018</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>MERIDIAN ENTERPRISES PVT LTD;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>MERIDIAN ENTERPRISES PVT LTD</td>
	</tr><tr>
		<td>SKY PHARM-FEXO</td><td>FEXOFENADINE HYDROCHLORIDE</td><td>2018/5/5679</td><td>08/29/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>120MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>SKY PHARM-MET ER</td><td>METFORMIN HYDROCHLORIDE</td><td>2021/17.7/6087</td><td>01/22/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1000MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SKY PHARM-ROSUVASTATIN 10</td><td>ROSUVASTATIN CALCIUM</td><td>2019/12.8/5775</td><td>01/31/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>SKY PHARM-ROSUVASTATIN 20</td><td>ROSUVASTATIN CALCIUM</td><td>2019/12.8/5776</td><td>01/31/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>SKY PHARM-TADA 10MG</td><td>TADALAFIL</td><td>2018/21.8/5527</td><td>01/11/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SKY PHARM-TADA 20MG</td><td>TADALAFIL</td><td>2018/21.8/5528</td><td>01/11/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SKY PHARM-VALSARTAN</td><td>VALSARTAN</td><td>2019/12.3.5/5835</td><td>05/16/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>160MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>ADVENTURA INVESTMENTS LIMITED</td><td>JUBILANT GENERICS LIMITED</td>
	</tr><tr>
		<td>SKY-ZOLMITRIPTAN</td><td>ZOLMITRIPTAN</td><td>2018/8/5667</td><td>08/08/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>SKY PHARMACEUTICALS LTD</td><td>JUBILANT GENERICS SCIENCE LTD</td>
	</tr><tr>
		<td>SMOFKABIVEN EMULSION FOR INFUSION</td><td>GLUCOSE; AMINO ACIDS</td><td>2017/25.1/5500</td><td>12/13/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>42; 10; 20%</td><td>FRESENIUS KABI AB;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>SMOFKABIVEN PERIPHERAL EMULSION FOR INFUSION</td><td>GLUCOSE; AMINO ACIDS</td><td>2017/25.1/5501</td><td>12/13/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>13; 10; 20%</td><td>FRESENIUS KABI AB;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>SMONIL ER</td><td>BUPROPION HYDROCHLORIDE</td><td>2025/13.2.1/6837</td><td>01/24/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>SODIUM BICARBONATE</td><td>SODIUM BICARBONATE</td><td>2001/23.2.1/3938</td><td>06/29/2001</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>8.4 %W/V</td><td>B.BRAUN MELSUNGEN AG;  </td><td>B.BRAUN MELSUNGEN AG</td><td>B.BRAUN MELSUNGEN AG</td>
	</tr><tr>
		<td>SODIUM BICARBONATE</td><td>SODIUM BICARBONATE</td><td>94/23.2.2/2858</td><td>09/02/1994</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>8.5%</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>SODIUM BICARBONATE FRESENIUS 8.5% INJECTION</td><td>SODIUM BICARBONATE</td><td>2010/23.2.1/4651</td><td>12/20/2010</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>8.5%M/V</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>SODIUM CHLORIDE</td><td>SODIUM CHLORIDE</td><td>98/23.2.1/3468</td><td>07/30/1999</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.9% W/W</td><td>AUTOSTERILE;  </td><td>AUTOSTERILE</td><td>AUTOSTERILE</td>
	</tr><tr>
		<td>SODIUM CHLORIDE (1000ML)</td><td>SODIUM CHLORIDE</td><td>2025/23.2.1/6849</td><td>01/31/2025</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.9%</td><td>B.BRAUN INTERGRATED PHARMACEUTICAL PLANT;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>SODIUM CHLORIDE (100ML)</td><td>SODIUM CHLORIDE</td><td>2025/23.2.1/6847</td><td>01/30/2024</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.9 %</td><td>B.BRAUN INTERGRATED PHARMACEUTICAL PLANT;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>SODIUM CHLORIDE (200ML)</td><td>SODIUM CHLORIDE</td><td>2025/23.2.1/6848</td><td>01/31/2025</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.9%</td><td>B.BRAUN INTERGRATED PHARMACEUTICAL PLANT;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN MEDICAL (PTY) LTD</td>
	</tr><tr>
		<td>SODIUM CHLORIDE 0.9% ADCOCARE</td><td>SODIUM CHLORIDE</td><td>96/23.2.1/3099</td><td>05/29/1996</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PHARMACY MEDICINES (P.)</td><td>0.9%</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM CRITICAL CARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>SODIUM CHLORIDE 0.9% AND DEXTROSE 5%</td><td>DEXTROSE; SODIUM CHLORIDE</td><td>92/23.2.1/2664</td><td>06/24/1992</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.9; 5%</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>SODIUM CHLORIDE FRESENIUS 0.9%</td><td>SODIUM CHLORIDE</td><td>2003/23.2.1/4187</td><td>08/27/2003</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.9%</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>SODIUM CHLORIDE INTRAVENOUS INFUSION</td><td>SODIUM CHLORIDE</td><td>2013/23.2.1/4800</td><td>09/10/2013</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.9 % (W/V)</td><td>ACULIFE HEALTHCARE PRIVATE LTD;  </td><td>ACULIFE HEALTHCARE PRIVATE LTD</td><td>ACULIFE HEALTHCARE PRIVATE LTD</td>
	</tr><tr>
		<td>SODIUM CHLORIDE IV</td><td>SODIUM CHLORIDE</td><td>2017/23.2.1/5329</td><td>02/07/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.9%</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED;  </td><td>GRANITESIDE CHEMICALS (PVT) LTD</td><td>OTSUKA PHARMACEUTICALS INDIA PRIVATE LIMITED</td>
	</tr><tr>
		<td>SOFUDAC</td><td>FUSIDIC ACID</td><td>2017/14.1.1/5405</td><td>08/07/2017</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>GALENTIC PHARMA P/L;  </td><td>GALENTIC PHARMA (INDIA) PVT LTD</td><td>GALENTIC PHARMA (INDIA) PVT LTD</td>
	</tr><tr>
		<td>SOL-CART B</td><td>SODIUM HYDROGEN CARBONATE</td><td>2017/23.3.2/5308</td><td>03/22/2017</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>650G OR 760G</td><td>B.BRAUN AVITUM AG;  </td><td>B. BRAUN MEDICAL (PTY) LTD</td><td>B. BRAUN AVITUM AG. SCHWARZENBERGER</td>
	</tr><tr>
		<td>SOLPHYLLEX</td><td>AMMONIUM CHLORIDE; DIPHENYLPYRALINE HYDROCHLORIDE; ETOPHYLLINE; SODIUM CITRATE; THEOPHYLLINE</td><td>76/22.2.5/0695</td><td>09/15/1976</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>720; 8; 10; 300; 100MG/30ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>SOLPHYLLIN</td><td>THEOPHYLLINE; ETOPHYLLINE</td><td>76/22.2.5/0652</td><td>06/01/1976</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>80; 10MG/15ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>SOLU CORTEF</td><td>HYDROCORTISONE SODIUM SUCCINATE</td><td>80/17.1/1635 </td><td>12/10/1982</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/2ML</td><td>PHARMACIA NV/S.A;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PHARMACIA NV/S.A</td>
	</tr><tr>
		<td>SOLUBLE ASPIRIN</td><td>ASPIRIN</td><td>88/2.1/2141</td><td>01/25/1988</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>300MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>SOLUDINE</td><td>POVIDONE IODINE</td><td>2022/14.1.4/6345</td><td>11/04/2022</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>5%W/W</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>SOLUTION GENTIAN VIOLET BPC</td><td>CRYSTAL VIOLET </td><td>82/14.1.4/5875</td><td>01/19/1982</td><td>12/31/2027</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>0.5%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>SPEC OXYTOCIN</td><td>OXYTOCIN</td><td>2013/21.1.1/4804</td><td>10/03/2013</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10 IU</td><td>PANPHARMA GMBH;  </td><td>SPECPHARM (PTY) LTD</td><td>PANPHARMA GMBH</td>
	</tr><tr>
		<td>SPIRONOLACTONE</td><td>SPIRONOLACTONE</td><td>84/12.5.1/1813</td><td>06/12/1984</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>SPIRONOLACTONE</td><td>SPIRONOLACTONE</td><td>2024/12.5.1/6742</td><td>10/25/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>S-PYRIMAC</td><td>PYRIMETHAMINE; SULFADOXINE</td><td>2023/7.5/6471</td><td>08/22/2023</td><td>08/22/2028</td><td>TABLET; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>25; 500MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>STALOMAC 10</td><td>ESCITALOPRAM OXALATE</td><td>2024/13.2.1/6599</td><td>05/07/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>STALOMAC 20</td><td>ESCITALOPRAM OXALATE</td><td>2024/13.2.1/6600</td><td>05/07/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>STAMARIL</td><td>YELLOW FEVER STRAIN 17D VIRUS (LIVE ATTENUATED)</td><td>99/18.2/3637</td><td>12/16/1999</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000LD5</td><td>SANOFI PASTEUR S. A;  SANOFI PASTEUR S. A;  </td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td><td>SANOFI-AVENTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>STAPLEX</td><td>HYDROCHLOROTHIAZIDE</td><td>&nbsp;</td><td>06/03/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>CAPS PVT LTD;  </td><td>CAPS INTERNATIONAL EST</td><td>CAPS INTERNATIONAL EST</td>
	</tr><tr>
		<td>STAPLEX</td><td>HYDROCHLOROTHIAZIDE</td><td>83/12.5.1/1680</td><td>02/24/1983</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>STARVAL-AM 10/160</td><td>AMLODIPINE BESILATE; VALSARTAN</td><td>2017/12.3.5/5316</td><td>03/08/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 160MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>STARVAL-AM 5/160</td><td>AMLODIPINE BESYILATE; VALSARTAN</td><td>2017/12.3.5/5315</td><td>03/08/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 160MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>STATINOR 10</td><td>ROSUVASTATIN</td><td>2018/12.8/5533</td><td>01/25/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10 MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>STATINOR 20</td><td>ROSUVASTATIN</td><td>2018/12.8/5534</td><td>01/25/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20 MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>STATURIC 40</td><td>FEBUXOSTAT</td><td>2025/3.2/6947</td><td>05/07/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>STATURIC 80</td><td>FEBUXOSTAT</td><td>2025/3.2/6948</td><td>05/07/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES LTD</td><td>MSN LABORATORIES LTD</td>
	</tr><tr>
		<td>STATUS</td><td>EPHEDRINE HYDROCHLORIDE; THEOPHYLLINE</td><td>87/22.1.1/2052</td><td>03/26/1987</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>11; 130MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>STERILE PENICILLIN BENZATHINE</td><td>BENZATHINE PENICILLIN</td><td>2012/7.1.1/4753</td><td>10/03/2012</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.4MIU</td><td>KARNATAKA ANTIBIOTICS &amp; PHARMACEUTICALS;  </td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td><td>KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>STERILE POTASSIUM CHLORIDE SOLUTION</td><td>POTASSIUM CHLORIDE</td><td>5/24/528</td><td>12/10/1975</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15%</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAM CRITICAL CARE;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>STERILIZED WATER FORINJECTION</td><td>WATER FOR INJECTION</td><td>2012/23.2.2/4737</td><td>07/12/2012</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>00000</td><td>AMANTA HEALTHCARE LTD;  </td><td>AMANTA HEALTHCARE LTD</td><td>AMANTA HEALTHCARE LTD</td>
	</tr><tr>
		<td>STERNS</td><td>AMMONIUM CHLORIDE; EUCALYPTUS OIL; HONEY;  HOREHOUND; MENTHOL; PINE WHITE COMPOUND EXTRACT; TAR</td><td>76/22.2.5/630</td><td>05/11/1976</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1.15G; 115MG; 6.2G; 0.5G; 68MG; 1G; 33MG</td><td>DATLABS PRIVATE LIMITED;  ADCOCK INGRAMS SA (PTY) LTD;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAMS SA (PTY) LTD</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>STOP ALLERG</td><td>SODIUM CROMOGLYCATE</td><td>2013/19.9/4788</td><td>07/09/2013</td><td>12/31/2027</td><td>LIQUID</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>20MG/ML</td><td>TUBILUX PHARMA S.P.A;  </td><td>ADCOCK INGRAM LIMITED</td><td>GENOP HEALTHCARE (PTY) LTD</td>
	</tr><tr>
		<td>STOPAYNE</td><td>CODEINE PHOSPHATE; PARACETAMOL; PROMETHAZINE HYDROCHLORIDE</td><td>74/2.2/247</td><td>05/16/1974</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5; 120; 6.5MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>STOPAYNE</td><td>CAFFEINE; CODEINE PHOSPHATE; PARACETEMOL; MEPROBAMATE</td><td>74/2.2/0270</td><td>08/12/1974</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>32; 8; 320; 150MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>STREPSILS EUCALYPTUS MENTHOL</td><td>STREPSILS EUCALYPTUS MENTHOL</td><td>96/20.3.5/3170</td><td>10/14/1996</td><td>12/31/2027</td><td>TROCHE/LOZENGE; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1.20; 0.60; 8.0MG</td><td>BOOTS CO PTY LTD;  RECKITT BENKISER HEALTHCARE INTERNATIONAL LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>STREPSILS INTENSIVE</td><td>FLURBIPROFEN</td><td>2014/3.1/4889</td><td>06/11/2014</td><td>12/31/2027</td><td>TROCHE/LOZENGE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>8.75 MG</td><td>RECKITT BENCKISER HEALTHCARE INTERNATIONAL;  </td><td>RECKITT BENKISER PHARMACEUTICALS</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>STREPSILS ORANGE WITH VITAMIN C</td><td>AMYLMETACRESOL; DICHLOROBENZYL ALCOHOL; VITAMIN C</td><td>2025/20.3.5/6844</td><td>01/31/2025</td><td>&nbsp;</td><td>LOZENGES</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>0.6/1.2/33.5/74.9MG</td><td>RECKITT BENCKISER HEALTHCARE INTERNATIONAL;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>STREPSILS ORIGINAL LOZENGES</td><td>AMYLMETACRESOL; DICHLOROBENZYL ALCOHOL</td><td>2024/20.3.5/6741</td><td>10/25/2024</td><td>&nbsp;</td><td>LOZENGES</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>0.6MG/1.2MG</td><td>&nbsp;</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>STREPSILS WITH HONEY AND LEMON</td><td>DICHLORO BENZYL ALCOHOL; AMYLMETACRESOL</td><td>74/20.3.5/0274</td><td>08/20/1974</td><td>12/31/2027</td><td>TROCHE/LOZENGE; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1.2; 0.6MG</td><td>BOOTS CO PTY LTD;  RECKITT BENKISER HEALTHCARE INTERNATIONAL LTD;  </td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td><td>RECKITT BENCKISSER PHARMACEUTICALS PTY LTD</td>
	</tr><tr>
		<td>STREPTOMYCIN</td><td>STREPTOMYCIN SULPHATE</td><td>91/7.2.1/2511</td><td>08/06/1991</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5G</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>STREPTOSOL</td><td>STREPTOMYCIN SULPHATE</td><td>87/7.2.1/2055</td><td>03/26/1987</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5G/15ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>STROM</td><td>TRAMADOL HYDROCHLORIDE</td><td>2021/1.2.1/6185</td><td>10/05/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/ML</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>STUGERON</td><td>CINNARIZINE</td><td>92/12.3.1/2629</td><td>05/06/1992</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>SPECPHARM HOLDINGS PRIVATE LIMITED;  JANSSEN-CILAG SPA;  </td><td>JANSSEN PHARMACEUTICA (PTY) LTD</td><td>JANSSEN PHARMACEUTICA</td>
	</tr><tr>
		<td>SUCCICORT</td><td>HYDROCORTISONE</td><td>2021/17.1/6091</td><td>02/01/2021</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/VIAL</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>SUCCIMED</td><td>METHYL PREDNISOLONE</td><td>2022/17.1/6336</td><td>10/31/2022</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>SUCCIMED</td><td>METHYL PREDNISOLONE</td><td>2022/17.1/6335</td><td>10/31/2022</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>SULFAMETHOXAZOLE ; TRIMETHOPRIM</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>2024/7.2.3/6546</td><td>01/17/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>800; 160MG</td><td>MICRO LABS LIMITED;  MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>2024/7.2.3/6545</td><td>01/17/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400; 80MG</td><td>MICRO LABS LIMITED;  MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>SULPHAMETHOXAZOLE & TRIMETHOPRIM</td><td>SULPHAMETHOXAZOLE; TRIMETHOPRIM</td><td>2005/7.2.3/4363</td><td>03/11/2005</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200; 40MG/5ML</td><td>SM PHARMACEUTICALS;  </td><td>SM PHARMACEUTICALS</td><td>SM PHARMACEUTICALS</td>
	</tr><tr>
		<td>SULPHUR OINTMENT</td><td>SULPHUR</td><td>81/14.5.1/5858</td><td>10/19/1981</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100G</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>SULPHUR OINTMENT BP</td><td>SULPHUR PRECIPITATED</td><td>82/14.1.5/5854</td><td>01/19/1982</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>10%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>SUPAGREL 60</td><td>TICAGRELOR</td><td>2023/10.5/6380</td><td>02/20/2023</td><td>02/20/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>60MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>SUPAGREL 90</td><td>TICAGRELOR</td><td>2023/10.5/6381</td><td>02/22/2023</td><td>02/22/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>90MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>SUPIROCIN</td><td>MUPIROCIN</td><td>2002/7.2.5/4075</td><td>11/01/2002</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2% W/W</td><td>GLENMARK PHARMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICALS LTD</td><td>GLENMARK PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>SUPRADYN</td><td>MULTIVITAMIN; MULTIMINERAL</td><td>76/24.5/728</td><td>09/24/1976</td><td>12/31/2027</td><td>TABLET, EFFERVESCENT; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>&nbsp;</td><td>ROCHE PRODUCTS PTY LTD;  HOFFMAN LA ROCHE;  </td><td>BAYER (PTY) LTD</td><td>HOFFMAN LA ROCHE</td>
	</tr><tr>
		<td>SURGICAL SPIRIT BPC</td><td>ALCOHOL; CASTOR OIL; DIETHYL PHTHALATE; METHY SALICYLATE</td><td>82/14.1.4/5863</td><td>01/19/1982</td><td>12/31/2027</td><td>LIQUID</td><td>PHARMACY MEDICINES (P.)</td><td>100; 2.5; 2.0; 0.3%V/V</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>SURVANTA</td><td>PHOSPHOLIPIDS</td><td>2000/20.1.5/3696</td><td>03/13/2000</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>ABBOTT LABORATORIES;  ABBVIE DEUTSCHLAND GMBH % CO. KG;  ABBOTT LABORATORIES;  </td><td>ABBVIE PTY LTD</td><td>ABBVIE PTY LTD</td>
	</tr><tr>
		<td>SUSTA - K TABLETS</td><td>POTASSIUM CHLORIDE</td><td>78/23.1.2/1015</td><td>02/27/1978</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>600MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>ADCOCK INGRAM LIMITED</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>SUXAMETHONIUM CHLORIDE</td><td>SUXAMETHONIUM CHLORIDE</td><td>2019/1.3/5924</td><td>09/13/2019</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/ML</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA;  </td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td><td>MARTINDALE PHARMACEUTICALS T/A MARTINDALE PHARMA</td>
	</tr><tr>
		<td>SUXAMETHONIUM CHLORIDE FRESENIUS</td><td>SUXAMETHONIUM CHLORIDE</td><td>2003/1.3/4119</td><td>04/16/2003</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG/2ML</td><td>INTRAMED (PTY) LTD;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>SYCOCETAM</td><td>LEVETIRACETAM</td><td>2023/13.1/6454</td><td>08/02/2023</td><td>08/02/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>MARCYRL PHARMACEUTICAL INDUSTRIES;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>SYMBICORT TURBUHALER 160/4.5MCG</td><td>&nbsp;</td><td>2025/22.1.4/6893</td><td>03/06/2025</td><td>03/05/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>ASTRAZENECA AB,;  </td><td>ASTRAZENECA AB,</td><td>ASTRAZENECA AB,</td>
	</tr><tr>
		<td>SYMBICORT TURBUHALER 80/4.5MCG</td><td>&nbsp;</td><td>2025/22.1.4/6892</td><td>03/06/2025</td><td>03/05/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>&nbsp;</td><td>ASTRAZENECA AB,;  </td><td>ASTRAZENECA AB,</td><td>ASTRAZENECA AB,</td>
	</tr><tr>
		<td>SYNOBIOGEN</td><td>&nbsp;</td><td>2025/31/6876</td><td>02/24/2025</td><td>02/23/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>TACROZ FORTE</td><td>TACROLIMUS</td><td>2017/14.19/5474</td><td>11/01/2017</td><td>12/31/2027</td><td>GEL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.0315%</td><td>GLENMARK PHARAMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>TACROZ FORTE</td><td>TACROLIMUS</td><td>2017/14.18/5469</td><td>10/31/2017</td><td>12/31/2027</td><td>GEL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1%</td><td>GLENMARK PHARAMACEUTICALS LTD;  </td><td>GLENMARK PHARMACEUTICAL LIMITED</td><td>GLENMARK PHARMACEUTICAL LIMITED</td>
	</tr><tr>
		<td>TAFIGADO</td><td>TENOFOVIR ALAFENAMIDE FUMARATE</td><td>2018/7.13/5759</td><td>12/17/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>TAGERA FORTE</td><td>SECNIDAZOLE</td><td>2004/7.6/4318</td><td>11/17/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>UNICHEM LABORATORIES LTD;  UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>TALZENNA </td><td>TOLAZOPARIB TOSYLATE</td><td>2022/9.7/6299</td><td>07/06/2022</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.25MG</td><td>EXCELLA GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD</td><td>PFIZER INC</td>
	</tr><tr>
		<td>TALZENNA</td><td>TALAZOPARIB</td><td>2022/9.7/6300</td><td>07/06/2022</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1MG</td><td>EXCELLA GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>TAMOLTRA</td><td>PARACETAMOL; TRAMADOL HYDROCHLORIDE</td><td>2022/2.2/6236</td><td>01/28/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>325; 37.5MG</td><td>KRKA D.D, NOVO MESTO;  </td><td>PHARMA DYNAMICS PTY LTD</td><td>PHARMA DYNAMICS PTY LTD</td>
	</tr><tr>
		<td>TAMSUMAC 0.4</td><td>TAMSULOSIN HYDROCHLORIDE</td><td>2023/12.3.1/6453</td><td>07/31/2023</td><td>07/31/2028</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.4MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>TAPACID</td><td>PANTOPRAZOLE</td><td>2020/16.7/6013</td><td>07/06/2020</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/10ML</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>TARTAR CONTROL LISTERINE ANTISEPTIC</td><td>ALCOHOL; THYMOL; ZINC</td><td>2021/20.3.4/6146</td><td>07/02/2021</td><td>12/31/2027</td><td>SOLUTION, GARGEL; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>4.54ML; 12.78MG; 18.0MG</td><td>JOHNSON &amp; JOHNSON PTY LTD EAST LONDON;  JOHNSON &amp; JOHNSON (PVT) LTD;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>TASIGNA</td><td>NILOTINIB HYDROCHLORIDE MONOHYDRATE</td><td>2015/9.7/4998</td><td>03/13/2015</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200 MG</td><td>NOVARTIS PHARMA STEIN AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>TASIGNA</td><td>NILOTINIB HYDROCHLORIDE MONOHYDRATE</td><td>2015/9.7/4997</td><td>03/12/2015</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150 MG</td><td>NOVARTIS PHARMA STEIN AG;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>TAVIN EM</td><td>EMTRICITABINE; TENOFOVIR DISOPROXIL FUMERATE</td><td>2018/7.13/5551</td><td>01/30/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 200MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>TAZOCIN 4EF</td><td>PIPERACILLIN SODIUM; TAZOBACTAM SODIUM</td><td>2012/7.1.2/4750</td><td>09/10/2012</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4; 0.5G</td><td>WYETH PARENTERALS;  WYETH LEDERLE SPA;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INC</td>
	</tr><tr>
		<td>TAZPEN</td><td>PIPERACILLIN SODIUM; TAZOBACTUM SODIUM</td><td>2018/7.1.2/5718</td><td>10/12/2018</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4; 0.5G</td><td>MYLAN LABORATORIES BETA LACTAM DIVISION;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>TEAR MAX EYE DROPS</td><td>SODIUM CARBOXYMETHYLCELLULOSE</td><td>2018/19.1/5704</td><td>10/01/2018</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5%</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>TEARLIN-0.5%</td><td>CARBOXY METHYL CELLULOSE SODIUM</td><td>2023/19.10. /6438</td><td>07/06/2023</td><td>07/06/2028</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACY MEDICINES (P.)</td><td>0.5 %W/V</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>TEARLIN-1.0%</td><td>CARBOXY METHYL CELLULOSE SODIUM</td><td>2023/19.10. /6439</td><td>07/06/2023</td><td>07/06/2028</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PHARMACY MEDICINES (P.)</td><td>1.0 %W/V</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>TEEJEL</td><td>CHOLINE SALICYLATE</td><td>2022/20.3.2/0773</td><td>11/09/1976</td><td>12/31/2027</td><td>GEL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>87.1MG/G</td><td>FIDELIO HEALTHCARE LIMBURG GMBH;  </td><td>MUNDIPHARMA SOUTH AFRICA (PTY) LTD</td><td>MUNDIPHARMA SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>TEGRETOL</td><td>CARBAMAZEPINE</td><td>90/13.1/2441</td><td>02/07/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>NOVARTIS PHARMA SERVICES AG;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>TEGRETOL 2%</td><td>CARBAMAZEPINE</td><td>92/13.1/2681</td><td>07/16/1992</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG/5ML</td><td>DELPHARM HUNINGUE S.A.S;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>TEGRETOL CR</td><td>CARBAMAZEPINE</td><td>92/13.1/2679</td><td>07/16/1992</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>NOVARTIS FARMA SPA AG;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>TEGRETOL CR 400</td><td>CARBAMAZEPINE</td><td>2014/13.1/4878</td><td>05/13/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS PHARMA S.P.A Y;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>TEICOPLANIN MYLAN</td><td>TEICOPLANIN</td><td>2022/7.2.5/6296</td><td>06/29/2022</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/VIAL</td><td>MYLAN LABORATORIES BETA LACTAM DIVISION;  </td><td>MYLAN LABORATORIES LIMITED (STERILE PRODUCT DIVISION)</td><td>MYLAN LABORATORIES LIMITED (STERILE PRODUCT DIVISION)</td>
	</tr><tr>
		<td>TELAMENT PAEDIATRIC DROPS</td><td>SIMETHICONE</td><td>94/16/2837</td><td>04/21/1994</td><td>12/31/2027</td><td>SOLUTION/DROPS; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5%</td><td>PHARMA-Q (PTY) LTD T/A COSI PHARMACEUTICALS;  </td><td>TIGER  CONSUMER BRANDS</td><td>TIGER  CONSUMER BRANDS</td>
	</tr><tr>
		<td>TELDAY-20</td><td>TELMISARTAN</td><td>2012/12.3.5/4740</td><td>08/10/2012</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>TORRENT PHARMACEUTICALS;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TELDAY-40</td><td>TELMISARTAN</td><td>2012/12.3.5/4741</td><td>08/10/2012</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TELHI 80</td><td>TELMISARTAN</td><td>2017/12.3.5/5399</td><td>07/24/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80 MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>TELI 40</td><td>TELMISARTAN</td><td>2017/12.3.5/5398</td><td>07/24/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>CADILA PHARMACEUTICALS LIMITED;  </td><td>CADILA PHARMACEUTICALS LIMITED</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>TELTAS</td><td>TELMISARTAN</td><td>2017/12.3.5/5396</td><td>07/18/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>TELTAS-40H</td><td>HYDROCHLOROTHIAZIDE; TELMISARTAN</td><td>2018/12.3.5/5546</td><td>01/29/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 40MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICALS LTD</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>TEMORO</td><td>TEMOZOLOMIDE</td><td>2017/9.1.4/5319</td><td>03/08/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>TEMORO</td><td>TEMOZOLOMIDE</td><td>2017/9.1.4/5318</td><td>03/08/2017</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>TENOFOVIR ALAFENAMIDE</td><td>TENOFOVIR ALAFENAMIDE FUMARATE</td><td>2023/7.13/6450</td><td>07/20/2023</td><td>07/20/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>TENOFOVIR ALAFENAMIDE</td><td>TENOFOVIR ALAFENAMIDE FUMARATE</td><td>2023/7.13/6496</td><td>10/26/2023</td><td>10/26/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>TENOFOVIR DISOPROXIL FUMARATE </td><td>TENOFOVIR DISOPROXIL FUMARATE</td><td>2018/7.13/5695</td><td>09/14/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>LAURUS LABS LIMITED;  </td><td>LAURUS LABS LIMITED</td><td>LAURUS LABS LIMITED</td>
	</tr><tr>
		<td>TENOFOVIR DISOPROXIL FUMARATE</td><td>TENOFOVIR DISOPROXIL FUMARATE</td><td>2018/7.13/5575</td><td>03/01/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>STRIDES ARCOLAB LTD;  </td><td>STRIDES ARCOLAB LTD</td><td>STRIDES ARCOLAB LTD</td>
	</tr><tr>
		<td>TENOFOVIR DISOPROXIL FUMARATE TABLETS 300MG</td><td>TENOFOVIR DISOPROXIL FUMARATE</td><td>2013/7.13/4795</td><td>08/23/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300 MG</td><td>HETERO DRUGS LTD;  HETERO DRUGS LTD;  </td><td>HETERO DRUGS LTD</td><td>HETERO DRUGS LTD</td>
	</tr><tr>
		<td>TENOFOVIR DISOPROXIL FUMARATE; LAMIVUDINE; DOLUTEGRAVIR</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2020/7.13/6065</td><td>12/14/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>STRIDES PHARMA SCIENCE LIMITED;  </td><td>STRIDES SHASUN LIMITED </td><td>STRIDES SHASUN LIMITED.</td>
	</tr><tr>
		<td>TENOFOVIR DISOPROXIL FUMERATE</td><td>TENOFOVIR DISOPROXIL FUMARATE</td><td>2015/7.13/5070</td><td>07/10/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300 MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LTD</td><td>MACLEODS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>TENOFOVIR DISOPROXIL FUMURATE; EMITRICITABINE; EFAVIRENZ</td><td>EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2018/7.13/5574</td><td>03/01/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 200; 300MG</td><td>STRIDES ARCOLAB LTD;  </td><td>STRIDES ARCOLAB LTD</td><td>STRIDES ARCOLAB LTD</td>
	</tr><tr>
		<td>TENOLAM</td><td>LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2013/7.13/4794</td><td>08/23/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 300MG</td><td>HETERO DRUGS LTD;  HETERO LABS LIMITED;  </td><td>HETERO DRUGS LTD</td><td>HETERO DRUGS LTD</td>
	</tr><tr>
		<td>TENORIC-50</td><td>ATENOLOL; CHLORTHALIDONE</td><td>2010/12.3.2/4623</td><td>03/29/2010</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>IPCA LABORATORIES LIMITED;  </td><td>IPCA LABORATORIES LTD</td><td>IPCA LABORATORIES LTD</td>
	</tr><tr>
		<td>TENTAVAIR 160MCG</td><td>CICLESONIDE</td><td>2024/22.1.3/6740</td><td>10/28/2024</td><td>&nbsp;</td><td>AEROSOL; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>160MCG</td><td>MDI PHARMA;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>TENTAVAIR 80MCG</td><td>CICLESONIDE</td><td>2024/22.1.3/6739</td><td>10/28/2024</td><td>&nbsp;</td><td>AEROSOL; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MCG</td><td>MDI PHARMA;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>TENUATE DOSPAN</td><td>DIETHYLPROPION HYDROCHLORIDE</td><td>76/16.9.1/713</td><td>09/23/1976</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG</td><td>DOW CHEMICAL AFRICA PTY LTD;  </td><td>ADCOCK INGRAM</td><td>ADCOCK INGRAM</td>
	</tr><tr>
		<td>TENVIR EM</td><td>EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2012/7.13/4727</td><td>04/02/2012</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 200MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>TERBIFIN</td><td>TERBINAFINE HYDROCHLORIDE</td><td>2010/7.1.2/4640</td><td>08/12/2010</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>TERBIFIN</td><td>TERBINAFINE HYDROCHLORIDE</td><td>2011/7.12/4673</td><td>04/15/2011</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1% W/W</td><td>CIPLA LTD;  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>TETRACYCLINE</td><td>TETRACYCLINE HYDROCHLORIDE</td><td>76/19.1.1/577</td><td>01/14/1976</td><td>12/31/2027</td><td>OINTMENT; OPHTHALMIC</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>TETRACYCLINE HYDROCHLORIDE</td><td>TETRACYCLINE HYDROCHLORIDE</td><td>2006/19.1.1/4440</td><td>08/11/2006</td><td>12/31/2027</td><td>OINTMENT; OPHTHALMIC</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>1% W/W</td><td>GALENTIC PHARMA P/L;  </td><td>GALENTIC PHARMA (INDIA) (PVT) LTD</td><td>GALENTIC PHARMA (INDIA) (PVT) LTD</td>
	</tr><tr>
		<td>TEXAMER</td><td>LEVOCETIRIZINE DIHYDROCHLORIDE</td><td>2021/5/6100</td><td>02/16/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>KRKA D.D, NOVO MESTO;  </td><td>PHARMA DYNAMICS PTY LTD</td><td>KRKA D.D, NOVO MESTO</td>
	</tr><tr>
		<td>TG-TOR 10</td><td>ATORVASTATIN CALCIUM</td><td>2005/12.8/4376</td><td>07/20/2005</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>TG-TOR 20</td><td>ATORVASTATIN CALCIUM</td><td>2005/12.8/4377</td><td>07/20/2005</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>THAMTOL</td><td>ETHAMBUTOL HYDROCHLORIDE</td><td>93/7.3/2776</td><td>03/15/1993</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>THEOPHYLLINE</td><td>THEOPHYLLINE</td><td>96/22.1.1/3078</td><td>04/22/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>THERMODOL</td><td>PARACETAMOL</td><td>2018/2.1/5607</td><td>04/30/2018</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1%</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>UNOSOURCE PHARMA LTD</td>
	</tr><tr>
		<td>THRYVE 10</td><td>ARIPIPRAZOLE</td><td>2019/13.2.3/5914</td><td>08/29/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>THRYVE 15</td><td>ARIPIPRAZOLE</td><td>2019/13.2.3/5915</td><td>08/29/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15 MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>THRYVE 5</td><td>ARIPIPRAZOLE</td><td>2019/13.2.3/5911</td><td>08/29/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>NEW AVAKASH INTERNATIONAL</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>TIMOLOL MALEATE</td><td>TIMOLOL</td><td>96/19.10/3126</td><td>07/03/1996</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5% W/V</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>TINY TOT COUGH MIXTURE</td><td>ACETIC ACID; AMMONIUM BICARBONATE; AMMONIA</td><td>77/22.2.5/904</td><td>04/22/1977</td><td>12/31/2027</td><td>MIXTURE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>&nbsp;</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>&nbsp;</td>
	</tr><tr>
		<td>TINY TOT GRIPE WATER</td><td>SODIUM BICARBONATE; DILL OIL</td><td>77/16.1/905</td><td>04/01/1977</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>0.05MG/ML</td><td>WALLACE LABORATORIES PVT LTD;  PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>WALLACE LABORATORIES PVT LTD</td><td>WALLACE LABORATORIES PVT LTD</td>
	</tr><tr>
		<td>TIVICAY</td><td>DOLUTEGRAVIR</td><td>2015/7.13/5021</td><td>04/28/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>GLAXO WELLCOME OPERATIONS;  GLAXO WELCOME S.A;  </td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td>
	</tr><tr>
		<td>TIVICAY</td><td>DOLUTEGRAVIR SODIUM</td><td>2021/7.13/6129</td><td>05/13/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>GLAXO-WELLCOME;  GLAXO WELLCOME OPERATIONS;  </td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td><td>GLAXOSMITHKLINE S.A (PTY) LTD</td>
	</tr><tr>
		<td>TOLVAT 15</td><td>TOLVAPTAN</td><td>2024/12.5.1/6630</td><td>06/06/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>TOLVAT 30</td><td>TOLVAPTAN</td><td>2024/12.5.1/6631</td><td>06/06/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG</td><td>MSN LABORATORIES LTD (FORMULATION DIVISION;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>TOOTHACHE TINCTURE</td><td>CAPSICUM; CLOVE OIL; BENZOIN; STORAX; TOLUBALSAM</td><td>82/20.3.3/5862</td><td>01/19/1982</td><td>12/31/2027</td><td>LIQUID</td><td>PHARMACY MEDICINES (P.)</td><td>2.222; 2.78; 2.78; 1.665; 0.555%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>TOPOTEL </td><td>TOPOTECAN HYDROCHLORIDE</td><td>2008/9.3/4513</td><td>02/08/2008</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG/2.5ML</td><td>FRESENIUS KABI ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>TOPOTEL 4</td><td>TOPOTECAN HYDROCHLORIDE</td><td>2008/9.3/4514</td><td>02/08/2008</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PHARMACY MEDICINES (P.)</td><td>4MG/4ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>TOPRIL-5</td><td>RAMIPRIL</td><td>2007/13.3.5/4511</td><td>12/14/2007</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>TORRENT PHARMACEUTICALS;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TORBAREC-200</td><td>CARBAMAZEPINE</td><td>95/13.1/3000</td><td>10/05/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TORIDIP</td><td>LERCANIDIPINE HYDROCHLORIDE</td><td>2018/12.6/5542</td><td>01/29/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TORIDIP 20</td><td>LERCANIDIPINE HYDROCHLORIDE</td><td>2019/12.6/5904</td><td>08/06/2019</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TORLEVA 250</td><td>LEVETIRACETAM</td><td>2016/13.1/5214</td><td>05/26/2016</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>250 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>TORLEVA 500</td><td>LEVETIRACETAM</td><td>2016/13.1/5213</td><td>05/26/2016</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TORLEVA 750</td><td>LEVETIRACETAM</td><td>2016/13.1/5212</td><td>05/26/2016</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>750 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>TORLOR-90</td><td>TICAGRELOR</td><td>2024/10.5/6686</td><td>08/19/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>90MG</td><td>TORRENT PHARMACEUTICAL LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TORPEZIL 10</td><td>DONEPEZIL HYDROCHLORIDE</td><td>2016/13.10/5200</td><td>04/27/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>TORPEZIL 5</td><td>DONEPEZIL HYDROCHLORIDE</td><td>2016/13.10/5199</td><td>04/27/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5 MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT EXPORTS LTD</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>TORRENT-CAPTOPRIL</td><td>CAPTOPRIL</td><td>2000/12.3.5/3685</td><td>02/29/2000</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TORRENT-LISINOPRIL-10</td><td>LISINOPRIL</td><td>2004/12.9/4272</td><td>05/13/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TORRENT-LISINOPRIL-5</td><td>LISINOPRIL</td><td>2004/12.9/4271</td><td>05/13/2004</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>TORRENT PHARMACEUTICALS LTD;  TORRENT PHARM LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TORRENT-SODIUM VALPROATE</td><td>SODIUM VALPROATE</td><td>96/13.1/3094</td><td>05/23/1996</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>200MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TOSININ 10</td><td>OXYTOCIN</td><td>2019/21.1.1/5841</td><td>05/25/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10IU/ML</td><td>STERIL-GENE LIFE SCIENCES PVT LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>TOZAAR-50</td><td>LOSARTAN POTASSIUM</td><td>2006/12.3.5/4450</td><td>10/09/2006</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TOZAAR-H</td><td>HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM</td><td>2015/12.3.5/5049</td><td>06/17/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50; 12.5MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TRACRIUM</td><td>ATRACURIUM BESYLATE</td><td>84/1.3/1848</td><td>10/10/1984</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>TRAMACETAMOL</td><td>ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE</td><td>2022/2.2/6223</td><td>01/13/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>325; 37.5MG</td><td>RUSAN PHARMA;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>TRAMADIN</td><td>TRAMADOL HYDROCHLORIDE</td><td>2018/2.1/5690</td><td>09/12/2018</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>UNOSOURCE PHARMA LTD</td>
	</tr><tr>
		<td>TRAMADOL; PARACETAMOL</td><td>PARACETAMOL; TRAMADOL HYDROCHLORIDE</td><td>2023/2.2/6405</td><td>05/05/2023</td><td>05/05/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>37.5; 325MG</td><td>ATHENA DRUG DELIVERY SOLUTIONS;  </td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td><td>PHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTD</td>
	</tr><tr>
		<td>TRAMAZOR</td><td>TRAMADOL HYDROCHLORIDE</td><td>2024/2.1/6783</td><td>01/02/2025</td><td>&nbsp;</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50mg/ml</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>ZORWAY EXIM PVT LTD</td><td>ZORWAY EXIM PVT LTD</td>
	</tr><tr>
		<td>TRAMOL</td><td>TRAMADOL HYDROCHLORIDE</td><td>2018/2.1/5560</td><td>02/07/2018</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>TRAMOL-P</td><td>PARACETAMOL; TRAMADOL HYDROCHLORIDE</td><td>2018/2.2/5535</td><td>01/25/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>325; 37.5MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>TRANEX</td><td>TRANEXAMIC ACID</td><td>2022/10.4/6310</td><td>07/25/2022</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG/5ML</td><td>IMMACULATE LIFESCIENCES PVT. LTD. ;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>IMMACULATE LIFESCIENCES PVT. LTD. </td>
	</tr><tr>
		<td>TRANEXAMIC ACID</td><td>TRANEXAMIC ACID</td><td>2024/10.4/6784</td><td>12/06/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG/5ML</td><td>SKYMAP PHARMACEUTICALS PVT LTD;  </td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td>
	</tr><tr>
		<td>TRANSLIPO C VAGINAL CREAM</td><td>CLOTRIMAZOLE</td><td>2025/14.17/6798</td><td>01/06/2025</td><td>&nbsp;</td><td>CREAMS</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>2% W/W</td><td>CENTAUR PHARMACEUTICALS PVT LTD;  </td><td>CENTAUR PHARMACEUTICALS PVT LTD</td><td>CENTAUR PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>TRAVATAN</td><td>TRAVOPROST</td><td>2003/19.5.1/4097</td><td>02/12/2003</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.004%</td><td>S. A. ALCON-COUVREUR N. V;  ALCON CUSI S. E.;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>TRAXOL - 500</td><td>CEFTRIAXONE SODIUM</td><td>2012/7.2.2/4747</td><td>09/06/2012</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>INJECT CARE PARENTERALS PVT LTD;  </td><td>CACHET PHARMACEUTICALS PVT LTD</td><td>CACHET PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>TRAXOL 1000</td><td>CEFTRIAXONE SODIUM</td><td>2012/7.2.2/4748</td><td>09/06/2012</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000 MG</td><td>INJECT CARE PARENTERALS PVT LTD;  </td><td>CACHET PHARMACEUTICALS PVT LTD</td><td>CACHET PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>TRAXOL 250</td><td>CEFTRIAXONE SODIUM</td><td>2012/7.2.2/4746</td><td>09/06/2012</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250 MG</td><td>INJECT CARE PARENTERALS PVT LTD;  </td><td>CACHET PHARMACEUTICALS PVT LTD</td><td>CACHET PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>TRENTOXIMAL</td><td>&nbsp;</td><td>2025/12.9/6907</td><td>04/01/2025</td><td>03/31/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>ROTABIOGEN FOR  PHARMACEUTICAL INVESTMENTS AND CHEMICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>TRESIBA FLEXTOUCH</td><td>INSULIN</td><td>2017/17.6/5490</td><td>12/06/2017</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100IU/ML</td><td>NOVO-NORDISK A/S;  </td><td>NOVO-NORDISK A/S</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>TREZAV</td><td>LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE</td><td>2011/7.13/4678</td><td>04/21/2011</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150; 200; 300MG</td><td>MYLAN LABORATORIES LTD;  MYLAN LAB LTD;  MYLAN LABORATORIES LIMITED;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>TRICHAZOLE</td><td>METRONIDAZOLE</td><td>2006/7.2.5/4438</td><td>07/10/2006</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG/100ML</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>TRICLOFEM</td><td>MEDROXYPROGESTERONE ACETATE</td><td>2022/21.2.3/6295</td><td>06/27/2022</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG/ML  (1ML)</td><td>PT TUNGGAL IDAMAN ABDI;  </td><td>MISSIONPHARMA A/S</td><td>MISSIONPHARMA A/S</td>
	</tr><tr>
		<td>TRIDEP-25</td><td>AMITRIPTYLINE HYDROCHLORIDE</td><td>95/13.2.1/2894</td><td>02/03/1995</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>TRI-DICLOFENAC</td><td>DICLOFENAC SODIUM</td><td>2019/3.1/5823</td><td>04/16/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG/3ML</td><td>M. J. BIOPHARMA;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>TRIEOVID SUPRABIO</td><td>MIXED TOCOTRIENOLS </td><td>2023/24.1.5/6518</td><td>11/21/2023</td><td>11/21/2028</td><td>CAPSULE</td><td>PHARMACY MEDICINES (P.)</td><td>15.38MG; 28.20MG; 6.42MG; 22.90IU; 12.82MG; 5.12MG</td><td>HOVID BERHAD;  </td><td>HOVID BERHAD</td><td>HOVID BERHAD</td>
	</tr><tr>
		<td>TRIEOVID SUPRABIO</td><td>MIXED TOCOTRIENOLS </td><td>2023/24.1.5/6519</td><td>11/21/2023</td><td>11/21/2028</td><td>CAPSULE</td><td>PHARMACY MEDICINES (P.)</td><td>61.25MG; 112.80MG; 25.68MG; 91.60IU; 51.28MG; 20.4</td><td>HOVID BERHAD;  </td><td>HOVID BERHAD</td><td>HOVID BERHAD</td>
	</tr><tr>
		<td>TRIFLUOPERAZINE 5</td><td>TRIFLUOPERAZINE HYDROCHLORIDE</td><td>2004/13.2.3/4273</td><td>06/21/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>TRIOLMESAR</td><td>AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL</td><td>2024/12.3/6680</td><td>07/31/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 12.5; 20.00MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>TRIOLMESAR FORTE 10</td><td>AMLODIPINE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL</td><td>2024/12.3/6681</td><td>07/31/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 12.5; 40MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>TRIVENZ</td><td>EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2016/7.13/5186</td><td>02/19/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600; 300; 300 MG</td><td>HETERO LABS LTD,;  </td><td>ADCOCK INGRAM LIMITED</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>TRUSFLUKS 20</td><td>ESOMEPRAZOLE MAGNESIUM TRIHYDRATE</td><td>2025/16.7/6935</td><td>04/30/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>LEE PHARMA LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>TRUSFLUKS 40</td><td>ESOMEPRAZOLE MAGNESIUM TRIHYDRATE</td><td>2025/16.7/6936</td><td>04/30/2025</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG</td><td>LEE PHARMA LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>TRYPTAL</td><td>AMITRIPTYLINE HYDROCHLORIDE</td><td>88/13.2.1/2189</td><td>08/22/1988</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>TYFLOX-500</td><td>CIPROFLOXACIN</td><td>2009/7.2.5/4565</td><td>06/11/2009</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>AJANTA PHARMA;  </td><td>AJANTA PHARMA</td><td>AJANTA PHARMA</td>
	</tr><tr>
		<td>TYGEPOL</td><td>TIGECYCLINE</td><td>2024/7.2.4/6542</td><td>01/11/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>TYKONIB 100</td><td>IMATINIB MESYLATE</td><td>2021/9.4/6202</td><td>10/28/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>MSN LABORATORIES PRIVATE LIMITED;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>TYKONIB 400</td><td>IMATINIB MESYLATE</td><td>2021/9.4/6201</td><td>10/28/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>400MG</td><td>MSN LABORATORIES PRIVATE LIMITED, FORMULATION DIVISION;  </td><td>MSN LABORATORIES PRIVATE LIMITED</td><td>MSN LABORATORIES PRIVATE LIMITED</td>
	</tr><tr>
		<td>TYPBAR TCV (0.5ML SINGLE DOSE VIAL)</td><td>TYPHOID VACCINE-VI CAPSULAR POLYSACCHARIDE</td><td>2022/18.2/6229</td><td>01/20/2022</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MCG/0.5ML</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED;  </td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td>
	</tr><tr>
		<td>TYPBAR TCV (2.5ML MULTIDOSE VIAL)</td><td>TYPHOID VACCINE-VI CAPSULAR POLYSACCHARIDE</td><td>2022/18.2/6231</td><td>01/20/2022</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MCG/0.5ML</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED;  </td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td>
	</tr><tr>
		<td>TYPBAR TCV (PREFILLED SYRINGE)</td><td>TYPHOID VACCINE-VI CAPSULAR POLYSACCHARIDE</td><td>2022/18.2/6230</td><td>01/20/2022</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MCG/0.5ML</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED;  </td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td><td>BHARAT BIOTECH INTERNATIONAL LIMITED</td>
	</tr><tr>
		<td>TYPHIBEV</td><td>TYPHOID VACCINE-VI CAPSULAR POLYSACCHARIDE</td><td>2022/18.2/6287</td><td>06/03/2022</td><td>12/31/2027</td><td>VACCINE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25 MCG</td><td>M/S BIOLOGICAL E LIMITED;  </td><td>M/S BIOLOGICAL E, LTD</td><td>M/S BIOLOGICAL E, LTD</td>
	</tr><tr>
		<td>ULCER GEL MAX</td><td>SIMETHICONE 30% EMULSION</td><td>2021/16.1/6158</td><td>07/28/2021</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>83.33ML/5ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS (PVT) LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>ULCERAN</td><td>RANITIDINE HYDROCHLORIDE</td><td>2002/16.7/4073</td><td>09/30/2002</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ULCERIN 400</td><td>CIMETIDINE</td><td>2005/16.7/4381</td><td>07/20/2005</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>400MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>ULCERINE 200</td><td>CIMETIDINE</td><td>2005/16.7/4380</td><td>07/20/2005</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>ULCERMED 200MG TABLETS</td><td>CIMETIDINE</td><td>95/16.7/2904</td><td>04/03/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ULCERMED 400MG TABLETS</td><td>CIMETIDINE</td><td>95/16.7/2905</td><td>04/03/1995</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>400MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ULTANE</td><td>SEVOFLURANE</td><td>99/1.1/3580</td><td>08/23/1999</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/250ML</td><td>CENTRAL GLASS CO LTD;  ABBVIE S. R. L;  AESICA QUEENBOROUGH LTD;  </td><td>ABBVIE PTY LTD</td><td>ABBVIE PTY LTD</td>
	</tr><tr>
		<td>ULTIBRO BREEZHALER</td><td>GLYCOPYRRONIUM BROMIDE; INDACATEROL (AS MALEATE)</td><td>2019/22.1.4/5851</td><td>06/05/2019</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>110; 50MCG</td><td>NORVATIS PHARMA AG ;  SIEGFRIED BARBERA S.L ;  </td><td>NORVATIS PHARMA AG </td><td>NORVATIS PHARMA AG </td>
	</tr><tr>
		<td>ULTRACILLIN LA</td><td>BENZATHINE PENICILLIN</td><td>87/7.1.1/2064</td><td>03/20/1987</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.4X10^6 U</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ULTRAVIST 300</td><td>IOPROMIDE</td><td>95/15.2/2983</td><td>08/17/1995</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>623MG/ML</td><td>BAYER AG, BERLIN;  </td><td>BAYER (PTY) LTD</td><td>BAYER PHARM AG</td>
	</tr><tr>
		<td>ULTRAVIST 370</td><td>IOPROMIDE</td><td>95/15.2/2984</td><td>08/17/1995</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>769MG/ML</td><td>BAYER AG, BERLIN;  </td><td>BAYER (PTY) LTD</td><td>BAYER PHARM AG</td>
	</tr><tr>
		<td>UMOXAZOLE</td><td>SULFAMETHOXAZOLE; TRIMETHOPRIM</td><td>2000/7.2.3/3724</td><td>05/17/2000</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>UMEDICA;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>UNICELIB 100</td><td>CELECOXIB</td><td>2004/3.1/4323</td><td>12/13/2004</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>UNICELIB 200</td><td>CELECOXIB</td><td>2004/3.1/4324</td><td>12/13/2004</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>UNICHLOR 25</td><td>CHLORTHALIDONE</td><td>2024/12.5.1/6678</td><td>07/31/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>UNICHLOR 50</td><td>CHLORTHALIDONE</td><td>2024/12.5.1/6679</td><td>07/31/2024</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>UNIDROL 10</td><td>ALFUZOSIN HYDROCHLORIDE</td><td>2024/21.7/6641</td><td>06/07/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>UNIENZYME CMPS</td><td>CHARCOAL ACTIVATED; DIASTASE; NICOTINAMIDE; PAPAIN; SIMETHICONE</td><td>2025/16.8.2/6818</td><td>01/14/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50/75/25/30/20MG16.8</td><td>UNICHEM LABORATORIES LTD;  </td><td>UNICHEM LABORATIES LIMITED</td><td>UNICHEM LABORATIES LIMITED</td>
	</tr><tr>
		<td>UNIGAS</td><td>OXYGEN</td><td>2021/31/6081</td><td>01/14/2021</td><td>12/31/2027</td><td>GAS; INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>93-96%</td><td>UNIGAS P/L;  </td><td>UNIGAS P/L</td><td>UNIGAS P/L</td>
	</tr><tr>
		<td>UNIPILL</td><td>&nbsp;</td><td>2025/21.2.2/6806</td><td>01/10/2025</td><td>01/09/2030</td><td>&nbsp;</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>&nbsp;</td><td>HLL LIFECARE LIMITED;  </td><td>HLL LIFECARE LIMITED</td><td>HLL LIFECARE LIMITED</td>
	</tr><tr>
		<td>UNIPROEX ER 250</td><td>DIVALPROEX SODIUM </td><td>2024/13.1/6607</td><td>05/16/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>UNIPROEX ER 500</td><td>DIVALPROEX SODIUM </td><td>2024/13.1/6608</td><td>05/16/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>UNOKETRO</td><td>KETOROLAC TROMETHAMINE</td><td>2024/3.1/6596</td><td>05/03/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>AKUMS DRUG & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>UNOTATION</td><td>TRANEXAMIC ACID</td><td>2023/10.4/6457</td><td>08/09/2023</td><td>08/09/2028</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>UPERIO</td><td>SACUBITRIL; VALSARTAN</td><td>2018/12.9/5721</td><td>11/01/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>24.3; 25.7MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMA SPA AG;  NOVARTIS SINGAPORE PHARMACEUTICAL MANF PTC LT;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>UPERIO</td><td>SACUBITRIL; VALSARTAN</td><td>2018/12.9/5723</td><td>11/01/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>97.2; 102.8MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMA SPA AG;  NOVARTIS SINGAPORE PHARMACEUTICAL MANF PTC LT;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>UPERIO</td><td>SACUBITRIL; VALSARTAN</td><td>2018/12.9/5722</td><td>11/01/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>48.6; 51.4MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS PHARMA S.P.A Y;  NOVARTIS SINGAPORE PHARMACEUTICAL MANF PTC LT;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>URANTOIN</td><td>NITROFURANTOIN</td><td>81/7.14/5846</td><td>12/29/1981</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>URAZIDE</td><td>AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE</td><td>84/12.5.1/1833</td><td>09/01/1984</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 50MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>URIDIX</td><td>NALIDIXIC ACID</td><td>2000/7.2.5/3799</td><td>11/06/2000</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG/5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>URIDIX</td><td>NALIDIXIC ACID</td><td>2003/7.2.5/4180</td><td>08/04/2003</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>URINORM 80</td><td>FEBUXOSTAT</td><td>2024/3.2/6568</td><td>03/14/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>80MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>UROGRAFIN 60%</td><td>MEGLUMINE AMIDOTRIZOATE; SODIUM AMIDOTRIZOATE</td><td>2018/15.2/5590</td><td>01/20/2009</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.52; 0.08  G/ML</td><td>BERLIMED SA;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>UTRIXONE</td><td>CEFTRIAXONE SODIUM</td><td>2001/7.2.2/3998</td><td>12/05/2001</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1G</td><td>UMEDICA LABORATORIES PVT. LTD;  INJECT CARE PARENTERALS PVT LTD;  </td><td>UMEDICA</td><td>UMEDICA</td>
	</tr><tr>
		<td>UTRIXONE-500</td><td>CEFTRIAXONE SODIUM</td><td>2011/7.2.2/4666</td><td>03/11/2011</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>UMEDICA LABORATORIES PVT. LTD;  INJECTCARE PARENTERALS PVT LTD;  </td><td>UMEDICA LABORATORIES PVT LTD</td><td>UMEDICA LABORATORIES PVT. LTD</td>
	</tr><tr>
		<td>UTROGESTAN</td><td>PROGESTERONE</td><td>95/17.4/2936</td><td>05/12/1995</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>SCHERER RP S.A;  BESINS ISCOVESCO LABORATORIES;  </td><td>MEDI CHALLENGE (PTY) LTD</td><td>BESINS ISCOVESCO LABORATORIES</td>
	</tr><tr>
		<td>UTROGESTAN 200MG</td><td>PROGESTERONE</td><td>2025/17.4/6882</td><td>03/03/2025</td><td>&nbsp;</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>NEXTPHARMA;  CYNDEA PHARMA S.L;  </td><td>MEDI CHALLENGE (Pty) Ltd</td><td>BESINS HEALTHCARE S.A</td>
	</tr><tr>
		<td>VALASAI 1000</td><td>VALACICLOVIR</td><td>2020/7.13/6057</td><td>12/08/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>VALASAI 500</td><td>VALACICLOVIR</td><td>2020/7.13/6056</td><td>12/08/2020</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td><td>INNOVATA PHARMACEUTICALS (PTY) LTD </td>
	</tr><tr>
		<td>VALEMBIC</td><td>AMLODIPINE; VALSARTAN</td><td>2016/12.3.5/5293</td><td>11/02/2016</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 160MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>ALEMBIC PHARMACEUTICALS LIMITED</td><td>ALEMBIC PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>VALMAC A 160/10</td><td>AMLODIPINE BESYILATE; VALSARTAN</td><td>2024/12.3.5/6638</td><td>06/12/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 160MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>VALMAC A 160/5</td><td>AMLODIPINE BESILATE; VALSARTAN</td><td>2024/12.3.5/6637</td><td>06/12/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 160MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>VALMAC H</td><td>HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2021/12.3.5/6150</td><td>07/19/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 80MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>VALMAC H 160</td><td>HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2021/12.3.5/6151</td><td>07/19/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 160MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>VALOID</td><td>CYCLIZINE HYDROCHLORIDE</td><td>2018/16.2/5697</td><td>09/20/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MG</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>VALOID ADULT</td><td>CYCLIZINE HYDROCHLORIDE</td><td>83/16.2/1674</td><td>02/02/1983</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>100MG</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LTD</td>
	</tr><tr>
		<td>VALOID PAEDIATRIC</td><td>CYCLIZINE HYDROCHLORIDE</td><td>83/16.2/1664</td><td>02/02/1983</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MG</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>VALOID PAEDIATRIC</td><td>CYCLIZINE HYDROCHLORIDE</td><td>80/16.2/1334</td><td>05/22/1980</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>12.5MG/ML</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>VALOSAR</td><td>LOSARTAN</td><td>2017/12.3.5/5332</td><td>03/06/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VALOSAR</td><td>LOSARTAN</td><td>2017/12.3.5/5333</td><td>02/07/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VALOSAR-H</td><td>HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM</td><td>2020/12.3.5/6016</td><td>07/20/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 50MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VALOSAR-H</td><td>HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM</td><td>2020/12.3.5/6015</td><td>07/20/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25; 100MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VALOVIR</td><td>VALACICLOVIR</td><td>2012/7.13/4726</td><td>03/22/2012</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>HETERO DRUGS LTD;  HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>VALPLUS 10+</td><td>AMLODIPINE BESYLATE; VALSARTAN</td><td>2024/12.3.5/6590</td><td>04/22/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 160MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>KARLADE GLOBAL DMCC </td><td>KARLADE GLOBAL DMCC </td>
	</tr><tr>
		<td>VALPLUS 5+</td><td>AMLODIPINE BESILATE; VALSARTAN</td><td>2024/12.3.5/6589</td><td>04/22/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 100MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>KARLADE GLOBAL DMCC </td><td>KARLADE GLOBAL DMCC </td>
	</tr><tr>
		<td>VALSAR 160</td><td>VALSARTAN</td><td>2015/12.3.5/5090</td><td>10/05/2015</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>160 MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>VALSAR HT 160/25</td><td>HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2023/12.3.5/6432</td><td>06/30/2023</td><td>06/30/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25; 160MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>VALSAR HT 80/12.5</td><td>HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2023/12.3.5/6431</td><td>06/30/2023</td><td>06/30/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80; 12.5MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>VALSARTAN</td><td>VALSARTAN</td><td>2021/12.3.5/6107</td><td>03/19/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA SA;  NOVARTIS PHARMA PRODUCTIONS GMGH;  SOLVIAS AG;  SANDOZ S.R.L;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>VALSARTAN</td><td>VALSARTAN</td><td>2021/12.3.5/6108</td><td>03/19/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>160MG</td><td>SANDOZ S.R.L;  SOLVIAS AG;  NOVARTIS PHARMA SERVICES AG;  NOVARTIS FARMACEUTICA S.A;  NOVARTIS PHARMA PRODUCTIONS GMGH;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>VALVASC 10/160</td><td>AMLODIPINE; VALSARTAN</td><td>2017/12.3.5/5442</td><td>10/11/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 160MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>VALVASC 5/160</td><td>AMLODIPINE; VALSARTAN</td><td>2017/12.3.5/5441</td><td>10/11/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 160MG</td><td>ALEMBIC PHARMACEUTICALS LIMITED (FORMULATION DIVISION);  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>VALZAAR-H</td><td>HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2014/12.3.5/4941</td><td>10/15/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 80MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT EXPORTS LTD</td>
	</tr><tr>
		<td>VALZAAR-H</td><td>HYDROCHLOROTHIAZIDE; VALSARTAN</td><td>2014/12.3.5/4942</td><td>10/15/2014</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>12.5; 160MG</td><td>TORRENT PHARMACEUTICALS LTD;  </td><td>TORRENT PHARMACEUTICALS</td><td>TORRENT PHARMACEUTICALS</td>
	</tr><tr>
		<td>VANCOMYCIN HYDROCHLORIDE</td><td>VANCOMYCIN HYDROCHLORIDE</td><td>2015/7.2.5/5138</td><td>12/15/2015</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG</td><td>AGILA SPECIAL PVT LTD;  MYLAN LABS LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>VANCONEX</td><td>VANCOMYCIN HYDROCHLORIDE</td><td>2019/7.2.5/5785</td><td>02/22/2019</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1GRAM</td><td>VENUS REMEDIES LTD;  </td><td>INNOVATA PHARMACEUTICALS LTD</td><td>INNOVATA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>VANMYCETIN</td><td>CHLORAMPHENICOL</td><td>2023/19.1.1/6533</td><td>12/08/2023</td><td>12/08/2028</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.5%W/V</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>VARI-CEPHALEXIN</td><td>CEFALEXIN MONOHYDRATE</td><td>96/7.2.2/3157</td><td>09/25/1996</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARI-CEPHALEXIN</td><td>CEFALEXIN MONOHYDRATE</td><td>96/7.2.2/3158</td><td>09/25/1996</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARICIDE</td><td>POVIDONE IODINE</td><td>95/14.1.4/2957</td><td>07/20/1995</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>7.5% W/V</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARICIDE</td><td>POVIDONE IODINE</td><td>93/14.1.4/2810</td><td>10/27/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>10% M/V</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARICIDE</td><td>POVIDONE IODINE</td><td>93/14.1.4/2809</td><td>09/16/1993</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>10%</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIDREX</td><td>HYDROCHLOROTHIAZIDE</td><td>94/12.5.1/2831</td><td>04/06/1994</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIFLEX</td><td>THEOPHYLLINE; ETOPHYLLINE; AMMONIUM CHLORIDE; DIPHENYLPYRALINE HYDROCHLORIDE</td><td>2002/22.25/4037</td><td>02/20/2002</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100; 10; 720; 8MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIGESIC</td><td>CODEINE PHOSPHATE; CAFFEINE; MEPROBAMATE; PARACETAMOL</td><td>2002/4.1/4031</td><td>02/08/2002</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>NARCOTIC MEDICINES, (N.)</td><td>300; 30; 150; 8MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIGLYBEN</td><td>GLIBENCLAMIDE</td><td>92/17.7/2598</td><td>03/16/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARI-HYDRASALTS</td><td>ORAL REHYDRATION SALT</td><td>2013/23.1.1/4771</td><td>03/25/2013</td><td>12/31/2027</td><td>POWDER, SOLUBLE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>13.5; 2.6; 1.5; 2.9G</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARI-HYDRASALTS ORANGE</td><td>DEXTROSE ANHYDROUS; SODIUM CHLORIDE; POTASSIUM CHLORIDE; TRISODIUM CITRATE DIHYDRATE</td><td>2016/23.1.1/5237</td><td>08/02/2016</td><td>12/31/2027</td><td>POWDER; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>13.5; 2.5; 1.5; 2.9 G/L</td><td>SMITHKLINE BEECHAM;  VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIPAN</td><td>PARACETAMOL</td><td>92/2.1/2617</td><td>04/28/1992</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIPAN</td><td>PARACETAMOL</td><td>92/2.1/2618</td><td>04/28/1992</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>120MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIPAN PAEDIATRIC</td><td>PARACETAMOL</td><td>2000/2.1/3703</td><td>04/10/2000</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>125MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIPAN SUGAR FREE SYRUP</td><td>PARACETAMOL</td><td>2003/2.1/4152</td><td>05/20/2003</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>120MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIPREX</td><td>PRAZOSIN HYDROCHLORIDE</td><td>88/12.3.1/2222</td><td>11/23/1988</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIPREX</td><td>PRAZOSIN HYDROCHLORIDE</td><td>88/12.3.1/2221</td><td>11/23/1988</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIPREX</td><td>PRAZOSIN HYDROCHLORIDE</td><td>88/12.3.1/2220</td><td>11/23/1988</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARI-PROPRANOLOL</td><td>PROPRANOLOL HYDROCHLORIDE</td><td>96/12.3.2/3167</td><td>10/14/1996</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>40MG </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARISTAN</td><td>MEFENAMIC ACID</td><td>2000/2.1/3761</td><td>08/22/2000</td><td>12/31/2027</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>50MG/5ML</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARISTAN</td><td>MEFENAMIC ACID</td><td>99/2.1/3560</td><td>07/14/1999</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>250MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIVAR</td><td>LAMIVUDINE; ZIDOVUDINE</td><td>2003/7.13/4174</td><td>07/17/2003</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150; 300 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VARIVAR PAEDIATRIC</td><td>LAMIVUDINE; ZIDOVUDINE</td><td>2009/7.13/4575</td><td>11/10/2009</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>30/60 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VAROXA 10</td><td>RIVAROXABAN</td><td>2024/10.2/6634</td><td>06/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>VAROXA 20</td><td>RIVAROXABAN</td><td>2024/10.2/6635</td><td>06/11/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>VASAR</td><td>VALSARTAN</td><td>2017/12.3.5/5391</td><td>07/06/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>80MG</td><td>HETERO LABS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>VAXCEL</td><td>HEPARIN SODIUM</td><td>2018/10.2/5724</td><td>11/01/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5000IU/ML</td><td>KOTRA PHARMA (M) SDN BHD;  </td><td>KOTRA PHARMA (M) SDN BHD</td><td>KOTRA PHARMA (M) SDN BHD</td>
	</tr><tr>
		<td>VENTEZE</td><td>SALBUTAMOL SULPHATE</td><td>93/22.1.1/2763</td><td>01/13/1993</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG/5ML</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  LABORATORIO ALDOUNION, S.A BARONESSA DE MALDA;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>VENTEZE</td><td>SALBUTAMOL SULPHATE</td><td>92/22.1.2/2671</td><td>07/10/1992</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG/ML</td><td>LENNON LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>VENTEZE</td><td>SALBUTAMOL SULPHATE</td><td>92/22.1.2/2736</td><td>10/19/1992</td><td>12/31/2027</td><td>AEROSOL; INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MCG</td><td>LABORATORIO ALDOUNION, S.A BARONESSA DE MALDA;  ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>VENTEZE-2</td><td>SALBUTAMOL SULPHATE</td><td>85/22.1.1/1921</td><td>09/11/1985</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>2MG</td><td>ASPEN SA OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>VENTEZE-4</td><td>SALBUTAMOL SULPHATE</td><td>85/22.1.1/1922</td><td>09/11/1985</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>4MG</td><td>ASPEN SA OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LIMITED</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>VENTOMAC 100</td><td>SALBUTAMOL SULPHATE</td><td>2024/22.1.2/6566</td><td>03/12/2024</td><td>12/31/2027</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MCG</td><td>OXALIS LABS;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>VERCAF</td><td>CEFACLOR</td><td>99/7.2.2/3582</td><td>10/28/1999</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>125MG </td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>VERCAF</td><td>CEFACLOR</td><td>99/7.2.2/3583</td><td>10/28/1999</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG </td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>VERCEF MR</td><td>CEFACLOR</td><td>99/7.2.5/3565</td><td>07/14/1999</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>375MG</td><td>RANBAXY LABS LTD;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>RANBAXY LABS LTD</td>
	</tr><tr>
		<td>VERMOR-15</td><td>MORPHINE SULPHATE</td><td>2022/4.1/6258</td><td>03/08/2022</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>15 MG/ML</td><td>VERVE HUMAN CARE LABORATORIES;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>VERMOX</td><td>MEBENDAZOLE</td><td>78/7.7/1027</td><td>05/01/1978</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>100MG/5ML</td><td>SPECPHARM HOLDINGS PRIVATE LIMITED;  JANSSEN PHARMACEUTICA;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JANSSEN PHARMACEUTICA</td>
	</tr><tr>
		<td>VERMOX</td><td>MEBENDAZOLE</td><td>76/7.7/0608</td><td>04/27/1976</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>100MG</td><td>JOHNSON &amp; JOHNSON (PVT) LTD;  SPECPHARM (PTY) LTD;  JANSSEN-CILAG SPA;  JANSSEN PHARMACEUTICA;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>VERMOX</td><td>MEBENDAZOLE</td><td>91/7.7/2437</td><td>01/24/1991</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>500MG</td><td>SPECPHARM (PTY) LTD;  JOHNSON &amp; JOHNSON (PVT) LTD;  JANSSEN-CILAG SPA;  </td><td>JOHNSON & JOHNSON (PVT) LTD</td><td>JOHNSON & JOHNSON (PVT) LTD</td>
	</tr><tr>
		<td>VERPAT</td><td>PETHIDINE</td><td>2018/4.1/5685</td><td>09/10/2018</td><td>12/31/2027</td><td>SOLUTION</td><td>NARCOTIC MEDICINES, (N.)</td><td>100MG</td><td>VERVE HUMAN CARE LABORATORIES;  </td><td>COSPHARM INVESTMENTS PVT LIMITED</td><td>VERVE HUMAN CARE LABORATORIES</td>
	</tr><tr>
		<td>VERQUVO </td><td>VERICIGUAT</td><td>2022/12.9/6308</td><td>07/25/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>VERQUVO</td><td>VERICIGUAT</td><td>2022/12.9/6309</td><td>07/25/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>VERQUVO 2.5</td><td>VERICIGUAT</td><td>2022/12.9/6307</td><td>07/25/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>VEUPOLIN 150</td><td>PREGABALIN</td><td>2021/13.1/6122</td><td>05/04/2021</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>150MG</td><td>SAI MIRRA INNOPHARM PVT LTD;  </td><td>N2SA LIMITED</td><td>N2SA LIMITED</td>
	</tr><tr>
		<td>VEUPOLIN 75</td><td>PREGABALIN</td><td>2021/13.1/6123</td><td>05/04/2021</td><td>12/31/2027</td><td>CAPSULE</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>75MG</td><td>SAI MIRRA INNOPHARM PVT LTD;  </td><td>N2SA LIMITED</td><td>N2SA LIMITED</td>
	</tr><tr>
		<td>VIACE</td><td>ENAPRIL MALEATE</td><td>2020/12.3.5/6030</td><td>08/31/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>20MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VIACE</td><td>ENALAPRIL MALEATE</td><td>2019/12.3.5/5771</td><td>01/25/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VIACE</td><td>ENALAPRIL MALEATE</td><td>2019/12.3.5/5838</td><td>05/21/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VIAGRA</td><td>SILDENAFIL CITRATE</td><td>2000/21.8/3779</td><td>09/14/2000</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>FAREVA AMBOISE;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>VIAGRA</td><td>SILDENAFIL CITRATE</td><td>2000/21.8/3778</td><td>09/14/2000</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>FAREVA AMBOISE;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>VIAGRA 25</td><td>SILDENAFIL CITRATE</td><td>2021/31/6145</td><td>07/02/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>35.112MG</td><td>FAREVA AMBOISE;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>VIAPHAGE</td><td>METFORMIN HYDROCHLORIDE</td><td>2021/17.7/6080</td><td>01/13/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VIAPHAGE XR</td><td>METFORMIN HYDROCHLORIDE</td><td>2024/17.7/6588</td><td>04/12/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>1000MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VIASALMOL</td><td>SALBUTAMOL SULPHATE</td><td>2024/22.1.2/6701</td><td>09/20/2024</td><td>&nbsp;</td><td>INHALATION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1MG</td><td>MDI PHARMA;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS PVT LTD</td>
	</tr><tr>
		<td>VICTOZA</td><td>LIRAGLUTIDE</td><td>2018/17.14/5710</td><td>10/09/2018</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>6MG/ML</td><td>NOVO-NORDISK A/S;  </td><td>NOVO-NORDISK A/S</td><td>NOVO-NORDISK A/S</td>
	</tr><tr>
		<td>VIDAGLIN</td><td>VILDAGLIPTIN</td><td>2023/17.7/6433</td><td>06/30/2023</td><td>06/30/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED;  </td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td><td>SUN PHARMACEUTICAL INDUSTRIES LIMITED</td>
	</tr><tr>
		<td>VIFEX</td><td>BROMHEXINE HYDROCHLORIDE; GUAIFENESIN; SALBUTAMOL SULPHATE</td><td>2019/22.2.2/5913</td><td>08/23/2019</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>2; 50; 1MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>VIFEX</td><td>SALBUTAMOL SULPHATE</td><td>2024/22.2.5/6703</td><td>09/27/2024</td><td>&nbsp;</td><td>LIQUID; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>1MG;2MG;50MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>VIGAMOX</td><td>MOXIFLOXACIN HYDROCHLORIDE</td><td>2025/19.1.1/6821</td><td>01/14/2025</td><td>12/31/2027</td><td>SUSPENSION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG/5ML</td><td>ALCON-COUVREUR n.v.;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>VILDAGLIPTIN</td><td>VILDAGLIPTIN</td><td>2021/17.7/6109</td><td>03/19/2021</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>NOVARTIS PHARMA STEIN AG;  NOVARTIS FARMACEUTICA SA;  </td><td>NOVARTIS SOUTH AFRICA (PTY) LTD</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>VILDEX</td><td>VILDAGLIPTIN</td><td>2023/17.7/6392</td><td>03/29/2023</td><td>03/29/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>VILDEX</td><td>VILDAGLIPTIN</td><td>2024/17.7/6792</td><td>12/10/2024</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>PULSE PHARMACEUTICALS PVT LTD ;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>VILIP 50</td><td>VILDAGLIPTIN</td><td>2024/17.7/6746</td><td>10/31/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>VINELBINE</td><td>VINORELBINE</td><td>2007/9.3.1/4468</td><td>01/16/2007</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>VINELBINE</td><td>VINORELBINE</td><td>2007/9.3.1/4469</td><td>01/16/2007</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG/ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>VINOSIN</td><td>VANCOMYCIN HYDROCHLORIDE</td><td>2024/7.2.5/6683</td><td>08/08/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1GRAM</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>VINOSIN 500MG</td><td>VANCOMYCIN HYDROCHLORIDE</td><td>2024/7.2.5/6709</td><td>09/30/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>VHB MEDI SCIENCES LIMITED;  </td><td>VHB MEDI SCIENCES LIMITED</td><td>VHB MEDI SCIENCES LIMITED</td>
	</tr><tr>
		<td>VIRADAY</td><td>EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2013/7.13/4792</td><td>08/15/2013</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300; 200; 600MG</td><td>CIPLA LTD;  CIPLA LIMITED;  CIPLA LIMITED (GOA UNIT VII);  </td><td>CIPLA LTD</td><td>CIPLA LTD</td>
	</tr><tr>
		<td>VIRAMED</td><td>ACYCLOVIR</td><td>2006/7.13/4411</td><td>03/09/2006</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>VIRAMED</td><td>ACYCLOVIR</td><td>2005/7.13/4383</td><td>07/20/2005</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>5% W/W</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>VIRAMED</td><td>ACYCLOVIR</td><td>2024/7.13/6788</td><td>12/10/2024</td><td>12/31/2027</td><td>SUSPENSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/5ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS (PVT) LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>VIRATAK</td><td>ACYCLOVIR</td><td>2000/7.13/3841</td><td>11/16/2000</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>5% W/W</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>VIRATAK</td><td>ACYCLOVIR</td><td>2002/7.13/4022</td><td>02/08/2002</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>VIREAD</td><td>TENOFOVIR DISOPROXIL FUMARATE</td><td>2009/7.13/4563</td><td>06/11/2009</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>MEDREICH STERILAB;  DATLABS PRIVATE LIMITED;  PHARMACARE LIMITED;  PATHEON INC;  PATHEON INC.;  PATHEON MANUFACTURING SERVICES LLC;  </td><td>GILEAD SCIENCES INC</td><td>GILEAD SCIENCES INC</td>
	</tr><tr>
		<td>VIROPIL</td><td>DOLUTEGRAVIR; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE</td><td>2021/7.13/6115</td><td>04/01/2021</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50; 300; 300MG</td><td>EMCURE PHARMACEUTICALS LTD;  </td><td>EMCURE PHARMACEUTICALS LTD</td><td>EMCURE PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>VIROSYL</td><td>ACYCLOVIR</td><td>2024/7.13/6575</td><td>03/15/2024</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>5%W/W</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>VISANNE</td><td>DIENOGEST</td><td>2017/21.8/5493</td><td>12/07/2017</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG</td><td>BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>VITALIPID NOVUM ADULT</td><td>VITAMIN A; VITAMIN D2; VITAMIN E; VITAMIN K1</td><td>2020/24.3/6036</td><td>09/15/2020</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.91MG; 15MCG; 0.5MCG;  194.1MCG</td><td>FRESENIUS KABI AB;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>VITALIPID NOVUM INFANT</td><td>VITAMIN A; VITAMIN D2; VITAMIN E; VITAMIN K1</td><td>2020/24.3/6035</td><td>09/15/2020</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>135.3MCG; 1.0MCG; 0.64MG; 20MCG </td><td>FRESENIUS KABI AB;  </td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td><td>FRESENIUS KABI SOUTH AFRICA (PTY) LTD</td>
	</tr><tr>
		<td>VITAMAKS</td><td>MULTIVITAMIN; MULTIMINERAL</td><td>2016/24.5/5229</td><td>06/24/2016</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>5 ML</td><td>S KANT HEALTHCARE LTD;  </td><td>SK AGE EXPORTS</td><td>S KANT HEALTHCARE LTD</td>
	</tr><tr>
		<td>VITAMIN B CO FORTE</td><td>NICOTINAMIDE; PYRIDOXIME HYDROCHLORIDE; THIAMINE HYDROCHLORIDE; RIBOFLAVINE</td><td>81/24.2/1380</td><td>02/25/1981</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>20; 2; 2; 5 MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>ADCOCK INGRAM LIMITED</td>
	</tr><tr>
		<td>VITAMIN B CO.</td><td>VITAMIN B COMPLEX</td><td>2017/24.2/5457</td><td>10/30/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5; 2.5; 25; 5; 2.5MG</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>DATLABS PRIVATE LIMITED</td>
	</tr><tr>
		<td>VITAMIN C</td><td>ASCORBIC ACID</td><td>80/22.1.4/1388</td><td>03/19/1981</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG</td><td>LANCASTER INDUSTRIAL PVT LTD;  </td><td>LANCASTER INDUSTRIAL PVT LTD</td><td>LANCASTER GROUP</td>
	</tr><tr>
		<td>VITAMIN C</td><td>ASCORBIC ACID</td><td>80/22.1.4/1209</td><td>01/19/1981</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>250MG</td><td>LANCASTER INDUSTRIAL PVT LTD;  </td><td>LANCASTER INDUSTRIAL PVT LTD</td><td>LANCASTER GROUP</td>
	</tr><tr>
		<td>VITCOFOL WITH IRON</td><td>FOLIC ACID; VITAMIN B12</td><td>2023/10.1.4/6412</td><td>05/31/2023</td><td>05/31/2028</td><td>SUSPENSION; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>5MCG; 100G; 0.5MG</td><td>FDC LTD;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>VIVIAN</td><td>DICLOFENAC DIETHYLAMINE</td><td>2015/3.1/5071</td><td>07/28/2015</td><td>12/31/2027</td><td>GEL</td><td>PHARMACY MEDICINES (P.)</td><td>1 % W/W</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>VIVIAN</td><td>DICLOFENAC SODIUM</td><td>2021/19.10. /6092</td><td>02/03/2021</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.1%W/V</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>VIVIAN-25</td><td>DICLOFENAC SODIUM</td><td>2004/3.1/4303</td><td>09/14/2004</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td><td>LINCOLN PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>VOLTAREN</td><td>DICLOFENAC SODIUM</td><td>77/3.1/884</td><td>03/29/1977</td><td>12/31/2027</td><td>SUPPOSITORY; RECTAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>NOVARTIS PHARMA SERVICES AG;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>VOLTAREN</td><td>DICLOFENAC SODIUM</td><td>79/3.1/1207</td><td>01/24/1979</td><td>12/31/2027</td><td>INJECTABLE; INJECTION, AMPOULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75MG/3ML</td><td>NOVARTIS PHARMA STEIN AG;  LEK PHARMACEUTICALS D.D;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>VOLTAREN</td><td>DICLOFENAC SODIUM</td><td>86/3.1/1876</td><td>01/28/1986</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>100MG</td><td>NOVARTIS PHARMACEUTICAL CORPORATION;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>VOLTAREN EC</td><td>DICLOFENAC SODIUM</td><td>75/3.1/530</td><td>09/15/1975</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>25MG</td><td>NOVARTIS PHARMACEUTICAL CORPORATION;  NOVARTIS FARMA SPA AG;  NOVARTIS URUNLERI ;  </td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td><td>NOVARTIS PHARMACEUTICAL CORPORATION</td>
	</tr><tr>
		<td>VOLTAREN EMULGEL</td><td>DICLOFENAC DIETHYLAMINE</td><td>87/3.1/2128</td><td>11/24/1987</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>1%</td><td>GSK CONSUMER HEALTH SA;  NOVARTIS PHARMA PRODUCTIONS GMGH;  </td><td>GSK CONSUMER HEALTH SA</td><td>GSK CONSUMER HEALTH SA</td>
	</tr><tr>
		<td>VOLTFAST 50MG</td><td>&nbsp;</td><td>2025/3.1/6918</td><td>04/11/2025</td><td>04/10/2030</td><td>&nbsp;</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>&nbsp;</td><td>MIPHARM S.P.A;  </td><td>NOVARTIS PHARMA SERVICES AG</td><td>NOVARTIS PHARMA SERVICES AG</td>
	</tr><tr>
		<td>VOLTNEX</td><td>DICLOFENAC SODIUM</td><td>2024/3.1/6540</td><td>01/09/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>75 MG/3ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>NOVO MEDI SCIENCES PVT LTD</td><td>NOVO MEDI SCIENCES PVT LTD</td>
	</tr><tr>
		<td>VOLUVEN</td><td>HYDROXYETHYL STARCH</td><td>2012/11.1/4738</td><td>07/19/2012</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>60G</td><td>FRESENIUS KABI;  FRESENIUS KABI SOUTH AFRICA (PTY) LTD;  FRESENIUS KABI MANUFACTURING S.A PVT LTD,;  </td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td><td>FRESENIUS KABI MANUFACTURING S.A PVT LTD,</td>
	</tr><tr>
		<td>VOMISTAT</td><td>ONDANSETRON HYRODROCHLORIDE</td><td>2020/16.2/6010</td><td>06/30/2020</td><td>12/31/2027</td><td>INJECTABLE; INJECTION, AMPOULE</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG/ML</td><td>LINCOLN PARENTERAL LIMITED;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>VONECIP</td><td>CIPROFLOXACIN LACTATE</td><td>2024/7.2.5/6688</td><td>08/20/2024</td><td>12/31/2027</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/100ML</td><td>AROMA ILAC SANAYI LTD. STI;  </td><td>WMT PHARMACEUTICALS</td><td>POLIFARMA ILAC SAN. VETIC. A.S. </td>
	</tr><tr>
		<td>VOVENIL</td><td>DICLOFENAC SODIUM</td><td>2024/3.1/6529</td><td>05/27/2024</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>AKUMS DRUG & PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>WAKE-UP </td><td>CAFFEINE ALKALOID</td><td>2020/13.7/5971</td><td>02/12/2020</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>75MG</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>KAREN PHARMA PVT LTD</td><td>KAREN PHARMA PVT LTD</td>
	</tr><tr>
		<td>WATER FOR INJECTION</td><td>WATER FOR INJECTION</td><td>92/23.2.2/2656</td><td>05/29/1992</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>WATER FOR INJECTION WITH CHLOROCRESOL</td><td>WATER FOR INJECTION; CHLOROCRESOL</td><td>91/23.02.02/2467</td><td>04/09/1991</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5ML</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>WATER FOR INJECTIONS</td><td>WATER FOR INJECTION</td><td>92/23/2668</td><td>06/24/1992</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1000ML</td><td>DATLABS PRIVATE LIMITED;  </td><td>DATLABS PRIVATE LIMITED</td><td>BAXTER-TRAVENOL LABORATORIES</td>
	</tr><tr>
		<td>WAXFREE</td><td>SODIUM BICARBONATE</td><td>2023/20.1.4/6428</td><td>06/29/2023</td><td>06/29/2028</td><td>SOLUTION</td><td>PHARMACY MEDICINES (P.)</td><td>5 %W/V</td><td>LINCOLN PHARMACEUTICALS;  </td><td>LINCOLN PHARMACEUTICALS LIMITED</td><td>LINCOLN PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>WELQUINE</td><td>LEVOFLOXACIN</td><td>2022/7.2.5/6263</td><td>03/17/2022</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500 MG/100ML</td><td>AKUMS DRUGS &amp; PHARMACEUTICALS LTD;  </td><td>COSPHARM INVESTMENTS</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>WHITE EMBROCATION</td><td>WHITE LINIMENT</td><td>81/14.15/5861</td><td>10/19/1981</td><td>12/31/2027</td><td>LINIMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>250ML</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>WHITFIELDS OINTMENT</td><td>BENZOIC ACID; SALICYLIC ACID</td><td>81/14.1.3/5860</td><td>10/19/1981</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>60; 30G</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>WHITFIELDS OINTMENT</td><td>BENZOIC ACID; SALICYLIC ACID</td><td>82/14.1.3/5977</td><td>01/19/1982</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>60; 30MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>WILCREAS-50</td><td>VILDAGLIPTIN</td><td>2025/17.7/6812</td><td>01/10/2025</td><td>&nbsp;</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>50MG</td><td>MICRO LABS LIMITED;  </td><td>MICRO LABS LIMITED</td><td>MICRO LABS LIMITED</td>
	</tr><tr>
		<td>WINLOMYLON</td><td>NALIDIXIC ACID</td><td>77/7.2.5/841</td><td>02/24/1977</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>500MG</td><td>DATLABS PRIVATE LIMITED;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  ADCOCK INGRAM LTD;  ADCOCK INGRAM LTD;  </td><td>ADCOCK INGRAMS SA (PTY) LTD</td><td>ADCOCK INGRAMS SA (PTY) LTD</td>
	</tr><tr>
		<td>WINPEN</td><td>AMOXICILLIN</td><td>2000/7.1.1/3818</td><td>11/16/2000</td><td>12/31/2027</td><td>CAPSULE; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>CADILA PHARMACEUTICALS LTD;  </td><td>CADILA PHARMACEUTICALS LTD</td><td>CADILA PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>WINTERGREEN OINTMENT</td><td>METHYL SALICYLATE</td><td>81/14.15/5871</td><td>10/19/1981</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500G</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>WOODS GREAT PEPPERMINT CURE G </td><td>GUAIFENESIN</td><td>2020/2.2/6055</td><td>12/08/2020</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100MG/5ML</td><td>WRAPSA (PTY) LTD;  </td><td>KALBE INTERNATIONAL SA</td><td>KALBE INTERNATIONAL SA</td>
	</tr><tr>
		<td>WOODS PEPPERMINT COUGH SYRUP</td><td>MENTHOL; PEPPERMINT OIL</td><td>87/22.2.5/2083</td><td>06/11/1987</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>5MG; 0.036ML/5ML</td><td>WRAPSA (PTY) LTD;  </td><td>PT KALBE FARMA</td><td>PT KALBE FARMA</td>
	</tr><tr>
		<td>WOODS PEPPERMINT COUGH SYRUP FOR CHILDREN</td><td>GUAIFENESIN; PEPPERMINT</td><td>92/22.2.2/2659</td><td>06/04/1992</td><td>12/31/2027</td><td>SYRUP; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>50MG/5ML</td><td>WRAPSA (PTY) LTD;  </td><td>PT KALBE FARMA</td><td>PT KALBE FARMA</td>
	</tr><tr>
		<td>WOODWARDS GRIPE WATER</td><td>SODIUM BICARBONATE; DILL OIL</td><td>79/16.1/1249</td><td>04/30/1979</td><td>12/31/2027</td><td>WATERS, AROMATIC; ORAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>2.5; 50MG/5ML</td><td>ASPEN SA MANUFACTURING OPERATIONS (PTY) LTD;  </td><td>PHARMACARE LTD</td><td>PHARMACARE LIMITED</td>
	</tr><tr>
		<td>WORMED</td><td>ALBENDAZOLE</td><td>2006/7.7/4426</td><td>05/15/2006</td><td>12/31/2027</td><td>SUSPENSION</td><td>PHARMACY MEDICINES (P.)</td><td>100MG/5ML</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD;  </td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td><td>PLUS FIVE PHARMACEUTICALS PVT LTD</td>
	</tr><tr>
		<td>XAFARIV 10</td><td>RIVAROXABAN</td><td>2023/10.2/6376</td><td>02/13/2023</td><td>02/13/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>XAFARIV 15</td><td>RIVAROXABAN</td><td>2023/10.2/6377</td><td>02/13/2023</td><td>02/13/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>XAFARIV 2.5</td><td>RIVAROXABAN</td><td>2023/10.2/6375</td><td>02/13/2023</td><td>02/13/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>XAFARIV 20</td><td>RIVAROXABAN</td><td>2023/10.2/6378</td><td>02/13/2023</td><td>02/13/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED [OTL]</td><td>MYLAN LABORATORIES LIMITED [OTL]</td>
	</tr><tr>
		<td>XAGULANT 2.5</td><td>APIXABAN</td><td>2022/10.2/6313</td><td>07/26/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2.5MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>XAGULANT 5</td><td>APIXABAN</td><td>2022/10.2/6314</td><td>07/26/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>XALACOM</td><td>LATANOPROST; TIMOLOL</td><td>2010/19.10/4604</td><td>03/26/2010</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MCG;5MG/ML</td><td>PFIZER MANUFACTURING;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>XALATAN</td><td>LATANOPROST</td><td>99/19.1.5/3609</td><td>10/25/1999</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MCG/ML</td><td>PFIZER MANUFACTURING;  </td><td>VIATRIS HEALTHCARE (PTY) LTD</td><td>VIATRIS HEADQUARTERS</td>
	</tr><tr>
		<td>XARELTO</td><td>RIVAROXABAN</td><td>2017/10.2/5362</td><td>05/05/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>XARELTO</td><td>RIVAROXABAN</td><td>2017/10.2/5363</td><td>05/05/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>15MG</td><td>BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>XARELTO 20</td><td>RIVAROXABAN</td><td>2017/10.2/5364</td><td>05/05/2017</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20MG</td><td>BAYER HEALTHCARE S.R.L;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>XELJANZ</td><td>TOFACITINIB</td><td>2014/3.3/4956</td><td>12/05/2014</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>5 MG</td><td>PFIZER MANUFACTURING DEUTSCHLAND GMBH;  </td><td>PFIZER LABORATORIES (PTY) LTD, S.A</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>XIFLOBITA</td><td>MOXIFLOXACIN HYDROCHLORIDE</td><td>2024/7.3/6671</td><td>07/22/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100 MG</td><td>MYLAN LAB LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>XYLONOR</td><td>LIGNOCAINE HYDROCHLORIDE; NORADRENALINE ACIDE TARTRATE</td><td>92/1.2.1/2703</td><td>09/01/1992</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>20; 0.025MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>YASMIN PLUS</td><td>DROSPIRENONE; ETHINYLESTRADIOL; LEVOMEFOLATE CALCIUM</td><td>2022/21.2.1/6234</td><td>01/27/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.3MG; 30MCG; 0.451MG</td><td>BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  BAYER AG, BERLIN;  </td><td>BAYER (PTY) LTD</td><td>BAYER PHARM AG</td>
	</tr><tr>
		<td>YASTRA 20</td><td>DROSPIRENONE; ETHINYLESTRADIOL</td><td>2023/21.2.1/6419</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3; 002MG</td><td>CYNDEA PHARMA S.L;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>YASTRA 30</td><td>DROSPERINONE; ETHINYLESTRADIOL</td><td>2023/21.2.1/6420</td><td>06/29/2023</td><td>06/29/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3; 0.03MG</td><td>CYNDEA PHARMA S.L;  </td><td>COSPHARM INVESTMENTS (PTY) LTD</td><td>COSPHARM INVESTMENTS (PTY) LTD</td>
	</tr><tr>
		<td>YAZ</td><td>DROSPERINONE; ETHINYLESTRADIOL</td><td>2018/21.2.1/5585</td><td>03/09/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>3MG; 20MCG</td><td>BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  BAYER AG;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>YAZ PLUS</td><td>DROSPIRENONE; ETHINYLESTRADIOL; LEVOMEFOLATE CALCIUM</td><td>2022/21.2.1/6235</td><td>01/27/2022</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.3MG; 20MCG; 0.451MG</td><td>BAYER WEIMAR GMBH &amp; CO. KG, WEIMAR;  BAYER AG, BERLIN;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>YESOM 40</td><td>ESOMEPRAZOLE SODIUM</td><td>2019/16.7/5943</td><td>11/21/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>40MG/ML</td><td>ASPIRO PHARMA LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>YOMESAN</td><td>NICLOSAMIDE</td><td>2019/7.7/5825</td><td>04/30/2019</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>BAYER OY;  </td><td>BAYER (PTY) LTD</td><td>BAYER AG</td>
	</tr><tr>
		<td>ZAM BUK HERBAL</td><td>CAMPHOR; EUCALYPTUS OIL; SASSAFRAS; THYME OIL</td><td>99/14.15/3597</td><td>09/21/1999</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>100G</td><td>ROCHE PRODUCTS PTY LTD;  ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>BAYER (PTY) LTD</td><td>BAYER CONSUMER CARE AG</td>
	</tr><tr>
		<td>ZEALARGY</td><td>RUPATADINE AS FUMARATE</td><td>2023/5/6464</td><td>08/11/2023</td><td>08/11/2028</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10MG</td><td>CADILA PHARMACEUTICALS LIMITED;  COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM INVESTMENTS PVT LTD</td><td>CADILA PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ZEE 250</td><td>AZITHROMYCIN DIHYDRATE</td><td>2018/7.2.5/5593</td><td>04/04/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>ZEE 500</td><td>AZITHROMYCIN DIHYDRATE</td><td>2018/7.2.5/5592</td><td>04/04/2018</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>ZEE SUSPENSION</td><td>AZITHROMYCIN DIHYDRATE</td><td>2022/7.2.5/6346</td><td>11/15/2022</td><td>12/31/2027</td><td>GRANULES, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/5ML</td><td>WORLD MEDICINE LTD;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>ZEPILEN</td><td>CEFAZOLIN SODIUM</td><td>2024/7.2.2/6544</td><td>01/11/2024</td><td>12/31/2027</td><td>POWDER/INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>1GRAM</td><td>MEDOCHEMIE LTD FACTORY C;  </td><td>MEDOCHEMIE LTD</td><td>MEDOCHEMIE LTD</td>
	</tr><tr>
		<td>ZESTAVAL</td><td>ALBENDAZOLE</td><td>94/7.7/2871</td><td>10/21/1994</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>200MG</td><td>REMEDICA LTD;  </td><td>REMEDICA LTD</td><td>REMEDICA LTD</td>
	</tr><tr>
		<td>ZETAKARDOVAL 10/160</td><td>AMLODIPINE BESILATE; VALSARTAN</td><td>2024/12.3.5/6728</td><td>10/17/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>10; 160MG</td><td>ZETA  PHARMA;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA</td>
	</tr><tr>
		<td>ZETAKARDOVAL 5/160</td><td>AMLODIPINE BESILATE; VALSARTAN</td><td>2024/12.3.5/6727</td><td>10/17/2024</td><td>&nbsp;</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 10TH SCHEDULE,  (P.P.10)</td><td>5; 160MG</td><td>ZETA PHARMA FOR PHARMACEUTICAL INDUSTRIES;  </td><td>ORANGE HEALTH P/L</td><td>INTRAPHARMA,</td>
	</tr><tr>
		<td>ZEXATE</td><td>METHOTREXATE</td><td>2005/9.2.1/4371</td><td>06/07/2005</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>25MG/ML</td><td>DABUR PHARMA LTD(PHARM. DIV.);  FRESENIUS ONCOLOGY LTD;  </td><td>FRESENIUS KABI ONCOLOGY LTD</td><td>FRESENIUS KABI ONCOLOGY LTD</td>
	</tr><tr>
		<td>ZIDOMAT</td><td>ZIDOVUDINE</td><td>2009/7.13/4559</td><td>05/12/2009</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ZIDOVUDINE</td><td>ZIDOVUDINE</td><td>2007/7.13/4485</td><td>04/24/2007</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ZIDOVUDINE</td><td>ZIDOVUDINE</td><td>2018/7.13/5671</td><td>08/09/2018</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/5ML</td><td>AUROBINDO;  </td><td>AUROBINDO PHARMA LIMITED</td><td>AUROBINDO PHARMA LIMITED</td>
	</tr><tr>
		<td>ZIDOVUDINE</td><td>ZIDOVUDINE</td><td>2005/7.13/4334</td><td>01/17/2005</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>300MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ZIDOVUDINE</td><td>ZIDOVUDINE</td><td>2015/7.13/5088</td><td>10/05/2015</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50 MG/ 5ML</td><td>HETERO DRUGS LTD;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ZIDOVUDINE</td><td>ZIDOVUDINE</td><td>2021/7.13/6110</td><td>03/19/2021</td><td>12/31/2027</td><td>LIQUID; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG/5ML</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ZINC AND CASTOR OIL CREAM</td><td>CASTOR OIL; ZINC</td><td>81/14.19/5867</td><td>10/19/1981</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>500; 75G</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>ZINC AND CASTOR OIL OINTMENT BP</td><td>ARACHIS OIL; CASTOR OIL; ZINC OXIDE</td><td>82/14.1.4/5981</td><td>01/19/1982</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>30.5%; 50%; 7.5%</td><td>CAPS PVT LTD;  </td><td>CAPS PVT LTD</td><td>CAPS PVT LTD</td>
	</tr><tr>
		<td>ZINC OXIDE</td><td>ZINC OXIDE</td><td>2016/14.1/5147</td><td>01/06/2016</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>10% W/W</td><td>GALENTIC PHARMA (INDIA) PVT LTD;  </td><td>GALENTIC PHARMA (INDIA) PVT LTD</td><td>GALENTIC PHARMA (INDIA) PVT LTD</td>
	</tr><tr>
		<td>ZINC OXIDE OINTMENT</td><td>ZINC OXIDE</td><td>81/14.19/5856</td><td>10/19/1981</td><td>12/31/2027</td><td>OINTMENT; TOPICAL</td><td>HOUSEHOLD REMEDIES (H.R.)</td><td>150G</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE;  </td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td><td>ZIMBABWE PHARMACEUTICALS HEALTHCARE</td>
	</tr><tr>
		<td>ZINC SULFATE</td><td>ZINC SULPHATE MONOHYDRATE</td><td>2018/16.6/5529</td><td>01/15/2018</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>20MG</td><td>MACLEODS PHARMACEUTICALS LTD;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ZINCHYDRA</td><td>ZINC SULPHATE</td><td>2015/16.6/4979</td><td>02/13/2015</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>40 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ZINCHYDRA ORANGE</td><td>ZINC SULPHATE</td><td>2016/16.6/5238</td><td>08/02/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>55 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ZINCODERM</td><td>ZINC OXIDE</td><td>2024/14.19/6541</td><td>01/12/2024</td><td>12/31/2027</td><td>CREAM; TOPICAL</td><td>PHARMACY MEDICINES (P.)</td><td>32 %W/W</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>ZINCOL</td><td>ZINC SULPHATE</td><td>2013/24.1.1/4776</td><td>05/28/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>20 MG</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD;  </td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td><td>VARICHEM PHARMACEUTICALS (PVT) LTD</td>
	</tr><tr>
		<td>ZINCORAL</td><td>ZINC GLUCONATE</td><td>2024/16.6/6563</td><td>02/27/2024</td><td>12/31/2027</td><td>SYRUP</td><td>PHARMACY MEDICINES (P.)</td><td>20 MG/5ML</td><td>COSPHARM PHARMACEUTICALS;  </td><td>COSPHARM PHARMACEUTICALS</td><td>COSPHARM PHARMACEUTICALS</td>
	</tr><tr>
		<td>ZINNIA P</td><td>ETHINYL ESTRADIOL; LEVONORGESTREL; PLACEBO</td><td>2012/12.2.1/4769</td><td>03/07/2013</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>150; 30MCG</td><td>SENADOR LABORATORIES PRIVATE LIMITED ;  </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td><td>SENADOR LABORATORIES PRIVATE LIMITED </td>
	</tr><tr>
		<td>ZIORAL 20 DT</td><td>ZINC SULPHATE MONOHYDRATE</td><td>2024/16.6/6647</td><td>07/01/2024</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>20MG</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>ZIQUANTA</td><td>PRAZIQUANTEL</td><td>2023/7.7/6451</td><td>07/20/2023</td><td>07/20/2028</td><td>TABLET, COATED; ORAL</td><td>PHARMACIST INITIATED MEDICINES, (P.I.M.)</td><td>600 MG</td><td>HETERO LABS LIMITED;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ZITHROMAX</td><td>AZITHROMYCIN</td><td>2001/7.2.5/3954</td><td>10/03/2001</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>PFIZER;  </td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>ZITHROMAX</td><td>AZITHROMYCIN</td><td>92/7.2.5/2684</td><td>07/28/1992</td><td>12/31/2027</td><td>POWDER, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>200MG/5ML</td><td>HAUPT PHARMA LATINA S.R.L;  </td><td>PHARMACEUTICAL & CHEMICAL DISTRIBUTORS P/L</td><td>PFIZER INCORPORATION</td>
	</tr><tr>
		<td>ZITHROMAX IV</td><td>AZITHROMYCIN</td><td>2010/7.2.5/4647</td><td>09/15/2010</td><td>12/31/2027</td><td>INJECTABLE; IV (INFUSION)</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>500MG</td><td>BEN VENUE LABS INC;  FAREVA AMBOISE;  AMGEN TECHNOLOGY IRELAND;  </td><td>PFIZER SPECIALITIES LTD</td><td>PFIZER SPECIALITIES LTD</td>
	</tr><tr>
		<td>ZMAX</td><td>AZITHROMYCIN</td><td>2010/7.2.5/4603</td><td>03/26/2010</td><td>12/31/2027</td><td>POWDER, FOR SUSPENSION; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2G</td><td>PFIZER PHARMACEUTICALS LLC;  </td><td>PFIZER SPECIALITIES LTD</td><td>PFIZER SPECIALITIES LTD</td>
	</tr><tr>
		<td>ZODOX-50</td><td>DOXORUBICIN HYDROCHLORIDE</td><td>2021/9.3.2/6074</td><td>01/07/2021</td><td>12/31/2027</td><td>SOLUTION; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG/ML</td><td>INTAS PHARMACEUTICALS LIMITED;  INTAS PHARMACEUTICALS LTD;  </td><td>INTAS PHARMACEUTICAL LIMITED</td><td>INTAS PHARMACEUTICALS LTD</td>
	</tr><tr>
		<td>ZOLADEX</td><td>GOSERELIN</td><td>94/9.5.2/2868</td><td>09/16/1994</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3.6MG</td><td>ASTRA ZENECA LIMITED;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>ZOLADEX LA</td><td>GOSERELIN</td><td>2016/9.5.2/5273</td><td>09/15/2016</td><td>12/31/2027</td><td>IMPLANT; SUBCUTANEOUS</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>10.8 MG</td><td>ASTRAZENECA UK LTD;  </td><td>ASTRA ZENECA LIMITED</td><td>ASTRA ZENECA LIMITED</td>
	</tr><tr>
		<td>ZOLDRO</td><td>ZOLEDRONIC ACID</td><td>2019/31/5920</td><td>09/06/2019</td><td>12/31/2027</td><td>INJECTABLE; INJECTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4MG/VIAL</td><td>ASPIRO PHARMA LIMITED;  </td><td>ASPIRO PHARMA LIMITED</td><td>ASPIRO PHARMA LIMITED</td>
	</tr><tr>
		<td>ZOLEDRONIC ACID MYLAN</td><td>ZOLEDRONIC ACID</td><td>2017/9.4/5412</td><td>08/08/2017</td><td>12/31/2027</td><td>SOLUTION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.8MG/ML</td><td>MYLAN LABS LTD;  </td><td>MYLAN LABS LTD</td><td>MYLAN LABS LTD</td>
	</tr><tr>
		<td>ZOLID</td><td>LINEZOLID</td><td>2016/7.2.5/5149</td><td>01/06/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>600 MG</td><td>HETERO LABS LTD,;  </td><td>HETERO LABS LTD</td><td>HETERO LABS LTD</td>
	</tr><tr>
		<td>ZOLOVA 4</td><td>ZOLEDRONIC ACID</td><td>2023/31/6483</td><td>09/27/2023</td><td>09/27/2028</td><td>SOLUTION; INFUSION</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>4MG</td><td>VENUS REMEDIES LTD;  </td><td>INNOVATA PHARMACEUTICALS</td><td>INNOVATA PHARMACEUTICALS</td>
	</tr><tr>
		<td>ZOPIMAC 2</td><td>ESZOPICLONE</td><td>2025/13.3/6933</td><td>04/30/2025</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>2MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ZOPIMAC 3</td><td>ZOPICLONE</td><td>2023/13.3/6486</td><td>10/10/2023</td><td>10/10/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>3MG</td><td>MACLEODS PHARMACEUTICALS LIMITED;  </td><td>MACLEODS PHARMACEUTICALS LIMITED</td><td>MACLEODS PHARMACEUTICALS LIMITED</td>
	</tr><tr>
		<td>ZOREGRA 100</td><td>SILDENAFIL CITRATE</td><td>2023/31/6384</td><td>02/24/2023</td><td>02/24/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>100MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>ZORWAY EXIM PVT LTD</td><td>ZORWAY EXIM PVT LTD</td>
	</tr><tr>
		<td>ZOREGRA 50</td><td>SILDENAFIL CITRATE</td><td>2023/31/6383</td><td>02/24/2023</td><td>02/24/2028</td><td>TABLET, COATED; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>50MG</td><td>JUBILANT GENERIC LIMITED;  </td><td>ZORWAY EXIM PVT LTD</td><td>ZORWAY EXIM PVT LTD</td>
	</tr><tr>
		<td>ZOVILAM</td><td>LAMIVUDINE; ZIDOVUDINE</td><td>2008/7.13/4534</td><td>07/07/2008</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>150; 300MG</td><td>MYLAN LABORATORIES LTD;  </td><td>MYLAN LABORATORIES LIMITED</td><td>MYLAN LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ZOXAN FLOXAN</td><td>CIPROFLOXACIN</td><td>2015/19.11/5066</td><td>07/10/2015</td><td>12/31/2027</td><td>SOLUTION/DROPS; OPHTHALMIC</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>0.3 G/100ML</td><td>FDC LIMITED;  </td><td>FDC LIMITED</td><td>FDC LIMITED</td>
	</tr><tr>
		<td>ZYNCET</td><td>CETIRIZINE HYDROCHLORIDE</td><td>2009/5/4549</td><td>01/30/2009</td><td>12/31/2027</td><td>TABLET, COATED; ORAL</td><td>PHARMACY MEDICINES (P.)</td><td>10MG</td><td>UNICHEM LABORATORIES LIMITED;  </td><td>UNICHEM LABORATORIES LIMITED</td><td>UNICHEM LABORATORIES LIMITED</td>
	</tr><tr>
		<td>ZYTIGA 250</td><td>ABIRATERONE ACETATE</td><td>2016/9.5.2/5202</td><td>05/05/2016</td><td>12/31/2027</td><td>TABLET; ORAL</td><td>PRESCRIPTION PREPARATIONS 9TH SCHEDULE,  (P.P.)</td><td>250 MG</td><td>PATHEON INC;  </td><td>JANSSEN PHARMACEUTICA (PTY) LTD</td><td>JANSSEN PHARMACEUTICA</td>
	</tr>
	</tbody>

</table>	</div>
</body></html>